,Column1,Column2,Column3,Column4,Column5,Column6,Column7
1,A0A0A0MPX8,A0A0A0MPX8_FELCA,Amyloid-beta A4 protein,APP,adult locomotory behavior [GO:0008344]; amyloid fibril formation [GO:1990000]; astrocyte activation involved in immune response [GO:0002265]; axo-dendritic transport [GO:0008088]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; cellular response to amyloid-beta [GO:1904646]; central nervous system development [GO:0007417]; cholesterol metabolic process [GO:0008203]; collateral sprouting in absence of injury [GO:0048669]; cytosolic mRNA polyadenylation [GO:0180011]; dendrite development [GO:0016358]; endocytosis [GO:0006897]; extracellular matrix organization [GO:0030198]; forebrain development [GO:0030900]; G2/M transition of mitotic cell cycle [GO:0000086]; intracellular copper ion homeostasis [GO:0006878]; ionotropic glutamate receptor signaling pathway [GO:0035235]; mating behavior [GO:0007617]; microglia development [GO:0014005]; microglial cell activation [GO:0001774]; modulation of excitatory postsynaptic potential [GO:0098815]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of neuron differentiation [GO:0045665]; neuromuscular process controlling balance [GO:0050885]; neuron apoptotic process [GO:0051402]; neuron cellular homeostasis [GO:0070050]; neuron projection maintenance [GO:1990535]; neuron remodeling [GO:0016322]; Notch signaling pathway [GO:0007219]; positive regulation of amyloid fibril formation [GO:1905908]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of chemokine production [GO:0032722]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of glycolytic process [GO:0045821]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of T cell migration [GO:2000406]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of multicellular organism growth [GO:0040014]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of presynapse assembly [GO:1905606]; regulation of spontaneous synaptic transmission [GO:0150003]; regulation of translation [GO:0006417]; response to oxidative stress [GO:0006979]; smooth endoplasmic reticulum calcium ion homeostasis [GO:0051563]; suckling behavior [GO:0001967]; synaptic assembly at neuromuscular junction [GO:0051124]; visual learning [GO:0008542],apical part of cell [GO:0045177]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; ciliary rootlet [GO:0035253]; clathrin-coated pit [GO:0005905]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; growth cone [GO:0030426]; membrane raft [GO:0045121]; neuromuscular junction [GO:0031594]; nuclear envelope lumen [GO:0005641]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; receptor complex [GO:0043235]; recycling endosome [GO:0055037]; smooth endoplasmic reticulum [GO:0005790]; spindle midzone [GO:0051233]; synaptic vesicle [GO:0008021],enzyme binding [GO:0019899]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; PTB domain binding [GO:0051425]; receptor ligand activity [GO:0048018]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor activator activity [GO:0030546]; signaling receptor binding [GO:0005102]; transition metal ion binding [GO:0046914]
2,A0A2I2U1M4,A0A2I2U1M4_FELCA,Tubulin alpha-1A chain,TUBA1A,adult locomotory behavior [GO:0008344]; cellular response to calcium ion [GO:0071277]; centrosome cycle [GO:0007098]; cerebellar cortex morphogenesis [GO:0021696]; cerebral cortex development [GO:0021987]; dentate gyrus development [GO:0021542]; forebrain morphogenesis [GO:0048853]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; homeostasis of number of cells within a tissue [GO:0048873]; intracellular protein transport [GO:0006886]; locomotory exploration behavior [GO:0035641]; memory [GO:0007613]; microtubule cytoskeleton organization [GO:0000226]; microtubule polymerization [GO:0046785]; mitotic cell cycle [GO:0000278]; motor behavior [GO:0061744]; neuron apoptotic process [GO:0051402]; neuron migration [GO:0001764]; neuron projection arborization [GO:0140058]; organelle transport along microtubule [GO:0072384]; pyramidal neuron differentiation [GO:0021859]; regulation of synapse organization [GO:0050807]; response to L-glutamate [GO:1902065]; response to mechanical stimulus [GO:0009612]; response to tumor necrosis factor [GO:0034612]; smoothened signaling pathway [GO:0007224]; startle response [GO:0001964]; synapse organization [GO:0050808]; visual learning [GO:0008542],axonemal microtubule [GO:0005879]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; microtubule [GO:0005874]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037],GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; structural constituent of cytoskeleton [GO:0005200]
3,A0A2I2U9W3,A0A2I2U9W3_FELCA,Cadherin-2 (Neural cadherin),CDH2,adherens junction organization [GO:0034332]; blood vessel morphogenesis [GO:0048514]; brain morphogenesis [GO:0048854]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell junction assembly [GO:0007043]; cerebral cortex development [GO:0021987]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homeostasis of number of cells [GO:0048872]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; mesenchymal cell migration [GO:0090497]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; neural crest cell development [GO:0014032]; neuroepithelial cell differentiation [GO:0060563]; neuroligin clustering involved in postsynaptic membrane assembly [GO:0097118]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of synaptic vesicle clustering [GO:2000809]; protein localization to plasma membrane [GO:0072659]; radial glial cell differentiation [GO:0060019]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]; regulation of postsynaptic density protein 95 clustering [GO:1902897]; striated muscle cell differentiation [GO:0051146]; synapse assembly [GO:0007416]; synaptic vesicle clustering [GO:0097091]; type B pancreatic cell development [GO:0003323],adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; catenin complex [GO:0016342]; cell surface [GO:0009986]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; fascia adherens [GO:0005916]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; postsynaptic specialization membrane [GO:0099634]; presynaptic active zone membrane [GO:0048787]; sarcolemma [GO:0042383],alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; gamma-catenin binding [GO:0045295]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; RNA binding [GO:0003723]
4,A0A2I2UAM6,A0A2I2UAM6_FELCA,Aquaporin-1 (Aquaporin-CHIP) (Water channel protein for red blood cells and kidney proximal tubule),AQP1,camera-type eye morphogenesis [GO:0048593]; carbon dioxide transmembrane transport [GO:0035378]; cellular hyperosmotic response [GO:0071474]; cellular response to cAMP [GO:0071320]; cellular response to copper ion [GO:0071280]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to mechanical stimulus [GO:0071260]; cellular response to mercury ion [GO:0071288]; cellular response to nitric oxide [GO:0071732]; cellular response to retinoic acid [GO:0071300]; cellular response to salt stress [GO:0071472]; cellular response to UV [GO:0034644]; cerebrospinal fluid secretion [GO:0033326]; cGMP-mediated signaling [GO:0019934]; corticotropin secretion [GO:0051458]; defense response to Gram-negative bacterium [GO:0050829]; establishment of localization in cell [GO:0051649]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; fibroblast migration [GO:0010761]; glomerular filtration [GO:0003094]; hyperosmotic response [GO:0006972]; intracellular water homeostasis [GO:0009992]; lateral ventricle development [GO:0021670]; lipid digestion [GO:0044241]; metanephric descending thin limb development [GO:0072220]; metanephric glomerulus vasculature development [GO:0072239]; metanephric proximal convoluted tubule segment 2 development [GO:0072232]; metanephric proximal straight tubule development [GO:0072230]; negative regulation of apoptotic process [GO:0043066]; odontogenesis [GO:0042476]; pancreatic juice secretion [GO:0030157]; positive regulation of angiogenesis [GO:0045766]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of saliva secretion [GO:0046878]; renal water absorption [GO:0070295]; renal water transport [GO:0003097]; secretory granule organization [GO:0033363]; sensory perception of pain [GO:0019233]; transepithelial water transport [GO:0035377]; wound healing [GO:0042060],ankyrin-1 complex [GO:0170014]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; caveola [GO:0005901]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear membrane [GO:0031965]; sarcolemma [GO:0042383],ammonium transmembrane transporter activity [GO:0008519]; carbon dioxide transmembrane transporter activity [GO:0035379]; ephrin receptor binding [GO:0046875]; glycerol transmembrane transporter activity [GO:0015168]; identical protein binding [GO:0042802]; intracellularly cGMP-activated cation channel activity [GO:0005223]; nitric oxide transmembrane transporter activity [GO:0030184]; potassium channel activity [GO:0005267]; water channel activity [GO:0015250]
5,A0A2I2UBN8,A0A2I2UBN8_FELCA,Junction plakoglobin,JUP,bundle of His cell-Purkinje myocyte adhesion involved in cell communication [GO:0086073]; canonical Wnt signaling pathway [GO:0060070]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cellular response to indole-3-methanol [GO:0071681]; desmosome assembly [GO:0002159]; detection of mechanical stimulus [GO:0050982]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; regulation of cell population proliferation [GO:0042127]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; skin development [GO:0043588],adherens junction [GO:0005912]; catenin complex [GO:0016342]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; desmosome [GO:0030057]; gamma-catenin-TCF7L2 complex [GO:0071665]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; Z disc [GO:0030018],alpha-catenin binding [GO:0045294]; cadherin binding [GO:0045296]; cytoskeletal protein-membrane anchor activity [GO:0106006]; nuclear receptor binding [GO:0016922]; protein phosphatase binding [GO:0019903]; transcription coactivator activity [GO:0003713]
6,A0A2I2UCH5,A0A2I2UCH5_FELCA,NPC intracellular cholesterol transporter 1,NPC1,adult walking behavior [GO:0007628]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol storage [GO:0010878]; cyclodextrin metabolic process [GO:2000900]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; gene expression [GO:0010467]; intestinal cholesterol absorption [GO:0030299]; intracellular cholesterol transport [GO:0032367]; liver development [GO:0001889]; macroautophagy [GO:0016236]; membrane raft organization [GO:0031579]; negative regulation of macroautophagy [GO:0016242]; negative regulation of TORC1 signaling [GO:1904262]; neurogenesis [GO:0022008]; programmed cell death [GO:0012501]; protein glycosylation [GO:0006486]; response to xenobiotic stimulus [GO:0009410]; sterol metabolic process [GO:0016125]; symbiont entry into host cell [GO:0046718],endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]
7,A0A2I2UGY1,A0A2I2UGY1_FELCA,Sodium/potassium-transporting ATPase subunit alpha,ATP1A1,cellular response to steroid hormone stimulus [GO:0071383]; heart contraction [GO:0060047]; intracellular potassium ion homeostasis [GO:0030007]; intracellular sodium ion homeostasis [GO:0006883]; membrane repolarization [GO:0086009]; negative regulation of glucocorticoid biosynthetic process [GO:0031947]; negative regulation of heart contraction [GO:0045822]; osmosensory signaling pathway [GO:0007231]; positive regulation of heart contraction [GO:0045823]; positive regulation of striated muscle contraction [GO:0045989]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of blood pressure [GO:0008217]; regulation of the force of heart contraction [GO:0002026]; response to glycoside [GO:1903416]; response to xenobiotic stimulus [GO:0009410]; sodium ion export across plasma membrane [GO:0036376],apical plasma membrane [GO:0016324]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; lateral plasma membrane [GO:0016328]; melanosome [GO:0042470]; organelle membrane [GO:0031090]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; sodium:potassium-exchanging ATPase complex [GO:0005890]; sperm flagellum [GO:0036126]; T-tubule [GO:0030315],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; P-type sodium:potassium-exchanging transporter activity [GO:0005391]; phosphatase activity [GO:0016791]; protein-folding chaperone binding [GO:0051087]; steroid hormone binding [GO:1990239]; transmembrane transporter binding [GO:0044325]
8,A0A2I2UH80,A0A2I2UH80_FELCA,Frizzled-4,FZD4,"angiogenesis [GO:0001525]; canonical Wnt signaling pathway [GO:0060070]; cell population proliferation [GO:0008283]; cellular response to leukemia inhibitory factor [GO:1990830]; cerebellum vasculature morphogenesis [GO:0061301]; endothelial cell differentiation [GO:0045446]; establishment of blood-brain barrier [GO:0060856]; extracellular matrix-cell signaling [GO:0035426]; locomotion involved in locomotory behavior [GO:0031987]; negative regulation of cell-substrate adhesion [GO:0010812]; non-canonical Wnt signaling pathway [GO:0035567]; Norrin signaling pathway [GO:0110135]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of neuron projection arborization [GO:0150012]; progesterone secretion [GO:0042701]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]; response to hypoxia [GO:0001666]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; retinal blood vessel morphogenesis [GO:0061304]; sensory perception of sound [GO:0007605]; substrate adhesion-dependent cell spreading [GO:0034446]; vasculogenesis [GO:0001570]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]",cell surface [GO:0009986]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886],amyloid-beta binding [GO:0001540]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; PDZ domain binding [GO:0030165]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]
9,A0A2I2UI65,A0A2I2UI65_FELCA,receptor protein-tyrosine kinase (EC 2.7.10.1),EPHB2,"angiogenesis [GO:0001525]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; B cell activation [GO:0042113]; camera-type eye morphogenesis [GO:0048593]; central nervous system projection neuron axonogenesis [GO:0021952]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; dendritic spine morphogenesis [GO:0060997]; ephrin receptor signaling pathway [GO:0048013]; inner ear morphogenesis [GO:0042472]; learning [GO:0007612]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell adhesion [GO:0007162]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of Ras protein signal transduction [GO:0046580]; neuron projection retraction [GO:0106028]; optic nerve morphogenesis [GO:0021631]; phosphorylation [GO:0016310]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell migration [GO:0030335]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of autophagosome assembly [GO:2000785]; regulation of blood coagulation [GO:0030193]; retinal ganglion cell axon guidance [GO:0031290]; roof of mouth development [GO:0060021]; trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission [GO:0099557]; urogenital system development [GO:0001655]",axon [GO:0030424]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734],amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; transmembrane-ephrin receptor activity [GO:0005005]
10,A0A2I2UII4,A0A2I2UII4_FELCA,Glutathione peroxidase,GPX1,angiogenesis involved in wound healing [GO:0060055]; arachidonic acid metabolic process [GO:0019369]; biological process involved in interaction with symbiont [GO:0051702]; blood vessel endothelial cell migration [GO:0043534]; cell redox homeostasis [GO:0045454]; endothelial cell development [GO:0001885]; epigenetic regulation of gene expression [GO:0040029]; fat cell differentiation [GO:0045444]; fibroblast proliferation [GO:0048144]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide catabolic process [GO:0042744]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; lipoxygenase pathway [GO:0019372]; myoblast differentiation [GO:0045445]; myoblast proliferation [GO:0051450]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; neuron apoptotic process [GO:0051402]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of proteasomal protein catabolic process [GO:0061136]; response to gamma radiation [GO:0010332]; response to hydrogen peroxide [GO:0042542]; response to hydroperoxide [GO:0033194]; response to selenium ion [GO:0010269]; response to symbiotic bacterium [GO:0009609]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]; skeletal muscle fiber development [GO:0048741]; skeletal muscle tissue regeneration [GO:0043403]; temperature homeostasis [GO:0001659]; triglyceride metabolic process [GO:0006641]; UV protection [GO:0009650]; vasodilation [GO:0042311],cytosol [GO:0005829]; Lewy body [GO:0097413]; mitochondrion [GO:0005739],glutathione peroxidase activity [GO:0004602]; phospholipid-hydroperoxide glutathione peroxidase activity [GO:0047066]; SH3 domain binding [GO:0017124]
11,A0A2I2UJB3,A0A2I2UJB3_FELCA,Radixin,RDX,actin filament capping [GO:0051693]; establishment of endothelial barrier [GO:0061028]; negative regulation of adherens junction organization [GO:1903392]; negative regulation of cell size [GO:0045792]; negative regulation of homotypic cell-cell adhesion [GO:0034111]; positive regulation of cell migration [GO:0030335]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of gene expression [GO:0010628]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein localization to early endosome [GO:1902966]; protein localization to plasma membrane [GO:0072659]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell shape [GO:0008360]; regulation of organelle assembly [GO:1902115]; regulation of ruffle assembly [GO:1900027],adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; microvillus [GO:0005902]; plasma membrane [GO:0005886],actin binding [GO:0003779]; ATPase binding [GO:0051117]; cell adhesion molecule binding [GO:0050839]
12,A0A2I2UK29,A0A2I2UK29_FELCA,Fibroblast growth factor receptor (EC 2.7.10.1),FGFR1,angiogenesis [GO:0001525]; auditory receptor cell development [GO:0060117]; branching involved in salivary gland morphogenesis [GO:0060445]; calcium ion homeostasis [GO:0055074]; cardiac muscle cell proliferation [GO:0060038]; cell maturation [GO:0048469]; cell projection assembly [GO:0030031]; cementum mineralization [GO:0071529]; chondrocyte differentiation [GO:0002062]; diphosphate metabolic process [GO:0071344]; embryonic limb morphogenesis [GO:0030326]; epithelial to mesenchymal transition [GO:0001837]; fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [GO:0035607]; gene expression [GO:0010467]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; lung-associated mesenchyme development [GO:0060484]; mesenchymal cell proliferation [GO:0010463]; midbrain development [GO:0030901]; middle ear morphogenesis [GO:0042474]; negative regulation of fibroblast growth factor production [GO:0090272]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron projection development [GO:0031175]; organ induction [GO:0001759]; outer ear morphogenesis [GO:0042473]; paraxial mesoderm development [GO:0048339]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell differentiation [GO:0045597]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic cell cycle DNA replication [GO:1903465]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of parathyroid hormone secretion [GO:2000830]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001239]; regulation of lateral mesodermal cell fate specification [GO:0048378]; regulation of phosphate transport [GO:0010966]; regulation of phosphorus metabolic process [GO:0051174]; response to sodium phosphate [GO:1904383]; sensory perception of sound [GO:0007605]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; ureteric bud development [GO:0001657]; ventricular zone neuroblast division [GO:0021847]; vitamin D3 metabolic process [GO:0070640],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007]; heparin binding [GO:0008201]; protein homodimerization activity [GO:0042803]; receptor-receptor interaction [GO:0090722]; SH2 domain binding [GO:0042169]
13,A0A2I2UP60,A0A2I2UP60_FELCA,Na(+)/H(+) exchange regulatory cofactor NHE-RF,NHERF1,actin cytoskeleton organization [GO:0030036]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; auditory receptor cell stereocilium organization [GO:0060088]; bile acid secretion [GO:0032782]; cerebrospinal fluid circulation [GO:0090660]; cilium organization [GO:0044782]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of Golgi localization [GO:0051683]; fibroblast migration [GO:0010761]; gland morphogenesis [GO:0022612]; glutathione transport [GO:0034635]; intracellular phosphate ion homeostasis [GO:0030643]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; microvillus assembly [GO:0030033]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of sodium ion transport [GO:0010766]; nuclear migration [GO:0007097]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; plasma membrane organization [GO:0007009]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; protein localization to plasma membrane [GO:0072659]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of renal phosphate excretion [GO:1903402]; renal phosphate ion absorption [GO:0097291]; renal sodium ion transport [GO:0003096]; sensory perception of sound [GO:0007605],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; endomembrane system [GO:0012505]; extracellular region [GO:0005576]; filopodium [GO:0030175]; microvillus [GO:0005902]; perinuclear region of cytoplasm [GO:0048471]; ruffle [GO:0001726]; sperm midpiece [GO:0097225]; stereocilium tip [GO:0032426],beta-2 adrenergic receptor binding [GO:0031698]; beta-catenin binding [GO:0008013]; channel activator activity [GO:0099103]; chloride channel regulator activity [GO:0017081]; dopamine receptor binding [GO:0050780]; growth factor receptor binding [GO:0070851]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; phosphatase binding [GO:0019902]; protein-membrane adaptor activity [GO:0043495]; signaling receptor binding [GO:0005102]; type 2 metabotropic glutamate receptor binding [GO:0031799]; type 3 metabotropic glutamate receptor binding [GO:0031800]
14,A0A2I2UR94,A0A2I2UR94_FELCA,Secreted frizzled-related protein 1,SFRP1,BMP signaling pathway [GO:0030509]; bone trabecula formation [GO:0060346]; canonical Wnt signaling pathway [GO:0060070]; cellular response to estradiol stimulus [GO:0071392]; cellular response to estrogen stimulus [GO:0071391]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to heparin [GO:0071504]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-1 [GO:0071347]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to starvation [GO:0009267]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin D [GO:0071305]; cellular response to X-ray [GO:0071481]; convergent extension involved in somitogenesis [GO:0090246]; digestive tract morphogenesis [GO:0048546]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; extrinsic apoptotic signaling pathway [GO:0097191]; female gonad development [GO:0008585]; hematopoietic stem cell differentiation [GO:0060218]; male gonad development [GO:0008584]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of bone remodeling [GO:0046851]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of planar cell polarity pathway involved in axis elongation [GO:2000041]; neural crest cell fate commitment [GO:0014034]; non-canonical Wnt signaling pathway [GO:0035567]; osteoblast differentiation [GO:0001649]; osteoclast differentiation [GO:0030316]; planar cell polarity pathway involved in axis elongation [GO:0003402]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of smoothened signaling pathway [GO:0045880]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; regulation of cell cycle process [GO:0010564]; regulation of midbrain dopaminergic neuron differentiation [GO:1904956]; regulation of neuron projection development [GO:0010975]; response to xenobiotic stimulus [GO:0009410]; somatic stem cell population maintenance [GO:0035019]; stromal-epithelial cell signaling involved in prostate gland development [GO:0044345]; ureteric bud development [GO:0001657]; Wnt signaling pathway involved in somitogenesis [GO:0090244],cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular space [GO:0005615],cysteine-type endopeptidase activity [GO:0004197]; frizzled binding [GO:0005109]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; Wnt-protein binding [GO:0017147]
15,A0A2I2UTQ4,A0A2I2UTQ4_FELCA,receptor protein-tyrosine kinase (EC 2.7.10.1),AXL,blood vessel remodeling [GO:0001974]; cell maturation [GO:0048469]; cell migration [GO:0016477]; cellular response to extracellular stimulus [GO:0031668]; cellular response to interferon-alpha [GO:0035457]; cellular response to lipopolysaccharide [GO:0071222]; dendritic cell differentiation [GO:0097028]; enzyme-linked receptor protein signaling pathway [GO:0007167]; erythrocyte homeostasis [GO:0034101]; establishment of localization in cell [GO:0051649]; forebrain cell migration [GO:0021885]; inflammatory response [GO:0006954]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of lymphocyte activation [GO:0051250]; negative regulation of macrophage cytokine production [GO:0010936]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type II interferon production [GO:0032689]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; neuron migration [GO:0001764]; neutrophil clearance [GO:0097350]; ovulation cycle [GO:0042698]; phagocytosis [GO:0006909]; platelet activation [GO:0030168]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of pinocytosis [GO:0048549]; positive regulation of viral life cycle [GO:1903902]; secretion by cell [GO:0032940]; spermatogenesis [GO:0007283]; substrate adhesion-dependent cell spreading [GO:0034446]; vagina development [GO:0060068],actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],ATP binding [GO:0005524]; phosphatidylserine binding [GO:0001786]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; virus receptor activity [GO:0001618]
16,A0A2I2UTZ7,A0A2I2UTZ7_FELCA,Angiotensin-converting enzyme (EC 3.4.-.-),ACE,amyloid-beta metabolic process [GO:0050435]; angiotensin maturation [GO:0002003]; angiotensin-activated signaling pathway [GO:0038166]; arachidonic acid secretion [GO:0050482]; bradykinin catabolic process [GO:0010815]; cell proliferation in bone marrow [GO:0071838]; heart contraction [GO:0060047]; hormone catabolic process [GO:0042447]; kidney development [GO:0001822]; male gonad development [GO:0008584]; negative regulation of gap junction assembly [GO:1903597]; negative regulation of gene expression [GO:0010629]; neutrophil mediated immunity [GO:0002446]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of systemic arterial blood pressure [GO:0003084]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of angiotensin metabolic process [GO:0060177]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of synaptic plasticity [GO:0048167]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; spermatogenesis [GO:0007283]; substance P catabolic process [GO:0010814],endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; lysosome [GO:0005764]; plasma membrane [GO:0005886],bradykinin receptor binding [GO:0031711]; carboxypeptidase activity [GO:0004180]; chloride ion binding [GO:0031404]; metallodipeptidase activity [GO:0070573]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; peptidyl-dipeptidase activity [GO:0008241]; tripeptidyl-peptidase activity [GO:0008240]; zinc ion binding [GO:0008270]
17,A0A2I2UWU9,A0A2I2UWU9_FELCA,Bis(monoacylglycero)phosphate synthase CLN5 (EC 3.1.2.22) (Ceroid-lipofuscinosis neuronal protein 5) (Palmitoyl protein thioesterase CLN5) (S-depalmitoylase CLN5),CLN5,"brain development [GO:0007420]; glycosylation [GO:0070085]; lysosomal lumen acidification [GO:0007042]; lysosome organization [GO:0007040]; neurogenesis [GO:0022008]; retrograde transport, endosome to Golgi [GO:0042147]; signal peptide processing [GO:0006465]; visual perception [GO:0007601]",cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; vacuolar lumen [GO:0005775],"bis(monoacylglycero)phosphate synthase activity [GO:0160121]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; long-chain fatty acyl-CoA hydrolase activity [GO:0052816]; mannose binding [GO:0005537]"
18,A0A2I2UZ39,A0A2I2UZ39_FELCA,Bridging integrator 1,BIN1,endosome to lysosome transport [GO:0008333]; lipid tube assembly [GO:0060988]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ventricular cardiac muscle cell action potential [GO:1903946]; nucleus localization [GO:0051647]; nucleus organization [GO:0006997]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; regulation of cell cycle process [GO:0010564]; regulation of endocytosis [GO:0030100]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of neuron differentiation [GO:0045664]; synaptic vesicle endocytosis [GO:0048488]; T-tubule organization [GO:0033292],axon [GO:0030424]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; lipid tube [GO:0060987]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; RNA polymerase II transcription repressor complex [GO:0090571]; synaptic vesicle [GO:0008021]; T-tubule [GO:0030315],actin filament binding [GO:0051015]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; protease binding [GO:0002020]; protein-folding chaperone binding [GO:0051087]; RNA polymerase binding [GO:0070063]; tau protein binding [GO:0048156]
19,A0A2I2UZM2,A0A2I2UZM2_FELCA,Heat shock cognate 71 kDa protein (EC 3.6.4.10) (Heat shock 70 kDa protein 8),HSPA8,"ATP metabolic process [GO:0046034]; chaperone cofactor-dependent protein refolding [GO:0051085]; clathrin coat disassembly [GO:0072318]; late endosomal microautophagy [GO:0061738]; mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of supramolecular fiber organization [GO:1902904]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; protein refolding [GO:0042026]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; regulation of cell cycle [GO:0051726]; regulation of postsynapse organization [GO:0099175]; regulation of protein stability [GO:0031647]; RNA splicing [GO:0008380]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; glycinergic synapse [GO:0098690]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; postsynaptic specialization membrane [GO:0099634]; presynapse [GO:0098793]; protein folding chaperone complex [GO:0101031]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein disaggregase activity [GO:0140545]; ATP-dependent protein folding chaperone [GO:0140662]; C3HC4-type RING finger domain binding [GO:0055131]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; phosphatidylserine binding [GO:0001786]; protein folding chaperone [GO:0044183]; protein-folding chaperone binding [GO:0051087]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]
20,A0A2I2V040,A0A2I2V040_FELCA,Prostaglandin reductase 1 (EC 1.3.1.48) (EC 1.3.1.74) (15-oxoprostaglandin 13-reductase) (Dithiolethione-inducible gene 1 protein) (Leukotriene B4 12-hydroxydehydrogenase) (NAD(P)H-dependent alkenal/one oxidoreductase),PTGR1,prostaglandin metabolic process [GO:0006693],cytoplasm [GO:0005737],13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; 2-alkenal reductase (NADPH) activity [GO:0035798]
21,A0A2I2V2H3,A0A2I2V2H3_FELCA,ADAM metallopeptidase domain 8,ADAM8,angiogenesis [GO:0001525]; canonical NF-kappaB signal transduction [GO:0007249]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; cellular response to hypoxia [GO:0071456]; inflammatory response [GO:0006954]; leukocyte migration involved in inflammatory response [GO:0002523]; lymphocyte chemotaxis [GO:0048247]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of bone resorption [GO:0045780]; positive regulation of cellular extravasation [GO:0002693]; positive regulation of eosinophil migration [GO:2000418]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fibronectin-dependent thymocyte migration [GO:2000415]; positive regulation of innate immune response [GO:0045089]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of neutrophil extravasation [GO:2000391]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of thymocyte apoptotic process [GO:0070245]; positive regulation of tumor necrosis factor (ligand) superfamily member 11 production [GO:2000309]; proteolysis [GO:0006508]; regulation of cell-cell adhesion [GO:0022407],alpha9-beta1 integrin-ADAM8 complex [GO:0071133]; cell surface [GO:0009986]; dense core granule membrane [GO:0032127]; phagolysosome [GO:0032010]; podosome [GO:0002102]; specific granule [GO:0042581]; tertiary granule [GO:0070820],calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]
22,A0A2I2V3V8,A0A2I2V3V8_FELCA,Filamin A,FLNA,"actin crosslink formation [GO:0051764]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; angiogenesis [GO:0001525]; blood vessel remodeling [GO:0001974]; cell-cell junction organization [GO:0045216]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; early endosome to late endosome transport [GO:0045022]; epithelial to mesenchymal transition [GO:0001837]; establishment of protein localization [GO:0045184]; heart morphogenesis [GO:0003007]; mitotic spindle assembly [GO:0090307]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; positive regulation of axon regeneration [GO:0048680]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; semaphorin-plexin signaling pathway [GO:0071526]; synapse organization [GO:0050808]; wound healing, spreading of cells [GO:0044319]",actin filament bundle [GO:0032432]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; Z disc [GO:0030018],actin filament binding [GO:0051015]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325]
23,A0A337RXS4,A0A337RXS4_FELCA,Nucleoprotein TPR,TPR,cellular response to interferon-alpha [GO:0035457]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mRNA export from nucleus [GO:0006406]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin formation [GO:0031453]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA import into nucleus [GO:0006404],cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615],chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; structural constituent of nuclear pore [GO:0017056]; tubulin binding [GO:0015631]
24,A0A337RY03,A0A337RY03_FELCA,receptor protein-tyrosine kinase (EC 2.7.10.1),EPHB1,angiogenesis [GO:0001525]; axon guidance [GO:0007411]; camera-type eye morphogenesis [GO:0048593]; cell chemotaxis [GO:0060326]; cell-substrate adhesion [GO:0031589]; central nervous system projection neuron axonogenesis [GO:0021952]; dendritic spine morphogenesis [GO:0060997]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; ephrin receptor signaling pathway [GO:0048013]; establishment of cell polarity [GO:0030010]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of satellite cell differentiation [GO:1902725]; negative regulation of skeletal muscle satellite cell proliferation [GO:1902723]; neural precursor cell proliferation [GO:0061351]; optic nerve morphogenesis [GO:0021631]; positive regulation of synapse assembly [GO:0051965]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of JNK cascade [GO:0046328]; retinal ganglion cell axon guidance [GO:0031290]; skeletal muscle satellite cell activation [GO:0014719],axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; filopodium tip [GO:0032433]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; axon guidance receptor activity [GO:0008046]; protein-containing complex binding [GO:0044877]; transmembrane-ephrin receptor activity [GO:0005005]
25,A0A337S0K7,A0A337S0K7_FELCA,72 kDa type IV collagenase (EC 3.4.24.24) (72 kDa gelatinase) (Matrix metalloproteinase-2),MMP2,blood vessel maturation [GO:0001955]; bone trabecula formation [GO:0060346]; cellular response to amino acid stimulus [GO:0071230]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV-A [GO:0071492]; collagen catabolic process [GO:0030574]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; intramembranous ossification [GO:0001957]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; proteolysis [GO:0006508]; response to amyloid-beta [GO:1904645]; response to hypoxia [GO:0001666]; tissue remodeling [GO:0048771],extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; sarcomere [GO:0030017],metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]
26,A0A337S424,A0A337S424_FELCA,Receptor protein-tyrosine kinase (EC 2.7.10.1),EGFR,cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; cellular response to amino acid stimulus [GO:0071230]; cellular response to cadmium ion [GO:0071276]; cellular response to estradiol stimulus [GO:0071392]; cellular response to growth factor stimulus [GO:0071363]; cellular response to reactive oxygen species [GO:0034614]; cerebral cortex cell migration [GO:0021795]; digestive tract morphogenesis [GO:0048546]; embryonic placenta development [GO:0001892]; epithelial cell proliferation [GO:0050673]; ERBB2-EGFR signaling pathway [GO:0038134]; eyelid development in camera-type eye [GO:0061029]; hair follicle development [GO:0001942]; morphogenesis of an epithelial fold [GO:0060571]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiocyte differentiation [GO:1905208]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of protein catabolic process [GO:0042177]; neurogenesis [GO:0022008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of JNK cascade [GO:0046328]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; response to UV-A [GO:0070141]; salivary gland morphogenesis [GO:0007435],"basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cell surface [GO:0009986]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; membrane raft [GO:0045121]; multivesicular body, internal vesicle lumen [GO:0097489]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ruffle membrane [GO:0032587]",actin filament binding [GO:0051015]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; epidermal growth factor binding [GO:0048408]; epidermal growth factor receptor activity [GO:0005006]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein phosphatase binding [GO:0019903]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; ubiquitin protein ligase binding [GO:0031625]
27,A0A337S4V2,A0A337S4V2_FELCA,Glypican-3,GPC3,"anterior/posterior axis specification [GO:0009948]; body morphogenesis [GO:0010171]; bone mineralization [GO:0030282]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; cell migration [GO:0016477]; cell proliferation involved in metanephros development [GO:0072203]; coronary vasculature development [GO:0060976]; embryonic hindlimb morphogenesis [GO:0035116]; epithelial cell proliferation [GO:0050673]; lung development [GO:0030324]; mesenchymal cell proliferation involved in ureteric bud development [GO:0072138]; mesonephric duct morphogenesis [GO:0072180]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of growth [GO:0045926]; negative regulation of smoothened signaling pathway [GO:0045879]; osteoclast differentiation [GO:0030316]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endocytosis [GO:0045807]; positive regulation of glucose import [GO:0046326]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; regulation of protein localization to membrane [GO:1905475]; response to bacterium [GO:0009617]; smoothened signaling pathway [GO:0007224]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; side of membrane [GO:0098552],peptidyl-dipeptidase inhibitor activity [GO:0060422]
28,A0A337S6T1,A0A337S6T1_FELCA,Heat shock protein HSP 90-alpha,HSP90AA1,activation of innate immune response [GO:0002218]; cellular response to heat [GO:0034605]; cellular response to virus [GO:0098586]; chaperone-mediated protein complex assembly [GO:0051131]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein polymerization [GO:0032273]; protein folding [GO:0006457]; protein insertion into mitochondrial outer membrane [GO:0045040]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of protein localization [GO:0032880]; regulation of protein ubiquitination [GO:0031396]; telomerase holoenzyme complex assembly [GO:1905323]; telomere maintenance via telomerase [GO:0007004],axonal growth cone [GO:0044295]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; disordered domain specific binding [GO:0097718]; DNA polymerase binding [GO:0070182]; GTPase binding [GO:0051020]; histone deacetylase binding [GO:0042826]; nitric-oxide synthase regulator activity [GO:0030235]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase binding [GO:1990782]; scaffold protein binding [GO:0097110]; tau protein binding [GO:0048156]; TPR domain binding [GO:0030911]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]
29,A0A337S9P8,A0A337S9P8_FELCA,Nicastrin,NCSTN,adult behavior [GO:0030534]; amyloid precursor protein biosynthetic process [GO:0042983]; amyloid-beta formation [GO:0034205]; cellular response to calcium ion [GO:0071277]; central nervous system myelination [GO:0022010]; dopamine receptor signaling pathway [GO:0007212]; epithelial cell proliferation [GO:0050673]; glutamate receptor signaling pathway [GO:0007215]; learning or memory [GO:0007611]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; myeloid cell homeostasis [GO:0002262]; neuron apoptotic process [GO:0051402]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; protein processing [GO:0016485]; regulation of long-term synaptic potentiation [GO:1900271]; short-term synaptic potentiation [GO:1990926]; T cell proliferation [GO:0042098],endoplasmic reticulum [GO:0005783]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021],"aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; ATPase binding [GO:0051117]; growth factor receptor binding [GO:0070851]; protein-macromolecule adaptor activity [GO:0030674]"
30,A0A337SBA6,A0A337SBA6_FELCA,Adapter molecule crk,CRK,actin cytoskeleton organization [GO:0030036]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cerebellar neuron development [GO:0098749]; cerebral cortex development [GO:0021987]; dendrite development [GO:0016358]; enzyme-linked receptor protein signaling pathway [GO:0007167]; ephrin receptor signaling pathway [GO:0048013]; establishment of cell polarity [GO:0030010]; helper T cell diapedesis [GO:0035685]; hippocampus development [GO:0021766]; lipid metabolic process [GO:0006629]; negative regulation of cell motility [GO:2000146]; negative regulation of wound healing [GO:0061045]; neuron migration [GO:0001764]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; postsynaptic specialization assembly [GO:0098698]; reelin-mediated signaling pathway [GO:0038026]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell shape [GO:0008360]; regulation of dendrite development [GO:0050773]; regulation of T cell migration [GO:2000404],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],ephrin receptor binding [GO:0046875]; phosphotyrosine residue binding [GO:0001784]; receptor tyrosine kinase binding [GO:0030971]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591]; signaling receptor complex adaptor activity [GO:0030159]; ubiquitin protein ligase binding [GO:0031625]
31,A0A337SBE9,A0A337SBE9_FELCA,Nerve growth factor receptor,NGFR,axon guidance [GO:0007411]; cellular response to amyloid-beta [GO:1904646]; central nervous system development [GO:0007417]; circadian regulation of gene expression [GO:0032922]; detection of temperature stimulus [GO:0016048]; dorsal aorta development [GO:0035907]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast proliferation [GO:0048144]; hair follicle morphogenesis [GO:0031069]; intracellular glucose homeostasis [GO:0001678]; intracellular protein transport [GO:0006886]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration [GO:0030336]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of hair follicle development [GO:0051799]; nerve development [GO:0021675]; neuron apoptotic process [GO:0051402]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of odontogenesis of dentin-containing tooth [GO:0042488]; positive regulation of protein localization to nucleus [GO:1900182]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; Rho protein signal transduction [GO:0007266],cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793],calmodulin binding [GO:0005516]; coreceptor activity [GO:0015026]; death receptor activity [GO:0005035]; nerve growth factor binding [GO:0048406]; small GTPase binding [GO:0031267]; ubiquitin protein ligase binding [GO:0031625]
32,A0A337SBT0,A0A337SBT0_FELCA,TGF-beta receptor type-1 (EC 2.7.11.30) (Transforming growth factor-beta receptor type I),TGFBR1,activin receptor signaling pathway [GO:0032924]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; blastocyst development [GO:0001824]; cellular response to growth factor stimulus [GO:0071363]; collagen fibril organization [GO:0030199]; coronary artery morphogenesis [GO:0060982]; embryonic cranial skeleton morphogenesis [GO:0048701]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epicardium morphogenesis [GO:1905223]; epithelial to mesenchymal transition [GO:0001837]; filopodium assembly [GO:0046847]; germ cell migration [GO:0008354]; heart development [GO:0007507]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; male gonad development [GO:0008584]; myofibroblast differentiation [GO:0036446]; negative regulation of cell migration [GO:0030336]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; nervous system development [GO:0007399]; neuron fate commitment [GO:0048663]; parathyroid gland development [GO:0060017]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of gene expression [GO:0010628]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of vasculature development [GO:1904018]; post-embryonic development [GO:0009791]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of protein ubiquitination [GO:0031396]; response to cholesterol [GO:0070723]; roof of mouth development [GO:0060021]; thymus development [GO:0048538]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222],activin receptor complex [GO:0048179]; bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; endosome [GO:0005768]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transforming growth factor beta ligand-receptor complex [GO:0070021],"activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; I-SMAD binding [GO:0070411]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type I [GO:0005025]; type II transforming growth factor beta receptor binding [GO:0005114]; ubiquitin protein ligase binding [GO:0031625]"
33,A0A337SC03,A0A337SC03_FELCA,P2X purinoceptor,P2RX4,apoptotic signaling pathway [GO:0097190]; calcium ion transmembrane transport [GO:0070588]; cellular response to ATP [GO:0071318]; membrane depolarization [GO:0051899]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of endothelial cell chemotaxis [GO:2001028]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle contraction [GO:0055117]; relaxation of cardiac muscle [GO:0055119]; response to fluid shear stress [GO:0034405],lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794],ATP binding [GO:0005524]; cadherin binding [GO:0045296]; extracellularly ATP-gated monoatomic cation channel activity [GO:0004931]; identical protein binding [GO:0042802]; ligand-gated calcium channel activity [GO:0099604]; purinergic nucleotide receptor activity [GO:0001614]
34,A0A337SCD2,A0A337SCD2_FELCA,Annexin,ANXA2,angiogenesis [GO:0001525]; cell-matrix adhesion [GO:0007160]; collagen fibril organization [GO:0030199]; epithelial cell apoptotic process [GO:1904019]; fibrinolysis [GO:0042730]; lung development [GO:0030324]; membrane raft assembly [GO:0001765]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of low-density lipoprotein particle receptor catabolic process [GO:0032804]; negative regulation of receptor internalization [GO:0002091]; osteoclast development [GO:0036035]; positive regulation of low-density lipoprotein particle clearance [GO:1905581]; positive regulation of plasminogen activation [GO:0010756]; positive regulation of receptor recycling [GO:0001921]; positive regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905602]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vacuole organization [GO:0044090]; positive regulation of vesicle fusion [GO:0031340]; regulation of neurogenesis [GO:0050767]; response to activity [GO:0014823]; vesicle budding from membrane [GO:0006900],AnxA2-p11 complex [GO:1990665]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; membrane raft [GO:0045121]; midbody [GO:0030496]; myelin sheath adaxonal region [GO:0035749]; nucleus [GO:0005634]; PCSK9-AnxA2 complex [GO:1990667]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; RNA polymerase II transcription regulator complex [GO:0090575]; sarcolemma [GO:0042383]; Schmidt-Lanterman incisure [GO:0043220]; vesicle membrane [GO:0012506],"calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; phospholipase A2 inhibitor activity [GO:0019834]; protease binding [GO:0002020]; S100 protein binding [GO:0044548]; serine-type endopeptidase inhibitor activity [GO:0004867]"
35,A0A337SCS9,A0A337SCS9_FELCA,14-3-3 protein epsilon,YWHAE,cellular response to heat [GO:0034605]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; MAPK cascade [GO:0000165]; negative regulation of calcium ion export across plasma membrane [GO:1905913]; negative regulation of peptidyl-serine dephosphorylation [GO:1902309]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; positive regulation of protein export from nucleus [GO:0046827]; protein localization [GO:0008104]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to nucleus [GO:0034504]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of membrane repolarization [GO:0060306]; regulation of mitotic cell cycle [GO:0007346]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886],calcium channel regulator activity [GO:0005246]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; phosphoserine residue binding [GO:0050815]; potassium channel regulator activity [GO:0015459]; protein heterodimerization activity [GO:0046982]; protein sequestering activity [GO:0140311]; scaffold protein binding [GO:0097110]; signaling adaptor activity [GO:0035591]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625]
36,A0A337SDI4,A0A337SDI4_FELCA,Endothelin receptor type B (Endothelin receptor non-selective type),EDNRB,aldosterone metabolic process [GO:0032341]; calcium ion transmembrane transport [GO:0070588]; calcium-mediated signaling [GO:0019722]; canonical Wnt signaling pathway [GO:0060070]; chordate pharynx development [GO:0160093]; developmental pigmentation [GO:0048066]; endothelin receptor signaling pathway [GO:0086100]; enteric nervous system development [GO:0048484]; enteric smooth muscle cell differentiation [GO:0035645]; establishment of endothelial barrier [GO:0061028]; gene expression [GO:0010467]; heparin metabolic process [GO:0030202]; macrophage chemotaxis [GO:0048246]; melanocyte differentiation [GO:0030318]; negative regulation of neuron maturation [GO:0014043]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell migration [GO:0001755]; neuroblast migration [GO:0097402]; peripheral nervous system development [GO:0007422]; podocyte differentiation [GO:0072112]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; posterior midgut development [GO:0007497]; protein transmembrane transport [GO:0071806]; regulation of heart rate [GO:0002027]; regulation of pH [GO:0006885]; renal albumin absorption [GO:0097018]; renal sodium excretion [GO:0035812]; renal sodium ion absorption [GO:0070294]; renin secretion into blood stream [GO:0002001]; response to organic substance [GO:0010033]; response to sodium phosphate [GO:1904383]; vasoconstriction [GO:0042310]; vein smooth muscle contraction [GO:0014826],plasma membrane [GO:0005886],endothelin receptor activity [GO:0004962]; peptide hormone binding [GO:0017046]
37,A0A337SFQ4,A0A337SFQ4_FELCA,Dystroglycan 1 (Dystroglycan) (Dystrophin-associated glycoprotein 1),DAG1,axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; branching involved in salivary gland morphogenesis [GO:0060445]; cellular response to organic cyclic compound [GO:0071407]; commissural neuron axon guidance [GO:0071679]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; heart morphogenesis [GO:0003007]; membrane protein ectodomain proteolysis [GO:0006509]; microtubule anchoring [GO:0034453]; morphogenesis of an epithelial sheet [GO:0002011]; morphogenesis of an epithelium [GO:0002009]; muscle attachment [GO:0016203]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cell migration [GO:0030336]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; nerve development [GO:0021675]; nerve maturation [GO:0021682]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; protein transport [GO:0015031]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of synapse organization [GO:0050807]; regulation of synaptic plasticity [GO:0048167]; response to muscle activity [GO:0014850]; retrograde trans-synaptic signaling by trans-synaptic protein complex [GO:0098942],basement membrane [GO:0005604]; cell-cell junction [GO:0005911]; contractile ring [GO:0070938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystroglycan complex [GO:0016011]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; lamellipodium [GO:0030027]; membrane raft [GO:0045121]; node of Ranvier [GO:0033268]; nucleoplasm [GO:0005654]; photoreceptor ribbon synapse [GO:0098684]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383],actin binding [GO:0003779]; alpha-actinin binding [GO:0051393]; calcium ion binding [GO:0005509]; dystroglycan binding [GO:0002162]; laminin binding [GO:0043236]; protein-containing complex binding [GO:0044877]; SH2 domain binding [GO:0042169]; structural constituent of muscle [GO:0008307]; tubulin binding [GO:0015631]; vinculin binding [GO:0017166]; virus receptor activity [GO:0001618]
38,A0A337SG59,A0A337SG59_FELCA,Cadherin-1 (Epithelial cadherin),CDH1,adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell junction assembly [GO:0007043]; cellular response to indole-3-methanol [GO:0071681]; cellular response to lithium ion [GO:0071285]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-cell adhesion [GO:0022408]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein import into nucleus [GO:0042307]; protein localization to plasma membrane [GO:0072659]; synapse assembly [GO:0007416],adherens junction [GO:0005912]; apical junction complex [GO:0043296]; catenin complex [GO:0016342]; cortical actin cytoskeleton [GO:0030864]; cytoplasmic side of plasma membrane [GO:0009898]; flotillin complex [GO:0016600]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802],ankyrin binding [GO:0030506]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; gamma-catenin binding [GO:0045295]; GTPase activating protein binding [GO:0032794]; identical protein binding [GO:0042802]
39,A0A337SMY8,A0A337SMY8_FELCA,Neuropilin 2,NRP2,angiogenesis [GO:0001525]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; cellular response to leukemia inhibitory factor [GO:1990830]; dorsal root ganglion morphogenesis [GO:1904835]; facial nerve structural organization [GO:0021612]; facioacoustic ganglion development [GO:1903375]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; negative chemotaxis [GO:0050919]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; outflow tract septum morphogenesis [GO:0003148]; regulation of postsynapse organization [GO:0099175]; sensory neuron axon guidance [GO:0097374]; sympathetic ganglion development [GO:0061549]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; trigeminal ganglion development [GO:0061551]; ventral trunk neural crest cell migration [GO:0036486]; vestibulocochlear nerve structural organization [GO:0021649],axon [GO:0030424]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211],heparin binding [GO:0008201]; metal ion binding [GO:0046872]; semaphorin receptor activity [GO:0017154]; vascular endothelial growth factor receptor activity [GO:0005021]
40,A0A337SRL4,A0A337SRL4_FELCA,Low-density lipoprotein receptor,LDLR,amyloid-beta clearance by cellular catabolic process [GO:0150094]; artery morphogenesis [GO:0048844]; cellular response to fatty acid [GO:0071398]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; cholesterol metabolic process [GO:0008203]; high-density lipoprotein particle clearance [GO:0034384]; intestinal cholesterol absorption [GO:0030299]; lipoprotein catabolic process [GO:0042159]; long-term memory [GO:0007616]; low-density lipoprotein particle clearance [GO:0034383]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of astrocyte activation [GO:0061889]; negative regulation of gene expression [GO:0010629]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of receptor recycling [GO:0001920]; phagocytosis [GO:0006909]; phospholipid transport [GO:0015914]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of triglyceride biosynthetic process [GO:0010867]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cholesterol metabolic process [GO:0090181]; regulation of phosphatidylcholine catabolic process [GO:0010899]; response to caloric restriction [GO:0061771],apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; low-density lipoprotein particle [GO:0034362]; lysosome [GO:0005764]; PCSK9-LDLR complex [GO:1990666]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; somatodendritic compartment [GO:0036477]; sorting endosome [GO:0097443],amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; lipoprotein particle binding [GO:0071813]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; protease binding [GO:0002020]; very-low-density lipoprotein particle receptor activity [GO:0030229]
41,A0A337SUE7,A0A337SUE7_FELCA,Solute carrier family 22 member 1 (Organic cation transporter 1),SLC22A1,acetylcholine transport [GO:0015870]; acyl carnitine transmembrane transport [GO:1902616]; cellular detoxification [GO:1990748]; dopamine uptake [GO:0090494]; epinephrine transport [GO:0048241]; monoatomic cation transport [GO:0006812]; norepinephrine transport [GO:0015874]; organic cation transport [GO:0015695]; serotonin uptake [GO:0051610],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; lateral plasma membrane [GO:0016328]; presynapse [GO:0098793],(R)-carnitine transmembrane transporter activity [GO:1901235]; acetylcholine transmembrane transporter activity [GO:0005277]; monoamine transmembrane transporter activity [GO:0008504]; organic anion transmembrane transporter activity [GO:0008514]; organic cation transmembrane transporter activity [GO:0015101]; prostaglandin transmembrane transporter activity [GO:0015132]; putrescine transmembrane transporter activity [GO:0015489]; pyrimidine nucleoside transmembrane transporter activity [GO:0015214]; spermidine transmembrane transporter activity [GO:0015606]; thiamine transmembrane transporter activity [GO:0015234]; toxin transmembrane transporter activity [GO:0019534]; xenobiotic transmembrane transporter activity [GO:0042910]
42,A0A337SXF4,A0A337SXF4_FELCA,Neprilysin (EC 3.4.24.11) (Atriopeptidase) (Enkephalinase) (Neutral endopeptidase 24.11) (Skin fibroblast elastase),MME,amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; bradykinin catabolic process [GO:0010815]; cellular response to cytokine stimulus [GO:0071345]; cellular response to UV-A [GO:0071492]; cellular response to UV-B [GO:0071493]; creatinine metabolic process [GO:0046449]; hormone catabolic process [GO:0042447]; kidney development [GO:0001822]; learning or memory [GO:0007611]; neuropeptide processing [GO:0061837]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neurogenesis [GO:0050769]; protein processing [GO:0016485]; replicative senescence [GO:0090399]; sensory perception of pain [GO:0019233]; substance P catabolic process [GO:0010814],axon [GO:0030424]; brush border [GO:0005903]; dendrite [GO:0030425]; early endosome [GO:0005769]; membrane raft [GO:0045121]; neuron projection terminus [GO:0044306]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802],cardiolipin binding [GO:1901612]; exopeptidase activity [GO:0008238]; metalloendopeptidase activity [GO:0004222]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]
43,A0A5F5XD94,A0A5F5XD94_FELCA,Protein-glutamine gamma-glutamyltransferase 2 (EC 2.3.2.13) (EC 3.5.1.44) (Isopeptidase TGM2) (Protein-glutamine deamidase TGM2) (Protein-glutamine dopaminyltransferase TGM2) (Protein-glutamine histaminyltransferase TGM2) (Protein-glutamine noradrenalinyltransferase TGM2) (Protein-glutamine serotonyltransferase TGM2) (Tissue transglutaminase) (Transglutaminase-2),TGM2,proteolysis [GO:0006508],chromosome [GO:0005694]; cytosol [GO:0005829]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886],GTP binding [GO:0005525]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]
44,A0A5F5XHI8,A0A5F5XHI8_FELCA,Aldo-keto reductase family 1 member A1 (EC 1.1.1.19) (EC 1.1.1.2) (EC 1.1.1.20) (EC 1.1.1.372) (EC 1.1.1.54) (Alcohol dehydrogenase [NADP(+)]) (Aldehyde reductase) (Glucuronate reductase) (Glucuronolactone reductase) (S-nitroso-CoA reductase),AKR1A1,aldehyde catabolic process [GO:0046185]; cellular detoxification of aldehyde [GO:0110095]; D-glucuronate catabolic process [GO:0042840]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; glucuronate catabolic process to xylulose 5-phosphate [GO:0019640]; L-ascorbic acid biosynthetic process [GO:0019853],apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; synapse [GO:0045202],aldose reductase (NADPH) activity [GO:0004032]; allyl-alcohol dehydrogenase activity [GO:0047655]; glucuronolactone reductase activity [GO:0047941]; L-glucuronate reductase activity [GO:0047939]; S-nitrosoglutathione reductase (NADH) activity [GO:0080007]
45,A0A5F5XKH5,A0A5F5XKH5_FELCA,Cartilage oligomeric matrix protein,COMP,apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; BMP signaling pathway [GO:0030509]; bone mineralization [GO:0030282]; cartilage homeostasis [GO:1990079]; cellular senescence [GO:0090398]; chondrocyte development [GO:0002063]; chondrocyte proliferation [GO:0035988]; collagen fibril organization [GO:0030199]; growth plate cartilage development [GO:0003417]; limb development [GO:0060173]; multicellular organism growth [GO:0035264]; musculoskeletal movement [GO:0050881]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hemostasis [GO:1900047]; platelet aggregation [GO:0070527]; positive regulation of chondrocyte proliferation [GO:1902732]; protein homooligomerization [GO:0051260]; protein processing [GO:0016485]; protein secretion [GO:0009306]; regulation of bone mineralization [GO:0030500]; regulation of gene expression [GO:0010468]; response to unfolded protein [GO:0006986]; skin development [GO:0043588]; tendon development [GO:0035989]; vascular associated smooth muscle cell development [GO:0097084]; vascular associated smooth muscle contraction [GO:0014829],collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991],BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; protease binding [GO:0002020]
46,A0A5F5XXR7,A0A5F5XXR7_FELCA,Ras-related protein Rab-11A (EC 3.6.5.2),RAB11A,"amyloid-beta clearance by transcytosis [GO:0150093]; astral microtubule organization [GO:0030953]; establishment of protein localization to organelle [GO:0072594]; exocytosis [GO:0006887]; exosomal secretion [GO:1990182]; melanosome transport [GO:0032402]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic spindle assembly [GO:0090307]; multivesicular body assembly [GO:0036258]; neuron projection development [GO:0031175]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; protein localization to cell surface [GO:0034394]; protein localization to cilium [GO:0061512]; protein transmembrane transport [GO:0071806]; regulation of cilium assembly [GO:1902017]; regulation of cytokinesis [GO:0032465]; regulation of early endosome to recycling endosome transport [GO:1902954]; regulation of endocytic recycling [GO:2001135]; regulation of multivesicular body size [GO:0010796]; regulation of protein localization to centrosome [GO:1904779]",centriolar satellite [GO:0034451]; centriole [GO:0005814]; cleavage furrow [GO:0032154]; endocytic vesicle membrane [GO:0030666]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; kinetochore microtubule [GO:0005828]; multivesicular body [GO:0005771]; phagocytic vesicle [GO:0045335]; postsynaptic recycling endosome [GO:0098837]; protein-containing complex [GO:0032991]; recycling endosome membrane [GO:0055038]; spindle pole [GO:0000922]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133],dynein light intermediate chain binding [GO:0051959]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; myosin V binding [GO:0031489]
47,A0A5F5XZJ7,A0A5F5XZJ7_FELCA,furin (EC 3.4.21.75) (Dibasic-processing enzyme) (Paired basic amino acid residue-cleaving enzyme),FURIN,blastocyst formation [GO:0001825]; cytokine precursor processing [GO:0140447]; dibasic protein processing [GO:0090472]; negative regulation of low-density lipoprotein particle receptor catabolic process [GO:0032804]; negative regulation of transforming growth factor beta1 production [GO:0032911]; nerve growth factor production [GO:0032902]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; positive regulation of viral entry into host cell [GO:0046598]; regulation of cholesterol transport [GO:0032374]; regulation of signal transduction [GO:0009966]; secretion by cell [GO:0032940]; signal peptide processing [GO:0006465]; viral life cycle [GO:0019058]; zymogen activation [GO:0031638],cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140],heparan sulfate binding [GO:1904399]; heparin binding [GO:0008201]; nerve growth factor binding [GO:0048406]; peptide binding [GO:0042277]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252]; serine-type endopeptidase inhibitor activity [GO:0004867]
48,A0A5F5Y0Z4,A0A5F5Y0Z4_FELCA,Lipopolysaccharide-binding protein (LBP),LBP,acute-phase response [GO:0006953]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; cellular response to lipoteichoic acid [GO:0071223]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; detection of molecule of bacterial origin [GO:0032490]; innate immune response [GO:0045087]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; lipopolysaccharide transport [GO:0015920]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; macrophage activation involved in immune response [GO:0002281]; negative regulation of tumor necrosis factor production [GO:0032720]; neutrophil chemotaxis [GO:0030593]; positive regulation of chemokine production [GO:0032722]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of macrophage activation [GO:0043032]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of respiratory burst involved in inflammatory response [GO:0060265]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of tumor necrosis factor production [GO:0032760],cell surface [GO:0009986]; extracellular space [GO:0005615],coreceptor activity [GO:0015026]; lipopeptide binding [GO:0071723]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; signaling receptor binding [GO:0005102]
49,A0A5F5Y366,A0A5F5Y366_FELCA,Laminin subunit alpha 5,LAMA5,animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; branching involved in salivary gland morphogenesis [GO:0060445]; branching involved in ureteric bud morphogenesis [GO:0001658]; cilium assembly [GO:0060271]; hair follicle development [GO:0001942]; integrin-mediated signaling pathway [GO:0007229]; lung development [GO:0030324]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of embryonic epithelium [GO:0016331]; muscle organ development [GO:0007517]; odontogenesis of dentin-containing tooth [GO:0042475]; postsynapse organization [GO:0099173]; protein localization to plasma membrane [GO:0072659]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; regulation of epithelial cell proliferation [GO:0050678]; skeletal system morphogenesis [GO:0048705]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]; trunk neural crest cell migration [GO:0036484],basement membrane [GO:0005604]; extracellular matrix of synaptic cleft [GO:0098965]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; laminin-10 complex [GO:0043259]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; synaptic cleft [GO:0043083],extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]
50,B0LSW3,LIS1_FELCA,Platelet-activating factor acetylhydrolase IB subunit beta (Lissencephaly-1 protein) (LIS-1) (PAF acetylhydrolase 45 kDa subunit) (PAF-AH 45 kDa subunit) (PAF-AH alpha) (PAFAH alpha),PAFAH1B1 LIS1,acrosome assembly [GO:0001675]; actin cytoskeleton organization [GO:0030036]; adult locomotory behavior [GO:0008344]; ameboidal-type cell migration [GO:0001667]; auditory receptor cell development [GO:0060117]; brain morphogenesis [GO:0048854]; cell division [GO:0051301]; chemical synaptic transmission [GO:0007268]; cochlea development [GO:0090102]; corpus callosum morphogenesis [GO:0021540]; cortical microtubule organization [GO:0043622]; establishment of mitotic spindle orientation [GO:0000132]; establishment of planar polarity of embryonic epithelium [GO:0042249]; germ cell development [GO:0007281]; hippocampus development [GO:0021766]; interneuron migration [GO:1904936]; JNK cascade [GO:0007254]; layer formation in cerebral cortex [GO:0021819]; learning or memory [GO:0007611]; lipid catabolic process [GO:0016042]; maintenance of centrosome location [GO:0051661]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; microtubule organizing center organization [GO:0031023]; microtubule sliding [GO:0051012]; modulation of chemical synaptic transmission [GO:0050804]; myeloid leukocyte migration [GO:0097529]; negative regulation of JNK cascade [GO:0046329]; neuroblast proliferation [GO:0007405]; neuromuscular process controlling balance [GO:0050885]; nuclear membrane disassembly [GO:0051081]; nuclear migration [GO:0007097]; osteoclast development [GO:0036035]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of embryonic development [GO:0040019]; protein secretion [GO:0009306]; radial glia-guided pyramidal neuron migration [GO:0140650]; reelin-mediated signaling pathway [GO:0038026]; regulation of microtubule cytoskeleton organization [GO:0070507]; retrograde axonal transport [GO:0008090]; transmission of nerve impulse [GO:0019226]; vesicle transport along microtubule [GO:0047496],1-alkyl-2-acetylglycerophosphocholine esterase complex [GO:0008247]; astral microtubule [GO:0000235]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; glutamatergic synapse [GO:0098978]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; motile cilium [GO:0031514]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; Schaffer collateral - CA1 synapse [GO:0098685]; stereocilium [GO:0032420],dynein complex binding [GO:0070840]; identical protein binding [GO:0042802]; microtubule plus-end binding [GO:0051010]; phosphoprotein binding [GO:0051219]; protein heterodimerization activity [GO:0046982]
51,M3VUE2,M3VUE2_FELCA,Serine/threonine-protein kinase receptor (EC 2.7.11.30),ACVRL1,"angiogenesis [GO:0001525]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; cellular response to growth factor stimulus [GO:0071363]; dorsal aorta morphogenesis [GO:0035912]; dorsal/ventral pattern formation [GO:0009953]; endocardial cushion morphogenesis [GO:0003203]; endothelial tube morphogenesis [GO:0061154]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell growth [GO:0030308]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of gene expression [GO:0010629]; positive regulation of angiogenesis [GO:0045766]; positive regulation of bicellular tight junction assembly [GO:1903348]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of blood pressure [GO:0008217]; retina vasculature development in camera-type eye [GO:0061298]; transforming growth factor beta receptor signaling pathway [GO:0007179]; venous blood vessel development [GO:0060841]; wound healing, spreading of epidermal cells [GO:0035313]",BMP receptor complex [GO:0070724]; cell surface [GO:0009986]; plasma membrane [GO:0005886],"activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; BMP receptor activity [GO:0098821]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type I [GO:0005025]"
52,M3VUU7,M3VUU7_FELCA,Calreticulin,CALR,cellular senescence [GO:0090398]; cortical actin cytoskeleton organization [GO:0030866]; ERAD pathway [GO:0036503]; negative regulation of intracellular steroid hormone receptor signaling pathway [GO:0033144]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; negative regulation of trophoblast cell migration [GO:1901164]; peptide antigen assembly with MHC class I protein complex [GO:0002502]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of gene expression [GO:0010628]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of phagocytosis [GO:0050766]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein export from nucleus [GO:0006611]; protein folding [GO:0006457]; protein localization to nucleus [GO:0034504]; protein stabilization [GO:0050821]; regulation of meiotic nuclear division [GO:0040020],cortical granule [GO:0060473]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; MHC class I peptide loading complex [GO:0042824]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; ribosome [GO:0005840]; sarcoplasmic reticulum lumen [GO:0033018],calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; complement component C1q complex binding [GO:0001849]; integrin binding [GO:0005178]; molecular sequestering activity [GO:0140313]; mRNA binding [GO:0003729]; nuclear androgen receptor binding [GO:0050681]; nuclear export signal receptor activity [GO:0005049]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]
53,M3VVL7,M3VVL7_FELCA,Glucosylceramidase (EC 3.2.1.45),GBA1,antigen processing and presentation [GO:0019882]; autophagosome organization [GO:1905037]; brain morphogenesis [GO:0048854]; cell maturation [GO:0048469]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; cerebellar Purkinje cell layer formation [GO:0021694]; cholesterol metabolic process [GO:0008203]; determination of adult lifespan [GO:0008340]; glucosylceramide catabolic process [GO:0006680]; hematopoietic stem cell proliferation [GO:0071425]; homeostasis of number of cells [GO:0048872]; lipid glycosylation [GO:0030259]; lipid storage [GO:0019915]; lymphocyte migration [GO:0072676]; lysosome organization [GO:0007040]; microglia differentiation [GO:0014004]; microglial cell proliferation [GO:0061518]; mitophagy [GO:0000423]; motor behavior [GO:0061744]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of protein-containing complex assembly [GO:0031333]; neuromuscular process [GO:0050905]; neuron apoptotic process [GO:0051402]; positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization [GO:1904925]; positive regulation of neuronal action potential [GO:1904457]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein lipidation [GO:1903061]; positive regulation of protein-containing complex disassembly [GO:0043243]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; pyramidal neuron differentiation [GO:0021859]; regulation of TOR signaling [GO:0032006]; respiratory electron transport chain [GO:0022904]; sphingosine biosynthetic process [GO:0046512]; T cell differentiation in thymus [GO:0033077]; termination of signal transduction [GO:0023021],endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; trans-Golgi network [GO:0005802],galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; scavenger receptor binding [GO:0005124]; steryl-beta-glucosidase activity [GO:0050295]
54,M3VW05,M3VW05_FELCA,Transitional endoplasmic reticulum ATPase (EC 3.6.4.6) (15S Mg(2+)-ATPase p97 subunit) (Valosin-containing protein),VCP,"aggresome assembly [GO:0070842]; ATP metabolic process [GO:0046034]; autophagosome maturation [GO:0097352]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; cellular response to misfolded protein [GO:0071218]; double-strand break repair [GO:0006302]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; flavin adenine dinucleotide catabolic process [GO:0072389]; mitotic spindle disassembly [GO:0051228]; NADH metabolic process [GO:0006734]; negative regulation of protein localization to chromatin [GO:0120186]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of oxidative phosphorylation [GO:1903862]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein K63-linked deubiquitination [GO:1903006]; positive regulation of protein-containing complex assembly [GO:0031334]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; protein-DNA covalent cross-linking repair [GO:0106300]; retrograde protein transport, ER to cytosol [GO:0030970]; stress granule disassembly [GO:0035617]; translesion synthesis [GO:0019985]; viral genome replication [GO:0019079]",ATPase complex [GO:1904949]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; Derlin-1 retrotranslocation complex [GO:0036513]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; proteasome complex [GO:0000502]; site of double-strand break [GO:0035861]; synapse [GO:0045202]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; VCP-NSFL1C complex [GO:1990730],ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; BAT3 complex binding [GO:1904288]; deubiquitinase activator activity [GO:0035800]; identical protein binding [GO:0042802]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; lipid binding [GO:0008289]; MHC class I protein binding [GO:0042288]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein domain specific binding [GO:0019904]; protein phosphatase binding [GO:0019903]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-modified protein reader activity [GO:0140036]; ubiquitin-specific protease binding [GO:1990381]
55,M3VYE6,M3VYE6_FELCA,Villin-1,VIL1,actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell differentiation [GO:0030855]; intestinal D-glucose absorption [GO:0001951]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of actin filament depolymerization [GO:0030836]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of actin nucleation [GO:0051125]; regulation of cell shape [GO:0008360]; regulation of lamellipodium morphogenesis [GO:2000392]; regulation of microvillus length [GO:0032532]; regulation of wound healing [GO:0061041]; response to bacterium [GO:0009617]; terminal web assembly [GO:1902896],actin cytoskeleton [GO:0015629]; actin filament bundle [GO:0032432]; brush border [GO:0005903]; cytoplasm [GO:0005737]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; ruffle [GO:0001726],"actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; lysophosphatidic acid binding [GO:0035727]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein homodimerization activity [GO:0042803]"
56,M3W050,M3W050_FELCA,Proteinase-activated receptor 1 (Thrombin receptor),F2R,"cell-cell junction maintenance [GO:0045217]; connective tissue replacement involved in inflammatory response wound healing [GO:0002248]; dendritic cell homeostasis [GO:0036145]; homeostasis of number of cells within a tissue [GO:0048873]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of renin secretion into blood stream [GO:1900134]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; platelet activation [GO:0030168]; positive regulation of blood coagulation [GO:0030194]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell migration [GO:0030335]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of vasoconstriction [GO:0045907]; regulation of interleukin-1 beta production [GO:0032651]; regulation of synaptic plasticity [GO:0048167]; response to lipopolysaccharide [GO:0032496]; trans-synaptic signaling by endocannabinoid, modulating synaptic transmission [GO:0099553]",caveola [GO:0005901]; cell surface [GO:0009986]; early endosome [GO:0005769]; late endosome [GO:0005770]; plasma membrane [GO:0005886]; platelet dense tubular network [GO:0031094]; synapse [GO:0045202],G-protein alpha-subunit binding [GO:0001965]; G-protein beta-subunit binding [GO:0031681]; signaling receptor binding [GO:0005102]; thrombin-activated receptor activity [GO:0015057]
57,M3W0P6,M3W0P6_FELCA,Platelet-derived growth factor receptor beta (PDGF-R-beta) (PDGFR-beta) (EC 2.7.10.1) (Beta platelet-derived growth factor receptor) (Beta-type platelet-derived growth factor receptor),PDGFRB,cell chemotaxis [GO:0060326]; phosphatidylinositol metabolic process [GO:0046488]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway [GO:0038091]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661],cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; platelet-derived growth factor beta-receptor activity [GO:0005019]; platelet-derived growth factor binding [GO:0048407]; platelet-derived growth factor receptor binding [GO:0005161]; protein kinase binding [GO:0019901]; vascular endothelial growth factor binding [GO:0038085]
58,M3W0W8,M3W0W8_FELCA,Charged multivesicular body protein 2a (Chromatin-modifying protein 2a),CHMP2A,autophagosome maturation [GO:0097352]; endosome transport via multivesicular body sorting pathway [GO:0032509]; exit from mitosis [GO:0010458]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport [GO:0045324]; membrane invagination [GO:0010324]; midbody abscission [GO:0061952]; mitotic metaphase chromosome alignment [GO:0007080]; negative regulation of centriole elongation [GO:1903723]; nuclear membrane reassembly [GO:0031468]; plasma membrane repair [GO:0001778]; positive regulation of exosomal secretion [GO:1903543]; protein homooligomerization [GO:0051260]; protein polymerization [GO:0051258]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702],amphisome membrane [GO:1904930]; chromatin [GO:0000785]; cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; membrane coat [GO:0030117]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886],phosphatidylcholine binding [GO:0031210]; protein domain specific binding [GO:0019904]
59,M3W0Z1,M3W0Z1_FELCA,Dipeptidase (EC 3.4.13.19),DPEP1,antibiotic metabolic process [GO:0016999]; cellular response to xenobiotic stimulus [GO:0071466]; glutathione catabolic process [GO:0006751]; homocysteine metabolic process [GO:0050667]; inflammatory response [GO:0006954]; leukotriene D4 catabolic process [GO:1901749]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; neutrophil chemotaxis [GO:0030593]; proteolysis [GO:0006508],apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; side of membrane [GO:0098552],beta-lactamase activity [GO:0008800]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metallodipeptidase activity [GO:0070573]; modified amino acid binding [GO:0072341]; zinc ion binding [GO:0008270]
60,M3W1Z4,M3W1Z4_FELCA,4-trimethylaminobutyraldehyde dehydrogenase (EC 1.2.1.19) (EC 1.2.1.3) (EC 1.2.1.46) (EC 1.2.1.47) (Aldehyde dehydrogenase family 9 member A1) (Formaldehyde dehydrogenase) (Gamma-aminobutyraldehyde dehydrogenase),ALDH9A1,cellular aldehyde metabolic process [GO:0006081]; protein homotetramerization [GO:0051289],cytoplasm [GO:0005737],4-trimethylammoniobutyraldehyde dehydrogenase activity [GO:0047105]; aminobutyraldehyde dehydrogenase activity [GO:0019145]; formaldehyde dehydrogenase activity [GO:0018467]
61,M3W230,M3W230_FELCA,Uromodulin,UMOD,antibacterial innate immune response [GO:0140367]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; cellular response to unfolded protein [GO:0034620]; chaperone-mediated protein folding [GO:0061077]; citric acid secretion [GO:0046720]; collecting duct development [GO:0072044]; connective tissue replacement [GO:0097709]; defense response to Gram-negative bacterium [GO:0050829]; endoplasmic reticulum organization [GO:0007029]; ERAD pathway [GO:0036503]; glomerular filtration [GO:0003094]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; intracellular calcium ion homeostasis [GO:0006874]; intracellular chloride ion homeostasis [GO:0030644]; intracellular phosphate ion homeostasis [GO:0030643]; intracellular sodium ion homeostasis [GO:0006883]; juxtaglomerular apparatus development [GO:0072051]; leukocyte cell-cell adhesion [GO:0007159]; lipid metabolic process [GO:0006629]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; micturition [GO:0060073]; multicellular organismal response to stress [GO:0033555]; neutrophil migration [GO:1990266]; organ or tissue specific immune response [GO:0002251]; potassium ion homeostasis [GO:0055075]; protein localization to vacuole [GO:0072665]; protein transport into plasma membrane raft [GO:0044861]; regulation of blood pressure [GO:0008217]; regulation of protein transport [GO:0051223]; regulation of urine volume [GO:0035809]; renal sodium ion absorption [GO:0070294]; renal urate salt excretion [GO:0097744]; renal water homeostasis [GO:0003091]; response to lipopolysaccharide [GO:0032496]; response to water deprivation [GO:0009414]; response to xenobiotic stimulus [GO:0009410]; RNA splicing [GO:0008380]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; urate transport [GO:0015747]; urea transmembrane transport [GO:0071918],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; ciliary membrane [GO:0060170]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; side of membrane [GO:0098552]; spindle pole [GO:0000922],calcium ion binding [GO:0005509]; IgG binding [GO:0019864]
62,M3W2F5,M3W2F5_FELCA,Collagen type I alpha 1 chain,COL1A1,blood vessel development [GO:0001568]; bone trabecula formation [GO:0060346]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cellular response to amino acid stimulus [GO:0071230]; cellular response to mechanical stimulus [GO:0071260]; collagen biosynthetic process [GO:0032964]; collagen fibril organization [GO:0030199]; embryonic skeletal system development [GO:0048706]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; intramembranous ossification [GO:0001957]; negative regulation of cell-substrate adhesion [GO:0010812]; ossification [GO:0001503]; osteoblast differentiation [GO:0001649]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; protein localization to nucleus [GO:0034504]; protein transport [GO:0015031]; response to mechanical stimulus [GO:0009612]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; skin development [GO:0043588]; skin morphogenesis [GO:0043589]; tooth mineralization [GO:0034505]; visual perception [GO:0007601],collagen type I trimer [GO:0005584]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular space [GO:0005615],extracellular matrix structural constituent conferring tensile strength [GO:0030020]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; platelet-derived growth factor binding [GO:0048407]; protease binding [GO:0002020]
63,M3W544,M3W544_FELCA,"CRK like proto-oncogene, adaptor protein",CRKL,acetylcholine receptor signaling pathway [GO:0095500]; anterior/posterior pattern specification [GO:0009952]; B cell apoptotic process [GO:0001783]; blood vessel development [GO:0001568]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cellular response to interleukin-7 [GO:0098761]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to xenobiotic stimulus [GO:0071466]; cerebellar neuron development [GO:0098749]; cerebral cortex development [GO:0021987]; chordate pharynx development [GO:0160093]; cranial skeletal system development [GO:1904888]; dendrite development [GO:0016358]; endothelin receptor signaling pathway [GO:0086100]; enzyme-linked receptor protein signaling pathway [GO:0007167]; establishment of cell polarity [GO:0030010]; fibroblast growth factor receptor signaling pathway [GO:0008543]; helper T cell diapedesis [GO:0035685]; hippocampus development [GO:0021766]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; neuron migration [GO:0001764]; outflow tract morphogenesis [GO:0003151]; parathyroid gland development [GO:0060017]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glial cell migration [GO:1903977]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; postsynaptic specialization assembly [GO:0098698]; reelin-mediated signaling pathway [GO:0038026]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell growth [GO:0001558]; regulation of dendrite development [GO:0050773]; regulation of T cell migration [GO:2000404]; retinoic acid receptor signaling pathway [GO:0048384]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; urogenital system development [GO:0001655],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of postsynaptic membrane [GO:0098890]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991],identical protein binding [GO:0042802]; phosphotyrosine residue binding [GO:0001784]; receptor tyrosine kinase binding [GO:0030971]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; signaling adaptor activity [GO:0035591]
64,M3W5B5,M3W5B5_FELCA,LDL receptor related protein 2,LRP2,aorta development [GO:0035904]; cell population proliferation [GO:0008283]; coronary artery morphogenesis [GO:0060982]; diol metabolic process [GO:0034311]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; kidney development [GO:0001822]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359],apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],calcium ion binding [GO:0005509]; hormone binding [GO:0042562]; protein-folding chaperone binding [GO:0051087]
65,M3W6I2,M3W6I2_FELCA,"Actin, cytoplasmic 2 (Gamma-actin)",ACTG1,angiogenesis [GO:0001525]; axonogenesis [GO:0007409]; cell motility [GO:0048870]; cellular response to type II interferon [GO:0071346]; morphogenesis of a polarized epithelium [GO:0001738]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; positive regulation of wound healing [GO:0090303]; protein localization to bicellular tight junction [GO:1902396]; regulation of focal adhesion assembly [GO:0051893]; regulation of stress fiber assembly [GO:0051492]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of transepithelial transport [GO:0150111]; sarcomere organization [GO:0045214]; tight junction assembly [GO:0120192],actin filament [GO:0005884]; apical junction complex [GO:0043296]; axon [GO:0030424]; basal body patch [GO:0120220]; calyx of Held [GO:0044305]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; membrane [GO:0016020]; myofibril [GO:0030016]; NuA4 histone acetyltransferase complex [GO:0035267]; phagocytic vesicle [GO:0045335]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202],identical protein binding [GO:0042802]; profilin binding [GO:0005522]; protein kinase binding [GO:0019901]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]; ubiquitin protein ligase binding [GO:0031625]
66,M3W6S5,M3W6S5_FELCA,Purine nucleoside phosphorylase (EC 2.4.2.1) (Inosine-guanosine phosphorylase),PNP,allantoin metabolic process [GO:0000255]; dAMP catabolic process [GO:0046059]; deoxyadenosine catabolic process [GO:0006157]; deoxyinosine catabolic process [GO:0006149]; immune response [GO:0006955]; IMP catabolic process [GO:0006204]; inosine catabolic process [GO:0006148]; nicotinamide riboside catabolic process [GO:0006738]; nucleotide biosynthetic process [GO:0009165]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of T cell proliferation [GO:0042102]; purine ribonucleoside salvage [GO:0006166]; response to xenobiotic stimulus [GO:0009410]; urate biosynthetic process [GO:0034418],cytoplasm [GO:0005737]; cytosol [GO:0005829],guanosine phosphorylase activity [GO:0047975]; identical protein binding [GO:0042802]; nucleoside binding [GO:0001882]; phosphate ion binding [GO:0042301]; purine nucleobase binding [GO:0002060]; purine-nucleoside phosphorylase activity [GO:0004731]
67,M3W8K5,M3W8K5_FELCA,"Legumain (EC 3.4.22.34) (Protease, cysteine 1)",LGMN,antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; associative learning [GO:0008306]; cellular response to amyloid-beta [GO:1904646]; cellular response to calcium ion [GO:0071277]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; dendritic spine organization [GO:0097061]; memory [GO:0007613]; negative regulation of ERBB signaling pathway [GO:1901185]; negative regulation of gene expression [GO:0010629]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of monocyte chemotaxis [GO:0090026]; proteolysis involved in protein catabolic process [GO:0051603]; receptor catabolic process [GO:0032801]; renal system process [GO:0003014]; response to acidic pH [GO:0010447]; self proteolysis [GO:0097264]; vacuolar protein processing [GO:0006624],apical part of cell [GO:0045177]; extracellular region [GO:0005576]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; perinuclear region of cytoplasm [GO:0048471],cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activator activity [GO:0061133]
68,M3W8V8,M3W8V8_FELCA,Serine/threonine-protein kinase receptor (EC 2.7.11.30),ACVR1,acute inflammatory response [GO:0002526]; atrial septum primum morphogenesis [GO:0003289]; BMP signaling pathway [GO:0030509]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac muscle cell fate commitment [GO:0060923]; cellular response to growth factor stimulus [GO:0071363]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube morphogenesis [GO:0003143]; endocardial cushion cell fate commitment [GO:0061445]; endocardial cushion formation [GO:0003272]; endocardial cushion fusion [GO:0003274]; gastrulation with mouth forming second [GO:0001702]; germ cell development [GO:0007281]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; neural crest cell migration [GO:0001755]; pharyngeal system development [GO:0060037]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cell migration [GO:0030335]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; smooth muscle cell differentiation [GO:0051145]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ventricular septum morphogenesis [GO:0060412],activin receptor complex [GO:0048179]; apical part of cell [GO:0045177]; BMP receptor complex [GO:0070724]; plasma membrane [GO:0005886],"activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; BMP receptor activity [GO:0098821]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase binding [GO:1990782]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type I [GO:0005025]"
69,M3WAB7,M3WAB7_FELCA,Mitogen-activated protein kinase (EC 2.7.11.24),MAPK7,calcineurin-NFAT signaling cascade [GO:0033173]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to transforming growth factor beta stimulus [GO:0071560]; intracellular signal transduction [GO:0035556]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of response to cytokine stimulus [GO:0060761]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of angiogenesis [GO:0045765],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; PML body [GO:0016605],ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; mitogen-activated protein kinase binding [GO:0051019]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]
70,M3WAV8,M3WAV8_FELCA,Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor),PDGFRA,adrenal gland development [GO:0030325]; cardiac myofibril assembly [GO:0055003]; cell chemotaxis [GO:0060326]; cellular response to amino acid stimulus [GO:0071230]; cellular response to reactive oxygen species [GO:0034614]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; estrogen metabolic process [GO:0008210]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; hematopoietic progenitor cell differentiation [GO:0002244]; in utero embryonic development [GO:0001701]; Leydig cell differentiation [GO:0033327]; lung development [GO:0030324]; luteinization [GO:0001553]; male genitalia development [GO:0030539]; metanephric glomerular capillary formation [GO:0072277]; negative regulation of platelet activation [GO:0010544]; odontogenesis of dentin-containing tooth [GO:0042475]; platelet aggregation [GO:0070527]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway [GO:0038091]; positive regulation of chemotaxis [GO:0050921]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of mesenchymal stem cell differentiation [GO:2000739]; retina vasculature development in camera-type eye [GO:0061298]; roof of mouth development [GO:0060021]; signal transduction involved in regulation of gene expression [GO:0023019]; white fat cell differentiation [GO:0050872],cell junction [GO:0030054]; cilium [GO:0005929]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; microvillus [GO:0005902]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; platelet-derived growth factor alpha-receptor activity [GO:0005018]; platelet-derived growth factor binding [GO:0048407]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; vascular endothelial growth factor binding [GO:0038085]; vascular endothelial growth factor receptor activity [GO:0005021]
71,M3WB86,M3WB86_FELCA,Sodium/potassium-transporting ATPase subunit beta,ATP1B1,ATP metabolic process [GO:0046034]; cardiac muscle contraction [GO:0060048]; cell adhesion [GO:0007155]; intracellular calcium ion homeostasis [GO:0006874]; intracellular potassium ion homeostasis [GO:0030007]; intracellular sodium ion homeostasis [GO:0006883]; membrane repolarization [GO:0086009]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of sodium ion export across plasma membrane [GO:1903278]; potassium ion import across plasma membrane [GO:1990573]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; regulation of calcium ion transmembrane transport [GO:1903169]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of gene expression [GO:0010468]; relaxation of cardiac muscle [GO:0055119]; sodium ion export across plasma membrane [GO:0036376],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; organelle membrane [GO:0031090]; sodium:potassium-exchanging ATPase complex [GO:0005890]; sperm flagellum [GO:0036126]; T-tubule [GO:0030315],ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; P-type sodium:potassium-exchanging transporter activity [GO:0005391]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]
72,M3WF45,M3WF45_FELCA,Thrombospondin 1,THBS1,cell adhesion [GO:0007155]; cell migration [GO:0016477]; chronic inflammatory response [GO:0002544]; engulfment of apoptotic cell [GO:0043652]; immune response [GO:0006955]; negative regulation of angiogenesis [GO:0016525]; negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II [GO:0002581]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of dendritic cell antigen processing and presentation [GO:0002605]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of nitric oxide mediated signal transduction [GO:0010751]; negative regulation of plasminogen activation [GO:0010757]; negative regulation of sprouting angiogenesis [GO:1903671]; nitric oxide-cGMP-mediated signaling [GO:0038060]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of chemotaxis [GO:0050921]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of macrophage activation [GO:0043032]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of phosphorylation [GO:0042327]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of translation [GO:0045727]; positive regulation of tumor necrosis factor production [GO:0032760]; response to calcium ion [GO:0051592]; response to glucose [GO:0009749]; response to magnesium ion [GO:0032026]; response to xenobiotic stimulus [GO:0009410]; sprouting angiogenesis [GO:0002040],collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; fibrinogen complex [GO:0005577]; platelet alpha granule [GO:0031091],calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; endopeptidase inhibitor activity [GO:0004866]; fibrinogen binding [GO:0070051]; fibroblast growth factor binding [GO:0017134]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; low-density lipoprotein particle binding [GO:0030169]; phosphatidylserine binding [GO:0001786]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]
73,M3WFH8,M3WFH8_FELCA,N-acetyl-alpha-glucosaminidase,NAGLU,adult behavior [GO:0030534]; amyloid precursor protein metabolic process [GO:0042982]; aorta morphogenesis [GO:0035909]; astrocyte activation [GO:0048143]; autophagy [GO:0006914]; cardiac muscle cell development [GO:0055013]; cell surface receptor signaling pathway via STAT [GO:0097696]; cellular lipid catabolic process [GO:0044242]; cellular response to organic cyclic compound [GO:0071407]; cellular response to oxidative stress [GO:0034599]; cerebellar Purkinje cell layer development [GO:0021680]; collagen metabolic process [GO:0032963]; cone retinal bipolar cell differentiation [GO:1904390]; cytoplasm organization [GO:0007028]; determination of adult lifespan [GO:0008340]; endothelium development [GO:0003158]; exploration behavior [GO:0035640]; ganglioside metabolic process [GO:0001573]; Golgi organization [GO:0007030]; hair follicle morphogenesis [GO:0031069]; heparan sulfate proteoglycan catabolic process [GO:0030200]; heparan sulfate proteoglycan metabolic process [GO:0030201]; heparin metabolic process [GO:0030202]; hormone metabolic process [GO:0042445]; inner ear receptor cell development [GO:0060119]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; limb development [GO:0060173]; liver development [GO:0001889]; locomotor rhythm [GO:0045475]; lysosome organization [GO:0007040]; maintenance of blood-brain barrier [GO:0035633]; microglia differentiation [GO:0014004]; microglial cell activation [GO:0001774]; middle ear morphogenesis [GO:0042474]; mitral valve morphogenesis [GO:0003183]; motor behavior [GO:0061744]; multicellular organismal-level iron ion homeostasis [GO:0060586]; nerve development [GO:0021675]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein processing [GO:0016485]; response to disaccharide [GO:0034285]; response to lipopolysaccharide [GO:0032496]; response to wounding [GO:0009611]; retinal rod cell development [GO:0046548]; rod bipolar cell differentiation [GO:1904389]; sequestering of iron ion [GO:0097577]; superoxide metabolic process [GO:0006801]; toll-like receptor 4 signaling pathway [GO:0034142]; vesicle tethering [GO:0099022],extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202],alpha-N-acetylglucosaminidase activity [GO:0004561]
74,M3WFK0,M3WFK0_FELCA,Fatty acid synthase (EC 1.1.1.100) (EC 1.3.1.39) (EC 2.3.1.38) (EC 2.3.1.39) (EC 2.3.1.41) (EC 2.3.1.85) (EC 3.1.2.14) (EC 4.2.1.59),FASN,cellular response to interleukin-4 [GO:0071353]; establishment of endothelial intestinal barrier [GO:0090557]; ether lipid biosynthetic process [GO:0008611]; fatty acid biosynthetic process [GO:0006633]; glandular epithelial cell development [GO:0002068]; inflammatory response [GO:0006954]; mammary gland development [GO:0030879]; modulation by host of viral process [GO:0044788]; monocyte differentiation [GO:0030224]; neutrophil differentiation [GO:0030223],cytoplasm [GO:0005737]; cytosol [GO:0005829]; glycogen granule [GO:0042587]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886],(3R)-hydroxyacyl-[acyl-carrier-protein] dehydratase activity [GO:0019171]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; [acyl-carrier-protein] S-acetyltransferase activity [GO:0004313]; [acyl-carrier-protein] S-malonyltransferase activity [GO:0004314]; enoyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0141148]; fatty acid synthase activity [GO:0004312]; fatty acyl-[ACP] hydrolase activity [GO:0016297]; phosphopantetheine binding [GO:0031177]
75,M3WFT4,M3WFT4_FELCA,78 kDa glucose-regulated protein (Binding-immunoglobulin protein) (Heat shock protein 70 family protein 5) (Heat shock protein family A member 5) (Immunoglobulin heavy chain-binding protein),HSPA5,"cellular response to glucose starvation [GO:0042149]; cellular response to interleukin-4 [GO:0071353]; cerebellar Purkinje cell layer development [GO:0021680]; cerebellum structural organization [GO:0021589]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; ERAD pathway [GO:0036503]; maintenance of protein localization in endoplasmic reticulum [GO:0035437]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of cell migration [GO:0030335]; positive regulation of protein ubiquitination [GO:0031398]; post-translational protein targeting to membrane, translocation [GO:0031204]; protein refolding [GO:0042026]",cell surface [GO:0009986]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein domain specific binding [GO:0019904]; protein folding chaperone [GO:0044183]; ribosome binding [GO:0043022]; ubiquitin protein ligase binding [GO:0031625]
76,M3WIG3,M3WIG3_FELCA,Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (Sorting protein-related receptor containing LDLR class A repeats),SORL1,diet induced thermogenesis [GO:0002024]; endosome to plasma membrane protein transport [GO:0099638]; insulin receptor recycling [GO:0038020]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of neurofibrillary tangle assembly [GO:1902997]; negative regulation of neurogenesis [GO:0050768]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of triglyceride catabolic process [GO:0010897]; neuropeptide signaling pathway [GO:0007218]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of early endosome to recycling endosome transport [GO:1902955]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of glial cell-derived neurotrophic factor production [GO:1900168]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to early endosome [GO:1902966]; post-Golgi vesicle-mediated transport [GO:0006892]; protein maturation [GO:0051604]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of smooth muscle cell migration [GO:0014910],cell surface [GO:0009986]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; multivesicular body membrane [GO:0032585]; nuclear envelope lumen [GO:0005641]; perinucleolar compartment [GO:0097356]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658],amyloid-beta binding [GO:0001540]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; low-density lipoprotein particle binding [GO:0030169]; neuropeptide binding [GO:0042923]; small GTPase binding [GO:0031267]; transmembrane signaling receptor activity [GO:0004888]
77,M3WJI8,M3WJI8_FELCA,Moesin (Membrane-organizing extension spike protein),MSN,cellular response to testosterone stimulus [GO:0071394]; establishment of endothelial barrier [GO:0061028]; establishment of epithelial cell apical/basal polarity [GO:0045198]; gland morphogenesis [GO:0022612]; immunological synapse formation [GO:0001771]; membrane to membrane docking [GO:0022614]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of gene expression [GO:0010628]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein localization to early endosome [GO:1902966]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of lymphocyte migration [GO:2000401]; regulation of organelle assembly [GO:1902115]; T cell aggregation [GO:0070489]; T cell migration [GO:0072678]; T cell proliferation [GO:0042098],adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; microvillus [GO:0005902]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; uropod [GO:0001931],actin binding [GO:0003779]; cell adhesion molecule binding [GO:0050839]; double-stranded RNA binding [GO:0003725]; protein kinase binding [GO:0019901]; signaling receptor binding [GO:0005102]
78,M3WJM9,M3WJM9_FELCA,Histidine-rich glycoprotein (Histidine-proline-rich glycoprotein),HRG,antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cytolysis by host of symbiont cells [GO:0051838]; defense response to fungus [GO:0050832]; fibrinolysis [GO:0042730]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of lamellipodium assembly [GO:0010593]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; platelet activation [GO:0030168]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel remodeling [GO:2000504]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of immune response to tumor cell [GO:0002839]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of gene expression [GO:0010468]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of platelet activation [GO:0010543]; regulation of protein-containing complex assembly [GO:0043254],cell surface [GO:0009986]; extracellular region [GO:0005576],cysteine-type endopeptidase inhibitor activity [GO:0004869]; heme binding [GO:0020037]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; immunoglobulin binding [GO:0019865]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor binding [GO:0005102]; zinc ion binding [GO:0008270]
79,M3WKP2,M3WKP2_FELCA,Clusterin,CLU,cell morphogenesis [GO:0000902]; central nervous system myelin maintenance [GO:0032286]; chaperone-mediated protein complex assembly [GO:0051131]; chaperone-mediated protein folding [GO:0061077]; immune complex clearance [GO:0002434]; microglial cell activation [GO:0001774]; microglial cell proliferation [GO:0061518]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neurofibrillary tangle assembly [GO:1902998]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of tumor necrosis factor production [GO:0032760]; protein import [GO:0017038]; protein stabilization [GO:0050821]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; regulation of amyloid-beta clearance [GO:1900221]; regulation of apoptotic process [GO:0042981]; regulation of cell population proliferation [GO:0042127]; regulation of neuronal signal transduction [GO:1902847]; response to misfolded protein [GO:0051788]; response to virus [GO:0009615],apical dendrite [GO:0097440]; cell periphery [GO:0071944]; cell surface [GO:0009986]; chromaffin granule [GO:0042583]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrial inner membrane [GO:0005743]; neurofibrillary tangle [GO:0097418]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum lumen [GO:0099020]; spherical high-density lipoprotein particle [GO:0034366]; synapse [GO:0045202],amyloid-beta binding [GO:0001540]; low-density lipoprotein particle receptor binding [GO:0050750]; misfolded protein binding [GO:0051787]; protein carrier chaperone [GO:0140597]; protein-containing complex binding [GO:0044877]; tau protein binding [GO:0048156]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]
80,M3WLD9,M3WLD9_FELCA,Collagen type VI alpha 1 chain,COL6A1,2-oxoglutarate metabolic process [GO:0006103]; adipose tissue development [GO:0060612]; apoptotic nuclear changes [GO:0030262]; autophagy [GO:0006914]; basement membrane organization [GO:0071711]; bone development [GO:0060348]; bone mineralization [GO:0030282]; canonical Wnt signaling pathway [GO:0060070]; cartilage development [GO:0051216]; caveola assembly [GO:0070836]; cell morphogenesis [GO:0000902]; cellular response to amino acid stimulus [GO:0071230]; circadian rhythm [GO:0007623]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; endodermal cell differentiation [GO:0035987]; energy reserve metabolic process [GO:0006112]; extracellular matrix assembly [GO:0085029]; fat cell proliferation [GO:0070341]; gene expression [GO:0010467]; glycolytic process [GO:0006096]; hair follicle development [GO:0001942]; heart development [GO:0007507]; homeostasis of number of cells [GO:0048872]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; limb joint morphogenesis [GO:0036022]; lung alveolus development [GO:0048286]; lung epithelial cell differentiation [GO:0060487]; lung morphogenesis [GO:0060425]; mitochondrial depolarization [GO:0051882]; mitochondrial transmembrane transport [GO:1990542]; mitochondrion organization [GO:0007005]; multicellular organismal locomotion [GO:0071965]; muscle cell apoptotic process [GO:0010657]; muscle system process [GO:0003012]; myelination in peripheral nervous system [GO:0022011]; neuron apoptotic process [GO:0051402]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; protein tetramerization [GO:0051262]; reactive oxygen species metabolic process [GO:0072593]; reduction of food intake in response to dietary excess [GO:0002023]; regulation of cell size [GO:0008361]; regulation of collagen fibril organization [GO:1904026]; respiratory system process [GO:0003016]; response to bleomycin [GO:1904975]; response to decreased oxygen levels [GO:0036293]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to muscle activity [GO:0014850]; response to pain [GO:0048265]; response to peptide [GO:1901652]; response to polyamine macromolecule [GO:1904583]; response to reactive oxygen species [GO:0000302]; response to toxic substance [GO:0009636]; response to UV [GO:0009411]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; sensory perception of mechanical stimulus [GO:0050954]; single fertilization [GO:0007338]; skeletal muscle fiber development [GO:0048741]; skeletal muscle fiber differentiation [GO:0098528]; skeletal muscle tissue growth [GO:0048630]; skeletal muscle tissue regeneration [GO:0043403]; tissue remodeling [GO:0048771]; transmission of nerve impulse [GO:0019226]; tricarboxylic acid cycle [GO:0006099]; uterus development [GO:0060065],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; intracellular vesicle [GO:0097708]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; myofibril [GO:0030016]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529],collagen binding [GO:0005518]; platelet-derived growth factor binding [GO:0048407]
81,M3WM95,M3WM95_FELCA,Sortilin 1,SORT1,endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; endosome transport via multivesicular body sorting pathway [GO:0032509]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; glucose import [GO:0046323]; Golgi to endosome transport [GO:0006895]; Golgi to lysosome transport [GO:0090160]; maintenance of synapse structure [GO:0099558]; myotube differentiation [GO:0014902]; negative regulation of fat cell differentiation [GO:0045599]; neuropeptide signaling pathway [GO:0007218]; neurotrophin TRK receptor signaling pathway [GO:0048011]; plasma membrane to endosome transport [GO:0048227]; protein targeting to lysosome [GO:0006622]; regulation of gene expression [GO:0010468]; response to insulin [GO:0032868]; vesicle organization [GO:0016050],cell surface [GO:0009986]; cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network transport vesicle [GO:0030140],"enzyme binding [GO:0019899]; nerve growth factor binding [GO:0048406]; nerve growth factor receptor activity [GO:0010465]; neurotensin receptor activity, non-G protein-coupled [GO:0030379]; retromer complex binding [GO:1905394]"
82,M3WPG6,M3WPG6_FELCA,Apolipoprotein A-I (Apolipoprotein A1),APOA1,acylglycerol homeostasis [GO:0055090]; adrenal gland development [GO:0030325]; blood vessel endothelial cell migration [GO:0043534]; cholesterol biosynthetic process [GO:0006695]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; cholesterol metabolic process [GO:0008203]; endothelial cell proliferation [GO:0001935]; G protein-coupled receptor signaling pathway [GO:0007186]; glucocorticoid metabolic process [GO:0008211]; high-density lipoprotein particle assembly [GO:0034380]; high-density lipoprotein particle remodeling [GO:0034375]; integrin-mediated signaling pathway [GO:0007229]; lipid storage [GO:0019915]; lipoprotein biosynthetic process [GO:0042158]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cytokine production involved in immune response [GO:0002719]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; negative regulation of very-low-density lipoprotein particle remodeling [GO:0010903]; phosphatidylcholine biosynthetic process [GO:0006656]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol metabolic process [GO:0090205]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phospholipid efflux [GO:1902995]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein stabilization [GO:0050821]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of intestinal cholesterol absorption [GO:0030300]; regulation of protein phosphorylation [GO:0001932]; reverse cholesterol transport [GO:0043691]; triglyceride homeostasis [GO:0070328]; vitamin transport [GO:0051180],chylomicron [GO:0042627]; endocytic vesicle [GO:0030139]; extracellular vesicle [GO:1903561]; high-density lipoprotein particle [GO:0034364]; low-density lipoprotein particle [GO:0034362]; spherical high-density lipoprotein particle [GO:0034366]; very-low-density lipoprotein particle [GO:0034361],amyloid-beta binding [GO:0001540]; apolipoprotein A-I receptor binding [GO:0034191]; chemorepellent activity [GO:0045499]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; high-density lipoprotein particle binding [GO:0008035]; high-density lipoprotein particle receptor binding [GO:0070653]; identical protein binding [GO:0042802]; phosphatidylcholine-sterol O-acyltransferase activator activity [GO:0060228]; phospholipid binding [GO:0005543]
83,M3WPK6,M3WPK6_FELCA,receptor protein-tyrosine kinase (EC 2.7.10.1),EPHA7,axon guidance [GO:0007411]; brain development [GO:0007420]; branching morphogenesis of a nerve [GO:0048755]; ephrin receptor signaling pathway [GO:0048013]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of synapse assembly [GO:0051964]; nephric duct morphogenesis [GO:0072178]; neuron apoptotic process [GO:0051402]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell-cell adhesion [GO:0022407]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of postsynapse organization [GO:0099175]; regulation of protein autophosphorylation [GO:0031952]; retinal ganglion cell axon guidance [GO:0031290],dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; axon guidance receptor activity [GO:0008046]; chemorepellent activity [GO:0045499]; GPI-linked ephrin receptor activity [GO:0005004]; growth factor binding [GO:0019838]; transmembrane-ephrin receptor activity [GO:0005005]
84,M3WSI8,M3WSI8_FELCA,Prothrombin (EC 3.4.21.5) (Coagulation factor II),F2,acute-phase response [GO:0006953]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell surface receptor signaling pathway [GO:0007166]; cytolysis by host of symbiont cells [GO:0051838]; fibrinolysis [GO:0042730]; G protein-coupled receptor signaling pathway [GO:0007186]; ligand-gated ion channel signaling pathway [GO:1990806]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of proteolysis [GO:0045861]; neutrophil-mediated killing of gram-negative bacterium [GO:0070945]; platelet activation [GO:0030168]; positive regulation of blood coagulation [GO:0030194]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of insulin secretion [GO:0032024]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900738]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; proteolysis [GO:0006508]; regulation of cell shape [GO:0008360]; regulation of cytosolic calcium ion concentration [GO:0051480],collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615],calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; lipopolysaccharide binding [GO:0001530]; serine-type endopeptidase activity [GO:0004252]; signaling receptor binding [GO:0005102]; thrombospondin receptor activity [GO:0070053]
85,M3WU80,M3WU80_FELCA,Transforming protein RhoA,RHOA,"alpha-beta T cell lineage commitment [GO:0002363]; androgen receptor signaling pathway [GO:0030521]; angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001998]; aortic valve formation [GO:0003189]; apical junction assembly [GO:0043297]; apolipoprotein A-I-mediated signaling pathway [GO:0038027]; beta selection [GO:0043366]; bone trabecula morphogenesis [GO:0061430]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell-matrix adhesion [GO:0007160]; cellular response to chemokine [GO:1990869]; cellular response to lipopolysaccharide [GO:0071222]; cerebral cortex cell migration [GO:0021795]; cytoplasmic microtubule organization [GO:0031122]; endothelial cell migration [GO:0043542]; endothelial tube lumen extension [GO:0097498]; establishment of epithelial cell apical/basal polarity [GO:0045198]; forebrain radial glial cell differentiation [GO:0021861]; kidney development [GO:0001822]; mitotic cleavage furrow formation [GO:1903673]; mitotic spindle assembly [GO:0090307]; motor neuron apoptotic process [GO:0097049]; negative chemotaxis [GO:0050919]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell size [GO:0045792]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of intracellular steroid hormone receptor signaling pathway [GO:0033144]; negative regulation of motor neuron apoptotic process [GO:2000672]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; neuron migration [GO:0001764]; odontogenesis [GO:0042476]; ossification involved in bone maturation [GO:0043931]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cytokinesis [GO:0032467]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of podosome assembly [GO:0071803]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of T cell migration [GO:2000406]; positive regulation of vascular associated smooth muscle contraction [GO:1904695]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of neuron projection development [GO:0010975]; regulation of osteoblast proliferation [GO:0033688]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of transcription by RNA polymerase II [GO:0006357]; Rho protein signal transduction [GO:0007266]; Roundabout signaling pathway [GO:0035385]; semaphorin-plexin signaling pathway [GO:0071526]; skeletal muscle satellite cell migration [GO:1902766]; skeletal muscle tissue development [GO:0007519]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; wound healing, spreading of cells [GO:0044319]",apical junction complex [GO:0043296]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin binding [GO:0017022]; protein kinase binding [GO:0019901]
86,M3WV39,M3WV39_FELCA,"Multiple inositol polyphosphate phosphatase 1 (EC 3.1.3.62) (EC 3.1.3.80) (2,3-bisphosphoglycerate 3-phosphatase)",MINPP1,intracellular monoatomic cation homeostasis [GO:0030003],endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],"acid phosphatase activity [GO:0003993]; bisphosphoglycerate 3-phosphatase activity [GO:0034417]; inositol bisphosphate phosphatase activity [GO:0016312]; inositol hexakisphosphate 2-phosphatase activity [GO:0052826]; inositol phosphate phosphatase activity [GO:0052745]; inositol trisphosphate phosphatase activity [GO:0046030]; inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity [GO:0030351]; inositol-1,4,5,6-tetrakisphosphate 6-phosphatase activity [GO:0030352]"
87,M3WX79,M3WX79_FELCA,CCN family member 1 (Cellular communication network factor 1) (Protein CYR61),CCN1,"apoptotic process involved in heart morphogenesis [GO:0003278]; atrial septum morphogenesis [GO:0060413]; atrioventricular valve morphogenesis [GO:0003181]; cell adhesion [GO:0007155]; chondroblast differentiation [GO:0060591]; chorio-allantoic fusion [GO:0060710]; extracellular matrix organization [GO:0030198]; intussusceptive angiogenesis [GO:0002041]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of apoptotic process [GO:0043066]; osteoblast differentiation [GO:0001649]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; reactive oxygen species metabolic process [GO:0072593]; regulation of ERK1 and ERK2 cascade [GO:0070372]; signal transduction [GO:0007165]; ventricular septum development [GO:0003281]; wound healing, spreading of cells [GO:0044319]",extracellular space [GO:0005615],extracellular matrix binding [GO:0050840]; growth factor binding [GO:0019838]; integrin binding [GO:0005178]
88,M3WXF7,M3WXF7_FELCA,vesicle-fusing ATPase (EC 3.6.4.6),VPS4B,angiogenesis [GO:0001525]; canonical Wnt signaling pathway [GO:0060070]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ESCRT III complex disassembly [GO:1904903]; establishment of blood-brain barrier [GO:0060856]; late endosomal microautophagy [GO:0061738]; midbody abscission [GO:0061952]; mitotic metaphase chromosome alignment [GO:0007080]; multivesicular body assembly [GO:0036258]; negative regulation of exosomal secretion [GO:1903542]; nucleus organization [GO:0006997]; positive regulation of centriole elongation [GO:1903724]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; potassium ion transport [GO:0006813]; protein depolymerization [GO:0051261]; regulation of mitotic spindle assembly [GO:1901673]; response to lipid [GO:0033993]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vacuole organization [GO:0007033]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702],centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; spindle pole [GO:0000922],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]
89,M3WXJ4,M3WXJ4_FELCA,Charged multivesicular body protein 4B,CHMP4B,autophagosome maturation [GO:0097352]; exit from mitosis [GO:0010458]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; maintenance of lens transparency [GO:0036438]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic metaphase chromosome alignment [GO:0007080]; nervous system process [GO:0050877]; nuclear membrane reassembly [GO:0031468]; plasma membrane repair [GO:0001778]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; protein polymerization [GO:0051258]; regulation of autophagy [GO:0010506]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vesicle budding from membrane [GO:0006900]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702],amphisome membrane [GO:1904930]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; membrane coat [GO:0030117]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643],protein homodimerization activity [GO:0042803]
90,M3WYR7,M3WYR7_FELCA,protein deglycase (EC 3.5.1.124) (Maillard deglycase) (Parkinsonism-associated deglycase) (Protein DJ-1) (Protein/nucleic acid deglycase DJ-1),PARK7,"adult locomotory behavior [GO:0008344]; autophagy [GO:0006914]; cellular response to glyoxal [GO:0036471]; cellular response to hydrogen peroxide [GO:0070301]; detection of oxidative stress [GO:0070994]; detoxification of copper ion [GO:0010273]; detoxification of hydrogen peroxide [GO:0061691]; detoxification of mercury ion [GO:0050787]; DNA repair [GO:0006281]; dopamine uptake involved in synaptic transmission [GO:0051583]; glucose homeostasis [GO:0042593]; glutathione deglycation [GO:0036531]; glycolate biosynthetic process [GO:0046295]; glyoxal metabolic process [GO:1903189]; guanine deglycation, glyoxal removal [GO:0106046]; guanine deglycation, methylglyoxal removal [GO:0106045]; inflammatory response [GO:0006954]; insulin secretion [GO:0030073]; lactate biosynthetic process [GO:0019249]; membrane depolarization [GO:0051899]; membrane hyperpolarization [GO:0060081]; methylglyoxal catabolic process to lactate [GO:0061727]; mitochondrion organization [GO:0007005]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein K48-linked deubiquitination [GO:1903094]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of TRAIL-activated apoptotic signaling pathway [GO:1903122]; positive regulation of acute inflammatory response to antigenic stimulus [GO:0002866]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of L-dopa biosynthetic process [GO:1903197]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of mitochondrial membrane potential [GO:0051881]; response to oxidative stress [GO:0006979]; single fertilization [GO:0007338]",cell body [GO:0044297]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane raft [GO:0045121]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; presynapse [GO:0098793],"cupric ion binding [GO:1903135]; cuprous ion binding [GO:1903136]; cytokine binding [GO:0019955]; glyoxalase (glycolic acid-forming) activity [GO:1990422]; kinase binding [GO:0019900]; L-dopa decarboxylase activator activity [GO:0036478]; mercury ion binding [GO:0045340]; mRNA binding [GO:0003729]; nuclear androgen receptor binding [GO:0050681]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; oxygen sensor activity [GO:0019826]; peptidase activity [GO:0008233]; peroxiredoxin activity [GO:0051920]; protein deglycase activity [GO:0036524]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; signaling receptor binding [GO:0005102]; small protein activating enzyme binding [GO:0044388]; superoxide dismutase copper chaperone activity [GO:0016532]; transcription coactivator activity [GO:0003713]; tyrosine 3-monooxygenase activator activity [GO:0036470]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-specific protease binding [GO:1990381]"
91,M3WYV4,M3WYV4_FELCA,Sodium-coupled monocarboxylate transporter 1 (Electrogenic sodium monocarboxylate cotransporter) (Solute carrier family 5 member 8),SLC5A8,acetate transport [GO:0006846]; chloride transport [GO:0006821]; iodide transport [GO:0015705]; nicotinate transport [GO:2001142]; nitrate transmembrane transport [GO:0015706]; propanoate transmembrane transport [GO:0015730]; pyruvate transport [GO:0006848]; sodium ion transport [GO:0006814],apical plasma membrane [GO:0016324]; GINS complex [GO:0000811],lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; organic acid:sodium symporter activity [GO:0005343]; propionate transmembrane transporter activity [GO:0015552]
92,M3X077,M3X077_FELCA,Neurogenic locus notch homolog protein 1,NOTCH1,aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; atrioventricular node development [GO:0003162]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac vascular smooth muscle cell development [GO:0060948]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart looping [GO:0001947]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222],adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],"calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888]"
93,M3X374,M3X374_FELCA,Sphingomyelin phosphodiesterase (EC 3.1.4.12),SMPD1,cellular response to calcium ion [GO:0071277]; cellular response to UV [GO:0034644]; ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; plasma membrane repair [GO:0001778]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of viral entry into host cell [GO:0046598]; response to interleukin-1 [GO:0070555]; response to ionizing radiation [GO:0010212]; response to tumor necrosis factor [GO:0034612]; response to type I interferon [GO:0034340]; response to virus [GO:0009615]; sphingomyelin catabolic process [GO:0006685]; symbiont entry into host cell [GO:0046718]; termination of signal transduction [GO:0023021],endolysosome [GO:0036019]; extracellular space [GO:0005615]; lysosome [GO:0005764]; plasma membrane [GO:0005886],"acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; zinc ion binding [GO:0008270]"
94,M3X3D3,M3X3D3_FELCA,Lysosomal phospholipase A and acyltransferase (EC 3.1.1.32) (EC 3.1.1.4) (EC 3.1.1.5) (1-O-acylceramide synthase) (LCAT-like lysophospholipase) (Lysophospholipase 3) (Lysosomal phospholipase A2) (Phospholipase A2 group XV),PLA2G15,ceramide metabolic process [GO:0006672]; diacylglycerol biosynthetic process [GO:0006651]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylethanolamine catabolic process [GO:0046338]; phosphatidylglycerol metabolic process [GO:0046471]; phosphatidylserine metabolic process [GO:0006658],extracellular space [GO:0005615]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654],acylglycerol O-acyltransferase activity [GO:0016411]; calcium-independent phospholipase A2 activity [GO:0047499]; O-acyltransferase activity [GO:0008374]; phospholipase A1 activity [GO:0008970]; zinc ion binding [GO:0008270]
95,M3X3T9,M3X3T9_FELCA,Plasminogen (EC 3.4.21.7),PLG,"biological process involved in interaction with symbiont [GO:0051702]; blood coagulation [GO:0007596]; extracellular matrix disassembly [GO:0022617]; fibrinolysis [GO:0042730]; labyrinthine layer blood vessel development [GO:0060716]; mononuclear cell migration [GO:0071674]; muscle cell cellular homeostasis [GO:0046716]; myoblast differentiation [GO:0045445]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of fibrinolysis [GO:0051918]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of fibrinolysis [GO:0051919]; proteolysis [GO:0006508]; tissue regeneration [GO:0042246]; tissue remodeling [GO:0048771]; trans-synaptic signaling by BDNF, modulating synaptic transmission [GO:0099183]; trophoblast giant cell differentiation [GO:0060707]",external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Schaffer collateral - CA1 synapse [GO:0098685],apolipoprotein binding [GO:0034185]; endopeptidase activity [GO:0004175]; kinase binding [GO:0019900]; protease binding [GO:0002020]; protein antigen binding [GO:1990405]; protein domain specific binding [GO:0019904]; protein-folding chaperone binding [GO:0051087]; serine-type endopeptidase activity [GO:0004252]; signaling receptor binding [GO:0005102]
96,M3XCH2,M3XCH2_FELCA,CD2 associated protein,CD2AP,actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; adipose tissue development [GO:0060612]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell junction organization [GO:0045216]; collateral sprouting [GO:0048668]; endothelium development [GO:0003158]; ERK1 and ERK2 cascade [GO:0070371]; filopodium assembly [GO:0046847]; glucose import [GO:0046323]; immunological synapse formation [GO:0001771]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; liver development [GO:0001889]; localization of cell [GO:0051674]; lymph node development [GO:0048535]; maintenance of blood-brain barrier [GO:0035633]; male gonad development [GO:0008584]; membrane organization [GO:0061024]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of transforming growth factor beta1 production [GO:0032911]; nerve growth factor signaling pathway [GO:0038180]; neurotrophin TRK receptor signaling pathway [GO:0048011]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; podocyte differentiation [GO:0072112]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein secretion [GO:0050714]; protein catabolic process [GO:0030163]; protein heterooligomerization [GO:0051291]; protein secretion [GO:0009306]; Rab protein signal transduction [GO:0032482]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of synaptic plasticity [GO:0048167]; renal albumin absorption [GO:0097018]; response to glial cell derived neurotrophic factor [GO:1990790]; response to insulin [GO:0032868]; response to oxidative stress [GO:0006979]; response to transforming growth factor beta [GO:0071559]; response to virus [GO:0009615]; response to wounding [GO:0009611]; stress-activated MAPK cascade [GO:0051403]; synapse organization [GO:0050808]; T cell receptor signaling pathway [GO:0050852]; transforming growth factor beta1 production [GO:0032905],cell leading edge [GO:0031252]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; fibrillar center [GO:0001650]; filamentous actin [GO:0031941]; growth cone [GO:0030426]; late endosome [GO:0005770]; neuromuscular junction [GO:0031594]; nuclear envelope lumen [GO:0005641]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; slit diaphragm [GO:0036057]; trans-Golgi network membrane [GO:0032588]; vesicle [GO:0031982],actin filament binding [GO:0051015]; clathrin binding [GO:0030276]; identical protein binding [GO:0042802]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; SH3 domain binding [GO:0017124]
97,M3XCN6,M3XCN6_FELCA,Protein disulfide-isomerase (EC 5.3.4.1),P4HB,cellular response to hypoxia [GO:0071456]; cellular response to interleukin-7 [GO:0098761]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; insulin processing [GO:0030070]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976],cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; lamellipodium [GO:0030027]; procollagen-proline 4-dioxygenase complex [GO:0016222],actin binding [GO:0003779]; integrin binding [GO:0005178]; procollagen-proline 4-dioxygenase activity [GO:0004656]; protein disulfide isomerase activity [GO:0003756]; protein heterodimerization activity [GO:0046982]; protein-disulfide reductase activity [GO:0015035]; thiol oxidase activity [GO:0016972]
98,M3XCQ9,M3XCQ9_FELCA,receptor protein serine/threonine kinase (EC 2.7.11.30),BMPR1A,angiogenesis [GO:0001525]; atrioventricular node cell development [GO:0060928]; BMP signaling pathway [GO:0030509]; cardiac right ventricle morphogenesis [GO:0003215]; cellular response to growth factor stimulus [GO:0071363]; central nervous system neuron differentiation [GO:0021953]; chondrocyte differentiation [GO:0002062]; developmental growth [GO:0048589]; dorsal aorta morphogenesis [GO:0035912]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; ectoderm development [GO:0007398]; embryonic digit morphogenesis [GO:0042733]; embryonic organ development [GO:0048568]; endocardial cushion formation [GO:0003272]; epithelial cell proliferation [GO:0050673]; fibrous ring of heart morphogenesis [GO:1905285]; heart formation [GO:0060914]; hindlimb morphogenesis [GO:0035137]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; lateral mesoderm development [GO:0048368]; lung development [GO:0030324]; mesendoderm development [GO:0048382]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; Mullerian duct regression [GO:0001880]; negative regulation of gene expression [GO:0010629]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of neurogenesis [GO:0050768]; negative regulation of smooth muscle cell migration [GO:0014912]; neural crest cell development [GO:0014032]; neural plate mediolateral regionalization [GO:0021998]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; outflow tract septum morphogenesis [GO:0003148]; paraxial mesoderm structural organization [GO:0048352]; pharyngeal arch artery morphogenesis [GO:0061626]; pituitary gland development [GO:0021983]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardiac ventricle development [GO:1904414]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta2 production [GO:0032915]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; regulation of cellular senescence [GO:2000772]; regulation of lateral mesodermal cell fate specification [GO:0048378]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; somitogenesis [GO:0001756]; transforming growth factor beta receptor signaling pathway [GO:0007179]; tricuspid valve morphogenesis [GO:0003186]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222],caveola [GO:0005901]; external side of plasma membrane [GO:0009897]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],"ATP binding [GO:0005524]; BMP binding [GO:0036122]; BMP receptor activity [GO:0098821]; protein homodimerization activity [GO:0042803]; SMAD binding [GO:0046332]; transforming growth factor beta receptor activity, type I [GO:0005025]"
99,P07412,HBB_FELCA,Hemoglobin subunit beta-A/B (Beta-A/B-globin) (Hemoglobin beta-A/B chain),HBB,cellular oxidant detoxification [GO:0098869]; hydrogen peroxide catabolic process [GO:0042744],haptoglobin-hemoglobin complex [GO:0031838]; hemoglobin complex [GO:0005833],heme binding [GO:0020037]; hemoglobin alpha binding [GO:0031721]; metal ion binding [GO:0046872]; organic acid binding [GO:0043177]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]
100,P11979,KPYM_FELCA,Pyruvate kinase PKM (EC 2.7.1.40) (Pyruvate kinase muscle isozyme) (Threonine-protein kinase PKM2) (EC 2.7.11.1) (Tyrosine-protein kinase PKM2) (EC 2.7.10.2),PKM PKM2,cellular response to insulin stimulus [GO:0032869]; glycolytic process [GO:0006096]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of sprouting angiogenesis [GO:1903672],cytoplasm [GO:0005737]; nucleus [GO:0005634]; rough endoplasmic reticulum [GO:0005791],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; mRNA binding [GO:0003729]; potassium ion binding [GO:0030955]; protein tyrosine kinase activity [GO:0004713]; pyruvate kinase activity [GO:0004743]
101,P13369,CSF1R_FELCA,Macrophage colony-stimulating factor 1 receptor (CSF-1 receptor) (CSF-1-R) (CSF-1R) (M-CSF-R) (EC 2.7.10.1) (Proto-oncogene c-Fms) (CD antigen CD115),CSF1R FMS,cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to cytokine stimulus [GO:0071345]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; osteoclast differentiation [GO:0030316]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of bone resorption [GO:0045124]; regulation of cell shape [GO:0008360]; regulation of macrophage migration [GO:1905521]; regulation of MAPK cascade [GO:0043408]; ruffle organization [GO:0031529],cell surface [GO:0009986]; CSF1-CSF1R complex [GO:1990682]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],ATP binding [GO:0005524]; cytokine binding [GO:0019955]; growth factor binding [GO:0019838]; macrophage colony-stimulating factor receptor activity [GO:0005011]
102,P49064,ALBU_FELCA,Albumin (allergen Fel d 2),ALB,cellular response to calcium ion starvation [GO:0072732]; cellular response to starvation [GO:0009267]; negative regulation of mitochondrial depolarization [GO:0051902],cytoplasm [GO:0005737]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991],DNA binding [GO:0003677]; enterobactin binding [GO:1903981]; fatty acid binding [GO:0005504]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]; toxic substance binding [GO:0015643]
103,P49614,HEXB_FELCA,Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (N-acetyl-beta-glucosaminidase subunit beta),HEXB,carbohydrate metabolic process [GO:0005975]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan metabolic process [GO:0030203]; single fertilization [GO:0007338],cortical granule [GO:0060473]; lysosome [GO:0005764]; membrane [GO:0016020],beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]
104,P53713,ITB1_FELCA,Integrin beta-1 (Fibronectin receptor subunit beta) (VLA-4 subunit beta) (CD antigen CD29),ITGB1,cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; integrin-mediated signaling pathway [GO:0007229]; muscle organ development [GO:0007517]; myoblast differentiation [GO:0045445]; myoblast fusion [GO:0007520]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of cell migration [GO:0030335]; positive regulation of protein localization to plasma membrane [GO:1903078]; receptor internalization [GO:0031623]; regulation of collagen catabolic process [GO:0010710],cell surface [GO:0009986]; focal adhesion [GO:0005925]; integrin alpha9-beta1 complex [GO:0034679]; integrin complex [GO:0008305]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; recycling endosome [GO:0055037]; ruffle membrane [GO:0032587]; synapse [GO:0045202],collagen binding involved in cell-matrix adhesion [GO:0098639]; fibronectin binding [GO:0001968]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]
105,P79169,SCF_FELCA,Kit ligand (Mast cell growth factor) (MGF) (Stem cell factor) (SCF) (c-Kit ligand) [Cleaved into: Soluble KIT ligand (sKITLG)],KITLG SCF,cell adhesion [GO:0007155]; positive regulation of cell population proliferation [GO:0008284],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886],cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; stem cell factor receptor binding [GO:0005173]
106,P79171,AMPN_FELCA,Aminopeptidase N (AP-N) (fAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (CD antigen CD13),ANPEP APN,angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]
107,Q28889,KIT_FELCA,Mast/stem cell growth factor receptor Kit (SCFR) (EC 2.7.10.1) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (CD antigen CD117),KIT,actin cytoskeleton organization [GO:0030036]; B cell differentiation [GO:0030183]; cell chemotaxis [GO:0060326]; cytokine-mediated signaling pathway [GO:0019221]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; digestive tract development [GO:0048565]; embryonic hemopoiesis [GO:0035162]; erythrocyte differentiation [GO:0030218]; erythropoietin-mediated signaling pathway [GO:0038162]; Fc receptor signaling pathway [GO:0038093]; hematopoietic progenitor cell differentiation [GO:0002244]; immature B cell differentiation [GO:0002327]; inflammatory response [GO:0006954]; Kit signaling pathway [GO:0038109]; lamellipodium assembly [GO:0030032]; mast cell degranulation [GO:0043303]; mast cell differentiation [GO:0060374]; megakaryocyte development [GO:0035855]; melanocyte adhesion [GO:0097326]; melanocyte differentiation [GO:0030318]; melanocyte migration [GO:0097324]; ovarian follicle development [GO:0001541]; pigmentation [GO:0043473]; positive regulation of cell migration [GO:0030335]; positive regulation of dendritic cell cytokine production [GO:0002732]; positive regulation of mast cell cytokine production [GO:0032765]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of cell shape [GO:0008360]; spermatogenesis [GO:0007283]; stem cell differentiation [GO:0048863]; T cell differentiation [GO:0030217],plasma membrane [GO:0005886]; receptor complex [GO:0043235],ATP binding [GO:0005524]; cytokine binding [GO:0019955]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]
108,Q29486,PPBT_FELCA,"Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase liver/bone/kidney isozyme) (Phosphoamidase) (Phosphocreatine phosphatase) (EC 3.9.1.1)",ALPL,bone mineralization [GO:0030282]; dephosphorylation [GO:0016311]; positive regulation of cold-induced thermogenesis [GO:0120162],mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; side of membrane [GO:0098552],ADP phosphatase activity [GO:0043262]; alkaline phosphatase activity [GO:0004035]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; inorganic diphosphate phosphatase activity [GO:0004427]; phosphoamidase activity [GO:0050187]; phosphoethanolamine phosphatase activity [GO:0052732]; pyridoxal phosphatase activity [GO:0033883]; pyrophosphatase activity [GO:0016462]
109,Q2WGK2,JAM1_FELCA,Junctional adhesion molecule A (JAM-A) (Junctional adhesion molecule 1) (JAM-1) (CD antigen CD321),F11R JAM1,cell adhesion [GO:0007155]; establishment of endothelial intestinal barrier [GO:0090557]; intestinal absorption [GO:0050892]; regulation of membrane permeability [GO:0090559],bicellular tight junction [GO:0005923]; plasma membrane [GO:0005886],virus receptor activity [GO:0001618]
110,Q56H28,ACE2_FELCA,Angiotensin-converting enzyme 2 (EC 3.4.17.23) (ACE-related carboxypeptidase) (EC 3.4.17.-) [Cleaved into: Processed angiotensin-converting enzyme 2],ACE2,proteolysis [GO:0006508],apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; virus receptor activity [GO:0001618]
111,Q594P2,MYOC_FELCA,"Myocilin [Cleaved into: Myocilin, N-terminal fragment (Myocilin 20 kDa N-terminal fragment); Myocilin, C-terminal fragment (Myocilin 35 kDa N-terminal fragment)]",MYOC,bone development [GO:0060348]; clustering of voltage-gated sodium channels [GO:0045162]; ERBB2-ERBB3 signaling pathway [GO:0038133]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; neuron projection development [GO:0031175]; non-canonical Wnt signaling pathway [GO:0035567]; osteoblast differentiation [GO:0001649]; positive regulation of cell migration [GO:0030335]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of MAPK cascade [GO:0043408]; signal transduction [GO:0007165]; skeletal muscle hypertrophy [GO:0014734],cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial outer membrane [GO:0005741]; node of Ranvier [GO:0033268]; rough endoplasmic reticulum [GO:0005791],metal ion binding [GO:0046872]
112,Q66RN5,EF1A1_FELCA,Elongation factor 1-alpha 1 (EF-1-alpha-1) (EC 3.6.5.-) (Elongation factor Tu) (EF-Tu) (Eukaryotic elongation factor 1 A-1) (eEF1A-1),EEF1A1 EEF1A,cellular response to epidermal growth factor stimulus [GO:0071364]; regulation of D-erythro-sphingosine kinase activity [GO:1900022]; translation [GO:0006412]; translational elongation [GO:0006414],cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]
113,Q8HXS3,PPIA_FELCA,"Peptidyl-prolyl cis-trans isomerase A (PPIase A) (EC 5.2.1.8) (Cyclophilin A) (Cyclosporin A-binding protein) (Rotamase A) [Cleaved into: Peptidyl-prolyl cis-trans isomerase A, N-terminally processed]",PPIA CYPA,activation of protein kinase B activity [GO:0032148]; apoptotic process [GO:0006915]; cell adhesion molecule production [GO:0060352]; cellular response to oxidative stress [GO:0034599]; endothelial cell activation [GO:0042118]; leukocyte chemotaxis [GO:0030595]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein K48-linked ubiquitination [GO:0061944]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of stress-activated MAPK cascade [GO:0032873]; neutrophil chemotaxis [GO:0030593]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein phosphorylation [GO:0001934]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of apoptotic signaling pathway [GO:2001233]; regulation of viral genome replication [GO:0045069],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleus [GO:0005634],cyclosporin A binding [GO:0016018]; heparan sulfate binding [GO:1904399]; integrin binding [GO:0005178]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]
114,Q8I034,EST5A_FELCA,Carboxylesterase 5A (EC 3.1.1.1) (Carboxylesterase-like urinary excreted protein) (Cauxin),CES5A CES7,,extracellular region [GO:0005576],carboxylesterase activity [GO:0106435]
115,Q9N2C1,LEP_FELCA,Leptin (Obesity factor),LEP OB,activation of protein kinase C activity [GO:1990051]; adipose tissue development [GO:0060612]; adult feeding behavior [GO:0008343]; angiogenesis [GO:0001525]; aorta development [GO:0035904]; bile acid metabolic process [GO:0008206]; bone growth [GO:0098868]; cellular response to insulin stimulus [GO:0032869]; cellular response to leptin stimulus [GO:0044320]; central nervous system neuron development [GO:0021954]; cholesterol metabolic process [GO:0008203]; determination of adult lifespan [GO:0008340]; eating behavior [GO:0042755]; elastin metabolic process [GO:0051541]; energy reserve metabolic process [GO:0006112]; fatty acid beta-oxidation [GO:0006635]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; hormone metabolic process [GO:0042445]; insulin secretion [GO:0030073]; intestinal absorption [GO:0050892]; leptin-mediated signaling pathway [GO:0033210]; lipid metabolic process [GO:0006629]; negative regulation of appetite [GO:0032099]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of autophagy [GO:0010507]; negative regulation of glucagon secretion [GO:0070093]; negative regulation of glucose import [GO:0046325]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phagocytosis [GO:0006909]; placenta development [GO:0001890]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of developmental growth [GO:0048639]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of TOR signaling [GO:0032008]; positive regulation of tumor necrosis factor production [GO:0032760]; prostaglandin secretion [GO:0032310]; regulation of angiogenesis [GO:0045765]; regulation of bone remodeling [GO:0046850]; regulation of brown fat cell differentiation [GO:0090335]; regulation of cell cycle [GO:0051726]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of endothelial cell proliferation [GO:0001936]; regulation of gluconeogenesis [GO:0006111]; regulation of insulin secretion [GO:0050796]; regulation of intestinal cholesterol absorption [GO:0030300]; regulation of natural killer cell activation [GO:0032814]; regulation of natural killer cell mediated cytotoxicity [GO:0042269]; regulation of natural killer cell proliferation [GO:0032817]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of steroid biosynthetic process [GO:0050810]; response to dietary excess [GO:0002021]; response to insulin [GO:0032868]; sexual reproduction [GO:0019953]; T cell differentiation [GO:0030217],cytoplasm [GO:0005737]; extracellular space [GO:0005615],DNA binding [GO:0003677]; hormone activity [GO:0005179]; leptin receptor binding [GO:1990460]; peptide hormone receptor binding [GO:0051428]
116,Q9N2D5,G3P_FELCA,Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12) (Peptidyl-cysteine S-nitrosylase GAPDH) (EC 2.6.99.-),GAPDH GAPD,glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; innate immune response [GO:0045087]; microtubule cytoskeleton organization [GO:0000226]; neuron apoptotic process [GO:0051402]; peptidyl-cysteine S-trans-nitrosylation [GO:0035606]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of type I interferon production [GO:0032481]; protein stabilization [GO:0050821]; regulation of translation [GO:0006417],cytoplasm [GO:0005737]; cytosol [GO:0005829]; GAIT complex [GO:0097452]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634],glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; microtubule binding [GO:0008017]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; peptidyl-cysteine S-nitrosylase activity [GO:0035605]
117,Q9N2I7,DPP4_FELCA,Dipeptidyl peptidase 4 (EC 3.4.14.5) (Dipeptidyl peptidase IV) (DPP IV) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form)],DPP4 CD26,cell adhesion [GO:0007155]; endothelial cell migration [GO:0043542]; negative regulation of extracellular matrix disassembly [GO:0010716]; positive regulation of cell population proliferation [GO:0008284]; proteolysis [GO:0006508]; T cell costimulation [GO:0031295],anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; extracellular region [GO:0005576]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; membrane raft [GO:0045121]; plasma membrane [GO:0005886],aminopeptidase activity [GO:0004177]; dipeptidyl-peptidase activity [GO:0008239]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]; signaling receptor binding [GO:0005102]
118,W5LV43,W5LV43_FELCA,Platelet-derived growth factor subunit B (PDGF-2) (Platelet-derived growth factor B chain) (Platelet-derived growth factor beta polypeptide),PDGFB,cellular response to growth factor stimulus [GO:0071363]; gene expression [GO:0010467]; interleukin-18-mediated signaling pathway [GO:0035655]; monocyte chemotaxis [GO:0002548]; negative regulation of gene expression [GO:0010629]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of phosphatidylinositol biosynthetic process [GO:0010512]; negative regulation of platelet activation [GO:0010544]; negative regulation of vascular associated smooth muscle cell differentiation [GO:1905064]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of chemotaxis [GO:0050921]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of glomerular mesangial cell proliferation [GO:0072126]; positive regulation of hyaluronan biosynthetic process [GO:1900127]; positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway [GO:0035793]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of vascular associated smooth muscle cell dedifferentiation [GO:1905176]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein kinase C signaling [GO:0070528]; reactive oxygen species metabolic process [GO:0072593]; response to wounding [GO:0009611],cell surface [GO:0009986]; extracellular space [GO:0005615]; membrane [GO:0016020]; platelet-derived growth factor complex [GO:1990265],chemoattractant activity [GO:0042056]; collagen binding [GO:0005518]; growth factor activity [GO:0008083]; platelet-derived growth factor binding [GO:0048407]; platelet-derived growth factor receptor binding [GO:0005161]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; superoxide-generating NADPH oxidase activator activity [GO:0016176]
119,A0A2I2U2C0,A0A2I2U2C0_FELCA,Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor),FAS,activation-induced cell death of T cells [GO:0006924]; cellular response to amino acid starvation [GO:0034198]; cellular response to hyperoxia [GO:0071455]; cellular response to mechanical stimulus [GO:0071260]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; Fas signaling pathway [GO:0036337]; immune response [GO:0006955]; motor neuron apoptotic process [GO:0097049]; necroptotic signaling pathway [GO:0097527]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of protein phosphorylation [GO:0001934]; regulation of stress-activated MAPK cascade [GO:0032872],CD95 death-inducing signaling complex [GO:0031265]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; membrane raft [GO:0045121]; nuclear body [GO:0016604],calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; tumor necrosis factor receptor activity [GO:0005031]
120,A0A2I2U3E4,A0A2I2U3E4_FELCA,Alpha-actinin-4 (Non-muscle alpha-actinin 4),ACTN4,actin cytoskeleton organization [GO:0030036]; muscle cell development [GO:0055001]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; positive regulation of cell migration [GO:0030335]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; retinoic acid receptor signaling pathway [GO:0048384]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; vesicle transport along actin filament [GO:0030050],anchoring junction [GO:0070161]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; stress fiber [GO:0001725]; Z disc [GO:0030018],actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; nuclear receptor coactivator activity [GO:0030374]; nuclear retinoic acid receptor binding [GO:0042974]; nucleoside binding [GO:0001882]; protein homodimerization activity [GO:0042803]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transmembrane transporter binding [GO:0044325]
121,A0A2I2U3N0,A0A2I2U3N0_FELCA,Superoxide dismutase (EC 1.15.1.1),SOD2,intracellular oxygen homeostasis [GO:0032364]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of cell migration [GO:0030335]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; positive regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching [GO:1905932]; protein homotetramerization [GO:0051289]; regulation of transcription by RNA polymerase II [GO:0006357],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],identical protein binding [GO:0042802]; manganese ion binding [GO:0030145]; superoxide dismutase activity [GO:0004784]
122,A0A2I2U4B5,A0A2I2U4B5_FELCA,Nucleoside diphosphate kinase (EC 2.7.4.6),NME2,CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of apoptotic process [GO:0043066]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; UTP biosynthetic process [GO:0006228],cell periphery [GO:0071944]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; ruffle [GO:0001726],ATP binding [GO:0005524]; G-quadruplex DNA binding [GO:0051880]; GDP binding [GO:0019003]; nucleoside diphosphate kinase activity [GO:0004550]; transcription coactivator activity [GO:0003713]
123,A0A2I2U5A2,A0A2I2U5A2_FELCA,Aquaporin-2 (ADH water channel) (Aquaporin-CD) (Collecting duct water channel protein) (WCH-CD) (Water channel protein for renal collecting duct),AQP2,actin filament organization [GO:0007015]; cellular response to copper ion [GO:0071280]; cellular response to mercury ion [GO:0071288]; cellular response to water deprivation [GO:0042631]; metanephric collecting duct development [GO:0072205]; protein homotetramerization [GO:0051289]; renal water transport [GO:0003097]; water transport [GO:0006833],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lateral plasma membrane [GO:0016328]; lumenal side of membrane [GO:0098576]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037],glycerol transmembrane transporter activity [GO:0015168]; water channel activity [GO:0015250]
124,A0A2I2U6L5,A0A2I2U6L5_FELCA,Glypican-1,GPC1,cell migration [GO:0016477]; heparan sulfate proteoglycan catabolic process [GO:0030200]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; positive regulation of skeletal muscle cell differentiation [GO:2001016]; regulation of protein localization to membrane [GO:1905475],cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; side of membrane [GO:0098552]; synapse [GO:0045202],copper ion binding [GO:0005507]; fibroblast growth factor binding [GO:0017134]; laminin binding [GO:0043236]
125,A0A2I2U7V2,A0A2I2U7V2_FELCA,Frizzled class receptor 7,FZD7,canonical Wnt signaling pathway [GO:0060070]; mesenchymal to epithelial transition [GO:0060231]; negative regulation of cardiac muscle cell differentiation [GO:2000726]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of ectodermal cell fate specification [GO:0042666]; non-canonical Wnt signaling pathway [GO:0035567]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphorylation [GO:0042327]; regulation of canonical Wnt signaling pathway [GO:0060828]; skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration [GO:0014834]; somatic stem cell division [GO:0048103]; stem cell population maintenance [GO:0019827]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell differentiation in thymus [GO:0033077],plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038],"frizzled binding [GO:0005109]; G protein-coupled receptor activity [GO:0004930]; PDZ domain binding [GO:0030165]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]"
126,A0A2I2U8W9,A0A2I2U8W9_FELCA,Vimentin,VIM,astrocyte development [GO:0014002]; Bergmann glial cell differentiation [GO:0060020]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to muramyl dipeptide [GO:0071225]; cellular response to type II interferon [GO:0071346]; intermediate filament organization [GO:0045109]; lens fiber cell development [GO:0070307]; negative regulation of neuron projection development [GO:0010977]; neuron projection development [GO:0031175]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of gene expression [GO:0010628]; regulation of mRNA stability [GO:0043488],axon [GO:0030424]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; nuclear matrix [GO:0016363]; peroxisome [GO:0005777]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886],double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; keratin filament binding [GO:1990254]; protein domain specific binding [GO:0019904]; scaffold protein binding [GO:0097110]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of eye lens [GO:0005212]
127,A0A2I2U9B2,A0A2I2U9B2_FELCA,Tyrosine-protein kinase (EC 2.7.10.2),HCK,cell differentiation [GO:0030154]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of phagocytosis [GO:0050764]; regulation of podosome assembly [GO:0071801],actin filament [GO:0005884]; caveola [GO:0005901]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lysosome [GO:0005764]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; signaling receptor binding [GO:0005102]
128,A0A2I2UB75,A0A2I2UB75_FELCA,Cadherin 3,CDH3,adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell junction assembly [GO:0007043]; hair cycle process [GO:0022405]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; keratinization [GO:0031424]; negative regulation of timing of catagen [GO:0051796]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of melanosome transport [GO:1902910]; retina homeostasis [GO:0001895],adherens junction [GO:0005912]; catenin complex [GO:0016342]; cytoplasm [GO:0005737],beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]
129,A0A2I2UDB3,A0A2I2UDB3_FELCA,Chitinase-3-like protein 1,CHI3L1,apoptotic process [GO:0006915]; carbohydrate metabolic process [GO:0005975]; chitin catabolic process [GO:0006032]; inflammatory response [GO:0006954]; lung development [GO:0030324]; positive regulation of angiogenesis [GO:0045766]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; response to interleukin-1 [GO:0070555]; response to interleukin-6 [GO:0070741]; response to mechanical stimulus [GO:0009612]; response to tumor necrosis factor [GO:0034612],endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615],carbohydrate binding [GO:0030246]; chitin binding [GO:0008061]
130,A0A2I2UFL9,A0A2I2UFL9_FELCA,Hepcidin antimicrobial peptide,HAMP,cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; establishment of localization in cell [GO:0051649]; inflammatory response [GO:0006954]; intracellular iron ion homeostasis [GO:0006879]; iron ion transmembrane transport [GO:0034755]; macrophage activation [GO:0042116]; multicellular organismal-level iron ion homeostasis [GO:0060586]; myeloid cell homeostasis [GO:0002262]; negative regulation of bone resorption [GO:0045779]; negative regulation of inflammatory response [GO:0050728]; negative regulation of intestinal absorption [GO:1904479]; negative regulation of iron ion transmembrane transport [GO:0034760]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of macrophage activation [GO:0043032]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein catabolic process [GO:0030163]; response to iron ion [GO:0010039]; transcription by RNA polymerase II [GO:0006366],extracellular space [GO:0005615]; nucleus [GO:0005634],copper ion binding [GO:0005507]
131,A0A2I2UL25,A0A2I2UL25_FELCA,Peroxiredoxin-6 (EC 1.11.1.27),PRDX6,"cell redox homeostasis [GO:0045454]; glycerophospholipid catabolic process [GO:0046475]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; response to oxidative stress [GO:0006979]",cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; calcium-independent phospholipase A2 activity [GO:0047499]; glutathione peroxidase activity [GO:0004602]; identical protein binding [GO:0042802]; peroxiredoxin activity [GO:0051920]; ubiquitin protein ligase binding [GO:0031625]
132,A0A2I2UMT8,A0A2I2UMT8_FELCA,Ras-related protein Rab-8A (EC 3.6.5.2),RAB8A,cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; exocytosis [GO:0006887]; Golgi organization [GO:0007030]; Golgi vesicle fusion to target membrane [GO:0048210]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; protein secretion [GO:0009306]; regulation of autophagy [GO:0010506]; vesicle docking involved in exocytosis [GO:0006904],centriole [GO:0005814]; centrosome [GO:0005813]; dendritic spine [GO:0043197]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; trans-Golgi network transport vesicle [GO:0030140],GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]
133,A0A2I2URL1,A0A2I2URL1_FELCA,"ADP/ATP translocase (ADP,ATP carrier protein)",SLC25A4,adaptive thermogenesis [GO:1990845]; apoptotic mitochondrial changes [GO:0008637]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of necroptotic process [GO:0060546]; positive regulation of mitophagy [GO:1901526],mitochondrial inner membrane [GO:0005743]; mitochondrial permeability transition pore complex [GO:0005757],ATP:ADP antiporter activity [GO:0005471]; oxidative phosphorylation uncoupler activity [GO:0017077]; proton transmembrane transporter activity [GO:0015078]
134,A0A2I2USM1,A0A2I2USM1_FELCA,Monocarboxylate transporter 1 (Solute carrier family 16 member 1),SLC16A1,behavioral response to nutrient [GO:0051780]; centrosome cycle [GO:0007098]; glucose homeostasis [GO:0042593]; lipid metabolic process [GO:0006629]; plasma membrane lactate transport [GO:0035879]; pyruvate catabolic process [GO:0042867]; regulation of insulin secretion [GO:0050796]; response to food [GO:0032094],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; centrosome [GO:0005813]; intracellular membrane-bounded organelle [GO:0043231]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; synapse [GO:0045202],lactate:proton symporter activity [GO:0015650]; succinate transmembrane transporter activity [GO:0015141]
135,A0A2I2UTE6,A0A2I2UTE6_FELCA,phosphopyruvate hydratase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase),ENO1,canonical glycolysis [GO:0061621]; glycolytic process [GO:0006096]; negative regulation of cell growth [GO:0030308]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of muscle contraction [GO:0045933]; positive regulation of plasminogen activation [GO:0010756]; response to virus [GO:0009615],cell cortex [GO:0005938]; cell surface [GO:0009986]; nuclear outer membrane [GO:0005640]; phosphopyruvate hydratase complex [GO:0000015]; plasma membrane [GO:0005886],"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; GTPase binding [GO:0051020]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; protein homodimerization activity [GO:0042803]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]"
136,A0A2I2UTR9,A0A2I2UTR9_FELCA,Neogenin 1,NEO1,axon guidance [GO:0007411]; cell-cell adhesion [GO:0098609]; intracellular iron ion homeostasis [GO:0006879]; multicellular organismal-level iron ion homeostasis [GO:0060586]; myoblast fusion [GO:0007520]; negative regulation of axon regeneration [GO:0048681]; negative regulation of protein secretion [GO:0050709]; neuron migration [GO:0001764]; positive regulation of BMP signaling pathway [GO:0030513]; protein secretion [GO:0009306]; regulation of DNA-templated transcription [GO:0006355],axonal growth cone [GO:0044295]; cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797],BMP receptor binding [GO:0070700]; cadherin binding [GO:0045296]; co-receptor binding [GO:0039706]; signaling receptor activity [GO:0038023]
137,A0A2I2UU60,A0A2I2UU60_FELCA,"Oxidized purine nucleoside triphosphate hydrolase (EC 3.6.1.56) (2-hydroxy-dATP diphosphatase) (7,8-dihydro-8-oxoguanine triphosphatase) (8-oxo-dGTPase) (Methylated purine nucleoside triphosphate hydrolase) (Nucleoside diphosphate-linked moiety X motif 1)",NUDT1,DNA protection [GO:0042262],nucleus [GO:0005634],"8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity [GO:0008413]; metal ion binding [GO:0046872]"
138,A0A2I2UU74,A0A2I2UU74_FELCA,Paraoxonase (EC 3.1.1.2),PON1,aromatic compound catabolic process [GO:0019439]; carboxylic acid catabolic process [GO:0046395]; cholesterol metabolic process [GO:0008203]; organophosphate catabolic process [GO:0046434]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of cholesterol efflux [GO:0010875]; response to toxic substance [GO:0009636],extracellular space [GO:0005615]; spherical high-density lipoprotein particle [GO:0034366],acyl-L-homoserine-lactone lactonohydrolase activity [GO:0102007]; aryldialkylphosphatase activity [GO:0004063]; arylesterase activity [GO:0004064]; calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; protein homodimerization activity [GO:0042803]
139,A0A2I2UXU4,A0A2I2UXU4_FELCA,Voltage-dependent anion-selective channel protein 1,VDAC1,apoptotic process [GO:0006915]; behavioral fear response [GO:0001662]; epithelial cell differentiation [GO:0030855]; learning [GO:0007612]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcium import into the mitochondrion [GO:0110099]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; neuron-neuron synaptic transmission [GO:0007270]; positive regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:1905091],membrane raft [GO:0045121]; mitochondrial nucleoid [GO:0042645]; mitochondrial outer membrane [GO:0005741]; mitochondrial permeability transition pore complex [GO:0005757]; plasma membrane [GO:0005886]; synapse [GO:0045202],ceramide binding [GO:0097001]; cholesterol binding [GO:0015485]; identical protein binding [GO:0042802]; oxysterol binding [GO:0008142]; phosphatidylcholine binding [GO:0031210]; porin activity [GO:0015288]; protein kinase binding [GO:0019901]; transmembrane transporter binding [GO:0044325]; voltage-gated monoatomic anion channel activity [GO:0008308]
140,A0A2I2UZE5,A0A2I2UZE5_FELCA,Peroxiredoxin-1 (EC 1.11.1.24),PRDX1,canonical NF-kappaB signal transduction [GO:0007249]; cell redox homeostasis [GO:0045454]; erythrocyte homeostasis [GO:0034101]; fibroblast proliferation [GO:0048144]; hydrogen peroxide catabolic process [GO:0042744]; leukocyte activation [GO:0045321]; natural killer cell activation [GO:0030101]; natural killer cell mediated cytotoxicity [GO:0042267]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of stress-activated MAPK cascade [GO:0032872]; removal of superoxide radicals [GO:0019430]; response to oxidative stress [GO:0006979],cytosol [GO:0005829]; nucleus [GO:0005634],identical protein binding [GO:0042802]; thioredoxin peroxidase activity [GO:0008379]
141,A0A2I2V1M2,A0A2I2V1M2_FELCA,Sorbitol dehydrogenase (SDH) (XDH) (EC 1.1.1.14) (EC 1.1.1.9) (L-iditol 2-dehydrogenase) (Polyol dehydrogenase) (Xylitol dehydrogenase),SORD,flagellated sperm motility [GO:0030317]; fructose biosynthetic process [GO:0046370]; glucuronate catabolic process to xylulose 5-phosphate [GO:0019640]; L-xylitol catabolic process [GO:0051160]; sorbitol catabolic process [GO:0006062],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514],D-sorbitol dehydrogenase (acceptor) activity [GO:0047833]; D-xylulose reductase activity [GO:0046526]; identical protein binding [GO:0042802]; L-iditol 2-dehydrogenase activity [GO:0003939]; NAD binding [GO:0051287]; zinc ion binding [GO:0008270]
142,A0A2I2V455,A0A2I2V455_FELCA,N-acylethanolamine-hydrolyzing acid amidase (EC 3.5.1.23) (EC 3.5.1.60) (Acylsphingosine deacylase NAAA),NAAA,fatty acid metabolic process [GO:0006631]; lipid catabolic process [GO:0016042],lysosome [GO:0005764]; membrane [GO:0016020],ceramidase activity [GO:0102121]; fatty acid amide hydrolase activity [GO:0017064]; N-acylsphingosine amidohydrolase activity [GO:0017040]
143,A0A337RXK1,A0A337RXK1_FELCA,Arylsulfatase (EC 3.1.6.1) (EC 3.1.6.14) (N-acetylglucosamine-6-sulfatase),SULF2,,cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; Golgi stack [GO:0005795],calcium ion binding [GO:0005509]; sulfuric ester hydrolase activity [GO:0008484]
144,A0A337RYS5,A0A337RYS5_FELCA,protein-tyrosine-phosphatase (EC 3.1.3.48),PTPRD,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; neuron differentiation [GO:0030182]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse assembly [GO:0051965]; presynaptic membrane assembly [GO:0097105]; regulation of immune response [GO:0050776]; regulation of postsynaptic density assembly [GO:0099151]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling by trans-synaptic complex [GO:0099545],glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685],cell adhesion molecule binding [GO:0050839]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]
145,A0A337RZZ8,A0A337RZZ8_FELCA,Calbindin,CALB1,cellular response to organic substance [GO:0071310]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; metanephric collecting duct development [GO:0072205]; metanephric connecting tubule development [GO:0072286]; metanephric distal convoluted tubule development [GO:0072221]; metanephric part of ureteric bud development [GO:0035502]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; retina layer formation [GO:0010842]; short-term memory [GO:0007614],cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; synapse [GO:0045202]; terminal bouton [GO:0043195],calcium ion binding [GO:0005509]; calcium ion binding involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099567]; calcium ion binding involved in regulation of presynaptic cytosolic calcium ion concentration [GO:0099534]; vitamin D binding [GO:0005499]; zinc ion binding [GO:0008270]
146,A0A337S0H8,A0A337S0H8_FELCA,EPH-related receptor tyrosine kinase ligand 7,EFNA5,axon guidance [GO:0007411]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to forskolin [GO:1904322]; collateral sprouting [GO:0048668]; ephrin receptor signaling pathway [GO:0048013]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of synapse assembly [GO:0051965]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell morphogenesis [GO:0022604]; regulation of cell-cell adhesion [GO:0022407]; regulation of focal adhesion assembly [GO:0051893]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of microtubule cytoskeleton organization [GO:0070507]; retinal ganglion cell axon guidance [GO:0031290]; synaptic membrane adhesion [GO:0099560],adherens junction [GO:0005912]; basement membrane [GO:0005604]; external side of plasma membrane [GO:0009897]; GABA-ergic synapse [GO:0098982]; plasma membrane [GO:0005886],chemorepellent activity [GO:0045499]; ephrin receptor binding [GO:0046875]; neurotrophin TRKB receptor binding [GO:0005169]
147,A0A337S381,A0A337S381_FELCA,Profilin,PFN2,actin cytoskeleton organization [GO:0030036]; modification of postsynaptic actin cytoskeleton [GO:0098885]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of stress fiber assembly [GO:0051496]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein stabilization [GO:0050821]; regulation of actin filament polymerization [GO:0030833]; regulation of synaptic vesicle exocytosis [GO:2000300],cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; postsynapse [GO:0098794]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685],"actin binding [GO:0003779]; actin monomer binding [GO:0003785]; ATP hydrolysis activity [GO:0016887]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"
148,A0A337S4Q5,A0A337S4Q5_FELCA,Galectin,LGALS3,eosinophil chemotaxis [GO:0048245]; epithelial cell differentiation [GO:0030855]; macrophage chemotaxis [GO:0048246]; monocyte chemotaxis [GO:0002548]; negative regulation of endocytosis [GO:0045806]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neutrophil chemotaxis [GO:0030593]; positive chemotaxis [GO:0050918]; positive regulation of calcium ion import [GO:0090280]; positive regulation of mononuclear cell migration [GO:0071677]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of T cell apoptotic process [GO:0070232]; regulation of T cell proliferation [GO:0042129]; RNA splicing [GO:0008380],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; immunological synapse [GO:0001772]; mitochondrial inner membrane [GO:0005743]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681],chemoattractant activity [GO:0042056]; disaccharide binding [GO:0048030]; IgE binding [GO:0019863]; laminin binding [GO:0043236]; molecular condensate scaffold activity [GO:0140693]; protein phosphatase binding [GO:0019903]
149,A0A337S5X4,A0A337S5X4_FELCA,Guanine nucleotide-binding protein subunit alpha,GNA11,"action potential [GO:0001508]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cellular response to pH [GO:0071467]; cranial skeletal system development [GO:1904888]; developmental pigmentation [GO:0048066]; endothelin receptor signaling pathway [GO:0086100]; heart development [GO:0007507]; ion channel modulating, G protein-coupled receptor signaling pathway [GO:0099105]; ligand-gated ion channel signaling pathway [GO:1990806]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; positive regulation of insulin secretion [GO:0032024]; regulation of blood pressure [GO:0008217]; regulation of melanocyte differentiation [GO:0045634]; skeletal system development [GO:0001501]",cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; synapse [GO:0045202],enzyme regulator activity [GO:0030234]; G protein activity [GO:0003925]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]
150,A0A337S9K0,A0A337S9K0_FELCA,Peptidylglycine alpha-amidating monooxygenase,PAM,peptide amidation [GO:0001519]; response to zinc ion [GO:0010043],extracellular region [GO:0005576]; transport vesicle membrane [GO:0030658],copper ion binding [GO:0005507]; L-ascorbic acid binding [GO:0031418]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]; zinc ion binding [GO:0008270]
151,A0A337S9L8,A0A337S9L8_FELCA,Protein kinase C and casein kinase substrate in neurons 2,PACSIN2,actin cytoskeleton organization [GO:0030036]; caveola assembly [GO:0070836]; caveolin-mediated endocytosis [GO:0072584]; cell projection morphogenesis [GO:0048858]; cytoskeleton organization [GO:0007010]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of endocytosis [GO:0045806]; plasma membrane tubulation [GO:0097320]; protein localization to endosome [GO:0036010]; regulation of endocytosis [GO:0030100],caveola [GO:0005901]; cell-cell junction [GO:0005911]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587],cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; phosphatidic acid binding [GO:0070300]; phospholipid binding [GO:0005543]
152,A0A337SCB7,A0A337SCB7_FELCA,protein-tyrosine-phosphatase (EC 3.1.3.48),PTPRS,cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; corpus callosum development [GO:0022038]; establishment of endothelial intestinal barrier [GO:0090557]; hippocampus development [GO:0021766]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of axon extension [GO:0030517]; negative regulation of axon regeneration [GO:0048681]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of toll-like receptor 9 signaling pathway [GO:0034164]; regulation of postsynaptic density assembly [GO:0099151]; spinal cord development [GO:0021510]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling [GO:0099537],cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685],chondroitin sulfate binding [GO:0035374]; heparin binding [GO:0008201]; protein tyrosine phosphatase activity [GO:0004725]
153,A0A337SD38,A0A337SD38_FELCA,Chloride intracellular channel protein,CLIC4,angiogenesis [GO:0001525]; branching morphogenesis of an epithelial tube [GO:0048754]; cellular response to calcium ion [GO:0071277]; endothelial cell morphogenesis [GO:0001886]; fertilization [GO:0009566]; keratinocyte differentiation [GO:0030216]; multicellular organism growth [GO:0035264]; negative regulation of cell migration [GO:0030336]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; vacuolar acidification [GO:0007035],apical part of cell [GO:0045177]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; microvillus [GO:0005902]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],chloride channel activity [GO:0005254]
154,A0A337SHI5,A0A337SHI5_FELCA,small monomeric GTPase (EC 3.6.5.2),RAB5A,amyloid-beta clearance by transcytosis [GO:0150093]; canonical Wnt signaling pathway [GO:0060070]; early endosome to late endosome transport [GO:0045022]; modulation by host of viral process [GO:0044788]; positive regulation of exocytosis [GO:0045921]; receptor internalization [GO:0031623]; regulation of endosome size [GO:0051036]; regulation of filopodium assembly [GO:0051489]; regulation of synaptic vesicle exocytosis [GO:2000300]; synaptic vesicle recycling [GO:0036465],actin cytoskeleton [GO:0015629]; cytoplasmic side of early endosome membrane [GO:0098559]; cytosol [GO:0005829]; early phagosome [GO:0032009]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; somatodendritic compartment [GO:0036477]; terminal bouton [GO:0043195],GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]
155,A0A337SNL3,A0A337SNL3_FELCA,Glucosylceramidase (EC 3.2.1.45),GBA1,cholesterol metabolic process [GO:0008203]; sphingolipid metabolic process [GO:0006665],lysosomal membrane [GO:0005765],galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; glycosyltransferase activity [GO:0016757]; steryl-beta-glucosidase activity [GO:0050295]
156,A0A337SRF9,A0A337SRF9_FELCA,Fibulin-1,FBLN1,"blood coagulation, fibrin clot formation [GO:0072378]; extracellular matrix organization [GO:0030198]; negative regulation of cell motility [GO:2000146]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]",basement membrane [GO:0005604]; elastic fiber [GO:0071953]; extracellular space [GO:0005615],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; fibrinogen binding [GO:0070051]; fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; peptidase activator activity [GO:0016504]
157,A0A337SS27,A0A337SS27_FELCA,Aminopeptidase N (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (Microsomal aminopeptidase),ANPEP,peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]
158,A0A337SU32,A0A337SU32_FELCA,Tumor susceptibility 101,TSG101,endosome to lysosome transport [GO:0008333]; exosomal secretion [GO:1990182]; extracellular transport [GO:0006858]; keratinocyte differentiation [GO:0030216]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; protein modification process [GO:0036211]; protein transport [GO:0015031]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of extracellular exosome assembly [GO:1903551]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]; viral release from host cell [GO:0019076],cytosol [GO:0005829]; early endosome [GO:0005769]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; late endosome [GO:0005770]; nucleolus [GO:0005730]; plasma membrane [GO:0005886],calcium-dependent protein binding [GO:0048306]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virion binding [GO:0046790]
159,A0A5F5XE91,A0A5F5XE91_FELCA,Kinesin-like protein,KIF12,microtubule-based movement [GO:0007018],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrial inner membrane [GO:0005743]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; serine-type endopeptidase inhibitor activity [GO:0004867]
160,A0A5F5XEZ3,A0A5F5XEZ3_FELCA,Vacuolar protein sorting-associated protein 18 homolog,VPS18,endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; organelle fusion [GO:0048284]; protein ubiquitination [GO:0016567]; regulation of synaptic vesicle exocytosis [GO:2000300]; symbiont entry into host cell [GO:0046718]; vesicle docking involved in exocytosis [GO:0006904],actin filament [GO:0005884]; AP-3 adaptor complex [GO:0030123]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; HOPS complex [GO:0030897]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765],actin binding [GO:0003779]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; syntaxin binding [GO:0019905]; ubiquitin protein ligase activity [GO:0061630]
161,A0A5F5XG72,A0A5F5XG72_FELCA,Adhesion G-protein coupled receptor G1 (G-protein coupled receptor 56),ADGRG1,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; cerebral cortex regionalization [GO:0021796]; hematopoietic stem cell homeostasis [GO:0061484]; layer formation in cerebral cortex [GO:0021819]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron migration [GO:2001223]; neural precursor cell proliferation [GO:0061351]; positive regulation of cell adhesion [GO:0045785]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of Rho protein signal transduction [GO:0035025]; protein kinase C signaling [GO:0070528]; Rho protein signal transduction [GO:0007266]; seminiferous tubule development [GO:0072520]; vascular endothelial growth factor production [GO:0010573],extracellular region [GO:0005576]; glial limiting end-foot [GO:0097451]; membrane raft [GO:0045121]; plasma membrane [GO:0005886],collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; heparin binding [GO:0008201]
162,A0A5F5XH70,A0A5F5XH70_FELCA,Ras-related protein Rab-10,RAB10,antigen processing and presentation [GO:0019882]; endoplasmic reticulum tubular network organization [GO:0071786]; endosomal transport [GO:0016197]; establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; exocytosis [GO:0006887]; protein secretion [GO:0009306]; regulated exocytosis [GO:0045055],cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; exocytic vesicle [GO:0070382]; Golgi apparatus [GO:0005794]; insulin-responsive compartment [GO:0032593]; membrane [GO:0016020]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; secretory vesicle [GO:0099503],GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]
163,A0A5F5XIY0,A0A5F5XIY0_FELCA,Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase),GAA,aorta development [GO:0035904]; cardiac muscle contraction [GO:0060048]; diaphragm contraction [GO:0002086]; glycogen catabolic process [GO:0005980]; glycophagy [GO:0061723]; heart morphogenesis [GO:0003007]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; muscle cell cellular homeostasis [GO:0046716]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; regulation of the force of heart contraction [GO:0002026]; tissue development [GO:0009888]; vacuolar sequestering [GO:0043181],autolysosome lumen [GO:0120282]; lysosomal membrane [GO:0005765],"alpha-1,4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]"
164,A0A5F5XL46,A0A5F5XL46_FELCA,Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (Sorting protein-related receptor containing LDLR class A repeats),SORL1,endocytosis [GO:0006897],early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; transport vesicle membrane [GO:0030658],
165,A0A5F5XMX8,A0A5F5XMX8_FELCA,Kynureninase (EC 3.7.1.3) (L-kynurenine hydrolase),KYNU,'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; L-kynurenine catabolic process [GO:0097053]; quinolinate biosynthetic process [GO:0019805]; response to type II interferon [GO:0034341]; response to vitamin B6 [GO:0034516]; tryptophan catabolic process to kynurenine [GO:0019441],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],3-hydroxykynureninase activity [GO:0061981]; kynureninase activity [GO:0030429]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]
166,A0A5F5XPA1,A0A5F5XPA1_FELCA,Annexin,ANXA11,cytokinetic process [GO:0032506]; phagocytosis [GO:0006909]; response to calcium ion [GO:0051592],azurophil granule [GO:0042582]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; specific granule [GO:0042581]; spindle [GO:0005819]; vesicle membrane [GO:0012506],calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786]; S100 protein binding [GO:0044548]
167,A0A5F5XSP5,A0A5F5XSP5_FELCA,Cytosol aminopeptidase (EC 3.4.11.1) (EC 3.4.11.5) (EC 3.4.13.23) (Cysteinylglycine-S-conjugate dipeptidase) (Leucine aminopeptidase 3) (Leucyl aminopeptidase) (Proline aminopeptidase) (Prolyl aminopeptidase),LAP3,proteolysis [GO:0006508],cytoplasm [GO:0005737],manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; peptidase activity [GO:0008233]
168,A0A5F5XWD4,A0A5F5XWD4_FELCA,Endoplasmin (94 kDa glucose-regulated protein) (Heat shock protein 90 kDa beta member 1),HSP90B1,"actin rod assembly [GO:0031247]; cellular response to ATP [GO:0071318]; ERAD pathway [GO:0036503]; negative regulation of apoptotic process [GO:0043066]; protein folding [GO:0006457]; response to hypoxia [GO:0001666]; retrograde protein transport, ER to cytosol [GO:0030970]",cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; melanosome [GO:0042470]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; sarcoplasmic reticulum lumen [GO:0033018],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; low-density lipoprotein particle receptor binding [GO:0050750]; protein phosphatase binding [GO:0019903]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]
169,A0A5F5XWS8,A0A5F5XWS8_FELCA,Aldo-keto reductase family 1 member B1 (EC 1.1.1.21) (EC 1.1.1.300) (Aldose reductase),AKR1B1,,cytoplasm [GO:0005737],oxidoreductase activity [GO:0016491]
170,A0A5F5XXB7,A0A5F5XXB7_FELCA,"Thioredoxin-dependent peroxide reductase, mitochondrial (EC 1.11.1.24) (Thioredoxin-dependent peroxiredoxin 3)",PRDX3,cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; maternal placenta development [GO:0001893]; mitochondrion organization [GO:0007005]; myeloid cell differentiation [GO:0030099]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]; regulation of mitochondrial membrane potential [GO:0051881]; response to hydrogen peroxide [GO:0042542]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979],cytosol [GO:0005829]; early endosome [GO:0005769]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; thioredoxin peroxidase activity [GO:0008379]
171,A0A5F5Y312,A0A5F5Y312_FELCA,Stratifin,SFN,establishment of skin barrier [GO:0061436]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; keratinization [GO:0031424]; keratinocyte development [GO:0003334]; keratinocyte proliferation [GO:0043616]; negative regulation of innate immune response [GO:0045824]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of epidermal cell differentiation [GO:0045606]; positive regulation of protein export from nucleus [GO:0046827]; protein export from nucleus [GO:0006611]; protein kinase A signaling [GO:0010737]; protein localization [GO:0008104]; regulation of cell cycle [GO:0051726]; regulation of epidermal cell division [GO:0010482]; release of cytochrome c from mitochondria [GO:0001836]; signal transduction [GO:0007165]; stem cell proliferation [GO:0072089],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],identical protein binding [GO:0042802]; phosphoserine residue binding [GO:0050815]; protein kinase binding [GO:0019901]; protein sequestering activity [GO:0140311]
172,A0A5F5Y533,A0A5F5Y533_FELCA,Kinesin-like protein,KIF12,microtubule-based movement [GO:0007018],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; microtubule [GO:0005874]; mitochondrial inner membrane [GO:0005743]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; serine-type endopeptidase inhibitor activity [GO:0004867]
173,K0J107,MDHM_FELCA,"Malate dehydrogenase, mitochondrial (EC 1.1.1.37)",MDH2,aerobic respiration [GO:0009060]; gluconeogenesis [GO:0006094]; malate metabolic process [GO:0006108]; tricarboxylic acid cycle [GO:0006099],cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],L-malate dehydrogenase activity [GO:0030060]; protein homodimerization activity [GO:0042803]
174,M3VU18,M3VU18_FELCA,Aminopeptidase (EC 3.4.11.-),ENPEP,angiogenesis [GO:0001525]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; glomerulus development [GO:0032835]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081],apical plasma membrane [GO:0016324]; brush border [GO:0005903]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]
175,M3VU38,M3VU38_FELCA,Plexin D1,PLXND1,aorta development [GO:0035904]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; dichotomous subdivision of terminal units involved in salivary gland branching [GO:0060666]; endothelial cell migration [GO:0043542]; kidney development [GO:0001822]; negative regulation of cell adhesion [GO:0007162]; negative regulation of neuron apoptotic process [GO:0043524]; outflow tract morphogenesis [GO:0003151]; positive regulation of axonogenesis [GO:0050772]; regulation of angiogenesis [GO:0045765]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; synapse assembly [GO:0007416]; synaptic target recognition [GO:0008039],axon [GO:0030424]; cell body [GO:0044297]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116],ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein domain specific binding [GO:0019904]; semaphorin receptor activity [GO:0017154]
176,M3VU87,M3VU87_FELCA,Calsyntenin-3,CLSTN3,"homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806]; regulation of cell growth [GO:0001558]; regulation of presynapse assembly [GO:1905606]; synapse assembly [GO:0007416]; synaptic transmission, GABAergic [GO:0051932]; synaptic transmission, glutamatergic [GO:0035249]",cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991],calcium ion binding [GO:0005509]; cell-cell adhesion mediator activity [GO:0098632]; neurexin family protein binding [GO:0042043]
177,M3VUF1,M3VUF1_FELCA,"3-hydroxyanthranilate 3,4-dioxygenase (EC 1.13.11.6) (3-hydroxyanthranilate oxygenase) (3-HAO) (3-hydroxyanthranilic acid dioxygenase) (HAD)",HAAO,'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; neuron cellular homeostasis [GO:0070050]; quinolinate biosynthetic process [GO:0019805]; quinolinate metabolic process [GO:0046874]; response to cadmium ion [GO:0046686]; response to zinc ion [GO:0010043]; tryptophan catabolic process [GO:0006569],cytoplasm [GO:0005737]; cytosol [GO:0005829],"3-hydroxyanthranilate 3,4-dioxygenase activity [GO:0000334]; ferrous iron binding [GO:0008198]"
178,M3VUU2,M3VUU2_FELCA,Peroxiredoxin-2 (EC 1.11.1.24) (Thioredoxin-dependent peroxiredoxin 2),PRDX2,cell redox homeostasis [GO:0045454]; defense response to tumor cell [GO:0002357]; extrinsic apoptotic signaling pathway [GO:0097191]; hydrogen peroxide catabolic process [GO:0042744]; leukocyte activation [GO:0045321]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of T cell differentiation [GO:0045581]; positive regulation of blood coagulation [GO:0030194]; positive regulation of MAPK cascade [GO:0043410]; regulation of hydrogen peroxide metabolic process [GO:0010310]; removal of superoxide radicals [GO:0019430]; respiratory burst involved in inflammatory response [GO:0002536]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; thymus development [GO:0048538],cytosol [GO:0005829],thioredoxin peroxidase activity [GO:0008379]
179,M3VVR5,M3VVR5_FELCA,Phosphodiesterase (EC 3.1.4.-),PDE3A,apoptotic signaling pathway [GO:0097190]; cAMP-mediated signaling [GO:0019933]; cellular response to cGMP [GO:0071321]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cGMP-mediated signaling [GO:0019934]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of vascular permeability [GO:0043116]; oocyte maturation [GO:0001556]; positive regulation of oocyte development [GO:0060282]; positive regulation of vascular permeability [GO:0043117]; regulation of meiotic nuclear division [GO:0040020]; response to xenobiotic stimulus [GO:0009410],cytosol [GO:0005829]; membrane [GO:0016020],"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cGMP-inhibited cyclic-nucleotide phosphodiesterase activity [GO:0004119]; estrogen binding [GO:0099130]; metal ion binding [GO:0046872]; nuclear estrogen receptor activity [GO:0030284]"
180,M3VWC6,M3VWC6_FELCA,Monocyte differentiation antigen CD14 (Myeloid cell-specific leucine-rich glycoprotein),CD14,cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of cytokine production [GO:0001819]; positive regulation of endocytosis [GO:0045807]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon production [GO:0032481]; positive regulation of type II interferon production [GO:0032729]; receptor-mediated endocytosis [GO:0006898]; toll-like receptor 4 signaling pathway [GO:0034142],external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lipopolysaccharide receptor complex [GO:0046696]; membrane raft [GO:0045121],lipopolysaccharide binding [GO:0001530]; lipopolysaccharide immune receptor activity [GO:0001875]; lipoteichoic acid binding [GO:0070891]
181,M3VWD8,M3VWD8_FELCA,Cytoplasmic aconitate hydratase (EC 4.2.1.3) (Citrate hydro-lyase) (Iron-responsive element-binding protein 1),ACO1,citrate metabolic process [GO:0006101]; intestinal absorption [GO:0050892]; intracellular iron ion homeostasis [GO:0006879]; post-embryonic development [GO:0009791]; regulation of translation [GO:0006417]; response to iron(II) ion [GO:0010040]; tricarboxylic acid cycle [GO:0006099],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739],"3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; iron-responsive element binding [GO:0030350]; metal ion binding [GO:0046872]"
182,M3VWS9,M3VWS9_FELCA,Glutathione hydrolase (EC 2.3.2.2) (EC 3.4.19.13) (Gamma-glutamyltransferase) (Gamma-glutamyltranspeptidase),GGT1,cysteine biosynthetic process [GO:0019344]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; peptide modification [GO:0031179]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; spermatogenesis [GO:0007283],plasma membrane [GO:0005886]; vesicle [GO:0031982],acyltransferase activity [GO:0016746]; glutathione hydrolase activity [GO:0036374]
183,M3VWW1,M3VWW1_FELCA,glycerophosphocholine cholinephosphodiesterase (EC 3.1.4.38) (Choline-specific glycerophosphodiester phosphodiesterase) (Ectonucleotide pyrophosphatase/phosphodiesterase family member 6),ENPP6,choline metabolic process [GO:0019695]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629],extracellular region [GO:0005576]; plasma membrane [GO:0005886],glycerophosphocholine cholinephosphodiesterase activity [GO:0047390]; glycerophosphodiester phosphodiesterase activity [GO:0008889]
184,M3VXP7,M3VXP7_FELCA,"Fructose-1,6-bisphosphatase isozyme 2 (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 2) (Muscle FBPase)",FBP2,"fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; sucrose biosynthetic process [GO:0005986]",anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Z disc [GO:0030018],"fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]"
185,M3VZX1,M3VZX1_FELCA,Protein S100 (S100 calcium-binding protein),S100A9,antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; astrocyte development [GO:0014002]; autocrine signaling [GO:0035425]; autophagy [GO:0006914]; chronic inflammatory response [GO:0002544]; endothelial cell migration [GO:0043542]; leukocyte migration involved in inflammatory response [GO:0002523]; modulation of process of another organism [GO:0035821]; neutrophil aggregation [GO:0070488]; neutrophil chemotaxis [GO:0030593]; positive regulation of inflammatory response [GO:0050729]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; regulation of integrin biosynthetic process [GO:0045113]; response to lipopolysaccharide [GO:0032496],calprotectin complex [GO:1990660]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; S100A9 complex [GO:1990662],antioxidant activity [GO:0016209]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]
186,M3W0B5,M3W0B5_FELCA,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial (EC 1.3.8.5) (2-methyl branched chain acyl-CoA dehydrogenase) (2-methylbutyryl-coenzyme A dehydrogenase)",ACADSB,fatty acid metabolic process [GO:0006631]; isoleucine catabolic process [GO:0006550],mitochondrion [GO:0005739],2-methylbutanoyl-CoA dehydrogenase activity [GO:0003853]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]
187,M3W0Q1,M3W0Q1_FELCA,Cathepsin S (EC 3.4.22.27),CTSS,adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; basement membrane disassembly [GO:0034769]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; immune response [GO:0006955]; positive regulation of apoptotic signaling pathway [GO:2001235]; protein processing [GO:0016485]; proteolysis involved in protein catabolic process [GO:0051603]; response to acidic pH [GO:0010447],extracellular space [GO:0005615]; late endosome [GO:0005770]; lysosome [GO:0005764]; phagocytic vesicle [GO:0045335],collagen binding [GO:0005518]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; cysteine-type endopeptidase activity [GO:0004197]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; proteoglycan binding [GO:0043394]
188,M3W0Q2,M3W0Q2_FELCA,Cathepsin K (EC 3.4.22.38),CTSK,bone resorption [GO:0045453]; collagen catabolic process [GO:0030574]; immune response [GO:0006955]; negative regulation of cartilage development [GO:0061037]; positive regulation of apoptotic signaling pathway [GO:2001235]; proteolysis involved in protein catabolic process [GO:0051603]; thyroid hormone generation [GO:0006590],apical plasma membrane [GO:0016324]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; lysosome [GO:0005764]; nucleoplasm [GO:0005654],collagen binding [GO:0005518]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; cysteine-type endopeptidase activity [GO:0004197]; fibronectin binding [GO:0001968]; proteoglycan binding [GO:0043394]
189,M3W148,M3W148_FELCA,Thrombospondin 4,THBS4,behavioral response to pain [GO:0048266]; endothelial cell-cell adhesion [GO:0071603]; myoblast migration [GO:0051451]; negative regulation of angiogenesis [GO:0016525]; positive regulation of cell division [GO:0051781]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of tissue remodeling [GO:0034103]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; sarcoplasmic reticulum [GO:0016529],calcium ion binding [GO:0005509]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; integrin binding [GO:0005178]
190,M3W1B8,M3W1B8_FELCA,Isocitrate dehydrogenase [NADP] (EC 1.1.1.42),IDH1,2-oxoglutarate metabolic process [GO:0006103]; glutathione metabolic process [GO:0006749]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; NADP metabolic process [GO:0006739]; regulation of phospholipid biosynthetic process [GO:0071071]; regulation of phospholipid catabolic process [GO:0060696]; response to oxidative stress [GO:0006979]; tricarboxylic acid cycle [GO:0006099],cytosol [GO:0005829]; mitochondrion [GO:0005739]; peroxisome [GO:0005777],isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]
191,M3W1S6,M3W1S6_FELCA,Semaphorin 4D,SEMA4D,axon guidance [GO:0007411]; bone trabecula morphogenesis [GO:0061430]; leukocyte aggregation [GO:0070486]; negative chemotaxis [GO:0050919]; negative regulation of cell adhesion [GO:0007162]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell migration [GO:0001755]; ossification involved in bone maturation [GO:0043931]; positive regulation of cell migration [GO:0030335]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of inhibitory synapse assembly [GO:1905704]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of cell shape [GO:0008360]; regulation of dendrite morphogenesis [GO:0048814]; semaphorin-plexin signaling pathway [GO:0071526],extracellular space [GO:0005615]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116],chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; transmembrane signaling receptor activity [GO:0004888]
192,M3W3B8,M3W3B8_FELCA,Frizzled-6,FZD6,"canonical Wnt signaling pathway [GO:0060070]; cell proliferation in midbrain [GO:0033278]; embryonic nail plate morphogenesis [GO:0035880]; establishment of body hair planar orientation [GO:0048105]; hair follicle development [GO:0001942]; inner ear morphogenesis [GO:0042472]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; neural tube closure [GO:0001843]; non-canonical Wnt signaling pathway [GO:0035567]; platelet activation [GO:0030168]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cell surface [GO:0009986]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930]; ubiquitin protein ligase binding [GO:0031625]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]
193,M3W4Q4,M3W4Q4_FELCA,Plasminogen activator inhibitor 1 (Endothelial plasminogen activator inhibitor) (Serpin E1),SERPINE1,angiogenesis [GO:0001525]; cellular response to lipopolysaccharide [GO:0071222]; defense response to Gram-negative bacterium [GO:0050829]; dentinogenesis [GO:0097187]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of plasminogen activation [GO:0010757]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of vascular wound healing [GO:0061044]; positive regulation of angiogenesis [GO:0045766]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of leukotriene production involved in inflammatory response [GO:0035491]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of odontoblast differentiation [GO:1901331]; positive regulation of receptor-mediated endocytosis [GO:0048260]; replicative senescence [GO:0090399],collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; serine protease inhibitor complex [GO:0097180],protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor binding [GO:0005102]
194,M3W4V0,M3W4V0_FELCA,Leucine rich repeat containing 8 VRAC subunit A,LRRC8A,aspartate transmembrane transport [GO:0015810]; cell volume homeostasis [GO:0006884]; chloride transmembrane transport [GO:1902476]; cyclic-GMP-AMP transmembrane import across plasma membrane [GO:0140361]; intracellular glucose homeostasis [GO:0001678]; monoatomic anion transmembrane transport [GO:0098656]; positive regulation of insulin secretion [GO:0032024]; positive regulation of myoblast differentiation [GO:0045663]; pre-B cell differentiation [GO:0002329]; protein hexamerization [GO:0034214]; response to osmotic stress [GO:0006970]; spermatogenesis [GO:0007283],cell surface [GO:0009986]; cytoplasm [GO:0005737]; lysosomal membrane [GO:0005765]; monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886],cyclic-GMP-AMP transmembrane transporter activity [GO:0140360]; identical protein binding [GO:0042802]; volume-sensitive anion channel activity [GO:0005225]
195,M3W5W5,M3W5W5_FELCA,Eukaryotic translation initiation factor 6 (eIF-6),EIF6 ITGB4BP,assembly of large subunit precursor of preribosome [GO:1902626]; cytosolic ribosome assembly [GO:0042256]; maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; positive regulation of translation [GO:0045727]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of glycolytic process [GO:0006110]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to insulin [GO:0032868]; ribosomal subunit export from nucleus [GO:0000054],"cytosol [GO:0005829]; lamin filament [GO:0005638]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]; synapse [GO:0045202]",ribosomal large subunit binding [GO:0043023]; translation initiation factor activity [GO:0003743]
196,M3W668,M3W668_FELCA,Protein disulfide-isomerase (EC 5.3.4.1),PDIA3,cellular response to interleukin-7 [GO:0098761]; extrinsic apoptotic signaling pathway [GO:0097191]; peptide antigen assembly with MHC class I protein complex [GO:0002502]; platelet aggregation [GO:0070527]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976],cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]; Tapasin-ERp57 complex [GO:0061779],identical protein binding [GO:0042802]; protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035]
197,M3W6R4,M3W6R4_FELCA,Sphingosine 1-phosphate receptor 1 (Sphingosine 1-phosphate receptor Edg-1),S1PR1,actin cytoskeleton organization [GO:0030036]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; angiogenesis [GO:0001525]; blood vessel maturation [GO:0001955]; brain development [GO:0007420]; cardiac muscle tissue growth involved in heart morphogenesis [GO:0003245]; cell population proliferation [GO:0008283]; heart trabecula morphogenesis [GO:0061384]; lamellipodium assembly [GO:0030032]; leukocyte chemotaxis [GO:0030595]; positive regulation of cell population proliferation [GO:0008284]; regulation of bone mineralization [GO:0030500]; regulation of bone resorption [GO:0045124]; regulation of cell adhesion [GO:0030155]; regulation of metabolic process [GO:0019222]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; T cell migration [GO:0072678],cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],G protein-coupled receptor binding [GO:0001664]; sphingosine-1-phosphate receptor activity [GO:0038036]
198,M3W955,APOA4_FELCA,Apolipoprotein A-IV (Apo-AIV) (ApoA-IV) (Apolipoprotein A4),APOA4,acylglycerol homeostasis [GO:0055090]; cholesterol efflux [GO:0033344]; cholesterol metabolic process [GO:0008203]; lipoprotein metabolic process [GO:0042157]; phospholipid efflux [GO:0033700],chylomicron [GO:0042627]; extracellular vesicle [GO:1903561]; high-density lipoprotein particle [GO:0034364]; low-density lipoprotein particle [GO:0034362]; very-low-density lipoprotein particle [GO:0034361],cholesterol transfer activity [GO:0120020]; phosphatidylcholine-sterol O-acyltransferase activator activity [GO:0060228]; phospholipid binding [GO:0005543]
199,M3W9A2,M3W9A2_FELCA,Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Threonyl dipeptidase),CNDP2,proteolysis [GO:0006508],cytosol [GO:0005829]; nucleoplasm [GO:0005654],carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]
200,M3W9M0,M3W9M0_FELCA,Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (Dipeptidyl transferase),CTSC,negative regulation of myelination [GO:0031642]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; proteolysis involved in protein catabolic process [GO:0051603]; T cell mediated cytotoxicity [GO:0001913],centrosome [GO:0005813]; extracellular space [GO:0005615]; lysosome [GO:0005764]; nucleoplasm [GO:0005654],cysteine-type endopeptidase activity [GO:0004197]; dipeptidyl-peptidase activity [GO:0008239]; peptidase activator activity involved in apoptotic process [GO:0016505]; serine-type endopeptidase activity [GO:0004252]
201,M3WAR8,M3WAR8_FELCA,Carbonic anhydrase (EC 4.2.1.1),CA4,bicarbonate transport [GO:0015701]; one-carbon metabolic process [GO:0006730],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; secretory granule membrane [GO:0030667]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658],carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]
202,M3WAZ7,M3WAZ7_FELCA,Receptor activity modifying protein 2,RAMP2,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adherens junction assembly [GO:0034333]; adrenomedullin receptor signaling pathway [GO:1990410]; angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; bicellular tight junction assembly [GO:0070830]; calcium ion transport [GO:0006816]; cellular response to hormone stimulus [GO:0032870]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of vascular permeability [GO:0043116]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of vasculogenesis [GO:2001214]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; receptor internalization [GO:0031623]; regulation of blood pressure [GO:0008217]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; sprouting angiogenesis [GO:0002040]; vascular associated smooth muscle cell development [GO:0097084]; vasculogenesis [GO:0001570],adrenomedullin receptor complex [GO:1903143]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; receptor complex [GO:0043235],adrenomedullin binding [GO:1990409]; adrenomedullin receptor activity [GO:0001605]; coreceptor activity [GO:0015026]
203,M3WB78,M3WB78_FELCA,"Fructose-1,6-bisphosphatase 1 (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 1) (Liver FBPase)",FBP1,"cellular response to magnesium ion [GO:0071286]; cellular response to xenobiotic stimulus [GO:0071466]; dephosphorylation [GO:0016311]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of gluconeogenesis [GO:0006111]; sucrose biosynthetic process [GO:0005986]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],"AMP binding [GO:0016208]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]"
204,M3WBF1,M3WBF1_FELCA,Intercellular adhesion molecule 1,ICAM1,cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cellular response to amyloid-beta [GO:1904646]; cellular response to glucose stimulus [GO:0071333]; cellular response to leukemia inhibitory factor [GO:1990830]; establishment of endothelial barrier [GO:0061028]; leukocyte cell-cell adhesion [GO:0007159]; membrane to membrane docking [GO:0022614]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; positive regulation of cellular extravasation [GO:0002693]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; receptor-mediated virion attachment to host cell [GO:0046813]; regulation of ruffle assembly [GO:1900027]; T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:0002291]; T cell antigen processing and presentation [GO:0002457]; T cell extravasation [GO:0072683],external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; membrane raft [GO:0045121]; plasma membrane [GO:0005886],integrin binding [GO:0005178]
205,M3WCK3,M3WCK3_FELCA,Desmoplakin,DSP,adherens junction organization [GO:0034332]; bundle of His cell-Purkinje myocyte adhesion involved in cell communication [GO:0086073]; cell-cell adhesion [GO:0098609]; desmosome organization [GO:0002934]; epithelial cell-cell adhesion [GO:0090136]; intermediate filament cytoskeleton organization [GO:0045104]; intermediate filament organization [GO:0045109]; keratinocyte differentiation [GO:0030216]; protein localization to cell-cell junction [GO:0150105]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; skin development [GO:0043588]; ventricular compact myocardium morphogenesis [GO:0003223]; wound healing [GO:0042060],adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; plasma membrane [GO:0005886],protein kinase C binding [GO:0005080]; scaffold protein binding [GO:0097110]; structural molecule activity [GO:0005198]
206,M3WEF4,M3WEF4_FELCA,Protein PALS1 (MAGUK p55 subfamily member 5) (Protein associated with Lin-7 1),PALS1,central nervous system neuron development [GO:0021954]; cerebral cortex development [GO:0021987]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; gene expression [GO:0010467]; generation of neurons [GO:0048699]; morphogenesis of an epithelial sheet [GO:0002011]; peripheral nervous system myelin maintenance [GO:0032287]; protein localization to myelin sheath abaxonal region [GO:0035750]; protein localization to plasma membrane [GO:0072659]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015],adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; bicellular tight junction [GO:0005923]; Golgi apparatus [GO:0005794]; lateral loop [GO:0043219]; myelin sheath adaxonal region [GO:0035749]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Schmidt-Lanterman incisure [GO:0043220],identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]
207,M3WGH2,M3WGH2_FELCA,Carboxypeptidase E (EC 3.4.17.10) (Carboxypeptidase H) (Enkephalin convertase) (Prohormone-processing carboxypeptidase),CPE,cardiac left ventricle morphogenesis [GO:0003214]; insulin processing [GO:0030070]; peptide hormone secretion [GO:0030072]; peptide metabolic process [GO:0006518]; protein localization to membrane [GO:0072657]; protein localization to secretory granule [GO:0033366]; protein processing [GO:0016485]; Wnt signaling pathway [GO:0016055],extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658],cell adhesion molecule binding [GO:0050839]; metallocarboxypeptidase activity [GO:0004181]; neurexin family protein binding [GO:0042043]; zinc ion binding [GO:0008270]
208,M3WII3,M3WII3_FELCA,Fibrinogen beta chain,FGB,"blood coagulation, fibrin clot formation [GO:0072378]; cell-matrix adhesion [GO:0007160]; fibrinolysis [GO:0042730]; induction of bacterial agglutination [GO:0043152]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; plasminogen activation [GO:0031639]; platelet aggregation [GO:0070527]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exocytosis [GO:0045921]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of peptide hormone secretion [GO:0090277]; positive regulation of protein secretion [GO:0050714]; positive regulation of vasoconstriction [GO:0045907]; protein polymerization [GO:0051258]; response to calcium ion [GO:0051592]",cell cortex [GO:0005938]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; platelet alpha granule [GO:0031091]; synapse [GO:0045202],cell adhesion molecule binding [GO:0050839]; protein-folding chaperone binding [GO:0051087]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198]
209,M3WLU0,M3WLU0_FELCA,Cathepsin B (EC 3.4.22.1),CTSB,cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; proteolysis involved in protein catabolic process [GO:0051603]; symbiont entry into host cell [GO:0046718]; thyroid hormone generation [GO:0006590],apical plasma membrane [GO:0016324]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; lysosome [GO:0005764]; peptidase inhibitor complex [GO:1904090]; perinuclear region of cytoplasm [GO:0048471],collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; proteoglycan binding [GO:0043394]
210,M3WLX7,M3WLX7_FELCA,Heart development protein with EGF like domains 1,HEG1,cardiac atrium morphogenesis [GO:0003209]; cardiac muscle tissue growth [GO:0055017]; cell-cell junction organization [GO:0045216]; endothelial cell morphogenesis [GO:0001886]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lung development [GO:0030324]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; multicellular organism growth [GO:0035264]; negative regulation of membrane permeability [GO:1905709]; negative regulation of Rho protein signal transduction [GO:0035024]; pericardium development [GO:0060039]; positive regulation of fibroblast growth factor production [GO:0090271]; post-embryonic development [GO:0009791]; protein localization to cell junction [GO:1902414]; regulation of body fluid levels [GO:0050878]; vasculogenesis [GO:0001570]; venous blood vessel morphogenesis [GO:0048845]; ventricular septum development [GO:0003281]; ventricular trabecula myocardium morphogenesis [GO:0003222],cell-cell junction [GO:0005911]; external side of plasma membrane [GO:0009897],calcium ion binding [GO:0005509]
211,M3WM59,M3WM59_FELCA,"Enoyl-CoA hydratase, mitochondrial (EC 4.2.1.17) (EC 5.3.3.8) (Enoyl-CoA hydratase 1) (Short-chain enoyl-CoA hydratase)",ECHS1,fatty acid beta-oxidation [GO:0006635],mitochondrion [GO:0005739],3-hydroxypropionyl-CoA dehydratase activity [GO:0043956]; enoyl-CoA hydratase activity [GO:0004300]
212,M3WMG2,M3WMG2_FELCA,Fibrillin 1,FBN1,anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; negative regulation of osteoclast development [GO:2001205]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501],basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; microfibril [GO:0001527],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]
213,M3WPT7,M3WPT7_FELCA,Growth/differentiation factor 8 (GDF-8) (Myostatin),MSTN,cellular response to dexamethasone stimulus [GO:0071549]; muscle cell cellular homeostasis [GO:0046716]; myoblast migration involved in skeletal muscle regeneration [GO:0014839]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myoblast proliferation [GO:2000818]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of satellite cell differentiation [GO:1902725]; negative regulation of skeletal muscle satellite cell proliferation [GO:1902723]; negative regulation of skeletal muscle tissue growth [GO:0048632]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of macrophage chemotaxis [GO:0010759]; skeletal muscle satellite cell differentiation [GO:0014816]; transforming growth factor beta receptor signaling pathway [GO:0007179],extracellular space [GO:0005615],cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; protein homodimerization activity [GO:0042803]
214,M3WSC8,M3WSC8_FELCA,Apolipoprotein C-III (Apolipoprotein C3),APOC3,cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; chylomicron remnant clearance [GO:0034382]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle remodeling [GO:0034375]; lipoprotein metabolic process [GO:0042157]; negative regulation of cholesterol import [GO:0060621]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of high-density lipoprotein particle clearance [GO:0010987]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of receptor-mediated endocytosis [GO:0048261]; negative regulation of triglyceride catabolic process [GO:0010897]; negative regulation of very-low-density lipoprotein particle clearance [GO:0010916]; negative regulation of very-low-density lipoprotein particle remodeling [GO:0010903]; phospholipid efflux [GO:0033700]; regulation of Cdc42 protein signal transduction [GO:0032489]; triglyceride catabolic process [GO:0019433]; triglyceride homeostasis [GO:0070328],chylomicron [GO:0042627]; intermediate-density lipoprotein particle [GO:0034363]; spherical high-density lipoprotein particle [GO:0034366]; very-low-density lipoprotein particle [GO:0034361],high-density lipoprotein particle receptor binding [GO:0070653]; lipase inhibitor activity [GO:0055102]; phospholipid binding [GO:0005543]
215,M3WSY6,M3WSY6_FELCA,Epidermal growth factor receptor pathway substrate 8,EPS8,actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; actin polymerization-dependent cell motility [GO:0070358]; adult locomotory behavior [GO:0008344]; barbed-end actin filament capping [GO:0051016]; behavioral response to ethanol [GO:0048149]; cellular response to leukemia inhibitory factor [GO:1990830]; dendritic cell migration [GO:0036336]; exit from mitosis [GO:0010458]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of cell shape [GO:0008360]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266],brush border [GO:0005903]; cell cortex [GO:0005938]; glutamatergic synapse [GO:0098978]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]; stereocilium tip [GO:0032426],actin binding [GO:0003779]; small GTPase binding [GO:0031267]
216,M3WTD7,M3WTD7_FELCA,Ras-related protein Rab-14 (EC 3.6.5.2),RAB14,defense response to bacterium [GO:0042742]; endocytic recycling [GO:0032456]; fibroblast growth factor receptor signaling pathway [GO:0008543]; Golgi to endosome transport [GO:0006895]; intracellular protein transport [GO:0006886]; phagolysosome assembly involved in apoptotic cell clearance [GO:0090387]; regulation of embryonic development [GO:0045995]; regulation of protein localization [GO:0032880],cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endomembrane system [GO:0012505]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802],GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]
217,M3WVD3,M3WVD3_FELCA,Epiregulin,EREG,cell-cell signaling [GO:0007267]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2-EGFR signaling pathway [GO:0038134]; ERBB2-ERBB4 signaling pathway [GO:0038135]; ERBB4-ERBB4 signaling pathway [GO:0038138]; keratinocyte proliferation [GO:0043616]; mRNA transcription [GO:0009299]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA replication [GO:0045740]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of innate immune response [GO:0045089]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of phosphorylation [GO:0042327],extracellular space [GO:0005615]; membrane [GO:0016020],epidermal growth factor receptor binding [GO:0005154]; growth factor activity [GO:0008083]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]
218,M3WVN3,M3WVN3_FELCA,Collagen type I alpha 2 chain,COL1A2,blood vessel development [GO:0001568]; bone mineralization [GO:0030282]; cellular response to amino acid stimulus [GO:0071230]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; extracellular matrix assembly [GO:0085029]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208]; regulation of blood pressure [GO:0008217]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; transforming growth factor beta receptor signaling pathway [GO:0007179],collagen type I trimer [GO:0005584]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615],extracellular matrix structural constituent conferring tensile strength [GO:0030020]; identical protein binding [GO:0042802]; platelet-derived growth factor binding [GO:0048407]; protease binding [GO:0002020]; protein-macromolecule adaptor activity [GO:0030674]; SMAD binding [GO:0046332]
219,M3WXV4,M3WXV4_FELCA,GTP-binding nuclear protein Ran,RAN,actin cytoskeleton organization [GO:0030036]; GTP metabolic process [GO:0046039]; mitotic sister chromatid segregation [GO:0000070]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; protein localization to nucleolus [GO:1902570]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; snRNA import into nucleus [GO:0061015],centriole [GO:0005814]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; recycling endosome [GO:0055037]; RNA nuclear export complex [GO:0042565],G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; pre-miRNA binding [GO:0070883]; protein heterodimerization activity [GO:0046982]
220,M3WXZ4,M3WXZ4_FELCA,"60 kDa heat shock protein, mitochondrial (EC 5.6.1.7) (60 kDa chaperonin) (Chaperonin 60) (Heat shock protein 60)",HSPD1,apoptotic mitochondrial changes [GO:0008637]; mitochondrial unfolded protein response [GO:0034514]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of T cell activation [GO:0050870]; positive regulation of type II interferon production [GO:0032729]; protein folding [GO:0006457]; protein import into mitochondrial intermembrane space [GO:0045041]; protein refolding [GO:0042026]; response to cold [GO:0009409]; T cell activation [GO:0042110],chaperonin-containing T-complex [GO:0005832]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759],ATP binding [GO:0005524]; ATP-dependent protein folding chaperone [GO:0140662]; protein-folding chaperone binding [GO:0051087]
221,M3X0W1,M3X0W1_FELCA,Telomeric repeat-binding factor 2-interacting protein 1 (TERF2-interacting telomeric protein 1) (Repressor/activator protein 1 homolog),TERF2IP,"intracellular signal transduction [GO:0035556]; negative regulation of DNA recombination at telomere [GO:0048239]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of telomere maintenance [GO:0032205]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; protection from non-homologous end joining at telomere [GO:0031848]; protein localization to chromosome, telomeric region [GO:0070198]; regulation of DNA-templated transcription [GO:0006355]; regulation of double-strand break repair via homologous recombination [GO:0010569]; telomere maintenance via telomere lengthening [GO:0010833]",cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; nuclear body [GO:0016604]; shelterin complex [GO:0070187],G-rich strand telomeric DNA binding [GO:0098505]; phosphatase binding [GO:0019902]; telomeric DNA binding [GO:0042162]
222,M3X1P3,M3X1P3_FELCA,Frizzled-2,FZD2,canonical Wnt signaling pathway [GO:0060070]; cell-cell signaling [GO:0007267]; cochlea morphogenesis [GO:0090103]; endothelial cell differentiation [GO:0045446]; hard palate development [GO:0060022]; inner ear receptor cell development [GO:0060119]; membranous septum morphogenesis [GO:0003149]; muscular septum morphogenesis [GO:0003150]; non-canonical Wnt signaling pathway [GO:0035567]; outflow tract morphogenesis [GO:0003151]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of DNA-templated transcription [GO:0045893]; sensory perception of smell [GO:0007608],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],PDZ domain binding [GO:0030165]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]
223,M3X1U0,M3X1U0_FELCA,EH domain containing 1,EHD1,cholesterol homeostasis [GO:0042632]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; protein homooligomerization [GO:0051260]; protein localization to cilium [GO:0061512]; protein localization to plasma membrane [GO:0072659],ciliary pocket membrane [GO:0020018]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; lipid droplet [GO:0005811]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; recycling endosome membrane [GO:0055038],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]
224,M3X4J3,M3X4J3_FELCA,small monomeric GTPase (EC 3.6.5.2),RAP1A,cellular response to cAMP [GO:0071320]; establishment of endothelial barrier [GO:0061028]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of neuron projection development [GO:0010976]; positive regulation of vasculogenesis [GO:2001214]; protein localization to plasma membrane [GO:0072659]; Rap protein signal transduction [GO:0032486]; regulation of cell junction assembly [GO:1901888]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; synaptic vesicle exocytosis [GO:0016079],glutamatergic synapse [GO:0098978]; guanyl-nucleotide exchange factor complex [GO:0032045]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; sperm midpiece [GO:0097225],GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267]
225,M3X816,M3X816_FELCA,14 kDa phosphohistidine phosphatase (EC 3.9.1.3) (Phosphohistidine phosphatase 1) (Protein histidine phosphatase),PHPT1,actin cytoskeleton organization [GO:0030036]; lamellipodium organization [GO:0097581]; negative regulation of T cell receptor signaling pathway [GO:0050860]; positive regulation of cell motility [GO:2000147],cytosol [GO:0005829]; leading edge of lamellipodium [GO:0061851]; nuclear body [GO:0016604]; plasma membrane [GO:0005886],actin filament binding [GO:0051015]; calcium channel inhibitor activity [GO:0019855]; protein histidine phosphatase activity [GO:0101006]; transmembrane transporter binding [GO:0044325]
226,M3X8X7,M3X8X7_FELCA,Interleukin 6 receptor,IL6R,endocrine pancreas development [GO:0031018]; interleukin-6-mediated signaling pathway [GO:0070102]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine production [GO:0032722]; positive regulation of glomerular mesangial cell proliferation [GO:0072126]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; vascular endothelial growth factor production [GO:0010573],apical plasma membrane [GO:0016324]; ciliary neurotrophic factor receptor complex [GO:0070110]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; interleukin-6 receptor complex [GO:0005896]; receptor complex [GO:0043235],ciliary neurotrophic factor binding [GO:0070119]; ciliary neurotrophic factor receptor activity [GO:0004897]; enzyme binding [GO:0019899]; interleukin-11 binding [GO:0019970]; interleukin-11 receptor activity [GO:0004921]; interleukin-6 binding [GO:0019981]; interleukin-6 receptor activity [GO:0004915]; interleukin-6 receptor binding [GO:0005138]; protein homodimerization activity [GO:0042803]
227,M3XDI4,M3XDI4_FELCA,Eukaryotic translation initiation factor 2-alpha kinase 1 (EC 2.7.11.1) (Heme-regulated eukaryotic initiation factor eIF-2-alpha kinase) (Hemin-sensitive initiation factor 2-alpha kinase),EIF2AK1,acute inflammatory response [GO:0002526]; establishment of localization in cell [GO:0051649]; HRI-mediated signaling [GO:0140468]; macrophage differentiation [GO:0030225]; multicellular organismal-level iron ion homeostasis [GO:0060586]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hemoglobin biosynthetic process [GO:0046986]; negative regulation of translation [GO:0017148]; phagocytosis [GO:0006909]; protoporphyrinogen IX metabolic process [GO:0046501]; regulation of eIF2 alpha phosphorylation by heme [GO:0010999]; response to iron ion starvation [GO:1990641],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; heme binding [GO:0020037]; protein homodimerization activity [GO:0042803]
228,M3XFG7,M3XFG7_FELCA,Interferon alpha/beta receptor 1 (IFN-R-1) (IFN-alpha/beta receptor 1) (Type I interferon receptor 1),IFNAR1,cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; cellular response to interferon-alpha [GO:0035457]; cellular response to interferon-beta [GO:0035458]; positive regulation of cellular respiration [GO:1901857]; response to lipopolysaccharide [GO:0032496]; type I interferon-mediated signaling pathway [GO:0060337],late endosome [GO:0005770]; lysosome [GO:0005764]; plasma membrane [GO:0005886],JAK pathway signal transduction adaptor activity [GO:0008269]; type I interferon binding [GO:0019962]; type I interferon receptor activity [GO:0004905]
229,M5AXY1,RET4_FELCA,Retinol binding protein 4 (Feline conceptus protein 1) (fCP1) (Plasma retinol-binding protein) (PRBP) (RBP),RBP4,retinol transport [GO:0034633],extracellular space [GO:0005615],retinal binding [GO:0016918]; retinol binding [GO:0019841]; retinol transmembrane transporter activity [GO:0034632]
230,O18754,PRIO_FELCA,Major prion protein (PrP) (CD antigen CD230),PRNP PRP,protein homooligomerization [GO:0051260],Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; side of membrane [GO:0098552],copper ion binding [GO:0005507]
231,O46432,MA2B1_FELCA,Lysosomal alpha-mannosidase (Laman) (EC 3.2.1.24) (Lysosomal acid alpha-mannosidase) (Mannosidase alpha class 2B member 1) (Mannosidase alpha-B),MAN2B1 MANB,mannose metabolic process [GO:0006013],lysosome [GO:0005764],alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]
232,O62657,SDF1_FELCA,Stromal cell-derived factor 1 (SDF-1) (C-X-C motif chemokine 12),CXCL12 SDF1,axon guidance [GO:0007411]; cell chemotaxis [GO:0060326]; chemokine-mediated signaling pathway [GO:0070098]; defense response [GO:0006952]; immune response [GO:0006955]; induction of positive chemotaxis [GO:0050930]; integrin activation [GO:0033622],external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615],chemokine activity [GO:0008009]; chemokine receptor binding [GO:0042379]; CXCR chemokine receptor binding [GO:0045236]; growth factor activity [GO:0008083]; integrin binding [GO:0005178]
233,O97524,BGLR_FELCA,Beta-glucuronidase (EC 3.2.1.31),GUSB,carbohydrate metabolic process [GO:0005975]; glucuronoside catabolic process [GO:0019391],extracellular space [GO:0005615]; lysosome [GO:0005764],beta-glucuronidase activity [GO:0004566]; carbohydrate binding [GO:0030246]; signaling receptor binding [GO:0005102]
234,P07405,HBA_FELCA,Hemoglobin subunit alpha (Alpha-globin) (Hemoglobin alpha chain) [Cleaved into: Hemopressin],HBA,cellular oxidant detoxification [GO:0098869]; hydrogen peroxide catabolic process [GO:0042744],haptoglobin-hemoglobin complex [GO:0031838]; hemoglobin complex [GO:0005833],heme binding [GO:0020037]; iron ion binding [GO:0005506]; organic acid binding [GO:0043177]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]
235,P19707,SAA_FELCA,Serum amyloid A protein (SAA) [Cleaved into: Amyloid protein A (Amyloid fibril protein AA)],SAA1,acute-phase response [GO:0006953],high-density lipoprotein particle [GO:0034364],
236,P40239,CD9_FELCA,CD9 antigen (CD antigen CD9),CD9,cell adhesion [GO:0007155]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; myoblast fusion involved in skeletal muscle regeneration [GO:0014905]; negative regulation of platelet aggregation [GO:0090331]; paranodal junction assembly [GO:0030913]; receptor internalization [GO:0031623]; single fertilization [GO:0007338]; sperm-egg recognition [GO:0035036],extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886],integrin binding [GO:0005178]
237,P55032,MMP7_FELCA,Matrilysin (EC 3.4.24.23) (Matrin) (Matrix metalloproteinase-7) (MMP-7) (Pump-1 protease) (Uterine metalloproteinase),MMP7,collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508],extracellular matrix [GO:0031012]; extracellular space [GO:0005615],endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]
238,P63052,RL40_FELCA,Ubiquitin-ribosomal protein eL40 fusion protein (Ubiquitin A-52 residue ribosomal protein fusion product 1) [Cleaved into: Ubiquitin; Large ribosomal subunit protein eL40 (60S ribosomal protein L40) (CEP52)],UBA52 UBCEP2,modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567]; translation [GO:0006412],cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202],protein tag activity [GO:0031386]; structural constituent of ribosome [GO:0003735]; ubiquitin protein ligase binding [GO:0031625]
239,Q28412,PROC_FELCA,Vitamin K-dependent protein C (EC 3.4.21.69) (Anticoagulant protein C) (Autoprothrombin IIA) (Blood coagulation factor XIV),PROC,blood coagulation [GO:0007596]; negative regulation of coagulation [GO:0050819]; negative regulation of inflammatory response [GO:0050728]; positive regulation of establishment of endothelial barrier [GO:1903142]; proteolysis [GO:0006508],endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794],serine-type endopeptidase activity [GO:0004252]
240,Q29487,PTGDS_FELCA,Prostaglandin-H2 D-isomerase (EC 5.3.99.2) (Glutathione-independent PGD synthase) (Lipocalin-type prostaglandin-D synthase) (Prostaglandin-D2 synthase) (PGD2 synthase) (PGDS) (PGDS2),PTGDS,"mast cell degranulation [GO:0043303]; prostaglandin biosynthetic process [GO:0001516]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]",extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum [GO:0005791],prostaglandin-D synthase activity [GO:0004667]; retinoid binding [GO:0005501]; small molecule binding [GO:0036094]
241,Q6SA95,FA9_FELCA,Coagulation factor IX (EC 3.4.21.22) (Christmas factor) [Cleaved into: Coagulation factor IXa light chain; Coagulation factor IXa heavy chain],F9,blood coagulation [GO:0007596]; proteolysis [GO:0006508]; zymogen activation [GO:0031638],extracellular space [GO:0005615],calcium ion binding [GO:0005509]; endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]
242,Q76B49,CD63_FELCA,CD63 antigen (CD antigen CD63),CD63,cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; endosome to melanosome transport [GO:0035646]; pigment granule maturation [GO:0048757]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746],"cell surface [GO:0009986]; extracellular region [GO:0005576]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; multivesicular body, internal vesicle [GO:0097487]; plasma membrane [GO:0005886]",
243,Q7YRU4,MDHC_FELCA,"Malate dehydrogenase, cytoplasmic (EC 1.1.1.37) (Aromatic alpha-keto acid reductase) (KAR) (EC 1.1.1.96) (Cytosolic malate dehydrogenase)",MDH1,malate metabolic process [GO:0006108]; NADH metabolic process [GO:0006734]; NADP metabolic process [GO:0006739]; oxaloacetate metabolic process [GO:0006107]; tricarboxylic acid cycle [GO:0006099],centrosome [GO:0005813]; cytosol [GO:0005829],hydroxyphenylpyruvate reductase activity [GO:0047995]; L-malate dehydrogenase activity [GO:0030060]
244,Q9MYZ3,TFR1_FELCA,Transferrin receptor protein 1 (TR) (TfR) (TfR1) (Trfr) (CD antigen CD71),TFRC,intracellular iron ion homeostasis [GO:0006879]; iron ion transport [GO:0006826]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of isotype switching [GO:0045830]; positive regulation of T cell proliferation [GO:0042102]; receptor internalization [GO:0031623]; transferrin transport [GO:0033572],external side of plasma membrane [GO:0009897]; melanosome [GO:0042470],transferrin receptor activity [GO:0004998]
245,Q9N2I5,FCG3A_FELCA,Low affinity immunoglobulin gamma Fc region receptor III-A (IgG Fc receptor III-A) (Fc-gamma RIII-alpha) (FcgammaRIIIA) (CD antigen CD16a),FCGR3A CD16,antibody-dependent cellular cytotoxicity [GO:0001788]; cell surface receptor signaling pathway [GO:0007166],external side of plasma membrane [GO:0009897],IgG binding [GO:0019864]; IgG receptor activity [GO:0019770]
246,A0A2I2U0T9,A0A2I2U0T9_FELCA,Notch receptor 2,NOTCH2,apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cellular response to tumor cell [GO:0071228]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355],nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]
247,A0A2I2U0V3,A0A2I2U0V3_FELCA,receptor protein serine/threonine kinase (EC 2.7.11.30),BMPR2,,membrane [GO:0016020]; receptor complex [GO:0043235],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]
248,A0A2I2U1I4,A0A2I2U1I4_FELCA,Tyrosine-protein kinase receptor (EC 2.7.10.1),NTRK3,cell differentiation [GO:0030154]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; nervous system development [GO:0007399],plasma membrane [GO:0005886],ATP binding [GO:0005524]; neurotrophin receptor activity [GO:0005030]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]
249,A0A2I2U1P2,A0A2I2U1P2_FELCA,Collectin-12,COLEC12,"cellular response to exogenous dsRNA [GO:0071360]; defense response to bacterium [GO:0042742]; phagocytosis, recognition [GO:0006910]; plasma membrane raft organization [GO:0044857]; toll-like receptor 3 signaling pathway [GO:0034138]",collagen trimer [GO:0005581]; membrane [GO:0016020],carbohydrate binding [GO:0030246]; low-density lipoprotein particle binding [GO:0030169]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; signaling receptor activity [GO:0038023]
250,A0A2I2U1V5,A0A2I2U1V5_FELCA,Alpha-galactosidase (EC 3.2.1.-),GLA,glycoside catabolic process [GO:0016139]; glycosphingolipid catabolic process [GO:0046479]; oligosaccharide metabolic process [GO:0009311],cytoplasm [GO:0005737]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764],alpha-galactosidase activity [GO:0004557]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]
251,A0A2I2U2J6,A0A2I2U2J6_FELCA,L-selectin,SELL,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; leukocyte migration [GO:0050900],plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]
252,A0A2I2U3F3,A0A2I2U3F3_FELCA,Proteasome subunit beta,PSMB6,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome core complex, beta-subunit complex [GO:0019774]",endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]
253,A0A2I2U3Z6,A0A2I2U3Z6_FELCA,"Isovaleryl-CoA dehydrogenase, mitochondrial (EC 1.3.8.1) (EC 1.3.8.4) (Butyryl-CoA dehydrogenase)",IVD,L-leucine catabolic process [GO:0006552],,flavin adenine dinucleotide binding [GO:0050660]; isovaleryl-CoA dehydrogenase activity [GO:0008470]
254,A0A2I2U480,A0A2I2U480_FELCA,Alpha-synuclein,SNCA,chemical synaptic transmission [GO:0007268]; regulation of dopamine secretion [GO:0014059]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488],axon terminus [GO:0043679]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634],cuprous ion binding [GO:1903136]
255,A0A2I2U4Z0,A0A2I2U4Z0_FELCA,L-lactate dehydrogenase (EC 1.1.1.27),LDHC,carboxylic acid metabolic process [GO:0019752],cytoplasm [GO:0005737],L-lactate dehydrogenase activity [GO:0004459]
256,A0A2I2U572,A0A2I2U572_FELCA,Lymphocyte cytosolic protein 1,LCP1,actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; cell migration [GO:0016477]; extracellular matrix disassembly [GO:0022617]; positive regulation of podosome assembly [GO:0071803]; protein kinase A signaling [GO:0010737]; regulation of intracellular protein transport [GO:0033157]; T cell activation involved in immune response [GO:0002286],actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; glial cell projection [GO:0097386]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; podosome [GO:0002102]; ruffle [GO:0001726]; stress fiber [GO:0001725],actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; GTPase binding [GO:0051020]; integrin binding [GO:0005178]
257,A0A2I2U579,A0A2I2U579_FELCA,SLIT and NTRK like family member 6,SLITRK6,adult locomotory behavior [GO:0008344]; auditory behavior [GO:0031223]; auditory receptor cell morphogenesis [GO:0002093]; axonogenesis [GO:0007409]; cochlea development [GO:0090102]; innervation [GO:0060384]; lens development in camera-type eye [GO:0002088]; linear vestibuloocular reflex [GO:0060007]; multicellular organism growth [GO:0035264]; positive regulation of synapse assembly [GO:0051965]; regulation of presynapse assembly [GO:1905606]; startle response [GO:0001964]; synapse assembly [GO:0007416]; vestibulocochlear nerve development [GO:0021562]; visual perception [GO:0007601],cell surface [GO:0009986]; plasma membrane [GO:0005886],
258,A0A2I2U5X4,A0A2I2U5X4_FELCA,Arginine vasopressin,AVP,ERK1 and ERK2 cascade [GO:0070371]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; protein kinase C signaling [GO:0070528]; symbiont entry into host cell [GO:0046718]; vasoconstriction [GO:0042310],extracellular space [GO:0005615]; secretory granule [GO:0030141],cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; neurohypophyseal hormone activity [GO:0005185]; neuropeptide hormone activity [GO:0005184]; protein kinase activity [GO:0004672]; V1A vasopressin receptor binding [GO:0031894]
259,A0A2I2U642,A0A2I2U642_FELCA,"Keratin, type I cytoskeletal 20 (Cytokeratin-20) (Keratin-20)",KRT20,cellular response to starvation [GO:0009267]; epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109]; regulation of protein secretion [GO:0050708],cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intermediate filament [GO:0005882],structural molecule activity [GO:0005198]
260,A0A2I2U673,A0A2I2U673_FELCA,Guanine nucleotide-binding protein G(i) subunit alpha-3 (G(i) alpha-3),GNAI3,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell division [GO:0051301]; dopamine receptor signaling pathway [GO:0007212]; GTP metabolic process [GO:0046039]; positive regulation of macroautophagy [GO:0016239],centrosome [GO:0005813]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; heterotrimeric G-protein complex [GO:0005834]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]
261,A0A2I2U6N9,A0A2I2U6N9_FELCA,bis(5'-adenosyl)-triphosphatase (EC 3.6.1.29) (AP3A hydrolase) (Ectonucleotide pyrophosphatase/phosphodiesterase family member 4),ENPP4,blood coagulation [GO:0007596]; positive regulation of blood coagulation [GO:0030194]; purine ribonucleoside catabolic process [GO:0046130],plasma membrane [GO:0005886],bis(5'-adenosyl)-triphosphatase activity [GO:0047710]
262,A0A2I2U6W9,A0A2I2U6W9_FELCA,MHC class I-like antigen recognition-like domain-containing protein,,"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent [GO:0002486]; antigen processing and presentation of endogenous peptide antigen via MHC class Ib [GO:0002476]; immune response [GO:0006955]; positive regulation of T cell mediated cytotoxicity [GO:0001916]",external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; lumenal side of endoplasmic reticulum membrane [GO:0098553]; MHC class I protein complex [GO:0042612]; phagocytic vesicle membrane [GO:0030670],peptide antigen binding [GO:0042605]; signaling receptor binding [GO:0005102]
263,A0A2I2U6X9,A0A2I2U6X9_FELCA,Ezrin (Cytovillin) (Villin-2) (p81),EZR,regulation of cell shape [GO:0008360],apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; microvillus membrane [GO:0031528]; ruffle membrane [GO:0032587],actin binding [GO:0003779]
264,A0A2I2U787,A0A2I2U787_FELCA,Adenylyl cyclase-associated protein,CAP2,actin filament organization [GO:0007015]; cAMP-mediated signaling [GO:0019933]; cell morphogenesis [GO:0000902]; presynaptic actin cytoskeleton organization [GO:0099140],cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]
265,A0A2I2U7X2,A0A2I2U7X2_FELCA,Reticulon 4 receptor,RTN4R,axon guidance [GO:0007411]; corpus callosum development [GO:0022038]; negative chemotaxis [GO:0050919]; negative regulation of axon extension [GO:0030517]; negative regulation of axon regeneration [GO:0048681]; neuronal signal transduction [GO:0023041]; positive regulation of Rho protein signal transduction [GO:0035025],axonal growth cone [GO:0044295]; dendritic shaft [GO:0043198]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; neuronal cell body [GO:0043025],chondroitin sulfate binding [GO:0035374]; ganglioside GM1 binding [GO:1905573]; ganglioside GT1b binding [GO:1905576]; heparin binding [GO:0008201]; neuregulin receptor activity [GO:0038131]; Roundabout binding [GO:0048495]
266,A0A2I2U7Y0,A0A2I2U7Y0_FELCA,Albumin,ALB,cellular response to calcium ion starvation [GO:0072732]; negative regulation of mitochondrial depolarization [GO:0051902],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; protein-containing complex [GO:0032991],DNA binding [GO:0003677]; enterobactin binding [GO:1903981]; exogenous protein binding [GO:0140272]; fatty acid binding [GO:0005504]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]; protein-folding chaperone binding [GO:0051087]; pyridoxal phosphate binding [GO:0030170]; toxic substance binding [GO:0015643]
267,A0A2I2U8C8,A0A2I2U8C8_FELCA,TAR DNA-binding protein 43,TARDBP,3'-UTR-mediated mRNA destabilization [GO:0061158]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; amyloid fibril formation [GO:1990000]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear inner membrane organization [GO:0071765]; positive regulation of protein import into nucleus [GO:0042307]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of gene expression [GO:0010468]; regulation of protein stability [GO:0031647]; RNA splicing [GO:0008380],chromatin [GO:0000785]; nucleoplasm [GO:0005654],identical protein binding [GO:0042802]; molecular condensate scaffold activity [GO:0140693]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]
268,A0A2I2U9C6,A0A2I2U9C6_FELCA,L-lactate dehydrogenase (EC 1.1.1.27),LDHB,lactate metabolic process [GO:0006089]; pyruvate metabolic process [GO:0006090],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],L-lactate dehydrogenase activity [GO:0004459]
269,A0A2I2UA74,A0A2I2UA74_FELCA,"Solute carrier family 2, facilitated glucose transporter member 5 (Fructose transporter) (Glucose transporter type 5, small intestine)",SLC2A5,cellular response to fructose stimulus [GO:0071332]; fructose import across plasma membrane [GO:1990539]; fructose transmembrane transport [GO:0015755]; regulation of systemic arterial blood pressure mediated by a chemical signal [GO:0003044],apical plasma membrane [GO:0016324]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383],fructose transmembrane transporter activity [GO:0005353]
270,A0A2I2UAA6,A0A2I2UAA6_FELCA,Ras-related protein Rab-4,RAB4A,protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100]; vesicle-mediated transport [GO:0016192],early endosome membrane [GO:0031901]; insulin-responsive compartment [GO:0032593]; plasma membrane [GO:0005886]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038],G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]
271,A0A2I2UAJ7,A0A2I2UAJ7_FELCA,Structural maintenance of chromosomes protein,SMC4,kinetochore organization [GO:0051383]; meiotic chromosome condensation [GO:0010032]; meiotic chromosome segregation [GO:0045132]; mitotic chromosome condensation [GO:0007076]; positive regulation of chromosome condensation [GO:1905821]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820],"chromosome, centromeric region [GO:0000775]; condensed nuclear chromosome [GO:0000794]; condensin complex [GO:0000796]; cytosol [GO:0005829]; nuclear speck [GO:0016607]",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; single-stranded DNA binding [GO:0003697]
272,A0A2I2UAK7,A0A2I2UAK7_FELCA,IST1 homolog (Charged multivesicular body protein 8),IST1,abscission [GO:0009838]; collateral sprouting [GO:0048668]; cytoskeleton-dependent cytokinesis [GO:0061640]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of proteolysis [GO:0045862]; protein localization [GO:0008104]; protein transport [GO:0015031]; viral capsid secondary envelopment [GO:0046745]; viral release from host cell [GO:0019076],centrosome [GO:0005813]; chromatin [GO:0000785]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Flemming body [GO:0090543],MIT domain binding [GO:0090541]; protein-containing complex binding [GO:0044877]
273,A0A2I2UAP2,A0A2I2UAP2_FELCA,Macrophage stimulating 1,MST1,embryo implantation [GO:0007566]; mammary duct terminal end bud growth [GO:0060763]; negative regulation of epithelial cell apoptotic process [GO:1904036]; positive regulation of gene expression [GO:0010628]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; proteolysis [GO:0006508]; regulation of macrophage chemotaxis [GO:0010758]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425],extracellular space [GO:0005615]; vacuole [GO:0005773],receptor tyrosine kinase binding [GO:0030971]
274,A0A2I2UAQ8,A0A2I2UAQ8_FELCA,Metalloproteinase inhibitor 3 (Tissue inhibitor of metalloproteinases 3),TIMP3,cellular response to organic substance [GO:0071310]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; response to cytokine [GO:0034097]; response to hormone [GO:0009725],basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615],metal ion binding [GO:0046872]; metalloendopeptidase inhibitor activity [GO:0008191]; protease binding [GO:0002020]
275,A0A2I2UBH3,A0A2I2UBH3_FELCA,Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8),PPIB,bone development [GO:0060348]; chaperone-mediated protein folding [GO:0061077]; neutrophil chemotaxis [GO:0030593]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of multicellular organism growth [GO:0040018]; protein folding [GO:0006457]; protein stabilization [GO:0050821],cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471],cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA polymerase binding [GO:0070063]
276,A0A2I2UCL3,A0A2I2UCL3_FELCA,FAT atypical cadherin 4,FAT4,branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307],apical part of cell [GO:0045177]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]
277,A0A2I2UCN9,A0A2I2UCN9_FELCA,Acyl-protein thioesterase 1 (EC 3.1.2.22) (Lysophospholipase 1) (Lysophospholipase I) (Palmitoyl-protein hydrolase),LYPLA1,,endoplasmic reticulum [GO:0005783]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886],hydrolase activity [GO:0016787]
278,A0A2I2UD44,A0A2I2UD44_FELCA,Programmed cell death 6,PDCD6,apoptotic process [GO:0006915]; cellular response to heat [GO:0034605]; COPII vesicle coating [GO:0048208]; intracellular protein transport [GO:0006886]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of protein monoubiquitination [GO:1902527]; response to calcium ion [GO:0051592]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324],COPII vesicle coat [GO:0030127]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; nucleoplasm [GO:0005654],calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; protein-membrane adaptor activity [GO:0043495]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]
279,A0A2I2UD52,A0A2I2UD52_FELCA,2-iminobutanoate/2-iminopropanoate deaminase (EC 3.5.99.10) (Translation inhibitor L-PSP ribonuclease),RIDA,lipid metabolic process [GO:0006629]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; organonitrogen compound catabolic process [GO:1901565],cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisome [GO:0005777],2-iminobutanoate deaminase activity [GO:0120242]; deaminase activity [GO:0019239]; mRNA binding [GO:0003729]
280,A0A2I2UD65,A0A2I2UD65_FELCA,Collagen type V alpha 2 chain,COL5A2,cellular response to amino acid stimulus [GO:0071230]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye morphogenesis [GO:0048592]; negative regulation of endodermal cell differentiation [GO:1903225]; skeletal system development [GO:0001501]; skin development [GO:0043588],collagen type V trimer [GO:0005588]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615],extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872]; SMAD binding [GO:0046332]
281,A0A2I2UDC4,A0A2I2UDC4_FELCA,Hepsin,HPN,basement membrane disassembly [GO:0034769]; negative regulation of apoptotic process [GO:0043066]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of cell growth [GO:0030307]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of plasminogen activation [GO:0010756]; proteolysis [GO:0006508]; regulation of cell shape [GO:0008360],cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886],serine-type endopeptidase activity [GO:0004252]; serine-type exopeptidase activity [GO:0070008]
282,A0A2I2UES4,A0A2I2UES4_FELCA,Vascular endothelial growth factor receptor 3 (EC 2.7.10.1),FLT4,angiogenesis [GO:0001525],plasma membrane [GO:0005886],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; vascular endothelial growth factor receptor activity [GO:0005021]
283,A0A2I2UF06,A0A2I2UF06_FELCA,Insulin-like growth factor-binding protein 5,IGFBP5,cellular response to cAMP [GO:0071320]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of translation [GO:0017148]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567],extracellular space [GO:0005615]; insulin-like growth factor ternary complex [GO:0042567],fibronectin binding [GO:0001968]; insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor II binding [GO:0031995]
284,A0A2I2UF62,A0A2I2UF62_FELCA,Anion exchange protein,SLC4A4,,basolateral plasma membrane [GO:0016323]; lateral plasma membrane [GO:0016328],monoatomic anion transmembrane transporter activity [GO:0008509]; sodium:bicarbonate symporter activity [GO:0008510]; solute:inorganic anion antiporter activity [GO:0005452]
285,A0A2I2UFI9,A0A2I2UFI9_FELCA,Transmembrane p24 trafficking protein 9,TMED9,COPI coating of Golgi vesicle [GO:0048205]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; positive regulation of organelle organization [GO:0010638],COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],cargo receptor activity [GO:0038024]; syntaxin binding [GO:0019905]
286,A0A2I2UGV7,A0A2I2UGV7_FELCA,Thy-1 membrane glycoprotein (Thy-1 antigen),THY1,heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; positive regulation of cellular extravasation [GO:0002693]; positive regulation of focal adhesion assembly [GO:0051894],apical plasma membrane [GO:0016324]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; membrane raft [GO:0045121],GTPase activator activity [GO:0005096]; integrin binding [GO:0005178]
287,A0A2I2UH10,A0A2I2UH10_FELCA,Versican core protein (Chondroitin sulfate proteoglycan core protein 2) (Large fibroblast proteoglycan) (PG-M),VCAN,cell adhesion [GO:0007155],extracellular region [GO:0005576]; interphotoreceptor matrix [GO:0033165]; photoreceptor outer segment [GO:0001750],calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]
288,A0A2I2UH51,A0A2I2UH51_FELCA,"Beta-1,4-galactosyltransferase (Beta-1,4-GalTase) (EC 2.4.1.-)",B4GALT1,carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486],Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139],glycosyltransferase activity [GO:0016757]; metal ion binding [GO:0046872]
289,A0A2I2UH63,A0A2I2UH63_FELCA,CD44 antigen (GP90 lymphocyte homing/adhesion receptor) (HUTCH-I) (Hermes antigen) (Hyaluronate receptor) (Phagocytic glycoprotein 1) (Phagocytic glycoprotein I),CD44,cell adhesion [GO:0007155],extracellular region [GO:0005576]; microvillus [GO:0005902]; plasma membrane [GO:0005886],hyaluronic acid binding [GO:0005540]
290,A0A2I2UHD0,A0A2I2UHD0_FELCA,Long-chain-fatty-acid--CoA ligase (EC 6.2.1.15) (EC 6.2.1.3) (Acyl-CoA synthetase) (Long-chain acyl-CoA synthetase),ACSL5,,endoplasmic reticulum membrane [GO:0005789]; mitochondrial outer membrane [GO:0005741],ATP binding [GO:0005524]; long-chain fatty acid-CoA ligase activity [GO:0004467]
291,A0A2I2UHT3,A0A2I2UHT3_FELCA,phosphopyruvate hydratase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase),ENO2,glycolytic process [GO:0006096],perikaryon [GO:0043204]; phosphopyruvate hydratase complex [GO:0000015]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886],magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]
292,A0A2I2UIN2,A0A2I2UIN2_FELCA,Vascular endothelial growth factor receptor 2 (EC 2.7.10.1),KDR,angiogenesis [GO:0001525]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; vascular endothelial growth factor receptor activity [GO:0005021]
293,A0A2I2UJ14,A0A2I2UJ14_FELCA,Beta-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (Enolase 3) (Muscle-specific enolase) (Skeletal muscle enolase),ENO3,canonical glycolysis [GO:0061621]; glycolytic process [GO:0006096],phosphopyruvate hydratase complex [GO:0000015]; plasma membrane [GO:0005886],magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]
294,A0A2I2UM02,A0A2I2UM02_FELCA,Adhesion G-protein coupled receptor G1 (G-protein coupled receptor 56),ADGRG1,cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; nervous system development [GO:0007399],extracellular region [GO:0005576]; membrane raft [GO:0045121]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930]; heparin binding [GO:0008201]
295,A0A2I2UMH4,A0A2I2UMH4_FELCA,Adenine phosphoribosyltransferase (EC 2.4.2.7),APRT,adenine salvage [GO:0006168]; AMP salvage [GO:0044209]; GMP salvage [GO:0032263]; grooming behavior [GO:0007625]; IMP salvage [GO:0032264]; purine ribonucleoside salvage [GO:0006166],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654],adenine binding [GO:0002055]; adenine phosphoribosyltransferase activity [GO:0003999]; AMP binding [GO:0016208]
296,A0A2I2UMR3,A0A2I2UMR3_FELCA,Insulin-like growth factor II,IGF2,glucose metabolic process [GO:0006006]; ossification [GO:0001503]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of cell division [GO:0051781]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of muscle cell differentiation [GO:0051147],extracellular space [GO:0005615],growth factor activity [GO:0008083]; hormone activity [GO:0005179]; insulin-like growth factor receptor binding [GO:0005159]; protein serine/threonine kinase activator activity [GO:0043539]
297,A0A2I2UPH5,A0A2I2UPH5_FELCA,Superoxide dismutase [Cu-Zn] (EC 1.15.1.1),SOD1,removal of superoxide radicals [GO:0019430],cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisome [GO:0005777],copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]
298,A0A2I2UPJ1,A0A2I2UPJ1_FELCA,Transporter,SLC6A1,amino acid transport [GO:0006865]; gamma-aminobutyric acid import [GO:0051939]; inorganic anion import across plasma membrane [GO:0098658]; neurotransmitter transport [GO:0006836]; response to inorganic substance [GO:0010035]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725],axon [GO:0030424]; cell surface [GO:0009986]; plasma membrane [GO:0005886],gamma-aminobutyric acid:sodium:chloride symporter activity [GO:0005332]
299,A0A2I2UQE2,A0A2I2UQE2_FELCA,Branched-chain-amino-acid aminotransferase (EC 2.6.1.42),BCAT1,amino acid biosynthetic process [GO:0008652]; branched-chain amino acid biosynthetic process [GO:0009082],,L-isoleucine transaminase activity [GO:0052656]; L-leucine transaminase activity [GO:0052654]; L-leucine:2-oxoglutarate aminotransferase activity [GO:0050048]; L-valine transaminase activity [GO:0052655]
300,A0A2I2UQJ5,A0A2I2UQJ5_FELCA,small monomeric GTPase (EC 3.6.5.2),RAB1B,autophagosome assembly [GO:0000045]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; positive regulation of glycoprotein metabolic process [GO:1903020]; regulation of autophagosome assembly [GO:2000785]; virion assembly [GO:0019068],endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; phagophore assembly site membrane [GO:0034045],GTP binding [GO:0005525]; GTPase activity [GO:0003924]
301,A0A2I2UQN2,A0A2I2UQN2_FELCA,"Hydroxyacylglutathione hydrolase, mitochondrial (EC 3.1.2.6) (Glyoxalase II)",HAGH,methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243],mitochondrial matrix [GO:0005759],hydroxyacylglutathione hydrolase activity [GO:0004416]; metal ion binding [GO:0046872]
302,A0A2I2UQW0,A0A2I2UQW0_FELCA,Aminopeptidase (EC 3.4.11.-),ERAP1,membrane protein ectodomain proteolysis [GO:0006509]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020],interleukin-6 receptor binding [GO:0005138]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]
303,A0A2I2UTY3,A0A2I2UTY3_FELCA,G protein-coupled receptor 37,GPR37,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cellular response to reactive oxygen species [GO:0034614]; dendrite development [GO:0016358]; dopamine biosynthetic process [GO:0042416]; locomotion involved in locomotory behavior [GO:0031987]; positive regulation of dopamine metabolic process [GO:0045964]; positive regulation of MAPK cascade [GO:0043410],cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; synapse [GO:0045202]; ubiquitin ligase complex [GO:0000151],G protein-coupled peptide receptor activity [GO:0008528]; Hsp70 protein binding [GO:0030544]; neuropeptide binding [GO:0042923]; neuropeptide receptor activity [GO:0008188]; PDZ domain binding [GO:0030165]; prosaposin receptor activity [GO:0036505]; ubiquitin protein ligase binding [GO:0031625]
304,A0A2I2UTY4,A0A2I2UTY4_FELCA,Ras homolog family member Q,RHOQ,actin filament organization [GO:0007015]; cortical actin cytoskeleton organization [GO:0030866]; endocytosis [GO:0006897]; establishment or maintenance of cell polarity [GO:0007163]; GTP metabolic process [GO:0046039]; insulin receptor signaling pathway [GO:0008286]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of glucose import [GO:0046326]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell shape [GO:0008360]; signal transduction [GO:0007165]; small GTPase-mediated signal transduction [GO:0007264],actin filament [GO:0005884]; membrane raft [GO:0045121]; plasma membrane [GO:0005886],GBD domain binding [GO:0032427]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; profilin binding [GO:0005522]; protein kinase binding [GO:0019901]
305,A0A2I2UU92,A0A2I2UU92_FELCA,Neuropilin,NRP1,angiogenesis [GO:0001525]; axon guidance [GO:0007411]; regulation of plasma membrane bounded cell projection organization [GO:0120035],membrane [GO:0016020],heparin binding [GO:0008201]; metal ion binding [GO:0046872]; semaphorin receptor activity [GO:0017154]; vascular endothelial growth factor receptor activity [GO:0005021]
306,A0A2I2UUM4,A0A2I2UUM4_FELCA,"Beta-defensin 1 (Defensin, beta 1)",DEFB1,antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cAMP-mediated signaling [GO:0019933]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response in mucosa [GO:0002227]; positive regulation of flagellated sperm motility involved in capacitation [GO:0060474],extracellular space [GO:0005615]; membrane [GO:0016020]; microvesicle [GO:1990742]; sperm midpiece [GO:0097225],CCR6 chemokine receptor binding [GO:0031731]; identical protein binding [GO:0042802]
307,A0A2I2UV62,A0A2I2UV62_FELCA,receptor protein-tyrosine kinase (EC 2.7.10.1),EPHA4,,early endosome [GO:0005769]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; ephrin receptor activity [GO:0005003]
308,A0A2I2UVC1,A0A2I2UVC1_FELCA,Integral membrane protein 2,ITM2B,negative regulation of amyloid precursor protein biosynthetic process [GO:0042985],endosome membrane [GO:0010008]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; plasma membrane [GO:0005886],amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]
309,A0A2I2UVC7,A0A2I2UVC7_FELCA,Tubulin alpha chain,TUBA1A,microtubule-based process [GO:0007017],cytoplasm [GO:0005737]; microtubule [GO:0005874],GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; structural constituent of cytoskeleton [GO:0005200]
310,A0A2I2UVF9,A0A2I2UVF9_FELCA,"NBL1, DAN family BMP antagonist",NBL1,animal organ morphogenesis [GO:0009887]; determination of dorsal identity [GO:0048263]; negative regulation of monocyte chemotaxis [GO:0090027]; neuron projection morphogenesis [GO:0048812]; positive regulation of neuron differentiation [GO:0045666]; sequestering of BMP from receptor via BMP binding [GO:0038098]; sequestering of BMP in extracellular matrix [GO:0035582],extracellular space [GO:0005615],BMP binding [GO:0036122]; identical protein binding [GO:0042802]; morphogen activity [GO:0016015]; receptor ligand activity [GO:0048018]
311,A0A2I2UVP7,A0A2I2UVP7_FELCA,Integrin subunit alpha 6,ITGA6,cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; ectodermal cell differentiation [GO:0010668]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; nail development [GO:0035878]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skin morphogenesis [GO:0043589],external side of plasma membrane [GO:0009897]; integrin complex [GO:0008305],insulin-like growth factor I binding [GO:0031994]; integrin binding [GO:0005178]; neuregulin binding [GO:0038132]
312,A0A2I2UVQ2,A0A2I2UVQ2_FELCA,Secreted phosphoprotein 1,SPP1,androgen catabolic process [GO:0006710]; cell adhesion [GO:0007155]; cellular response to testosterone stimulus [GO:0071394]; osteoblast differentiation [GO:0001649]; positive regulation of bone resorption [GO:0045780]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of estradiol secretion [GO:2000866]; response to vitamin D [GO:0033280],extracellular space [GO:0005615]; Golgi apparatus [GO:0005794],extracellular matrix binding [GO:0050840]; integrin binding [GO:0005178]; ion binding [GO:0043167]
313,A0A2I2UVW3,A0A2I2UVW3_FELCA,"Keratin, type I cytoskeletal 27 (Cytokeratin-27) (Keratin-27) (Type I inner root sheath-specific keratin-K25irs3)",KRT25 KRT27,epithelial cell differentiation [GO:0030855]; hair follicle morphogenesis [GO:0031069]; intermediate filament organization [GO:0045109],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intermediate filament [GO:0005882],structural molecule activity [GO:0005198]
314,A0A2I2UWI1,A0A2I2UWI1_FELCA,Disintegrin and metalloproteinase domain-containing protein 10 (EC 3.4.24.81) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease),ADAM10,proteolysis [GO:0006508],adherens junction [GO:0005912]; clathrin-coated vesicle [GO:0030136]; Golgi membrane [GO:0000139],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; SH3 domain binding [GO:0017124]
315,A0A2I2UXY4,A0A2I2UXY4_FELCA,Methanethiol oxidase (MTO) (EC 1.8.3.4) (Selenium-binding protein 1),SELENBP1,protein transport [GO:0015031],cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634],methanethiol oxidase activity [GO:0018549]; selenium binding [GO:0008430]
316,A0A2I2UZ20,A0A2I2UZ20_FELCA,Tubulin alpha chain,TUBA4A,microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278],cytoplasm [GO:0005737]; microtubule [GO:0005874],GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; protein kinase binding [GO:0019901]; structural constituent of cytoskeleton [GO:0005200]
317,A0A2I2V0F1,A0A2I2V0F1_FELCA,V-type proton ATPase subunit G,ATP6V1G1,cellular response to increased oxygen levels [GO:0036295]; intracellular iron ion homeostasis [GO:0006879]; synaptic vesicle lumen acidification [GO:0097401],"cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; transmembrane transporter complex [GO:1902495]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]","ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"
318,A0A2I2V0N3,A0A2I2V0N3_FELCA,Acid ceramidase (EC 3.5.1.23),ASAH1,fatty acid metabolic process [GO:0006631]; sphingolipid metabolic process [GO:0006665],extracellular region [GO:0005576]; lysosome [GO:0005764],ceramidase activity [GO:0102121]; fatty acid amide hydrolase activity [GO:0017064]; N-acylsphingosine amidohydrolase activity [GO:0017040]
319,A0A2I2V223,A0A2I2V223_FELCA,Tumor necrosis factor receptor superfamily member 1A (Tumor necrosis factor receptor 1) (Tumor necrosis factor receptor type I) (p55) (p60),TNFRSF1A,apoptotic process [GO:0006915]; inflammatory response [GO:0006954]; prostaglandin metabolic process [GO:0006693],Golgi membrane [GO:0000139]; plasma membrane [GO:0005886],tumor necrosis factor receptor activity [GO:0005031]
320,A0A2I2V293,A0A2I2V293_FELCA,receptor protein-tyrosine kinase (EC 2.7.10.1),EPHB4,angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; ephrin receptor signaling pathway [GO:0048013],plasma membrane [GO:0005886]; receptor complex [GO:0043235],ATP binding [GO:0005524]; ephrin receptor activity [GO:0005003]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]
321,A0A2I2V2F6,A0A2I2V2F6_FELCA,Secreted frizzled-related protein 3 (Frizzled-related protein 1) (FrzB-1),FRZB,cell differentiation [GO:0030154]; Wnt signaling pathway [GO:0016055],extracellular region [GO:0005576],
322,A0A2I2V3J5,A0A2I2V3J5_FELCA,Matrix Gla protein (MGP),MGP,cartilage development [GO:0051216]; cell differentiation [GO:0030154]; ossification [GO:0001503]; regulation of bone mineralization [GO:0030500],collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576],calcium ion binding [GO:0005509]
323,A0A2I2V3L7,A0A2I2V3L7_FELCA,Ectonucleotide pyrophosphatase/phosphodiesterase 2,ENPP2,estrous cycle [GO:0044849]; immune response [GO:0006955]; phosphatidylcholine catabolic process [GO:0034638]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; sphingolipid catabolic process [GO:0030149],extracellular space [GO:0005615]; membrane [GO:0016020],alkylglycerophosphoethanolamine phosphodiesterase activity [GO:0047391]; calcium ion binding [GO:0005509]; lysophospholipase activity [GO:0004622]; nucleic acid binding [GO:0003676]; phosphodiesterase I activity [GO:0004528]; polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]; zinc ion binding [GO:0008270]
324,A0A2I2V3S9,A0A2I2V3S9_FELCA,Lysosomal associated membrane protein 3,LAMP3,establishment of protein localization to organelle [GO:0072594]; negative regulation of proteasomal protein catabolic process [GO:1901799]; positive regulation of gene expression [GO:0010628]; regulation of autophagy [GO:0010506]; regulation of viral life cycle [GO:1903900]; response to interferon-alpha [GO:0035455],early endosome [GO:0005769]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],
325,A0A2I2V4P2,A0A2I2V4P2_FELCA,Complement C2 (EC 3.4.21.43) (C3/C5 convertase),C2,"complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; proteolysis [GO:0006508]",extracellular region [GO:0005576],serine-type endopeptidase activity [GO:0004252]
326,A0A2I2V4V3,A0A2I2V4V3_FELCA,Vacuolar proton pump subunit B (V-ATPase subunit B) (Vacuolar proton pump subunit B),ATP6V1B2,ATP metabolic process [GO:0046034]; synaptic vesicle lumen acidification [GO:0097401]; vacuolar acidification [GO:0007035],"apical plasma membrane [GO:0016324]; clathrin-coated vesicle membrane [GO:0030665]; cytosol [GO:0005829]; melanosome [GO:0042470]; microvillus [GO:0005902]; ruffle [GO:0001726]; synaptic vesicle membrane [GO:0030672]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]","ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"
327,A0A2I2V568,A0A2I2V568_FELCA,Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 (EC 3.1.4.1) (EC 3.6.1.9) (Phosphodiesterase I beta) (Phosphodiesterase I/nucleotide pyrophosphatase 3),ENPP3,,extracellular region [GO:0005576]; plasma membrane [GO:0005886],hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]
328,A0A2I2V5I2,A0A2I2V5I2_FELCA,Tripeptidyl-peptidase 1 (EC 3.4.14.9) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I),,central nervous system development [GO:0007417]; proteolysis [GO:0006508],,endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240]
329,A0A337RUT4,A0A337RUT4_FELCA,10-formyltetrahydrofolate dehydrogenase (EC 1.5.1.6),ALDH1L1,10-formyltetrahydrofolate catabolic process [GO:0009258]; biosynthetic process [GO:0009058]; one-carbon metabolic process [GO:0006730],cytosol [GO:0005829],aldehyde dehydrogenase (NAD+) activity [GO:0004029]; formyltetrahydrofolate dehydrogenase activity [GO:0016155]
330,A0A337RVG5,A0A337RVG5_FELCA,Ciliary neurotrophic factor receptor subunit alpha,CNTFR,brainstem development [GO:0003360]; ciliary neurotrophic factor-mediated signaling pathway [GO:0070120]; motor neuron apoptotic process [GO:0097049]; negative regulation of motor neuron apoptotic process [GO:2000672]; positive regulation of cell population proliferation [GO:0008284]; sex differentiation [GO:0007548]; skeletal muscle organ development [GO:0060538]; suckling behavior [GO:0001967],apical plasma membrane [GO:0016324]; ciliary neurotrophic factor receptor complex [GO:0070110]; CNTFR-CLCF1 complex [GO:0097059]; external side of plasma membrane [GO:0009897],ciliary neurotrophic factor receptor activity [GO:0004897]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; signaling receptor binding [GO:0005102]
331,A0A337RVS9,A0A337RVS9_FELCA,Beta-mannosidase (EC 3.2.1.25) (Lysosomal beta A mannosidase) (Mannanase),MANBA,carbohydrate metabolic process [GO:0005975],lysosome [GO:0005764],beta-mannosidase activity [GO:0004567]
332,A0A337RVY2,A0A337RVY2_FELCA,Insulin-like growth factor-binding protein 4,IGFBP4,MAPK cascade [GO:0000165]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of MAPK cascade [GO:0043410]; regulation of cell growth [GO:0001558]; regulation of glucose metabolic process [GO:0010906]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; type B pancreatic cell proliferation [GO:0044342],extracellular space [GO:0005615],insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor II binding [GO:0031995]
333,A0A337RYM9,A0A337RYM9_FELCA,Collagen type IV alpha 3 chain,COL4A3,collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; endothelial cell apoptotic process [GO:0072577]; extracellular matrix organization [GO:0030198]; glomerular basement membrane development [GO:0032836]; negative regulation of angiogenesis [GO:0016525]; negative regulation of vascular endothelial cell proliferation [GO:1905563],basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; membrane [GO:0016020],extracellular matrix structural constituent conferring tensile strength [GO:0030020]; integrin binding [GO:0005178]
334,A0A337RZV6,A0A337RZV6_FELCA,Nectin cell adhesion molecule 1,NECTIN1,desmosome organization [GO:0002934]; enamel mineralization [GO:0070166]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; iron ion transport [GO:0006826]; lens morphogenesis in camera-type eye [GO:0002089]; protein localization to cell junction [GO:1902414]; retina development in camera-type eye [GO:0060041],adherens junction [GO:0005912]; apical junction complex [GO:0043296]; cell-cell contact zone [GO:0044291]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; presynaptic active zone membrane [GO:0048787],cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]
335,A0A337S0K9,A0A337S0K9_FELCA,E3 ubiquitin-protein ligase (EC 2.3.2.26),HECTD1,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534],nuclear speck [GO:0016607],metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]
336,A0A337S2C8,A0A337S2C8_FELCA,Interleukin-4 receptor subunit alpha,IL4R,cytokine-mediated signaling pathway [GO:0019221]; production of molecular mediator involved in inflammatory response [GO:0002532],centriolar satellite [GO:0034451]; external side of plasma membrane [GO:0009897]; nucleoplasm [GO:0005654]; receptor complex [GO:0043235],cytokine receptor activity [GO:0004896]; interleukin-4 receptor activity [GO:0004913]
337,A0A337S2N1,A0A337S2N1_FELCA,Triokinase/FMN cyclase (EC 2.7.1.28) (EC 2.7.1.29) (EC 4.6.1.15) (Bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase (cyclizing)),TKFC,carbohydrate phosphorylation [GO:0046835]; fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate [GO:0061624]; glycerol catabolic process [GO:0019563]; negative regulation of MDA-5 signaling pathway [GO:0039534],cytosol [GO:0005829],ATP binding [GO:0005524]; FAD-AMP lyase (cyclizing) activity [GO:0034012]; glycerone kinase activity [GO:0004371]; triokinase activity [GO:0050354]
338,A0A337S2Y5,A0A337S2Y5_FELCA,Phosphoglycerate mutase (EC 5.4.2.11) (EC 5.4.2.4),PGAM1,gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; regulation of glycolytic process [GO:0006110]; regulation of pentose-phosphate shunt [GO:0043456]; respiratory burst [GO:0045730],cytosol [GO:0005829],"2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity [GO:0046538]; bisphosphoglycerate mutase activity [GO:0004082]; protein kinase binding [GO:0019901]"
339,A0A337S474,A0A337S474_FELCA,Urokinase-type plasminogen activator (EC 3.4.21.73),PLAU,fibrinolysis [GO:0042730]; plasminogen activation [GO:0031639]; positive regulation of cell migration [GO:0030335]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell population proliferation [GO:0042127]; regulation of smooth muscle cell migration [GO:0014910]; regulation of smooth muscle cell-matrix adhesion [GO:2000097]; response to hypoxia [GO:0001666]; smooth muscle cell migration [GO:0014909],cell surface [GO:0009986]; extracellular space [GO:0005615]; protein complex involved in cell-matrix adhesion [GO:0098637]; serine protease inhibitor complex [GO:0097180]; serine-type endopeptidase complex [GO:1905370],serine-type endopeptidase activity [GO:0004252]
340,A0A337S4R1,A0A337S4R1_FELCA,cAMP-dependent protein kinase type II-alpha regulatory subunit,PRKAR2A,regulation of protein phosphorylation [GO:0001932],axoneme [GO:0005930]; cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleotide-activated protein kinase complex [GO:0031588]; plasma membrane raft [GO:0044853],cAMP binding [GO:0030552]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; protein domain specific binding [GO:0019904]; protein kinase A catalytic subunit binding [GO:0034236]; ubiquitin protein ligase binding [GO:0031625]
341,A0A337S5G0,A0A337S5G0_FELCA,Cadherin-1 (Epithelial cadherin),CDH1,homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]
342,A0A337S7G1,A0A337S7G1_FELCA,Fibroblast growth factor receptor (EC 2.7.10.1),FGFR3,positive regulation of cell population proliferation [GO:0008284],plasma membrane [GO:0005886],ATP binding [GO:0005524]; fibroblast growth factor receptor activity [GO:0005007]
343,A0A337S7R6,A0A337S7R6_FELCA,von Willebrand factor (vWF),VWF,blood coagulation [GO:0007596]; cell-substrate adhesion [GO:0031589]; platelet activation [GO:0030168]; positive regulation of intracellular signal transduction [GO:1902533],collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Weibel-Palade body [GO:0033093],collagen binding [GO:0005518]; identical protein binding [GO:0042802]; immunoglobulin binding [GO:0019865]; integrin binding [GO:0005178]; protease binding [GO:0002020]; protein-folding chaperone binding [GO:0051087]
344,A0A337S8G3,A0A337S8G3_FELCA,Septin,SEPTIN2,cell division [GO:0051301],ciliary membrane [GO:0060170]; cleavage furrow [GO:0032154]; midbody [GO:0030496]; motile cilium [GO:0031514]; spindle [GO:0005819],GTP binding [GO:0005525]
345,A0A337S8L4,A0A337S8L4_FELCA,Low molecular weight phosphotyrosine protein phosphatase (LMW-PTP) (LMW-PTPase) (EC 3.1.3.2) (EC 3.1.3.48) (Low molecular weight cytosolic acid phosphatase),ACP1,,cytoplasm [GO:0005737],acid phosphatase activity [GO:0003993]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725]
346,A0A337S942,A0A337S942_FELCA,BMP and activin membrane-bound inhibitor homolog,BAMBI,cell migration [GO:0016477]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; regulation of cell shape [GO:0008360]; transforming growth factor beta receptor signaling pathway [GO:0007179],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],frizzled binding [GO:0005109]
347,A0A337S9I7,A0A337S9I7_FELCA,Glucose-6-phosphate isomerase (EC 5.3.1.9),GPI,erythrocyte homeostasis [GO:0034101]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; in utero embryonic development [GO:0001701]; mesoderm formation [GO:0001707]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of immunoglobulin production [GO:0002639],ciliary membrane [GO:0060170]; cytosol [GO:0005829]; extracellular space [GO:0005615],carbohydrate derivative binding [GO:0097367]; cytokine activity [GO:0005125]; glucose-6-phosphate isomerase activity [GO:0004347]; monosaccharide binding [GO:0048029]; ubiquitin protein ligase binding [GO:0031625]
348,A0A337S9V8,A0A337S9V8_FELCA,Mitogen-activated protein kinase kinase kinase 12 (EC 2.7.11.25),MAP3K12,JNK cascade [GO:0007254],cytoplasm [GO:0005737],ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; protein serine kinase activity [GO:0106310]
349,A0A337S9Y3,A0A337S9Y3_FELCA,Apolipoprotein E,CLPTM1 APOE,lipid transport [GO:0006869]; lipoprotein metabolic process [GO:0042157],chylomicron [GO:0042627]; high-density lipoprotein particle [GO:0034364]; multivesicular body [GO:0005771]; very-low-density lipoprotein particle [GO:0034361],heparin binding [GO:0008201]; lipid binding [GO:0008289]
350,A0A337S9Y6,A0A337S9Y6_FELCA,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial (EC 1.3.8.7)",ACADM,fatty acid beta-oxidation [GO:0006635],mitochondrial matrix [GO:0005759],flavin adenine dinucleotide binding [GO:0050660]; medium-chain fatty acyl-CoA dehydrogenase activity [GO:0070991]
351,A0A337SBR4,A0A337SBR4_FELCA,Prolactin-induced protein,PIP,detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; negative regulation of T cell apoptotic process [GO:0070233]; positive regulation of gene expression [GO:0010628]; proteolysis [GO:0006508]; regulation of immune system process [GO:0002682],extracellular space [GO:0005615]; nucleus [GO:0005634],aspartic-type endopeptidase activity [GO:0004190]; identical protein binding [GO:0042802]; IgG binding [GO:0019864]
352,A0A337SC09,A0A337SC09_FELCA,Kremen protein (Kringle-containing protein marking the eye and the nose),KREMEN1,apoptotic process [GO:0006915]; limb development [GO:0060173]; negative regulation of axon regeneration [GO:0048681]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; Wnt signaling pathway [GO:0016055],neuronal cell body [GO:0043025]; plasma membrane [GO:0005886],
353,A0A337SC81,A0A337SC81_FELCA,"Tsukushi, small leucine rich proteoglycan",TSKU,anterior commissure morphogenesis [GO:0021960]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; ciliary body morphogenesis [GO:0061073]; corpus callosum morphogenesis [GO:0021540]; energy homeostasis [GO:0097009]; hippocampus development [GO:0021766]; inner ear receptor cell stereocilium organization [GO:0060122]; lateral ventricle development [GO:0021670]; negative regulation of myofibroblast differentiation [GO:1904761]; negative regulation of neuron projection development [GO:0010977]; negative regulation of transforming growth factor beta1 production [GO:0032911]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of hair cycle [GO:0042635]; wound healing [GO:0042060],extracellular matrix [GO:0031012]; extracellular space [GO:0005615],transforming growth factor beta binding [GO:0050431]
354,A0A337SD93,A0A337SD93_FELCA,Inactive rhomboid protein (iRhom) (Rhomboid family member) (Rhomboid veinlet-like protein),RHBDF2,negative regulation of protein secretion [GO:0050709]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058],endoplasmic reticulum membrane [GO:0005789],serine-type endopeptidase activity [GO:0004252]
355,A0A337SDE6,A0A337SDE6_FELCA,complement subcomponent C1r (EC 3.4.21.41),C1R,"complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; zymogen activation [GO:0031638]",extracellular space [GO:0005615],calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]
356,A0A337SDQ4,A0A337SDQ4_FELCA,"Saoe class I histocompatibility antigen, A alpha chain-like",FLAI-K,"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent [GO:0002486]; antigen processing and presentation of endogenous peptide antigen via MHC class Ib [GO:0002476]; immune response [GO:0006955]; positive regulation of T cell mediated cytotoxicity [GO:0001916]",external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; lumenal side of endoplasmic reticulum membrane [GO:0098553]; MHC class I protein complex [GO:0042612]; phagocytic vesicle membrane [GO:0030670],peptide antigen binding [GO:0042605]; signaling receptor binding [GO:0005102]
357,A0A337SEC0,A0A337SEC0_FELCA,Galectin,LGALS1,actin rod assembly [GO:0031247]; cellular response to ATP [GO:0071318]; dephosphorylation [GO:0016311]; positive regulation of actin filament depolymerization [GO:0030836]; pyridoxal phosphate catabolic process [GO:0032361]; regulation of cytokinesis [GO:0032465]; regulation of mitotic nuclear division [GO:0007088],actin cytoskeleton [GO:0015629]; cell-cell junction [GO:0005911]; cleavage furrow [GO:0032154]; contractile ring [GO:0070938]; cytosol [GO:0005829]; extracellular space [GO:0005615]; lamellipodium [GO:0030027]; midbody [GO:0030496]; ruffle membrane [GO:0032587],heat shock protein binding [GO:0031072]; lactose binding [GO:0030395]; laminin binding [GO:0043236]; magnesium ion binding [GO:0000287]; phosphoprotein phosphatase activity [GO:0004721]; protein homodimerization activity [GO:0042803]; pyridoxal phosphatase activity [GO:0033883]
358,A0A337SEZ0,A0A337SEZ0_FELCA,Cadherin 24,CDH24,adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],adherens junction [GO:0005912]; catenin complex [GO:0016342],beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]
359,A0A337SFQ1,A0A337SFQ1_FELCA,Ephrin B3,EFNB3,"adult walking behavior [GO:0007628]; axon choice point recognition [GO:0016198]; axon guidance [GO:0007411]; ephrin receptor signaling pathway [GO:0048013]; negative regulation of axonogenesis [GO:0050771]; T cell costimulation [GO:0031295]; trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission [GO:0099557]",glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734],ephrin receptor binding [GO:0046875]
360,A0A337SFQ2,A0A337SFQ2_FELCA,Renin receptor (ATPase H(+)-transporting lysosomal accessory protein 2) (ATPase H(+)-transporting lysosomal-interacting protein 2) (Renin/prorenin receptor),ATP6AP2,,autophagosome membrane [GO:0000421]; clathrin-coated vesicle membrane [GO:0030665]; dendritic spine membrane [GO:0032591]; endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765]; synaptic vesicle membrane [GO:0030672],signaling receptor activity [GO:0038023]
361,A0A337SG88,A0A337SG88_FELCA,V-type proton ATPase subunit,ATP6V0D1,cellular response to increased oxygen levels [GO:0036295]; intracellular iron ion homeostasis [GO:0006879]; synaptic vesicle lumen acidification [GO:0097401]; vacuolar acidification [GO:0007035]; vacuolar transport [GO:0007034],"centrosome [GO:0005813]; early endosome [GO:0005769]; plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; presynapse [GO:0098793]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; transmembrane transporter complex [GO:1902495]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]","proton-transporting ATPase activity, rotational mechanism [GO:0046961]"
362,A0A337SG91,A0A337SG91_FELCA,Anion exchange protein,SLC4A4,,basolateral plasma membrane [GO:0016323]; lateral plasma membrane [GO:0016328],monoatomic anion transmembrane transporter activity [GO:0008509]; sodium:bicarbonate symporter activity [GO:0008510]; solute:inorganic anion antiporter activity [GO:0005452]
363,A0A337SHQ6,A0A337SHQ6_FELCA,Metalloproteinase inhibitor 2 (Tissue inhibitor of metalloproteinases 2),TIMP2,negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; response to cytokine [GO:0034097]; response to hormone [GO:0009725],extracellular matrix [GO:0031012]; extracellular space [GO:0005615],metalloendopeptidase inhibitor activity [GO:0008191]; protease binding [GO:0002020]; zinc ion binding [GO:0008270]
364,A0A337SJB3,A0A337SJB3_FELCA,Vitamin K-dependent protein C (EC 3.4.21.69) (Anticoagulant protein C) (Autoprothrombin IIA) (Blood coagulation factor XIV),PROC,blood coagulation [GO:0007596]; proteolysis [GO:0006508],endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794],calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]
365,A0A337SLC9,A0A337SLC9_FELCA,Molybdopterin synthase catalytic subunit (EC 2.8.1.12) (Molybdenum cofactor synthesis protein 2 large subunit) (Molybdenum cofactor synthesis protein 2B) (MOCS2B),MOCS2,Mo-molybdopterin cofactor biosynthetic process [GO:0006777],cytosol [GO:0005829]; molybdopterin synthase complex [GO:0019008]; nuclear speck [GO:0016607],molybdopterin synthase activity [GO:0030366]
366,A0A337SLL9,A0A337SLL9_FELCA,Glutathione S-transferase omega (GSTO) (EC 1.20.4.2) (EC 1.8.5.1) (EC 2.5.1.18) (Glutathione-dependent dehydroascorbate reductase) (Monomethylarsonic acid reductase),GSTO1,glutathione metabolic process [GO:0006749],cytoplasm [GO:0005737],glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; methylarsonate reductase activity [GO:0050610]
367,A0A337SMW2,A0A337SMW2_FELCA,Nidogen 2,NID2,canonical Wnt signaling pathway [GO:0060070]; cell-matrix adhesion [GO:0007160],basement membrane [GO:0005604]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]
368,A0A337SNC1,A0A337SNC1_FELCA,Proteasome subunit beta,PSMB5,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to oxidative stress [GO:0006979],"centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome core complex, beta-subunit complex [GO:0019774]",endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]
369,A0A337SPQ5,A0A337SPQ5_FELCA,Ectodysplasin A receptor,EDAR,cytokine-mediated signaling pathway [GO:0019221]; hair follicle development [GO:0001942]; odontogenesis of dentin-containing tooth [GO:0042475]; pigmentation [GO:0043473]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of gene expression [GO:0010628]; positive regulation of JNK cascade [GO:0046330]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; salivary gland cavitation [GO:0060662],apical part of cell [GO:0045177]; plasma membrane [GO:0005886],signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]
370,A0A337SPR9,A0A337SPR9_FELCA,Interleukin-1,IL1RN,inflammatory response to antigenic stimulus [GO:0002437]; insulin secretion [GO:0030073]; lipid metabolic process [GO:0006629]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; response to glucocorticoid [GO:0051384],centrosome [GO:0005813]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; vesicle [GO:0031982],"cytokine activity [GO:0005125]; interleukin-1 receptor antagonist activity [GO:0005152]; interleukin-1 type I receptor antagonist activity [GO:0045352]; interleukin-1 type II receptor antagonist activity [GO:0045353]; interleukin-1, type I receptor binding [GO:0005150]; interleukin-1, type II receptor binding [GO:0005151]"
371,A0A337SRA7,A0A337SRA7_FELCA,Alkaline phosphatase (EC 3.1.3.1),ALPI,,plasma membrane [GO:0005886]; side of membrane [GO:0098552],alkaline phosphatase activity [GO:0004035]; metal ion binding [GO:0046872]
372,A0A337SRW5,A0A337SRW5_FELCA,Cell division control protein 42 homolog (EC 3.6.5.2),CDC42,actin filament organization [GO:0007015]; anatomical structure morphogenesis [GO:0009653]; Cdc42 protein signal transduction [GO:0032488]; endocytosis [GO:0006897]; establishment or maintenance of cell polarity [GO:0007163]; positive regulation of cellular component organization [GO:0051130]; regulation of filopodium assembly [GO:0051489],centrosome [GO:0005813]; dendritic spine [GO:0043197]; midbody [GO:0030496]; plasma membrane [GO:0005886],G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]
373,A0A337SSN3,A0A337SSN3_FELCA,Cadherin 19,CDH19,adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],adherens junction [GO:0005912]; catenin complex [GO:0016342],beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]
374,A0A337SU79,A0A337SU79_FELCA,Cell adhesion molecule L1 like,CHL1,adult locomotory behavior [GO:0008344]; axon guidance [GO:0007411]; cognition [GO:0050890]; dendrite self-avoidance [GO:0070593]; exploration behavior [GO:0035640]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of neuron apoptotic process [GO:0043524]; neuron migration [GO:0001764],apical part of cell [GO:0045177]; axon [GO:0030424]; dendrite [GO:0030425]; plasma membrane [GO:0005886],cell-cell adhesion mediator activity [GO:0098632]; protease binding [GO:0002020]
375,A0A337SUG1,A0A337SUG1_FELCA,Hemojuvelin BMP co-receptor,HJV,activin receptor signaling pathway [GO:0032924]; BMP signaling pathway [GO:0030509]; intracellular iron ion homeostasis [GO:0006879]; multicellular organismal-level iron ion homeostasis [GO:0060586]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autoprocessing [GO:0016540]; transcription by RNA polymerase II [GO:0006366],BMP receptor complex [GO:0070724]; cell surface [GO:0009986]; extracellular space [GO:0005615]; HFE-transferrin receptor complex [GO:1990712]; plasma membrane [GO:0005886]; side of membrane [GO:0098552],BMP binding [GO:0036122]; BMP receptor activity [GO:0098821]; coreceptor activity [GO:0015026]; transferrin receptor binding [GO:1990459]
376,A0A337SWK3,A0A337SWK3_FELCA,Amine oxidase (EC 1.4.3.-),AOC3,amine metabolic process [GO:0009308]; response to antibiotic [GO:0046677],early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886],copper ion binding [GO:0005507]; primary amine oxidase activity [GO:0008131]; quinone binding [GO:0048038]
377,A0A5F5XBV5,A0A5F5XBV5_FELCA,Tubulin gamma complex associated protein 6,TUBGCP6,cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225],centrosome [GO:0005813]; cytoplasm [GO:0005737]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin ring complex [GO:0000931]; microtubule [GO:0005874]; spindle pole [GO:0000922],gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]
378,A0A5F5XBX6,A0A5F5XBX6_FELCA,4-hydroxyphenylpyruvate dioxygenase,HPD,aromatic amino acid metabolic process [GO:0009072],endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139],4-hydroxyphenylpyruvate dioxygenase activity [GO:0003868]; metal ion binding [GO:0046872]
379,A0A5F5XBY8,A0A5F5XBY8_FELCA,Leukotriene A(4) hydrolase (LTA-4 hydrolase) (EC 3.3.2.6),LTA4H,leukotriene biosynthetic process [GO:0019370]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],aminopeptidase activity [GO:0004177]; epoxide hydrolase activity [GO:0004301]; leukotriene-A4 hydrolase activity [GO:0004463]; metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270]
380,A0A5F5XCK4,A0A5F5XCK4_FELCA,Peflin (PEF protein with a long N-terminal hydrophobic domain) (Penta-EF hand domain-containing protein 1),PEF1,COPII vesicle coating [GO:0048208]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of protein monoubiquitination [GO:1902527]; response to calcium ion [GO:0051592],COPII vesicle coat [GO:0030127]; Cul3-RING ubiquitin ligase complex [GO:0031463],calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]
381,A0A5F5XDD6,A0A5F5XDD6_FELCA,Pterin-4-alpha-carbinolamine dehydratase (EC 4.2.1.96) (4-alpha-hydroxy-tetrahydropterin dehydratase) (Dimerization cofactor of hepatocyte nuclear factor 1-alpha) (Phenylalanine hydroxylase-stimulating protein) (Pterin carbinolamine dehydratase),PCBD1,tetrahydrobiopterin biosynthetic process [GO:0006729],cytosol [GO:0005829]; nucleoplasm [GO:0005654],4-alpha-hydroxytetrahydrobiopterin dehydratase activity [GO:0008124]; identical protein binding [GO:0042802]; phenylalanine 4-monooxygenase activity [GO:0004505]
382,A0A5F5XE19,A0A5F5XE19_FELCA,Podocalyxin (Podocalyxin-like protein 1),PODXL,cell migration [GO:0016477]; regulation of cell-cell adhesion [GO:0022407],apical plasma membrane [GO:0016324]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; membrane raft [GO:0045121]; microvillus [GO:0005902]; ruffle [GO:0001726],
383,A0A5F5XE59,A0A5F5XE59_FELCA,5'-3' exonuclease PLD3 (EC 3.1.16.1) (Choline phosphatase 3) (Phosphatidylcholine-hydrolyzing phospholipase D3) (Phospholipase D3),PLD3,myotube differentiation [GO:0014902]; regulation of cytokine production involved in inflammatory response [GO:1900015],early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765],single-stranded DNA 5'-3' DNA exonuclease activity [GO:0045145]
384,A0A5F5XER7,A0A5F5XER7_FELCA,Platelet-derived growth factor D,PDGFD,cellular response to amino acid stimulus [GO:0071230]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein autophosphorylation [GO:0031954]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730],extracellular space [GO:0005615]; membrane [GO:0016020],growth factor activity [GO:0008083]; platelet-derived growth factor receptor binding [GO:0005161]
385,A0A5F5XF81,A0A5F5XF81_FELCA,Osteocalcin,BGLAP,biomineral tissue development [GO:0031214]; bone development [GO:0060348]; osteoblast differentiation [GO:0001649]; regulation of bone mineralization [GO:0030500]; regulation of cellular response to insulin stimulus [GO:1900076]; response to vitamin D [GO:0033280]; response to vitamin K [GO:0032571],cytoplasm [GO:0005737]; extracellular region [GO:0005576],calcium ion binding [GO:0005509]; hormone activity [GO:0005179]; hydroxyapatite binding [GO:0046848]; structural constituent of bone [GO:0008147]
386,A0A5F5XFP7,A0A5F5XFP7_FELCA,Fumarylacetoacetase (EC 3.7.1.2) (Beta-diketonase) (Fumarylacetoacetate hydrolase),FAH,arginine catabolic process [GO:0006527]; homogentisate catabolic process [GO:1902000]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572],,fumarylacetoacetase activity [GO:0004334]; metal ion binding [GO:0046872]
387,A0A5F5XGF8,A0A5F5XGF8_FELCA,Gamma-aminobutyric acid type B receptor subunit 1,GABBR1,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214],cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA-ergic synapse [GO:0098982]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685],G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential [GO:0150047]
388,A0A5F5XGH7,A0A5F5XGH7_FELCA,Aspartate aminotransferase (EC 2.6.1.1),GOT1,amino acid biosynthetic process [GO:0008652],cytoplasm [GO:0005737],L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; L-cysteine transaminase activity [GO:0047801]; pyridoxal phosphate binding [GO:0030170]
389,A0A5F5XGP3,A0A5F5XGP3_FELCA,Clusterin,CLU,,chromaffin granule [GO:0042583]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],
390,A0A5F5XGQ1,A0A5F5XGQ1_FELCA,Serine/threonine-protein kinase receptor (EC 2.7.11.30),TGFBR2,apoptotic process [GO:0006915],membrane raft [GO:0045121]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; transforming growth factor beta receptor activity, type II [GO:0005026]"
391,A0A5F5XH32,A0A5F5XH32_FELCA,Ammonium transporter Rh type C (Rhesus blood group family type C glycoprotein),RHCG,ammonium homeostasis [GO:0097272]; ammonium transmembrane transport [GO:0072488]; intracellular monoatomic ion homeostasis [GO:0006873]; regulation of pH [GO:0006885]; transepithelial ammonium transport [GO:0070634],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886],ammonium transmembrane transporter activity [GO:0008519]; ankyrin binding [GO:0030506]; carbon dioxide transmembrane transporter activity [GO:0035379]; identical protein binding [GO:0042802]
392,A0A5F5XI01,A0A5F5XI01_FELCA,Dehydrogenase/reductase SDR family member 6 (EC 1.1.1.104) (EC 1.1.1.30) ((R)-beta-hydroxybutyrate dehydrogenase) (3-hydroxybutyrate dehydrogenase type 2) (4-oxo-L-proline reductase) (Oxidoreductase UCPA) (Short chain dehydrogenase/reductase family 15C member 1),BDH2,epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; siderophore biosynthetic process [GO:0019290],cytoplasm [GO:0005737]; cytosol [GO:0005829],3-hydroxybutyrate dehydrogenase activity [GO:0003858]; NAD binding [GO:0051287]
393,A0A5F5XI81,A0A5F5XI81_FELCA,Agrin,AGRN,cell differentiation [GO:0030154]; receptor clustering [GO:0043113],basement membrane [GO:0005604]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; laminin binding [GO:0043236]
394,A0A5F5XIU1,A0A5F5XIU1_FELCA,Laminin subunit alpha 4,LAMA4,blood vessel development [GO:0001568]; brown fat cell differentiation [GO:0050873]; cell adhesion [GO:0007155]; negative regulation of cold-induced thermogenesis [GO:0120163]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995],basement membrane [GO:0005604]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; synaptic cleft [GO:0043083],signaling receptor binding [GO:0005102]
395,A0A5F5XLK1,A0A5F5XLK1_FELCA,Annexin,ANXA1,adaptive immune response [GO:0002250],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; lateral plasma membrane [GO:0016328]; nucleus [GO:0005634]; phagocytic cup [GO:0001891],calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phospholipase A2 inhibitor activity [GO:0019834]
396,A0A5F5XLT1,A0A5F5XLT1_FELCA,Fibrinogen gamma chain,FGG,"blood coagulation, fibrin clot formation [GO:0072378]; cell-matrix adhesion [GO:0007160]; fibrinolysis [GO:0042730]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; plasminogen activation [GO:0031639]; platelet aggregation [GO:0070527]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exocytosis [GO:0045921]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of peptide hormone secretion [GO:0090277]; positive regulation of protein secretion [GO:0050714]; positive regulation of vasoconstriction [GO:0045907]; protein polymerization [GO:0051258]; protein secretion [GO:0009306]; response to calcium ion [GO:0051592]",collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; platelet alpha granule [GO:0031091],cell adhesion molecule binding [GO:0050839]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198]
397,A0A5F5XLV1,A0A5F5XLV1_FELCA,Pantetheinase (EC 3.5.1.92) (Pantetheine hydrolase) (Vascular non-inflammatory molecule 1),VNN1,,plasma membrane [GO:0005886]; side of membrane [GO:0098552],"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]"
398,A0A5F5XME0,A0A5F5XME0_FELCA,Fructose-bisphosphate aldolase (EC 4.1.2.13),ALDOB,glycolytic process [GO:0006096],centriolar satellite [GO:0034451]; cytoplasm [GO:0005737],fructose-1-phosphate aldolase activity [GO:0061609]; fructose-bisphosphate aldolase activity [GO:0004332]
399,A0A5F5XMJ0,A0A5F5XMJ0_FELCA,Carbonic anhydrase (EC 4.2.1.1),CA2,angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; one-carbon metabolic process [GO:0006730]; regulation of intracellular pH [GO:0051453]; regulation of monoatomic anion transport [GO:0044070],apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; cyanamide hydratase activity [GO:0018820]; zinc ion binding [GO:0008270]
400,A0A5F5XQY8,A0A5F5XQY8_FELCA,Scavenger receptor cysteine rich family member with 5 domains,SSC5D,defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterial lipoprotein [GO:0042494]; negative regulation of interleukin-8 production [GO:0032717],collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; membrane [GO:0016020],extracellular matrix binding [GO:0050840]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; scavenger receptor activity [GO:0005044]
401,A0A5F5XRH7,A0A5F5XRH7_FELCA,Annexin,ANXA6,apoptotic signaling pathway [GO:0097190]; calcium ion transport [GO:0006816]; mitochondrial calcium ion homeostasis [GO:0051560]; negative regulation of sequestering of calcium ion [GO:0051283]; regulation of muscle contraction [GO:0006937],cytoplasm [GO:0005737]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; sarcolemma [GO:0042383]; vesicle membrane [GO:0012506],calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; cholesterol binding [GO:0015485]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; ligand-gated monoatomic ion channel activity [GO:0015276]; phosphatidylserine binding [GO:0001786]
402,A0A5F5XRP9,A0A5F5XRP9_FELCA,Ras-related protein Rab-4,RAB4B,glucose import [GO:0046323]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100]; vesicle-mediated transport [GO:0016192],insulin-responsive compartment [GO:0032593]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037],G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]
403,A0A5F5XS01,A0A5F5XS01_FELCA,Ubiquitin-related modifier 1,URM1,protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble uridine modification [GO:0002098],cytosol [GO:0005829]; nucleus [GO:0005634],protein tag activity [GO:0031386]; sulfur carrier activity [GO:0097163]
404,A0A5F5XT00,A0A5F5XT00_FELCA,alpha-L-fucosidase (EC 3.2.1.51),FUCA2,fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139]; regulation of entry of bacterium into host cell [GO:2000535]; response to bacterium [GO:0009617],extracellular space [GO:0005615]; lysosome [GO:0005764],alpha-L-fucosidase activity [GO:0004560]
405,A0A5F5XTI2,A0A5F5XTI2_FELCA,Granulin,GRN,lysosomal lumen acidification [GO:0007042]; lysosomal transport [GO:0007041]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of lysosome organization [GO:1905673]; protein stabilization [GO:0050821]; regulation of inflammatory response [GO:0050727],endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886],protein-folding chaperone binding [GO:0051087]
406,A0A5F5XU62,A0A5F5XU62_FELCA,Alpha-galactosidase (EC 3.2.1.-),NAGA,carbohydrate catabolic process [GO:0016052]; glycolipid catabolic process [GO:0019377]; glycoside catabolic process [GO:0016139]; oligosaccharide metabolic process [GO:0009311],cytoplasm [GO:0005737]; lysosome [GO:0005764],alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456]; protein homodimerization activity [GO:0042803]
407,A0A5F5XUE7,A0A5F5XUE7_FELCA,V-type proton ATPase proteolipid subunit,ATP6V0C,positive regulation of Wnt signaling pathway [GO:0030177],"clathrin-coated vesicle membrane [GO:0030665]; membrane [GO:0016020]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; synaptic vesicle membrane [GO:0030672]; transmembrane transporter complex [GO:1902495]; vacuolar membrane [GO:0005774]","proton-transporting ATPase activity, rotational mechanism [GO:0046961]; ubiquitin protein ligase binding [GO:0031625]"
408,A0A5F5XWB9,A0A5F5XWB9_FELCA,Pentraxin family member,CRP,acute-phase response [GO:0006953]; innate immune response [GO:0045087]; negative regulation of lipid storage [GO:0010888]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; negative regulation of mononuclear cell proliferation [GO:0032945]; positive regulation of gene expression [GO:0010628]; positive regulation of superoxide anion generation [GO:0032930]; regulation of interleukin-8 production [GO:0032677]; vasoconstriction [GO:0042310],extracellular space [GO:0005615],calcium ion binding [GO:0005509]; complement component C1q complex binding [GO:0001849]; identical protein binding [GO:0042802]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor binding [GO:0050750]
409,A0A5F5XWC4,A0A5F5XWC4_FELCA,Glutamate receptor,GRIA4,"modulation of chemical synaptic transmission [GO:0050804]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; synaptic transmission, glutamatergic [GO:0035249]",AMPA glutamate receptor complex [GO:0032281]; dendritic spine [GO:0043197]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839],AMPA glutamate receptor activity [GO:0004971]; ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]
410,A0A5F5XXK1,A0A5F5XXK1_FELCA,Cadherin 15,CDH15,adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],adherens junction [GO:0005912]; catenin complex [GO:0016342]; caveola [GO:0005901]; Golgi apparatus [GO:0005794]; neuromuscular junction [GO:0031594],beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]
411,A0A5F5XYD7,A0A5F5XYD7_FELCA,"Beta-1,3-N-acetylglucosaminyltransferase (EC 2.4.1.222) (O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase)",RFNG,cell differentiation [GO:0030154]; nervous system development [GO:0007399]; pattern specification process [GO:0007389]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of Notch signaling pathway [GO:0008593],Golgi membrane [GO:0000139],metal ion binding [GO:0046872]; O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity [GO:0033829]
412,A0A5F5XYI6,A0A5F5XYI6_FELCA,Cyclic AMP-responsive element-binding protein 3-like protein 2,CREB3L2,chondrocyte differentiation [GO:0002062]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; regulation of transcription by RNA polymerase II [GO:0006357]; response to endoplasmic reticulum stress [GO:0034976],endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleoplasm [GO:0005654],"cAMP response element binding [GO:0035497]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]"
413,A0A5F5Y096,A0A5F5Y096_FELCA,MBL associated serine protease 2,MASP2,"complement activation, classical pathway [GO:0006958]; complement activation, lectin pathway [GO:0001867]; proteolysis [GO:0006508]",extracellular space [GO:0005615],calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; complement component C4b binding [GO:0001855]; serine-type endopeptidase activity [GO:0004252]
414,A0A5F5Y426,A0A5F5Y426_FELCA,"alpha-1,2-Mannosidase (EC 3.2.1.-)",MAN1A1,carbohydrate metabolic process [GO:0005975]; ERAD pathway [GO:0036503]; protein targeting to ER [GO:0045047],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139],"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]"
415,A0A5F5Y4L2,A0A5F5Y4L2_FELCA,LDL receptor related protein associated protein 1,LRPAP1,amyloid-beta clearance by transcytosis [GO:0150093]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of receptor internalization [GO:0002091]; negative regulation of very-low-density lipoprotein particle clearance [GO:0010916],cis-Golgi network [GO:0005801]; endomembrane system [GO:0012505]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; plasma membrane [GO:0005886]; rough endoplasmic reticulum lumen [GO:0048237],heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; receptor antagonist activity [GO:0048019]; receptor ligand activity [GO:0048018]; very-low-density lipoprotein particle receptor binding [GO:0070326]
416,A0A5F5Y4S8,A0A5F5Y4S8_FELCA,Nicotinate-nucleotide pyrophosphorylase [carboxylating] (EC 2.4.2.19) (Quinolinate phosphoribosyltransferase [decarboxylating]),QPRT,NAD biosynthetic process [GO:0009435],,nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]
417,A0A5F5Y5F5,A0A5F5Y5F5_FELCA,Matrix metalloproteinase-9 (EC 3.4.24.35) (92 kDa gelatinase) (92 kDa type IV collagenase) (Gelatinase B),MMP9,collagen catabolic process [GO:0030574]; proteolysis [GO:0006508],extracellular matrix [GO:0031012]; extracellular region [GO:0005576],metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]
418,A0A5F5Y690,A0A5F5Y690_FELCA,Arrestin domain containing 1,ARRDC1,extracellular transport [GO:0006858]; extracellular vesicle biogenesis [GO:0140112]; negative regulation of Notch signaling pathway [GO:0045746]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; extracellular vesicle [GO:1903561]; plasma membrane [GO:0005886],arrestin family protein binding [GO:1990763]; identical protein binding [GO:0042802]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]
419,D5MTH1,D5MTH1_FELCA,Cystatin C,CST3,defense response [GO:0006952]; negative regulation of blood vessel remodeling [GO:0060313]; negative regulation of collagen catabolic process [GO:0010711]; negative regulation of elastin catabolic process [GO:0060311]; negative regulation of extracellular matrix disassembly [GO:0010716]; negative regulation of proteolysis [GO:0045861]; supramolecular fiber organization [GO:0097435],cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; vesicle [GO:0031982],amyloid-beta binding [GO:0001540]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; identical protein binding [GO:0042802]; protease binding [GO:0002020]
420,E1AB55,K2C71_FELCA,"Keratin, type II cytoskeletal 71 (Cytokeratin-71) (CK-71) (Keratin-71) (K71)",KRT71,intermediate filament organization [GO:0045109]; keratinization [GO:0031424],cytoplasm [GO:0005737]; keratin filament [GO:0045095],structural constituent of skin epidermis [GO:0030280]
421,M3VU17,M3VU17_FELCA,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 (EC 1.14.11.4) (Lysyl hydroxylase 1)",PLOD1,epidermis development [GO:0008544]; response to hypoxia [GO:0001666],catalytic complex [GO:1902494]; endoplasmic reticulum [GO:0005783]; rough endoplasmic reticulum membrane [GO:0030867],iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-lysine 5-dioxygenase activity [GO:0008475]
422,M3VUE5,M3VUE5_FELCA,"Keratin, type II cytoskeletal 7 (Cytokeratin-7) (Keratin-7) (Type-II keratin Kb7)",KRT7,intermediate filament organization [GO:0045109]; keratinization [GO:0031424],cytosol [GO:0005829]; keratin filament [GO:0045095],structural constituent of skin epidermis [GO:0030280]
423,M3VUL6,M3VUL6_FELCA,Cadherin-6,CDH6,adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; Notch signaling pathway [GO:0007219]; synaptic membrane adhesion [GO:0099560],adherens junction [GO:0005912]; catenin complex [GO:0016342]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654],beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]
424,M3VUM2,M3VUM2_FELCA,Amphiregulin,AREG,dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis [GO:0060598]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell proliferation involved in mammary gland duct elongation [GO:0060750]; ERBB2-EGFR signaling pathway [GO:0038134]; G protein-coupled receptor signaling pathway [GO:0007186]; mammary gland alveolus development [GO:0060749]; mammary gland branching involved in thelarche [GO:0060744]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; response to estradiol [GO:0032355],cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634],epidermal growth factor receptor binding [GO:0005154]; growth factor activity [GO:0008083]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]
425,M3VUR6,M3VUR6_FELCA,N-acetylglucosamine-6-sulfatase (EC 3.1.6.14) (Glucosamine-6-sulfatase),GNS,glycosaminoglycan metabolic process [GO:0030203],lysosome [GO:0005764],glycosaminoglycan binding [GO:0005539]; metal ion binding [GO:0046872]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]
426,M3VUU5,M3VUU5_FELCA,Deoxyribonuclease-2-alpha (EC 3.1.22.1) (Acid DNase) (Deoxyribonuclease II alpha) (Lysosomal DNase II),DNASE2,apoptotic DNA fragmentation [GO:0006309]; enucleate erythrocyte differentiation [GO:0043353]; regulation of immune response [GO:0050776],lysosome [GO:0005764],deoxyribonuclease II activity [GO:0004531]
427,M3VVC0,M3VVC0_FELCA,Xylosyltransferase 1 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase I),XYLT1,chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; heparan sulfate proteoglycan biosynthetic process [GO:0015012],extracellular space [GO:0005615]; Golgi membrane [GO:0000139],metal ion binding [GO:0046872]; protein xylosyltransferase activity [GO:0030158]
428,M3VVI7,M3VVI7_FELCA,cathepsin X (EC 3.4.18.1),CTSZ,epithelial tube branching involved in lung morphogenesis [GO:0060441]; negative regulation of plasminogen activation [GO:0010757]; proteolysis involved in protein catabolic process [GO:0051603],cell cortex [GO:0005938]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosome [GO:0005764]; membrane [GO:0016020],carboxypeptidase activity [GO:0004180]; cysteine-type endopeptidase activity [GO:0004197]
429,M3VWF4,M3VWF4_FELCA,Phosphoinositide-3-kinase-interacting protein 1 (Kringle domain-containing protein HGFL),PIK3IP1,negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898],extracellular space [GO:0005615]; plasma membrane [GO:0005886],endopeptidase activity [GO:0004175]; phosphatidylinositol 3-kinase inhibitor activity [GO:0141039]; signaling receptor binding [GO:0005102]
430,M3VWG1,M3VWG1_FELCA,14-3-3 protein gamma,YWHAG,cellular response to glucose starvation [GO:0042149]; negative regulation of TORC1 signaling [GO:1904262]; protein localization [GO:0008104]; protein targeting [GO:0006605]; regulation of neuron differentiation [GO:0045664]; regulation of synaptic plasticity [GO:0048167]; signal transduction [GO:0007165],cytoplasm [GO:0005737],identical protein binding [GO:0042802]; insulin-like growth factor receptor binding [GO:0005159]; phosphoserine residue binding [GO:0050815]; protein domain specific binding [GO:0019904]; protein kinase C binding [GO:0005080]; protein sequestering activity [GO:0140311]
431,M3VWP9,M3VWP9_FELCA,Coatomer subunit beta',COPB2,"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139],structural molecule activity [GO:0005198]
432,M3VWU4,M3VWU4_FELCA,Sodium-dependent phosphate transport protein 2A (Na(+)-dependent phosphate cotransporter 2A) (Sodium/phosphate cotransporter 2A) (Solute carrier family 34 member 1),SLC34A1,intracellular phosphate ion homeostasis [GO:0030643]; response to cadmium ion [GO:0046686]; response to lead ion [GO:0010288]; response to mercury ion [GO:0046689]; sodium-dependent phosphate transport [GO:0044341],apical plasma membrane [GO:0016324]; brush border [GO:0005903]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nuclear speck [GO:0016607]; vesicle [GO:0031982],sodium:phosphate symporter activity [GO:0005436]
433,M3VWX8,M3VWX8_FELCA,Syntaxin-binding protein 2 (Protein unc-18 homolog 2) (Protein unc-18 homolog B),STXBP2,intracellular protein transport [GO:0006886]; leukocyte mediated cytotoxicity [GO:0001909]; neurotransmitter secretion [GO:0007269]; neutrophil degranulation [GO:0043312]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192],azurophil granule [GO:0042582]; cytolytic granule [GO:0044194]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; secretory granule [GO:0030141]; specific granule [GO:0042581]; tertiary granule [GO:0070820],syntaxin-1 binding [GO:0017075]; syntaxin-3 binding [GO:0030348]
434,M3VWY2,M3VWY2_FELCA,C-type lectin domain family 4 member G,CLEC4G,alpha-beta T cell proliferation [GO:0046633]; immature T cell proliferation in thymus [GO:0033080]; immune response [GO:0006955]; negative regulation of alpha-beta T cell proliferation [GO:0046642]; negative regulation of immature T cell proliferation in thymus [GO:0033088]; negative regulation of T cell mediated immunity [GO:0002710]; positive regulation of viral life cycle [GO:1903902]; T cell mediated immunity [GO:0002456],external side of plasma membrane [GO:0009897],carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; fructose binding [GO:0070061]; mannose binding [GO:0005537]; polysaccharide binding [GO:0030247]; virus coreceptor activity [GO:0120274]; virus receptor activity [GO:0001618]
435,M3VX11,M3VX11_FELCA,Cadherin-related family member 1 (Photoreceptor cadherin) (Protocadherin-21),CDHR1,cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell morphogenesis [GO:0008594]; photoreceptor cell outer segment organization [GO:0035845],photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]
436,M3VXE7,M3VXE7_FELCA,Methanethiol oxidase (MTO) (EC 1.8.3.4) (Selenium-binding protein 1),SELENBP1,protein transport [GO:0015031],cytosol [GO:0005829]; fibrillar center [GO:0001650]; membrane [GO:0016020],methanethiol oxidase activity [GO:0018549]; selenium binding [GO:0008430]
437,M3VXR1,M3VXR1_FELCA,"Keratin, type I cytoskeletal 10 (Cytokeratin-10) (Keratin-10)",KRT10,epidermis development [GO:0008544]; epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109]; keratinocyte differentiation [GO:0030216]; protein heterotetramerization [GO:0051290],cell surface [GO:0009986]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; keratin filament [GO:0045095],protein heterodimerization activity [GO:0046982]; structural constituent of skin epidermis [GO:0030280]
438,M3VXZ7,M3VXZ7_FELCA,small monomeric GTPase (EC 3.6.5.2),RAB5C,endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; plasma membrane to endosome transport [GO:0048227],early endosome membrane [GO:0031901]; endomembrane system [GO:0012505]; lipid droplet [GO:0005811]; plasma membrane [GO:0005886],GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]
439,M3VYI8,M3VYI8_FELCA,SLIT and NTRK like family member 1,SLITRK1,adult behavior [GO:0030534]; axonogenesis [GO:0007409]; homeostatic process [GO:0042592]; multicellular organism growth [GO:0035264]; positive regulation of axonogenesis [GO:0050772]; positive regulation of synapse assembly [GO:0051965]; regulation of presynapse assembly [GO:1905606]; synapse assembly [GO:0007416]; synaptic membrane adhesion [GO:0099560],GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; postsynaptic density membrane [GO:0098839],
440,M3VYK6,M3VYK6_FELCA,Ras-related protein Rab-3,RAB3D,bone resorption [GO:0045453]; exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; positive regulation of regulated secretory pathway [GO:1903307]; protein secretion [GO:0009306],cytoplasmic microtubule [GO:0005881]; endosome [GO:0005768]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; zymogen granule [GO:0042588],GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]
441,M3VZ93,M3VZ93_FELCA,Insulin like growth factor 2 receptor,IGF2R,lysosomal transport [GO:0007041]; positive regulation by host of viral process [GO:0044794],cell surface [GO:0009986]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; late endosome [GO:0005770]; nuclear envelope lumen [GO:0005641]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140],identical protein binding [GO:0042802]; insulin-like growth factor binding [GO:0005520]; mannose binding [GO:0005537]; phosphoprotein binding [GO:0051219]; retromer complex binding [GO:1905394]; signaling receptor activity [GO:0038023]
442,M3VZI2,M3VZI2_FELCA,Receptor like tyrosine kinase,RYK,axon extension involved in axon guidance [GO:0048846]; axonogenesis [GO:0007409]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of axon extension involved in axon guidance [GO:0048843]; positive regulation of MAPK cascade [GO:0043410]; skeletal system morphogenesis [GO:0048705],cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],ATP binding [GO:0005524]; frizzled binding [GO:0005109]; protein kinase activity [GO:0004672]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]
443,M3VZR2,M3VZR2_FELCA,YEATS domain containing 2,YEATS2,chromatin remodeling [GO:0006338]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of embryonic development [GO:0045995]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tubulin deacetylation [GO:0090043],ATAC complex [GO:0140672]; mitotic spindle [GO:0072686]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634],histone binding [GO:0042393]; histone reader activity [GO:0140566]; modification-dependent protein binding [GO:0140030]; TBP-class protein binding [GO:0017025]; transcription corepressor activity [GO:0003714]
444,M3VZX9,M3VZX9_FELCA,Protein NDRG1 (N-myc downstream-regulated gene 1 protein),NDRG1,"cellular response to hypoxia [GO:0071456]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; mast cell activation [GO:0045576]; negative regulation of cell population proliferation [GO:0008285]; peripheral nervous system myelin maintenance [GO:0032287]; signal transduction [GO:0007165]",adherens junction [GO:0005912]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038],cadherin binding [GO:0045296]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; small GTPase binding [GO:0031267]
445,M3W022,M3W022_FELCA,Fibrinogen alpha chain,FGA,"blood coagulation, common pathway [GO:0072377]; fibrinolysis [GO:0042730]; platelet aggregation [GO:0070527]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; protein polymerization [GO:0051258]",cell cortex [GO:0005938]; fibrinogen complex [GO:0005577]; synapse [GO:0045202],protein-macromolecule adaptor activity [GO:0030674]; signaling receptor binding [GO:0005102]
446,M3W046,M3W046_FELCA,Cadherin 11,CDH11,adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell junction assembly [GO:0007043]; corticospinal tract morphogenesis [GO:0021957]; focal adhesion assembly [GO:0048041]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of cell migration [GO:0030336],adherens junction [GO:0005912]; catenin complex [GO:0016342]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; Schaffer collateral - CA1 synapse [GO:0098685],beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]
447,M3W292,M3W292_FELCA,Laminin subunit beta 1,LAMB1,animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; endodermal cell differentiation [GO:0035987]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell migration [GO:0030335]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888],extracellular space [GO:0005615]; laminin complex [GO:0043256]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257],integrin binding [GO:0005178]; structural constituent of synapse-associated extracellular matrix [GO:0150043]
448,M3W2B8,M3W2B8_FELCA,Complement factor B (EC 3.4.21.47) (C3/C5 convertase),CFB,"complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]",extracellular region [GO:0005576],serine-type endopeptidase activity [GO:0004252]
449,M3W2V0,M3W2V0_FELCA,Apolipoprotein E,CLPTM1 APOE,lipid transport [GO:0006869]; lipoprotein metabolic process [GO:0042157],chylomicron [GO:0042627]; high-density lipoprotein particle [GO:0034364]; multivesicular body [GO:0005771]; very-low-density lipoprotein particle [GO:0034361],heparin binding [GO:0008201]; lipid binding [GO:0008289]
450,M3W3P5,M3W3P5_FELCA,Hyperpolarization activated cyclic nucleotide gated potassium channel 4,HCN4,cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane depolarization [GO:0003254]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725],axon [GO:0030424]; dendrite [GO:0030425]; HCN channel complex [GO:0098855]; perinuclear region of cytoplasm [GO:0048471],cAMP binding [GO:0030552]; identical protein binding [GO:0042802]; intracellularly cAMP-activated cation channel activity [GO:0005222]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated potassium channel activity involved in SA node cell action potential depolarization [GO:0086041]; voltage-gated sodium channel activity [GO:0005248]
451,M3W4B6,M3W4B6_FELCA,Proteasome activator complex subunit 1 (Proteasome activator 28 subunit alpha),PSME1,antigen processing and presentation of exogenous antigen [GO:0019884]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of proteasomal protein catabolic process [GO:0061136],cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; proteasome activator complex [GO:0008537],endopeptidase activator activity [GO:0061133]
452,M3W5N0,M3W5N0_FELCA,Serpin family F member 2,SERPINF2,blood vessel morphogenesis [GO:0048514]; collagen fibril organization [GO:0030199]; maintenance of blood vessel diameter homeostasis by renin-angiotensin [GO:0002034]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of plasminogen activation [GO:0010757]; positive regulation of cell differentiation [GO:0045597]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta production [GO:0071636],cell surface [GO:0009986]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577],protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase inhibitor activity [GO:0004867]
453,M3W5T1,M3W5T1_FELCA,"Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial (EC 2.3.1.61) (E2K)",DLST,L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; tricarboxylic acid cycle [GO:0006099],cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; oxoglutarate dehydrogenase complex [GO:0045252],dihydrolipoyllysine-residue succinyltransferase activity [GO:0004149]
454,M3W5X2,M3W5X2_FELCA,Transmembrane protein 106B,TMEM106B,dendrite morphogenesis [GO:0048813]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; lysosomal transport [GO:0007041]; lysosome localization [GO:0032418]; lysosome organization [GO:0007040]; neuron cellular homeostasis [GO:0070050]; positive regulation of dendrite development [GO:1900006]; regulation of lysosome organization [GO:1905671],late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886],ATPase binding [GO:0051117]
455,M3W828,M3W828_FELCA,Apolipoprotein M,APOM,cholesterol efflux [GO:0033344]; high-density lipoprotein particle assembly [GO:0034380]; high-density lipoprotein particle clearance [GO:0034384]; high-density lipoprotein particle remodeling [GO:0034375]; lipoprotein metabolic process [GO:0042157]; negative regulation of plasma lipoprotein oxidation [GO:0034445]; reverse cholesterol transport [GO:0043691],discoidal high-density lipoprotein particle [GO:0034365]; high-density lipoprotein particle [GO:0034364]; low-density lipoprotein particle [GO:0034362]; spherical high-density lipoprotein particle [GO:0034366]; very-low-density lipoprotein particle [GO:0034361],antioxidant activity [GO:0016209]; lipid transporter activity [GO:0005319]; phospholipid binding [GO:0005543]
456,M3W8G3,M3W8G3_FELCA,Cathepsin D (EC 3.4.23.5),CTSD,autophagosome assembly [GO:0000045]; insulin catabolic process [GO:1901143]; insulin receptor recycling [GO:0038020]; lipoprotein catabolic process [GO:0042159]; positive regulation of apoptotic process [GO:0043065]; proteolysis [GO:0006508]; regulation of establishment of protein localization [GO:0070201],endosome lumen [GO:0031904]; endosome membrane [GO:0010008]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; membrane raft [GO:0045121],aspartic-type endopeptidase activity [GO:0004190]
457,M3W8Q2,M3W8Q2_FELCA,Gamma-synuclein,SNCG,adult locomotory behavior [GO:0008344]; chemical synaptic transmission [GO:0007268]; protein secretion [GO:0009306]; regulation of dopamine secretion [GO:0014059]; regulation of neurotransmitter secretion [GO:0046928]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488],axon terminus [GO:0043679]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025],cuprous ion binding [GO:1903136]
458,M3W912,M3W912_FELCA,Alpha-L-fucosidase (EC 3.2.1.51),FUCA2,fucose metabolic process [GO:0006004],,alpha-L-fucosidase activity [GO:0004560]
459,M3W949,M3W949_FELCA,Metalloproteinase inhibitor 1 (Tissue inhibitor of metalloproteinases 1),TIMP1,cellular response to UV-A [GO:0071492]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; negative regulation of trophoblast cell migration [GO:1901164]; positive regulation of cell population proliferation [GO:0008284]; regulation of integrin-mediated signaling pathway [GO:2001044]; response to cytokine [GO:0034097]; response to hormone [GO:0009725],extracellular matrix [GO:0031012]; extracellular space [GO:0005615],cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; metalloendopeptidase inhibitor activity [GO:0008191]; protease binding [GO:0002020]; zinc ion binding [GO:0008270]
460,M3W9I5,M3W9I5_FELCA,Vitronectin,VTN,cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; immune response [GO:0006955]; oligodendrocyte differentiation [GO:0048709]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of smooth muscle cell migration [GO:0014911]; smooth muscle cell-matrix adhesion [GO:0061302],collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; peptidase inhibitor complex [GO:1904090]; protein complex involved in cell-matrix adhesion [GO:0098637],extracellular matrix binding [GO:0050840]; integrin binding [GO:0005178]; polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]
461,M3W9X1,M3W9X1_FELCA,Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 72),PDIA4,chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976],cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615],protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035]
462,M3WB92,M3WB92_FELCA,protein-lysine 6-oxidase (EC 1.4.3.13),LOXL4,collagen fibril organization [GO:0030199],collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; membrane [GO:0016020]; receptor complex [GO:0043235],copper ion binding [GO:0005507]; protein-lysine 6-oxidase activity [GO:0004720]
463,M3WBE5,M3WBE5_FELCA,Alpha-mannosidase (EC 3.2.1.-),MAN2A1,in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; mannose metabolic process [GO:0006013]; mitochondrion organization [GO:0007005]; N-glycan processing [GO:0006491]; positive regulation of neurogenesis [GO:0050769]; respiratory gaseous exchange by respiratory system [GO:0007585]; retina morphogenesis in camera-type eye [GO:0060042]; vacuole organization [GO:0007033],cis-Golgi network [GO:0005801]; extracellular space [GO:0005615]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139],"alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; metal ion binding [GO:0046872]"
464,M3WBH7,M3WBH7_FELCA,Glycerol-3-phosphate dehydrogenase [NAD(+)] (EC 1.1.1.8),GPD1,cellular response to cAMP [GO:0071320]; cellular response to tumor necrosis factor [GO:0071356]; gluconeogenesis [GO:0006094]; glycerol-3-phosphate catabolic process [GO:0046168]; glycerol-3-phosphate metabolic process [GO:0006072]; glycerophosphate shuttle [GO:0006127]; NADH oxidation [GO:0006116]; positive regulation of glycolytic process [GO:0045821],cytosol [GO:0005829]; glycerol-3-phosphate dehydrogenase (FAD) complex [GO:0009331],glycerol-3-phosphate dehydrogenase (NAD+) activity [GO:0141152]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]
465,M3WC88,M3WC88_FELCA,Laminin subunit beta 2,LAMB2,animal organ morphogenesis [GO:0009887]; astrocyte development [GO:0014002]; axon extension involved in regeneration [GO:0048677]; axon guidance [GO:0007411]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; metanephric glomerular basement membrane development [GO:0072274]; metanephric podocyte development [GO:0072249]; neuromuscular junction development [GO:0007528]; retina development in camera-type eye [GO:0060041]; Schwann cell development [GO:0014044]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]; visual perception [GO:0007601],laminin complex [GO:0043256]; laminin-3 complex [GO:0005608]; neuromuscular junction [GO:0031594]; synaptic cleft [GO:0043083],integrin binding [GO:0005178]; structural constituent of synapse-associated extracellular matrix [GO:0150043]
466,M3WED4,M3WED4_FELCA,Vascular cell adhesion molecule 1,VCAM1,amine metabolic process [GO:0009308]; cell adhesion [GO:0007155]; cell-cell adhesion in response to extracellular stimulus [GO:0140039]; cell-matrix adhesion [GO:0007160]; cellular response to amyloid-beta [GO:1904646]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; heterotypic cell-cell adhesion [GO:0034113]; inflammatory response [GO:0006954]; leukocyte tethering or rolling [GO:0050901]; membrane to membrane docking [GO:0022614]; positive regulation of T cell proliferation [GO:0042102],alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex [GO:0071065]; apical part of cell [GO:0045177]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; podosome [GO:0002102],cell adhesion mediator activity [GO:0098631]; integrin binding [GO:0005178]; primary amine oxidase activity [GO:0008131]
467,M3WEQ2,M3WEQ2_FELCA,Vasorin,VASN,cellular response to hypoxia [GO:0071456]; cellular response to redox state [GO:0071461]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512],cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886],transforming growth factor beta binding [GO:0050431]
468,M3WET8,M3WET8_FELCA,Angiopoietin like 3,ANGPTL3,artery morphogenesis [GO:0048844]; cell-matrix adhesion [GO:0007160]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; fatty acid metabolic process [GO:0006631]; glycerol metabolic process [GO:0006071]; lipid storage [GO:0019915]; phospholipid catabolic process [GO:0009395]; phospholipid homeostasis [GO:0055091]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of lipid catabolic process [GO:0050996]; triglyceride homeostasis [GO:0070328],cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; early endosome [GO:0005769]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794],growth factor activity [GO:0008083]; integrin binding [GO:0005178]; phospholipase inhibitor activity [GO:0004859]
469,M3WFI7,M3WFI7_FELCA,L-xylulose reductase (EC 1.1.1.10) (Dicarbonyl/L-xylulose reductase),DCXR,D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; glucuronate catabolic process to xylulose 5-phosphate [GO:0019640]; NADP metabolic process [GO:0006739]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; xylulose metabolic process [GO:0005997],brush border [GO:0005903]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; membrane [GO:0016020]; microvillus [GO:0005902],"carbonyl reductase (NADPH) activity [GO:0004090]; identical protein binding [GO:0042802]; L-xylulose reductase (NADPH) activity [GO:0050038]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]"
470,M3WFK3,M3WFK3_FELCA,14-3-3 protein beta/alpha,YWHAB,cytoplasmic sequestering of protein [GO:0051220]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of protein dephosphorylation [GO:0035308]; protein localization [GO:0008104]; protein targeting [GO:0006605]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471],histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; phosphoserine residue binding [GO:0050815]; protein domain specific binding [GO:0019904]; protein kinase inhibitor activity [GO:0004860]
471,M3WG01,M3WG01_FELCA,Plexin B2,PLXNB2,brain development [GO:0007420]; excitatory synapse assembly [GO:1904861]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell adhesion [GO:0007162]; neural tube closure [GO:0001843]; neuroblast proliferation [GO:0007405]; positive regulation of axonogenesis [GO:0050772]; positive regulation of neuron projection development [GO:0010976]; positive regulation of translation [GO:0045727]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of neuron migration [GO:2001222]; regulation of protein phosphorylation [GO:0001932],plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116],ATP binding [GO:0005524]; kinase activity [GO:0016301]; semaphorin receptor activity [GO:0017154]
472,M3WGM9,M3WGM9_FELCA,Deoxyribonuclease,DNASE1,apoptotic process [GO:0006915]; DNA catabolic process [GO:0006308]; neutrophil activation involved in immune response [GO:0002283]; regulation of acute inflammatory response [GO:0002673]; regulation of neutrophil mediated cytotoxicity [GO:0070948],extracellular region [GO:0005576]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; zymogen granule [GO:0042588],actin binding [GO:0003779]; deoxyribonuclease I activity [GO:0004530]; DNA binding [GO:0003677]
473,M3WGW7,M3WGW7_FELCA,Chondroitin sulfate proteoglycan 4,CSPG4,glial cell migration [GO:0008347]; intracellular signal transduction [GO:0035556]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; ruffle assembly [GO:0097178]; substrate-dependent cell migration [GO:0006929],nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ruffle [GO:0001726],coreceptor activity [GO:0015026]; protein kinase binding [GO:0019901]
474,M3WI48,M3WI48_FELCA,Sulfotransferase (EC 2.8.2.-),CHST3,carbohydrate metabolic process [GO:0005975]; chondroitin sulfate biosynthetic process [GO:0030206]; N-acetylglucosamine metabolic process [GO:0006044]; T cell homeostasis [GO:0043029],Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802],chondroitin 6-sulfotransferase activity [GO:0008459]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; proteoglycan sulfotransferase activity [GO:0050698]
475,M3WI95,M3WI95_FELCA,Complement component C9,C9,"complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; killing of cells of another organism [GO:0031640]; protein homooligomerization [GO:0051260]",extracellular space [GO:0005615]; membrane attack complex [GO:0005579]; other organism cell membrane [GO:0044218],
476,M3WIA6,M3WIA6_FELCA,Amine oxidase (EC 1.4.3.-),,amine metabolic process [GO:0009308]; response to antibiotic [GO:0046677],early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886],copper ion binding [GO:0005507]; primary amine oxidase activity [GO:0008131]; quinone binding [GO:0048038]
477,M3WIJ6,M3WIJ6_FELCA,"Cofilin-1 (Cofilin, non-muscle isoform)",CFL1,actin filament fragmentation [GO:0030043]; actin filament severing [GO:0051014]; mitotic cytokinesis [GO:0000281]; positive regulation by host of viral process [GO:0044794]; regulation of cell morphogenesis [GO:0022604]; regulation of dendritic spine morphogenesis [GO:0061001]; response to virus [GO:0009615],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; nucleus [GO:0005634]; ruffle membrane [GO:0032587],actin filament binding [GO:0051015]
478,M3WIV4,M3WIV4_FELCA,Epithelial cell adhesion molecule (Tumor-associated calcium signal transducer 1),EPCAM,negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; signal transduction involved in regulation of gene expression [GO:0023019]; stem cell differentiation [GO:0048863]; ureteric bud development [GO:0001657],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; lateral plasma membrane [GO:0016328],cadherin binding involved in cell-cell adhesion [GO:0098641]; protein-containing complex binding [GO:0044877]
479,M3WJ25,M3WJ25_FELCA,Cubilin,CUBN,cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; establishment of localization in cell [GO:0051649]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617],apical plasma membrane [GO:0016324]; brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; protein homodimerization activity [GO:0042803]
480,M3WJN7,M3WJN7_FELCA,"beta-galactoside alpha-(2,6)-sialyltransferase (EC 2.4.3.1)",ST6GAL1,N-acetylneuraminate metabolic process [GO:0006054]; protein N-linked glycosylation via asparagine [GO:0018279]; sialylation [GO:0097503],Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139],"beta-galactoside alpha-2,6-sialyltransferase activity [GO:0003835]; protein homodimerization activity [GO:0042803]"
481,M3WKC6,M3WKC6_FELCA,Coagulation factor VII (EC 3.4.21.21) (Serum prothrombin conversion accelerator),F7,blood coagulation [GO:0007596]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of platelet-derived growth factor receptor signaling pathway [GO:0010641]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of TOR signaling [GO:0032008]; protein processing [GO:0016485],extracellular space [GO:0005615]; serine-type peptidase complex [GO:1905286],calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]
482,M3WKC7,M3WKC7_FELCA,Coagulation factor X (EC 3.4.21.6) (Stuart factor),F10,blood coagulation [GO:0007596]; positive regulation of TOR signaling [GO:0032008]; proteolysis [GO:0006508],extracellular space [GO:0005615],calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; serine-type endopeptidase activity [GO:0004252]
483,M3WKX9,M3WKX9_FELCA,Proteasome subunit beta,PSMB7,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],"cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleus [GO:0005634]; proteasome core complex, beta-subunit complex [GO:0019774]",endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]
484,M3WL17,M3WL17_FELCA,Follitropin subunit beta (Follicle-stimulating hormone beta subunit) (Follitropin beta chain),FSHB,follicle-stimulating hormone signaling pathway [GO:0042699]; positive regulation of bone resorption [GO:0045780]; positive regulation of gene expression [GO:0010628]; positive regulation of steroid biosynthetic process [GO:0010893]; regulation of osteoclast differentiation [GO:0045670]; Sertoli cell proliferation [GO:0060011]; spermatogenesis [GO:0007283]; transforming growth factor beta receptor signaling pathway [GO:0007179],cytoplasm [GO:0005737]; extracellular space [GO:0005615]; follicle-stimulating hormone complex [GO:0016914],follicle-stimulating hormone activity [GO:0016913]
485,M3WLH3,M3WLH3_FELCA,Complement component C6,C6,"complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; killing of cells of another organism [GO:0031640]",extracellular space [GO:0005615]; membrane attack complex [GO:0005579],
486,M3WLW6,M3WLW6_FELCA,Serine peptidase inhibitor Kazal type 5,SPINK5,cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; epidermal cell differentiation [GO:0009913]; negative regulation of antibacterial peptide production [GO:0002787]; negative regulation of proteolysis [GO:0045861]; regulation of cell adhesion [GO:0030155],cell cortex [GO:0005938]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; epidermal lamellar body [GO:0097209]; extracellular region [GO:0005576]; perinuclear region of cytoplasm [GO:0048471],serine-type endopeptidase inhibitor activity [GO:0004867]
487,M3WM50,M3WM50_FELCA,BPI fold-containing family A member 1 (Palate lung and nasal epithelium clone protein),BPIFA1,antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response to virus [GO:0051607]; immune response in nasopharyngeal-associated lymphoid tissue [GO:0002395]; innate immune response [GO:0045087]; multicellular organismal-level water homeostasis [GO:0050891]; negative regulation of single-species biofilm formation in or on host organism [GO:1900229]; regulation of sodium ion transmembrane transport [GO:1902305]; surfactant homeostasis [GO:0043129],extracellular space [GO:0005615],lipid binding [GO:0008289]
488,M3WMY0,M3WMY0_FELCA,Actin-related protein 2/3 complex subunit 5,ARPC5,Arp2/3 complex-mediated actin nucleation [GO:0034314]; cell migration [GO:0016477]; regulation of actin filament polymerization [GO:0030833],Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; nucleus [GO:0005634],actin filament binding [GO:0051015]; structural constituent of cytoskeleton [GO:0005200]
489,M3WN87,M3WN87_FELCA,Nuclear receptor subfamily 1 group I member 3 (Constitutive androstane receptor),NR1I3,cell differentiation [GO:0030154]; lipid transport [GO:0006869]; lipoprotein metabolic process [GO:0042157]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944],cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; lipid binding [GO:0008289]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"
490,M3WNL1,M3WNL1_FELCA,Solute carrier family 12 member 4,SLC12A4,cell volume homeostasis [GO:0006884]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; lipid metabolic process [GO:0006629]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573],plasma membrane [GO:0005886]; synapse [GO:0045202],ATP binding [GO:0005524]; O-acyltransferase activity [GO:0008374]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]
491,M3WNP8,M3WNP8_FELCA,N-acylglucosamine 2-epimerase (EC 5.1.3.8) (GlcNAc 2-epimerase) (N-acetyl-D-glucosamine 2-epimerase) (Renin-binding protein),RENBP,carbohydrate metabolic process [GO:0005975]; N-acetylglucosamine metabolic process [GO:0006044]; N-acetylmannosamine metabolic process [GO:0006051]; N-acetylneuraminate catabolic process [GO:0019262],,identical protein binding [GO:0042802]; N-acylglucosamine 2-epimerase activity [GO:0050121]; peptidase inhibitor activity [GO:0030414]
492,M3WNY6,M3WNY6_FELCA,Chloride intracellular channel protein,CLIC1,chloride transport [GO:0006821]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of mitochondrial membrane potential [GO:0051881],chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],chloride channel activity [GO:0005254]
493,M3WQ57,M3WQ57_FELCA,"Beta-1,4-glucuronyltransferase 1 (I-beta-1,3-N-acetylglucosaminyltransferase) (N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase) (Poly-N-acetyllactosamine extension enzyme) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1)",B4GAT1,axon guidance [GO:0007411]; protein O-linked mannosylation [GO:0035269],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]
494,M3WR11,M3WR11_FELCA,Folate receptor alpha,FOLR1,anterior neural tube closure [GO:0061713]; axon regeneration [GO:0031103]; cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:0003253]; cell adhesion [GO:0007155]; folic acid metabolic process [GO:0046655]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; heart looping [GO:0001947]; neural crest cell migration involved in heart formation [GO:0003147]; pharyngeal arch artery morphogenesis [GO:0061626]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; sperm-egg recognition [GO:0035036],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of plasma membrane [GO:0009897]; nucleus [GO:0005634],folic acid binding [GO:0005542]; folic acid receptor activity [GO:0061714]; signaling receptor activity [GO:0038023]
495,M3WR70,M3WR70_FELCA,Ephrin-B1,EFNB1,cell differentiation [GO:0030154]; ephrin receptor signaling pathway [GO:0048013]; nervous system development [GO:0007399],membrane [GO:0016020],ephrin receptor binding [GO:0046875]
496,M3WR74,M3WR74_FELCA,"Fatty acid-binding protein, liver (L-FABP) (Liver-type fatty acid-binding protein)",FABP1,cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; fatty acid transport [GO:0015908]; negative regulation of apoptotic process [GO:0043066],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],antioxidant activity [GO:0016209]; chromatin binding [GO:0003682]; fatty acid binding [GO:0005504]
497,M3WRD9,M3WRD9_FELCA,Ras-related protein Rab-7a,RAB7A,autophagy [GO:0006914]; endosome to lysosome transport [GO:0008333]; lipid catabolic process [GO:0016042]; phagosome-lysosome fusion [GO:0090385],autophagosome membrane [GO:0000421]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome membrane [GO:0033162]; mitochondrial membrane [GO:0031966]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670],GTP binding [GO:0005525]; GTPase activity [GO:0003924]
498,M3WSA1,M3WSA1_FELCA,Gamma-interferon-inducible lysosomal thiol reductase (EC 1.8.-.-) (Gamma-interferon-inducible protein IP-30),IFI30,antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; negative regulation of fibroblast proliferation [GO:0048147]; protein stabilization [GO:0050821],cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular region [GO:0005576]; lysosome [GO:0005764],"oxidoreductase activity, acting on a sulfur group of donors [GO:0016667]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]"
499,M3WSM7,M3WSM7_FELCA,Histone H4,H4C4 H4C1 H4C11 H4C12 H4C13 H4C14 H4C19 H4C2 H4C3 H4C6 H4C8 H4C9 LOC123385657,nucleosome assembly [GO:0006334],nucleosome [GO:0000786]; nucleus [GO:0005634],DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]
500,M3WSQ5,M3WSQ5_FELCA,Prenylcysteine oxidase 1 (EC 1.8.3.5),PCYOX1,prenylated protein catabolic process [GO:0030327]; prenylcysteine catabolic process [GO:0030328],lysosome [GO:0005764]; very-low-density lipoprotein particle [GO:0034361],FAD binding [GO:0071949]; prenylcysteine oxidase activity [GO:0001735]
501,M3WSR7,M3WSR7_FELCA,C-X-C motif chemokine 16 (Transmembrane chemokine CXCL16),CXCL16,positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; receptor-mediated endocytosis [GO:0006898]; response to tumor necrosis factor [GO:0034612]; response to type II interferon [GO:0034341]; T cell chemotaxis [GO:0010818],extracellular space [GO:0005615]; membrane [GO:0016020],chemokine activity [GO:0008009]; low-density lipoprotein particle receptor activity [GO:0005041]; scavenger receptor activity [GO:0005044]
502,M3WU86,M3WU86_FELCA,Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 (Transducin beta chain 1),GNB1,cell population proliferation [GO:0008283]; G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; retina development in camera-type eye [GO:0060041]; sensory perception of taste [GO:0050909],cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; photoreceptor outer segment [GO:0001750],GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; protein-containing complex binding [GO:0044877]; signaling receptor complex adaptor activity [GO:0030159]
503,M3WVG6,M3WVG6_FELCA,Synapse associated protein 1,SYAP1,cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; positive regulation of fat cell differentiation [GO:0045600]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; TORC2 signaling [GO:0038203],cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202],
504,M3WWG3,M3WWG3_FELCA,"2',3'-cyclic-nucleotide 3'-phosphodiesterase (CNP) (CNPase) (EC 3.1.4.37)",CNP,adult locomotory behavior [GO:0008344]; axonogenesis [GO:0007409]; cyclic nucleotide catabolic process [GO:0009214]; oligodendrocyte differentiation [GO:0048709]; response to toxic substance [GO:0009636],cytoplasm [GO:0005737]; extracellular space [GO:0005615]; melanosome [GO:0042470]; membrane [GO:0016020]; myelin sheath [GO:0043209],"2',3'-cyclic-nucleotide 3'-phosphodiesterase activity [GO:0004113]; RNA binding [GO:0003723]"
505,M3WX61,M3WX61_FELCA,Ribonuclease A family member k6,RNASE6,antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; innate immune response [GO:0045087],cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; lysosome [GO:0005764],endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA nuclease activity [GO:0004540]
506,M3WXS7,M3WXS7_FELCA,Laminin subunit gamma 1,LAMC1,animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; cell migration [GO:0016477]; extracellular matrix disassembly [GO:0022617]; hemidesmosome assembly [GO:0031581]; protein-containing complex assembly [GO:0065003]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888],basement membrane [GO:0005604]; extracellular region [GO:0005576],extracellular matrix structural constituent [GO:0005201]
507,M3WZB0,M3WZB0_FELCA,ATP synthase subunit alpha,ATP5F1A,lipid metabolic process [GO:0006629]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776],"COP9 signalosome [GO:0008180]; mitochondrial proton-transporting ATP synthase, catalytic core [GO:0005754]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]","ADP binding [GO:0043531]; angiostatin binding [GO:0043532]; ATP binding [GO:0005524]; MHC class I protein binding [GO:0042288]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"
508,M3WZT2,M3WZT2_FELCA,Peptidoglycan recognition protein 1,PGLYRP1,antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; biological process involved in interaction with host [GO:0051701]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterium [GO:0016045]; killing of cells of another organism [GO:0031640]; negative regulation of inflammatory response [GO:0050728]; negative regulation of natural killer cell differentiation involved in immune response [GO:0032827]; negative regulation of type II interferon production [GO:0032689]; peptidoglycan catabolic process [GO:0009253],extracellular space [GO:0005615],Hsp70 protein binding [GO:0030544]; molecular adaptor activity [GO:0060090]; N-acetylmuramoyl-L-alanine amidase activity [GO:0008745]; peptidoglycan binding [GO:0042834]; peptidoglycan immune receptor activity [GO:0016019]; receptor ligand activity [GO:0048018]; zinc ion binding [GO:0008270]
509,M3X0B9,M3X0B9_FELCA,Fibronectin leucine rich transmembrane protein 2,FLRT2,axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; cell adhesion involved in heart morphogenesis [GO:0061343]; fibroblast growth factor receptor signaling pathway [GO:0008543]; positive regulation of synapse assembly [GO:0051965]; regulation of neuron migration [GO:2001222],cell-cell junction [GO:0005911]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886],chemorepellent activity [GO:0045499]; fibroblast growth factor receptor binding [GO:0005104]
510,M3X0E0,M3X0E0_FELCA,Secreted frizzled related protein 4,SFRP4,bone morphogenesis [GO:0060349]; canonical Wnt signaling pathway [GO:0060070]; cell differentiation [GO:0030154]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of sodium-dependent phosphate transport [GO:2000119]; non-canonical Wnt signaling pathway [GO:0035567]; phosphate ion homeostasis [GO:0055062]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epidermal cell differentiation [GO:0045606]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte apoptotic process [GO:1902174]; positive regulation of receptor internalization [GO:0002092],cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634],Wnt-protein binding [GO:0017147]
511,M3X0F5,M3X0F5_FELCA,Nuclear transport factor 2 (NTF-2),NUTF2,mRNA transport [GO:0051028]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606],cytosol [GO:0005829]; nuclear inner membrane [GO:0005637]; nuclear outer membrane [GO:0005640]; nuclear pore central transport channel [GO:0044613]; nucleoplasm [GO:0005654],identical protein binding [GO:0042802]; nuclear import signal receptor activity [GO:0061608]; small GTPase binding [GO:0031267]; structural constituent of nuclear pore [GO:0017056]
512,M3X166,M3X166_FELCA,Phosphoglycerate kinase (EC 2.7.2.3),PGK2,gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096],cytosol [GO:0005829]; sperm fibrous sheath [GO:0035686],ADP binding [GO:0043531]; ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]
513,M3X1J5,M3X1J5_FELCA,Peroxiredoxin-5 (EC 1.11.1.24),PRDX5,cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; hydrogen peroxide catabolic process [GO:0042744],cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777],thioredoxin peroxidase activity [GO:0008379]
514,M3X1L5,M3X1L5_FELCA,NPC intracellular cholesterol transporter 2 (Epididymal secretory protein E1),NPC2,cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol storage [GO:0010878]; gene expression [GO:0010467]; intracellular cholesterol transport [GO:0032367]; response to virus [GO:0009615]; sterol metabolic process [GO:0016125],extracellular space [GO:0005615]; lysosome [GO:0005764],cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; enzyme binding [GO:0019899]
515,M3X2H7,M3X2H7_FELCA,Leucine rich repeat containing 8 VRAC subunit D,LRRC8D,aspartate transmembrane transport [GO:0015810]; cellular response to osmotic stress [GO:0071470]; intracellular glucose homeostasis [GO:0001678]; monoatomic anion transmembrane transport [GO:0098656]; protein hexamerization [GO:0034214]; taurine transmembrane transport [GO:0015734],cytoplasm [GO:0005737]; monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886],volume-sensitive anion channel activity [GO:0005225]
516,M3X2J1,M3X2J1_FELCA,Voltage-dependent anion-selective channel protein 2,VDAC2,binding of sperm to zona pellucida [GO:0007339]; mitochondrial outer membrane permeabilization [GO:0097345]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein polymerization [GO:0032272],acrosomal vesicle [GO:0001669]; mitochondrial nucleoid [GO:0042645]; mitochondrial outer membrane [GO:0005741]; pore complex [GO:0046930]; sperm midpiece [GO:0097225],ceramide binding [GO:0097001]; cholesterol binding [GO:0015485]; nucleotide binding [GO:0000166]; oxysterol binding [GO:0008142]; phosphatidylcholine binding [GO:0031210]; porin activity [GO:0015288]; voltage-gated monoatomic anion channel activity [GO:0008308]
517,M3X3Z7,M3X3Z7_FELCA,Sialidase-1 (EC 3.2.1.18) (Lysosomal sialidase) (N-acetyl-alpha-neuraminidase 1),NEU1,ganglioside catabolic process [GO:0006689]; oligosaccharide catabolic process [GO:0009313],cell junction [GO:0030054]; cytoplasm [GO:0005737]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020],exo-alpha-(2->3)-sialidase activity [GO:0052794]; exo-alpha-(2->6)-sialidase activity [GO:0052795]; exo-alpha-(2->8)-sialidase activity [GO:0052796]; exo-alpha-sialidase activity [GO:0004308]
518,M3X4M3,M3X4M3_FELCA,Frizzled-1,FZD1,autocrine signaling [GO:0035425]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation [GO:0044338]; non-canonical Wnt signaling pathway [GO:0035567]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of mesenchymal stem cell differentiation [GO:2000739]; response to xenobiotic stimulus [GO:0009410],cell surface [GO:0009986]; plasma membrane [GO:0005886],frizzled binding [GO:0005109]; G protein-coupled receptor activity [GO:0004930]; PDZ domain binding [GO:0030165]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]
519,M3X4X1,M3X4X1_FELCA,Sorting nexin,SNX18,cleavage furrow formation [GO:0036089]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; mitotic cytokinesis [GO:0000281]; plasma membrane tubulation [GO:0097320]; positive regulation of autophagosome assembly [GO:2000786]; protein transport [GO:0015031],clathrin-coated vesicle [GO:0030136]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038],"phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"
520,M3X4Y2,M3X4Y2_FELCA,Twisted gastrulation BMP signaling modulator 1,TWSG1,"BMP signaling pathway [GO:0030509]; camera-type eye development [GO:0043010]; chondrocyte differentiation [GO:0002062]; forebrain development [GO:0030900]; hemopoiesis [GO:0030097]; mesoderm formation [GO:0001707]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of cytokine production [GO:0001818]; negative regulation of osteoblast differentiation [GO:0045668]; ossification [GO:0001503]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of BMP signaling pathway [GO:0030510]; salivary gland morphogenesis [GO:0007435]",extracellular space [GO:0005615],heparin binding [GO:0008201]; transforming growth factor beta binding [GO:0050431]
521,M3X5Z4,M3X5Z4_FELCA,Aminopeptidase (EC 3.4.11.-),NPEPPS,cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020],metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]
522,M3X6G1,M3X6G1_FELCA,Caveolae associated protein 1,CAVIN1,positive regulation of cell motility [GO:2000147]; protein secretion [GO:0009306]; rRNA transcription [GO:0009303]; termination of RNA polymerase I transcription [GO:0006363]; transcription initiation at RNA polymerase I promoter [GO:0006361],caveola [GO:0005901]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],identical protein binding [GO:0042802]; rRNA primary transcript binding [GO:0042134]
523,M3X6M9,M3X6M9_FELCA,Syndecan 4,SDC4,cell migration [GO:0016477]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of T cell proliferation [GO:0042130]; neural tube closure [GO:0001843]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; regulation of fibroblast migration [GO:0010762]; wound healing [GO:0042060],cell surface [GO:0009986]; membrane [GO:0016020],identical protein binding [GO:0042802]; thrombospondin receptor activity [GO:0070053]
524,M3X6Z7,M3X6Z7_FELCA,Heat shock 70 kDa protein 13 (Stress-70 protein chaperone microsome-associated 60 kDa protein),HSPA13,chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; heat shock protein binding [GO:0031072]; protein folding chaperone [GO:0044183]
525,M3X8P7,M3X8P7_FELCA,Apolipoprotein D (Apo-D),APOD,brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of T cell migration [GO:2000405]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246],cytoplasm [GO:0005737]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471],cholesterol binding [GO:0015485]
526,M3X940,M3X940_FELCA,Triokinase/FMN cyclase (EC 2.7.1.28) (EC 2.7.1.29) (EC 4.6.1.15) (Bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase (cyclizing)),TKFC,glycerol metabolic process [GO:0006071],,ATP binding [GO:0005524]; FAD-AMP lyase (cyclizing) activity [GO:0034012]; glycerone kinase activity [GO:0004371]
527,M3X9A1,M3X9A1_FELCA,Triosephosphate isomerase (EC 5.3.1.1),TPI1,canonical glycolysis [GO:0061621]; gluconeogenesis [GO:0006094]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; glycerol catabolic process [GO:0019563]; glycolytic process [GO:0006096],cytosol [GO:0005829],methylglyoxal synthase activity [GO:0008929]; protein homodimerization activity [GO:0042803]; triose-phosphate isomerase activity [GO:0004807]; ubiquitin protein ligase binding [GO:0031625]
528,M3X9Z0,M3X9Z0_FELCA,"Fatty acid-binding protein, heart (Fatty acid-binding protein 3) (Heart-type fatty acid-binding protein)",FABP3,brown fat cell differentiation [GO:0050873]; cholesterol homeostasis [GO:0042632]; intracellular lipid transport [GO:0032365]; long-chain fatty acid transport [GO:0015909]; phospholipid homeostasis [GO:0055091]; positive regulation of long-chain fatty acid import into cell [GO:0140214]; regulation of fatty acid oxidation [GO:0046320]; regulation of phosphatidylcholine biosynthetic process [GO:2001245],cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634],cytoskeletal protein binding [GO:0008092]; long-chain fatty acid binding [GO:0036041]; oleic acid binding [GO:0070538]
529,M3XC81,M3XC81_FELCA,Kynurenine formamidase (KFA) (KFase) (EC 3.5.1.9) (Arylformamidase) (N-formylkynurenine formamidase) (FKF),AFMID,'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; tryptophan catabolic process to kynurenine [GO:0019441],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],arylformamidase activity [GO:0004061]
530,O19015,BGAL_FELCA,Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase),GLB1 BGAL,carbohydrate metabolic process [GO:0005975],lysosome [GO:0005764]; vacuole [GO:0005773],beta-galactosidase activity [GO:0004565]
531,P0DM82,APOC1_FELCA,Apolipoprotein C-I (Apo-CI) (ApoC-I) (Apolipoprotein C1) [Cleaved into: Truncated apolipoprotein C-I],APOC1,lipid transport [GO:0006869]; lipoprotein metabolic process [GO:0042157]; negative regulation of cholesterol transport [GO:0032375]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of very-low-density lipoprotein particle clearance [GO:0010916]; triglyceride metabolic process [GO:0006641]; very-low-density lipoprotein particle clearance [GO:0034447],high-density lipoprotein particle [GO:0034364]; very-low-density lipoprotein particle [GO:0034361],fatty acid binding [GO:0005504]; phospholipase inhibitor activity [GO:0004859]
532,P41690,IL2RA_FELCA,Interleukin-2 receptor subunit alpha (IL-2 receptor subunit alpha) (IL-2-RA) (IL-2R subunit alpha) (IL2-RA) (CD antigen CD25),IL2RA,immune system process [GO:0002376]; inflammatory response [GO:0006954],membrane [GO:0016020],interleukin-2 binding [GO:0019976]; interleukin-2 receptor activity [GO:0004911]
533,Q2MHN1,FRIL_FELCA,Ferritin light chain (Ferritin L subunit),FTL,intracellular sequestering of iron ion [GO:0006880]; iron ion transport [GO:0006826],cytoplasm [GO:0005737]; intracellular ferritin complex [GO:0008043],ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; iron ion binding [GO:0005506]
534,Q52R91,GLHA_FELCA,Glycoprotein hormones alpha chain (Anterior pituitary glycoprotein hormones common subunit alpha) (Follicle-stimulating hormone alpha chain) (FSH-alpha) (Follitropin alpha chain) (Luteinizing hormone alpha chain) (LSH-alpha) (Lutropin alpha chain) (Thyroid-stimulating hormone alpha chain) (TSH-alpha) (Thyrotropin alpha chain),CGA,G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of steroid biosynthetic process [GO:0010893]; regulation of signaling receptor activity [GO:0010469]; thyroid hormone generation [GO:0006590],extracellular space [GO:0005615]; follicle-stimulating hormone complex [GO:0016914],follicle-stimulating hormone activity [GO:0016913]
535,Q5MGS7,B2MG_FELCA,Beta-2-microglobulin,B2M,antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; immune response [GO:0006955]; peptide antigen assembly with MHC class II protein complex [GO:0002503]; positive regulation of immune response [GO:0050778]; positive regulation of T cell activation [GO:0050870],extracellular region [GO:0005576]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; MHC class I protein complex [GO:0042612]; MHC class II protein complex [GO:0042613],MHC class II protein complex binding [GO:0023026]; peptide antigen binding [GO:0042605]
536,Q5R1M5,CELA1_FELCA,Chymotrypsin-like elastase family member 1 (EC 3.4.21.36) (Elastase-1),CELA1 ELA1 ELS1,proteolysis [GO:0006508],extracellular space [GO:0005615],metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]
537,Q95ND4,EGF_FELCA,Pro-epidermal growth factor (EGF) [Cleaved into: Epidermal growth factor],EGF,epidermal growth factor receptor signaling pathway [GO:0007173]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of MAPK cascade [GO:0043410]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425],plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; growth factor activity [GO:0008083]
538,A0A0A0MPZ9,A0A0A0MPZ9_FELCA,Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8),PPIA,apoptotic process [GO:0006915]; protein folding [GO:0006457],cytoplasm [GO:0005737]; extracellular region [GO:0005576]; nucleus [GO:0005634],peptidyl-prolyl cis-trans isomerase activity [GO:0003755]
539,A0A2I2U006,A0A2I2U006_FELCA,Nicotinamide N-methyltransferase,LOC101094108,methylation [GO:0032259],cytosol [GO:0005829],N-methyltransferase activity [GO:0008170]
540,A0A2I2U011,A0A2I2U011_FELCA,Fibronectin,FN1,acute-phase response [GO:0006953]; cell adhesion [GO:0007155]; regulation of cell shape [GO:0008360],extracellular region [GO:0005576],heparin binding [GO:0008201]
541,A0A2I2U027,A0A2I2U027_FELCA,Glycoprotein V platelet,GP5,"blood coagulation [GO:0007596]; blood coagulation, intrinsic pathway [GO:0007597]; positive regulation of platelet activation [GO:0010572]; release of sequestered calcium ion into cytosol [GO:0051209]",glycoprotein Ib-IX-V complex [GO:1990779],
542,A0A2I2U033,A0A2I2U033_FELCA,"Myosin regulatory light polypeptide 9 (Myosin regulatory light chain 2, smooth muscle isoform) (Myosin regulatory light chain 9)",MYL9,myofibril assembly [GO:0030239],cytoplasm [GO:0005737]; myofibril [GO:0030016]; myosin II complex [GO:0016460]; stress fiber [GO:0001725]; Z disc [GO:0030018],calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]
543,A0A2I2U057,A0A2I2U057_FELCA,Tropomyosin 3,TPM3,actin filament organization [GO:0007015]; muscle contraction [GO:0006936],actin filament [GO:0005884]; cytosol [GO:0005829]; stress fiber [GO:0001725],actin filament binding [GO:0051015]
544,A0A2I2U066,A0A2I2U066_FELCA,Reticulon 4 receptor like 1,RTN4RL1,corpus callosum development [GO:0022038]; negative regulation of axon regeneration [GO:0048681],cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],chondroitin sulfate binding [GO:0035374]; heparin binding [GO:0008201]; signaling receptor activity [GO:0038023]
545,A0A2I2U088,A0A2I2U088_FELCA,Adhesion G protein-coupled receptor G6,ADGRG6,cell surface receptor signaling pathway [GO:0007166],membrane [GO:0016020],G protein-coupled receptor activity [GO:0004930]
546,A0A2I2U0A6,A0A2I2U0A6_FELCA,Interleukin-1,IL36RN,antifungal humoral response [GO:0019732]; cellular response to lipopolysaccharide [GO:0071222]; inflammatory response to antigenic stimulus [GO:0002437]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of type II interferon production [GO:0032689],extracellular space [GO:0005615],cytokine activity [GO:0005125]; interleukin-1 receptor binding [GO:0005149]
547,A0A2I2U0D3,A0A2I2U0D3_FELCA,Adhesion G protein-coupled receptor L2,ADGRL2,cell surface receptor signaling pathway [GO:0007166],membrane [GO:0016020],carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]
548,A0A2I2U0U5,A0A2I2U0U5_FELCA,Amine oxidase (EC 1.4.3.-),AOC2,amine metabolic process [GO:0009308],plasma membrane [GO:0005886],copper ion binding [GO:0005507]; primary amine oxidase activity [GO:0008131]; quinone binding [GO:0048038]
549,A0A2I2U0Y4,A0A2I2U0Y4_FELCA,Carboxypeptidase B (EC 3.4.17.2),CPB1,proteolysis [GO:0006508],extracellular space [GO:0005615],metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]
550,A0A2I2U119,A0A2I2U119_FELCA,Delta like non-canonical Notch ligand 1,DLK1,,membrane [GO:0016020],calcium ion binding [GO:0005509]
551,A0A2I2U1C5,A0A2I2U1C5_FELCA,"Myosin-9 (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain IIa)",MYH9,regulation of cell shape [GO:0008360],cortical granule [GO:0060473]; myosin complex [GO:0016459],actin filament binding [GO:0051015]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]
552,A0A2I2U1C8,A0A2I2U1C8_FELCA,H(+)-transporting two-sector ATPase (EC 7.1.2.2),ATP6V1A,,"clathrin-coated vesicle membrane [GO:0030665]; proton-transporting V-type ATPase, V1 domain [GO:0033180]","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"
553,A0A2I2U1G6,A0A2I2U1G6_FELCA,Kinesin family member 21A,KIF21A,microtubule-based movement [GO:0007018],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856],ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]
554,A0A2I2U1J3,A0A2I2U1J3_FELCA,Nuclear receptor subfamily 1 group H member 4,NR1H4,bile acid signaling pathway [GO:0038183],nucleus [GO:0005634],bile acid binding [GO:0032052]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]
555,A0A2I2U1L8,A0A2I2U1L8_FELCA,Pro-epidermal growth factor,EGF,,,calcium ion binding [GO:0005509]; growth factor activity [GO:0008083]
556,A0A2I2U1S9,A0A2I2U1S9_FELCA,G protein subunit alpha transducin 3,GNAT3,adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; sensory perception of sweet taste [GO:0050916]; sensory perception of umami taste [GO:0050917],cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750],G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]
557,A0A2I2U1Z3,A0A2I2U1Z3_FELCA,Afamin,AFM,protein stabilization [GO:0050821]; protein transport within extracellular region [GO:0071693]; vitamin transport [GO:0051180],cytoplasm [GO:0005737]; extracellular space [GO:0005615],metal ion binding [GO:0046872]; vitamin E binding [GO:0008431]
558,A0A2I2U227,A0A2I2U227_FELCA,Lipocalin/cytosolic fatty-acid binding domain-containing protein,LOC101098498,,extracellular region [GO:0005576],small molecule binding [GO:0036094]
559,A0A2I2U232,A0A2I2U232_FELCA,Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein),LOC101098453,G protein-coupled receptor signaling pathway [GO:0007186],heterotrimeric G-protein complex [GO:0005834],G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]
560,A0A2I2U2A3,A0A2I2U2A3_FELCA,Radixin,RDX,actin filament capping [GO:0051693],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; microvillus [GO:0005902]; plasma membrane [GO:0005886],actin binding [GO:0003779]
561,A0A2I2U2C4,A0A2I2U2C4_FELCA,Collagen type VI alpha 2 chain,COL6A2,neuron apoptotic process [GO:0051402]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; response to UV [GO:0009411],collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383],collagen binding [GO:0005518]
562,A0A2I2U2D3,A0A2I2U2D3_FELCA,Histone H2A,H2AZ1,heterochromatin formation [GO:0031507],nucleosome [GO:0000786]; nucleus [GO:0005634],nucleosomal DNA binding [GO:0031492]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]
563,A0A2I2U2P0,A0A2I2U2P0_FELCA,G protein subunit beta 4,GNB4,G protein-coupled receptor signaling pathway [GO:0007186],cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834],protein-containing complex binding [GO:0044877]; signaling receptor complex adaptor activity [GO:0030159]
564,A0A2I2U310,A0A2I2U310_FELCA,NPC1 like intracellular cholesterol transporter 1,NPC1L1 DDX56,cholesterol homeostasis [GO:0042632]; cholesterol transport [GO:0030301]; intestinal cholesterol absorption [GO:0030299],plasma membrane [GO:0005886],cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]
565,A0A2I2U350,A0A2I2U350_FELCA,Complement factor I,CFI,complement activation [GO:0006956]; proteolysis [GO:0006508],membrane [GO:0016020],serine-type endopeptidase activity [GO:0004252]
566,A0A2I2U3H1,A0A2I2U3H1_FELCA,Insulin like growth factor binding protein 7,IGFBP7,cell adhesion [GO:0007155]; regulation of cell growth [GO:0001558]; regulation of signal transduction [GO:0009966],collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615],insulin-like growth factor binding [GO:0005520]
567,A0A2I2U3L7,A0A2I2U3L7_FELCA,Apolipoprotein M,APOM,lipid transport [GO:0006869],high-density lipoprotein particle [GO:0034364],
568,A0A2I2U3V1,A0A2I2U3V1_FELCA,3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.35),HADH,fatty acid metabolic process [GO:0006631],,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]"
569,A0A2I2U3V7,A0A2I2U3V7_FELCA,Collectin-11,COLEC11,,collagen trimer [GO:0005581]; extracellular region [GO:0005576],carbohydrate binding [GO:0030246]
570,A0A2I2U3Y6,A0A2I2U3Y6_FELCA,Phospholipid transfer protein,PLTP,,extracellular space [GO:0005615],lipid binding [GO:0008289]
571,A0A2I2U457,A0A2I2U457_FELCA,Calumenin,CALU,,endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018],calcium ion binding [GO:0005509]
572,A0A2I2U499,A0A2I2U499_FELCA,Battenin,CLN3,,lysosomal membrane [GO:0005765],
573,A0A2I2U4F9,A0A2I2U4F9_FELCA,Metalloproteinase inhibitor 1 (Tissue inhibitor of metalloproteinases 1),TIMP1,,,growth factor activity [GO:0008083]; metal ion binding [GO:0046872]; metalloendopeptidase inhibitor activity [GO:0008191]
574,A0A2I2U4I8,A0A2I2U4I8_FELCA,Growth differentiation factor 10,GDF10,,extracellular region [GO:0005576],growth factor activity [GO:0008083]
575,A0A2I2U4L9,A0A2I2U4L9_FELCA,Biotinidase (EC 3.5.1.12),BTD,biotin metabolic process [GO:0006768],membrane [GO:0016020],"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]"
576,A0A2I2U4M0,A0A2I2U4M0_FELCA,Choline transporter-like protein,SLC44A2,,mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886],organic cation transmembrane transporter activity [GO:0015101]
577,A0A2I2U526,A0A2I2U526_FELCA,Cytochrome c domain-containing protein,,"apoptotic process [GO:0006915]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]",mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469],electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]
578,A0A2I2U551,A0A2I2U551_FELCA,Adenosylhomocysteinase (S-adenosyl-L-homocysteine hydrolase),AHCY,one-carbon metabolic process [GO:0006730],,
579,A0A2I2U5B1,A0A2I2U5B1_FELCA,Catenin beta-1 (Beta-catenin),CTNNB1,cell adhesion [GO:0007155],adherens junction [GO:0005912]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886],cadherin binding [GO:0045296]
580,A0A2I2U5I7,A0A2I2U5I7_FELCA,Ig-like domain-containing protein,,antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; immune response [GO:0006955],lumenal side of endoplasmic reticulum membrane [GO:0098553]; MHC class I protein complex [GO:0042612]; phagocytic vesicle membrane [GO:0030670],
581,A0A2I2U5J7,A0A2I2U5J7_FELCA,Coagulation factor XIII A chain,F13A1,"blood coagulation, fibrin clot formation [GO:0072378]",,metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]
582,A0A2I2U5R8,A0A2I2U5R8_FELCA,Adhesion G protein-coupled receptor L3,ADGRL3,cell surface receptor signaling pathway [GO:0007166],membrane [GO:0016020],carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]
583,A0A2I2U5V0,A0A2I2U5V0_FELCA,Carbonic anhydrase (EC 4.2.1.1),CA12,,membrane [GO:0016020],carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]
584,A0A2I2U5W5,A0A2I2U5W5_FELCA,Complement component C8 beta chain (Complement component 8 subunit beta),C8B,"complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; killing of cells of another organism [GO:0031640]",extracellular space [GO:0005615]; membrane attack complex [GO:0005579],
585,A0A2I2U5Z9,A0A2I2U5Z9_FELCA,NHL repeat containing 3,NHLRC3,negative regulation of translation [GO:0017148]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209],,translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]
586,A0A2I2U619,A0A2I2U619_FELCA,Lumican,LUM,positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta1 production [GO:0032914],extracellular space [GO:0005615]; fibrillar collagen trimer [GO:0005583],collagen binding [GO:0005518]
587,A0A2I2U679,A0A2I2U679_FELCA,Galectin-3-binding protein (Lectin galactoside-binding soluble 3-binding protein),CANT1,cell adhesion [GO:0007155],extracellular space [GO:0005615]; membrane [GO:0016020],calcium ion binding [GO:0005509]; nucleoside diphosphate phosphatase activity [GO:0017110]
588,A0A2I2U6D2,A0A2I2U6D2_FELCA,"Spectrin alpha, non-erythrocytic 1",SPTAN1,actin filament capping [GO:0051693],cell cortex [GO:0005938]; cytoskeleton [GO:0005856],calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]
589,A0A2I2U6J8,A0A2I2U6J8_FELCA,Globin domain-containing protein,LOC101098159,cellular oxidant detoxification [GO:0098869]; hydrogen peroxide catabolic process [GO:0042744],haptoglobin-hemoglobin complex [GO:0031838]; hemoglobin complex [GO:0005833],heme binding [GO:0020037]; hemoglobin alpha binding [GO:0031721]; metal ion binding [GO:0046872]; organic acid binding [GO:0043177]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]
590,A0A2I2U6R0,A0A2I2U6R0_FELCA,Acyl-CoA-binding protein,DBI,,endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794],fatty-acyl-CoA binding [GO:0000062]
591,A0A2I2U788,A0A2I2U788_FELCA,Argininosuccinate lyase,ASL,arginine biosynthetic process via ornithine [GO:0042450]; urea cycle [GO:0000050],,argininosuccinate lyase activity [GO:0004056]
592,A0A2I2U7X4,A0A2I2U7X4_FELCA,Heat shock protein HSP 90-beta,HSP90AB1,,dynein axonemal particle [GO:0120293]; melanosome [GO:0042470],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; unfolded protein binding [GO:0051082]
593,A0A2I2U8D7,A0A2I2U8D7_FELCA,C-type lectin domain-containing protein,LOC101082144,antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; positive regulation of cell population proliferation [GO:0008284]; response to peptide hormone [GO:0043434],extracellular space [GO:0005615],oligosaccharide binding [GO:0070492]; peptidoglycan binding [GO:0042834]; signaling receptor activity [GO:0038023]
594,A0A2I2U8E4,A0A2I2U8E4_FELCA,ferroxidase (EC 1.16.3.1),CP,,,copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491]
595,A0A2I2U8F6,A0A2I2U8F6_FELCA,Calreticulin,CALR3,ERAD pathway [GO:0036503]; protein folding [GO:0006457],endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635],calcium ion binding [GO:0005509]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]
596,A0A2I2U8P7,A0A2I2U8P7_FELCA,Histone H2B,,,nucleosome [GO:0000786]; nucleus [GO:0005634],DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]
597,A0A2I2U8R6,A0A2I2U8R6_FELCA,glutathione transferase (EC 2.5.1.18) (GST class-pi),GSTP1,,,glutathione transferase activity [GO:0004364]
598,A0A2I2U8Y1,A0A2I2U8Y1_FELCA,ADP-ribosylation factor 3,ARF3,intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192],Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886],GTP binding [GO:0005525]; GTPase activity [GO:0003924]
599,A0A2I2U991,A0A2I2U991_FELCA,Cytospin-A,SPECC1L,cell division [GO:0051301],cytoplasm [GO:0005737]; gap junction [GO:0005921]; spindle [GO:0005819],
600,A0A2I2U9A5,A0A2I2U9A5_FELCA,Serpin family F member 2,SERPINF2,,extracellular space [GO:0005615],serine-type endopeptidase inhibitor activity [GO:0004867]
601,A0A2I2U9I8,A0A2I2U9I8_FELCA,Serine protease inhibitor Kazal-type 1 (Pancreatic secretory trypsin inhibitor),SPINK1,negative regulation of calcium ion import [GO:0090281]; negative regulation of nitric oxide mediated signal transduction [GO:0010751]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; nitric oxide mediated signal transduction [GO:0007263]; regulation of acrosome reaction [GO:0060046]; regulation of store-operated calcium entry [GO:2001256]; sperm capacitation [GO:0048240],extracellular space [GO:0005615],serine-type endopeptidase inhibitor activity [GO:0004867]
602,A0A2I2U9S5,A0A2I2U9S5_FELCA,Prominin 1,PROM1,,microvillus membrane [GO:0031528],
603,A0A2I2U9Y7,A0A2I2U9Y7_FELCA,Integral membrane protein 2,ITM2C,,lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886],
604,A0A2I2UA27,A0A2I2UA27_FELCA,Glucosidase II alpha subunit,GANAB,carbohydrate metabolic process [GO:0005975],,alpha-glucosidase activity [GO:0090599]; carbohydrate binding [GO:0030246]
605,A0A2I2UA49,A0A2I2UA49_FELCA,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase (EC 3.2.2.6),BST1,,membrane [GO:0016020],"NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; transferase activity [GO:0016740]"
606,A0A2I2UA55,A0A2I2UA55_FELCA,Kazal type serine peptidase inhibitor domain 1,KAZALD1,extracellular matrix organization [GO:0030198]; regulation of cell growth [GO:0001558]; regulation of signal transduction [GO:0009966],extracellular space [GO:0005615]; interstitial matrix [GO:0005614],insulin-like growth factor binding [GO:0005520]
607,A0A2I2UAE6,A0A2I2UAE6_FELCA,Carboxypeptidase B2,CPB2,fibrinolysis [GO:0042730]; proteolysis [GO:0006508],,metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]
608,A0A2I2UAM2,A0A2I2UAM2_FELCA,Fibronectin,FN1,acute-phase response [GO:0006953]; cell adhesion [GO:0007155]; regulation of cell shape [GO:0008360],extracellular region [GO:0005576],heparin binding [GO:0008201]
609,A0A2I2UAR3,A0A2I2UAR3_FELCA,Lysyl oxidase homolog (EC 1.4.3.13),LOX,,extracellular space [GO:0005615],copper ion binding [GO:0005507]; protein-lysine 6-oxidase activity [GO:0004720]
610,A0A2I2UAT5,A0A2I2UAT5_FELCA,Tubulin beta chain,TUBB6,microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278],cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; mitotic spindle [GO:0072686],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]
611,A0A2I2UAX8,A0A2I2UAX8_FELCA,small monomeric GTPase (EC 3.6.5.2),RAB27B,,late endosome [GO:0005770]; membrane [GO:0016020],G protein activity [GO:0003925]; GTP binding [GO:0005525]
612,A0A2I2UB34,A0A2I2UB34_FELCA,Adhesion G protein-coupled receptor L1,ADGRL1,cell surface receptor signaling pathway [GO:0007166],membrane [GO:0016020],carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]
613,A0A2I2UB41,A0A2I2UB41_FELCA,G protein-coupled receptor class C group 5 member B,GPRC5B,cell volume homeostasis [GO:0006884],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],G protein-coupled receptor activity [GO:0004930]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]
614,A0A2I2UB49,A0A2I2UB49_FELCA,Tetraspanin,TSPAN8,regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283],cell surface [GO:0009986]; plasma membrane [GO:0005886],
615,A0A2I2UBB6,A0A2I2UBB6_FELCA,SH3 domain-containing protein,MIA2,,endoplasmic reticulum membrane [GO:0005789],
616,A0A2I2UBC8,A0A2I2UBC8_FELCA,Delta-like protein,JAG1,Notch signaling pathway [GO:0007219],membrane [GO:0016020],calcium ion binding [GO:0005509]; Notch binding [GO:0005112]
617,A0A2I2UBF3,A0A2I2UBF3_FELCA,Tubulin beta chain,TUBB4A,microtubule-based process [GO:0007017],cytoplasm [GO:0005737]; microtubule [GO:0005874],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]
618,A0A2I2UBL3,A0A2I2UBL3_FELCA,Rho GDP-dissociation inhibitor 1 (Rho-GDI alpha),ARHGDIA,Rho protein signal transduction [GO:0007266],cytosol [GO:0005829]; membrane [GO:0016020],Rho GDP-dissociation inhibitor activity [GO:0005094]
619,A0A2I2UC18,A0A2I2UC18_FELCA,Phosphoglycerate kinase (EC 2.7.2.3),,gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096],cytosol [GO:0005829],ADP binding [GO:0043531]; ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]
620,A0A2I2UC45,A0A2I2UC45_FELCA,NAD(P)(+)--arginine ADP-ribosyltransferase (EC 2.4.2.31) (Mono(ADP-ribosyl)transferase),ART3,,membrane [GO:0016020],NAD+-protein-arginine ADP-ribosyltransferase activity [GO:0106274]; nucleotidyltransferase activity [GO:0016779]
621,A0A2I2UC58,A0A2I2UC58_FELCA,Multiple EGF like domains 9,MEGF9,animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; tissue development [GO:0009888],basement membrane [GO:0005604]; membrane [GO:0016020],extracellular matrix structural constituent [GO:0005201]
622,A0A2I2UC97,A0A2I2UC97_FELCA,Calumenin,CALU,,extracellular region [GO:0005576],calcium ion binding [GO:0005509]
623,A0A2I2UCR1,A0A2I2UCR1_FELCA,Desmocollin 2,DSC2,homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],desmosome [GO:0030057]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]
624,A0A2I2UCX4,A0A2I2UCX4_FELCA,Very low density lipoprotein receptor,VLDLR,cholesterol metabolic process [GO:0008203]; endocytosis [GO:0006897]; lipid transport [GO:0006869],membrane [GO:0016020],calcium ion binding [GO:0005509]
625,A0A2I2UD00,A0A2I2UD00_FELCA,Oxysterol-binding protein,OSBPL2 ADRM1,lipid transport [GO:0006869],cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886],cholesterol binding [GO:0015485]
626,A0A2I2UDN6,A0A2I2UDN6_FELCA,Filamin C,FLNC,actin cytoskeleton organization [GO:0030036],intracellular non-membrane-bounded organelle [GO:0043232],actin filament binding [GO:0051015]
627,A0A2I2UDS4,A0A2I2UDS4_FELCA,Phospholipase B-like (EC 3.1.1.-),PLBD2,lipid catabolic process [GO:0016042],,phospholipase activity [GO:0004620]
628,A0A2I2UE17,A0A2I2UE17_FELCA,Sulfhydryl oxidase (EC 1.8.3.2),QSOX1,,membrane [GO:0016020],flavin-dependent sulfhydryl oxidase activity [GO:0016971]
629,A0A2I2UED7,A0A2I2UED7_FELCA,Cytoplasmic linker associated protein 1,CLASP1,negative regulation of cytoskeleton organization [GO:0051494]; negative regulation of supramolecular fiber organization [GO:1902904]; regulation of microtubule polymerization or depolymerization [GO:0031110],centrosome [GO:0005813]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776],microtubule binding [GO:0008017]
630,A0A2I2UEZ6,A0A2I2UEZ6_FELCA,Insulin-like growth factor-binding protein 2,IGFBP2,positive regulation of activated T cell proliferation [GO:0042104]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567],extracellular space [GO:0005615],insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor II binding [GO:0031995]
631,A0A2I2UFC7,A0A2I2UFC7_FELCA,Vacuolar protein-sorting-associated protein 25 (ESCRT-II complex subunit VPS25),VPS25,protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328],cytosol [GO:0005829]; ESCRT II complex [GO:0000814]; nucleus [GO:0005634],protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198]
632,A0A2I2UFE0,A0A2I2UFE0_FELCA,Destrin (Actin-depolymerizing factor),DSTN,actin filament fragmentation [GO:0030043]; actin filament severing [GO:0051014]; cell motility [GO:0048870]; positive regulation of actin filament depolymerization [GO:0030836],actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737],actin filament binding [GO:0051015]
633,A0A2I2UFF7,A0A2I2UFF7_FELCA,Interferon alpha inducible protein 6,IFI6,apoptotic signaling pathway [GO:0097190]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of mitochondrial depolarization [GO:0051902]; reactive oxygen species metabolic process [GO:0072593]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; release of cytochrome c from mitochondria [GO:0001836],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],
634,A0A2I2UFJ4,A0A2I2UFJ4_FELCA,Fibulin 2,FBLN2,,extracellular region [GO:0005576],calcium ion binding [GO:0005509]
635,A0A2I2UFN2,A0A2I2UFN2_FELCA,Carbonyl reductase (NADPH) (EC 1.1.1.184),LOC102901316,,cytoplasm [GO:0005737],carbonyl reductase (NADPH) activity [GO:0004090]
636,A0A2I2UFP6,A0A2I2UFP6_FELCA,Carboxylic ester hydrolase (EC 3.1.1.-),CES5A CES1,,,carboxylic ester hydrolase activity [GO:0052689]
637,A0A2I2UFV4,A0A2I2UFV4_FELCA,GDNF family receptor alpha-2 (GDNF receptor alpha-2),GFRA2,nervous system development [GO:0007399],external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235],glial cell-derived neurotrophic factor receptor activity [GO:0016167]; heparan sulfate binding [GO:1904399]
638,A0A2I2UFV7,A0A2I2UFV7_FELCA,Tenascin C,TNC,,,
639,A0A2I2UFV8,A0A2I2UFV8_FELCA,E2 ubiquitin-conjugating enzyme (EC 2.3.2.23),UBE2G2,,,ATP binding [GO:0005524]; transferase activity [GO:0016740]
640,A0A2I2UG29,A0A2I2UG29_FELCA,Thrombospondin 2,THBS2,cell adhesion [GO:0007155]; negative regulation of angiogenesis [GO:0016525],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; platelet alpha granule [GO:0031091],calcium ion binding [GO:0005509]; heparin binding [GO:0008201]
641,A0A2I2UGF8,A0A2I2UGF8_FELCA,Retinol binding protein 1,RBP1,fatty acid transport [GO:0015908]; regulation of granulocyte differentiation [GO:0030852]; response to vitamin A [GO:0033189]; retinoic acid biosynthetic process [GO:0002138]; retinol metabolic process [GO:0042572]; vitamin A metabolic process [GO:0006776],cytosol [GO:0005829]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],all-trans-retinol binding [GO:1904768]; fatty acid binding [GO:0005504]
642,A0A2I2UGY0,A0A2I2UGY0_FELCA,Solute carrier family 12 member 1,SLC12A1,cell volume homeostasis [GO:0006884]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; sodium ion homeostasis [GO:0055078]; sodium ion transmembrane transport [GO:0035725],apical plasma membrane [GO:0016324],sodium:potassium:chloride symporter activity [GO:0008511]
643,A0A2I2UH03,A0A2I2UH03_FELCA,Collectin subfamily member 10,COLEC10,"complement activation, lectin pathway [GO:0001867]; cranial skeletal system development [GO:1904888]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]",collagen trimer [GO:0005581]; extracellular space [GO:0005615]; multivesicular body [GO:0005771],chemoattractant activity [GO:0042056]; mannose binding [GO:0005537]
644,A0A2I2UHA0,A0A2I2UHA0_FELCA,EPH receptor A10,EPHA10,axon guidance [GO:0007411]; ephrin receptor signaling pathway [GO:0048013],dendrite [GO:0030425]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; transmembrane-ephrin receptor activity [GO:0005005]
645,A0A2I2UHD5,A0A2I2UHD5_FELCA,"Type 2 lactosamine alpha-2,3-sialyltransferase (CMP-NeuAc:beta-galactoside alpha-2,3-sialyltransferase VI) (ST3Gal VI) (Sialyltransferase 10)",ST3GAL6,protein glycosylation [GO:0006486],Golgi membrane [GO:0000139],sialyltransferase activity [GO:0008373]
646,A0A2I2UHH3,A0A2I2UHH3_FELCA,small monomeric GTPase (EC 3.6.5.2),KRAS,signal transduction [GO:0007165],plasma membrane [GO:0005886],GTP binding [GO:0005525]; GTPase activity [GO:0003924]
647,A0A2I2UHQ6,A0A2I2UHQ6_FELCA,"Papilin, proteoglycan like sulfated glycoprotein",PAPLN,extracellular matrix organization [GO:0030198],extracellular region [GO:0005576],serine-type endopeptidase inhibitor activity [GO:0004867]
648,A0A2I2UHV5,A0A2I2UHV5_FELCA,Retinoic acid receptor responder protein 2 (Chemerin),RARRES2,cell differentiation [GO:0030154]; chemotaxis [GO:0006935]; inflammatory response [GO:0006954]; regulation of lipid catabolic process [GO:0050994],extracellular region [GO:0005576],signaling receptor binding [GO:0005102]
649,A0A2I2UHZ6,A0A2I2UHZ6_FELCA,MBL associated serine protease 1,MASP1,complement activation [GO:0006956]; innate immune response [GO:0045087]; proteolysis [GO:0006508],extracellular region [GO:0005576],calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]
650,A0A2I2UI11,A0A2I2UI11_FELCA,Mannose binding lectin 1,MBL1,"complement activation, classical pathway [GO:0006958]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-positive bacterium [GO:0050830]; killing by host of symbiont cells [GO:0051873]; positive regulation of phagocytosis [GO:0050766]; surfactant homeostasis [GO:0043129]",collagen trimer [GO:0005581]; extracellular space [GO:0005615]; multivesicular body [GO:0005771],mannose binding [GO:0005537]
651,A0A2I2UI32,A0A2I2UI32_FELCA,Heterogeneous nuclear ribonucleoprotein K,HNRNPK,,anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; podosome [GO:0002102]; spliceosomal complex [GO:0005681],DNA binding [GO:0003677]; RNA binding [GO:0003723]
652,A0A2I2UI95,A0A2I2UI95_FELCA,Glial fibrillary acidic protein,GFAP,,intermediate filament [GO:0005882],
653,A0A2I2UIC2,A0A2I2UIC2_FELCA,procollagen-lysine 5-dioxygenase (EC 1.14.11.4),PLOD2,,endoplasmic reticulum membrane [GO:0005789],iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-lysine 5-dioxygenase activity [GO:0008475]
654,A0A2I2UIG2,A0A2I2UIG2_FELCA,Histone H3,H3C5,,nucleosome [GO:0000786]; nucleus [GO:0005634],DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]
655,A0A2I2UIM4,A0A2I2UIM4_FELCA,Carbonyl reductase (NADPH) (EC 1.1.1.184),LOC102901316,,cytoplasm [GO:0005737],carbonyl reductase (NADPH) activity [GO:0004090]
656,A0A2I2UIQ7,A0A2I2UIQ7_FELCA,Insulin-like growth factor I (Somatomedin),IGF1,,extracellular space [GO:0005615],growth factor activity [GO:0008083]; hormone activity [GO:0005179]
657,A0A2I2UIU2,A0A2I2UIU2_FELCA,RING-type E3 ubiquitin transferase (EC 2.3.2.27),RNF167,,endomembrane system [GO:0012505]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020],zinc ion binding [GO:0008270]
658,A0A2I2UIZ2,A0A2I2UIZ2_FELCA,Hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase,H6PD,glucose metabolic process [GO:0006006]; pentose-phosphate shunt [GO:0006098],,6-phosphogluconolactonase activity [GO:0017057]; glucose-6-phosphate dehydrogenase activity [GO:0004345]; NADP binding [GO:0050661]
659,A0A2I2UJH0,A0A2I2UJH0_FELCA,Phosphoglycerate kinase (EC 2.7.2.3),PGK1,glycolytic process [GO:0006096],cytoplasm [GO:0005737],ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]
660,A0A2I2UJS0,A0A2I2UJS0_FELCA,Alpha-mannosidase (EC 3.2.1.-),MAN2B1,mannose metabolic process [GO:0006013]; protein modification process [GO:0036211],extracellular space [GO:0005615]; lysosome [GO:0005764]; nucleoplasm [GO:0005654],alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]
661,A0A2I2UKF8,A0A2I2UKF8_FELCA,Transmembrane p24 trafficking protein 7,TMED7,endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886],COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794],cargo receptor activity [GO:0038024]
662,A0A2I2UKH0,A0A2I2UKH0_FELCA,Choline transporter-like protein,EHMT2,,plasma membrane [GO:0005886],organic cation transmembrane transporter activity [GO:0015101]
663,A0A2I2UKK1,A0A2I2UKK1_FELCA,Uncharacterized protein,LOC101094346,"complement activation, classical pathway [GO:0006958]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]",axon [GO:0030424]; dendrite [GO:0030425]; extracellular space [GO:0005615]; synapse [GO:0045202],endopeptidase inhibitor activity [GO:0004866]
664,A0A2I2UKX6,A0A2I2UKX6_FELCA,Limbic system associated membrane protein,LSAMP,,plasma membrane [GO:0005886]; side of membrane [GO:0098552],
665,A0A2I2UL92,A0A2I2UL92_FELCA,Shroom family member 1,SHROOM1,,cytoplasm [GO:0005737]; microtubule [GO:0005874],actin filament binding [GO:0051015]
666,A0A2I2UL98,A0A2I2UL98_FELCA,Rho GDP dissociation inhibitor beta,ARHGDIB,negative regulation of trophoblast cell migration [GO:1901164]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266],cytosol [GO:0005829]; membrane [GO:0016020],GTPase activity [GO:0003924]; Rho GDP-dissociation inhibitor activity [GO:0005094]; small GTPase binding [GO:0031267]
667,A0A2I2ULA8,A0A2I2ULA8_FELCA,Nuclear mitotic apparatus protein 1,NUMA1,,intracellular organelle [GO:0043229]; membrane-bounded organelle [GO:0043227],
668,A0A2I2ULL1,A0A2I2ULL1_FELCA,Neurexophilin,NXPH2,,,signaling receptor binding [GO:0005102]
669,A0A2I2ULR9,A0A2I2ULR9_FELCA,14-3-3 protein epsilon,,protein localization [GO:0008104]; regulation of mitotic cell cycle [GO:0007346]; signal transduction [GO:0007165],cytoplasm [GO:0005737],phosphoserine residue binding [GO:0050815]
670,A0A2I2ULZ1,A0A2I2ULZ1_FELCA,Phosphatidylethanolamine-binding protein 1 (HCNPpp),PEBP1,negative regulation of MAPK cascade [GO:0043409],,serine-type endopeptidase inhibitor activity [GO:0004867]
671,A0A2I2ULZ3,A0A2I2ULZ3_FELCA,Superoxide dismutase [Cu-Zn] (EC 1.15.1.1),,removal of superoxide radicals [GO:0019430],cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisome [GO:0005777],copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]
672,A0A2I2UM04,A0A2I2UM04_FELCA,Heat shock cognate 71 kDa protein (EC 3.6.4.10) (Heat shock 70 kDa protein 8),,clathrin coat disassembly [GO:0072318]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],spliceosomal complex [GO:0005681],ATP binding [GO:0005524]; ATP-dependent protein folding chaperone [GO:0140662]
673,A0A2I2UM58,A0A2I2UM58_FELCA,Amyloid beta like protein 2,APLP2,,endomembrane system [GO:0012505]; membrane [GO:0016020],heparin binding [GO:0008201]; serine-type endopeptidase inhibitor activity [GO:0004867]; transition metal ion binding [GO:0046914]
674,A0A2I2UM78,A0A2I2UM78_FELCA,Transglutaminase 5,TGM5,,,metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]
675,A0A2I2UMK7,A0A2I2UMK7_FELCA,V-type proton ATPase subunit a,ATP6V0A1,,"clathrin-coated vesicle membrane [GO:0030665]; melanosome [GO:0042470]; synaptic vesicle membrane [GO:0030672]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]","proton-transporting ATPase activity, rotational mechanism [GO:0046961]"
676,A0A2I2UMR7,A0A2I2UMR7_FELCA,Serpin family B member 12,SERPINB12,hematopoietic progenitor cell differentiation [GO:0002244],cornified envelope [GO:0001533]; extracellular space [GO:0005615],serine-type endopeptidase inhibitor activity [GO:0004867]
677,A0A2I2UMV3,A0A2I2UMV3_FELCA,Liver-expressed antimicrobial peptide 2,LEAP2,antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response to bacterium [GO:0042742],extracellular region [GO:0005576],
678,A0A2I2UN04,A0A2I2UN04_FELCA,Annexin,ANXA7,,,calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]
679,A0A2I2UN28,A0A2I2UN28_FELCA,Cochlin,COCH,,,
680,A0A2I2UNJ3,A0A2I2UNJ3_FELCA,vesicle-fusing ATPase (EC 3.6.4.6),VPS4A,,late endosome membrane [GO:0031902],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]
681,A0A2I2UP08,A0A2I2UP08_FELCA,Sushi domain-containing protein,LOC101085428,complement activation [GO:0006956],extracellular space [GO:0005615],complement component C3b binding [GO:0001851]
682,A0A2I2UP29,A0A2I2UP29_FELCA,T cell immunoglobulin and mucin domain containing 4,TIMD4,"apoptotic cell clearance [GO:0043277]; cytoskeletal rearrangement involved in phagocytosis, engulfment [GO:0060097]",membrane [GO:0016020],phosphatidylserine binding [GO:0001786]
683,A0A2I2UP70,A0A2I2UP70_FELCA,Syntaxin 3,STX3,intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192],membrane [GO:0016020],SNAP receptor activity [GO:0005484]
684,A0A2I2UQ14,A0A2I2UQ14_FELCA,Peroxidasin,PXDN,response to oxidative stress [GO:0006979],extracellular region [GO:0005576],heme binding [GO:0020037]; lactoperoxidase activity [GO:0140825]; metal ion binding [GO:0046872]
685,A0A2I2UQ65,A0A2I2UQ65_FELCA,thioredoxin-dependent peroxiredoxin (EC 1.11.1.24),PRDX1,,,peroxiredoxin activity [GO:0051920]
686,A0A2I2UQ66,A0A2I2UQ66_FELCA,CXADR Ig-like cell adhesion molecule,CXADR,,adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; plasma membrane [GO:0005886],
687,A0A2I2UQ95,A0A2I2UQ95_FELCA,Galactocerebrosidase (EC 3.2.1.46) (Galactosylceramidase),GALC,galactosylceramide catabolic process [GO:0006683],,galactosylceramidase activity [GO:0004336]
688,A0A2I2UQB6,A0A2I2UQB6_FELCA,LDL receptor related protein 2,LRP2,endocytosis [GO:0006897],membrane [GO:0016020],calcium ion binding [GO:0005509]
689,A0A2I2UQD4,A0A2I2UQD4_FELCA,TNF receptor superfamily member 11a,TNFRSF11A,,membrane [GO:0016020],
690,A0A2I2UQQ2,A0A2I2UQQ2_FELCA,Eva-1 homolog C,EVA1C,,extracellular region [GO:0005576]; membrane [GO:0016020],carbohydrate binding [GO:0030246]; heparin binding [GO:0008201]
691,A0A2I2UR05,A0A2I2UR05_FELCA,Sepiapterin reductase (EC 1.1.1.153),SPR,nitric oxide biosynthetic process [GO:0006809]; tetrahydrobiopterin biosynthetic process [GO:0006729],cytosol [GO:0005829]; nucleoplasm [GO:0005654],sepiapterin reductase activity [GO:0004757]
692,A0A2I2URA0,A0A2I2URA0_FELCA,Golgi apparatus protein 1,GLG1,,Golgi membrane [GO:0000139]; microtubule organizing center [GO:0005815],
693,A0A2I2URE8,A0A2I2URE8_FELCA,Tropomyosin alpha-1 chain (Alpha-tropomyosin) (Tropomyosin-1),TPM1,,cytoskeleton [GO:0005856],actin binding [GO:0003779]
694,A0A2I2URE9,A0A2I2URE9_FELCA,Protein tyrosine phosphatase receptor type N,PTPRN,,secretory granule [GO:0030141]; synapse [GO:0045202]; transport vesicle membrane [GO:0030658],protein tyrosine phosphatase activity [GO:0004725]
695,A0A2I2URM2,A0A2I2URM2_FELCA,Glutathione S-transferase (EC 2.5.1.18),,xenobiotic metabolic process [GO:0006805],,glutathione transferase activity [GO:0004364]
696,A0A2I2URR0,A0A2I2URR0_FELCA,Protein S100 (S100 calcium-binding protein),S100A6,,nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; S100 protein binding [GO:0044548]
697,A0A2I2USF3,A0A2I2USF3_FELCA,Histone H2B,H2BC17,,nucleosome [GO:0000786]; nucleus [GO:0005634],DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]
698,A0A2I2USG0,A0A2I2USG0_FELCA,Integrin subunit alpha 3,ITGA3,cell adhesion [GO:0007155]; integrin-mediated signaling pathway [GO:0007229],integrin complex [GO:0008305],
699,A0A2I2USJ0,A0A2I2USJ0_FELCA,Vitamin K-dependent protein S,PROS1,fibrinolysis [GO:0042730],extracellular space [GO:0005615],calcium ion binding [GO:0005509]
700,A0A2I2USR5,A0A2I2USR5_FELCA,Insulin-like growth factor-binding protein 3,IGFBP3,apoptotic process [GO:0006915],extracellular region [GO:0005576],insulin-like growth factor binding [GO:0005520]
701,A0A2I2USV9,A0A2I2USV9_FELCA,Receptor tyrosine kinase like orphan receptor 1,ROR1,cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Wnt signaling pathway [GO:0016055],membrane [GO:0016020],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]
702,A0A2I2UTH6,A0A2I2UTH6_FELCA,Nucleobindin 2,NUCB2,,endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794],calcium ion binding [GO:0005509]
703,A0A2I2UTI9,A0A2I2UTI9_FELCA,Adhesion G protein-coupled receptor F5,ADGRF5,cell surface receptor signaling pathway [GO:0007166],plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930]
704,A0A2I2UTP2,A0A2I2UTP2_FELCA,TBC1 domain family member 31,TBC1D31,cilium assembly [GO:0060271],centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064],molecular adaptor activity [GO:0060090]
705,A0A2I2UTP3,A0A2I2UTP3_FELCA,receptor protein-tyrosine kinase (EC 2.7.10.1),EPHA5,,plasma membrane [GO:0005886],ATP binding [GO:0005524]; ephrin receptor activity [GO:0005003]
706,A0A2I2UTS2,A0A2I2UTS2_FELCA,Gelsolin (ADF) (Actin-depolymerizing factor),GSN,actin filament severing [GO:0051014]; barbed-end actin filament capping [GO:0051016]; cilium assembly [GO:0060271],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856],actin filament binding [GO:0051015]
707,A0A2I2UTT3,A0A2I2UTT3_FELCA,Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48),PTPRF,,membrane [GO:0016020],protein tyrosine phosphatase activity [GO:0004725]
708,A0A2I2UTY5,A0A2I2UTY5_FELCA,Nexilin F-actin binding protein,NEXN,axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of cell migration [GO:0030334]; regulation of cytoskeleton organization [GO:0051493],actin cytoskeleton [GO:0015629]; axon [GO:0030424]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; Z disc [GO:0030018],actin filament binding [GO:0051015]; cell-cell adhesion mediator activity [GO:0098632]; structural constituent of muscle [GO:0008307]
709,A0A2I2UUG3,A0A2I2UUG3_FELCA,Tenascin C,TNC,,,
710,A0A2I2UUI4,A0A2I2UUI4_FELCA,Cathepsin L,LOC101086605,immune response [GO:0006955]; positive regulation of apoptotic signaling pathway [GO:2001235]; proteolysis involved in protein catabolic process [GO:0051603],extracellular space [GO:0005615]; lysosome [GO:0005764],cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; cysteine-type endopeptidase activity [GO:0004197]
711,A0A2I2UUP6,A0A2I2UUP6_FELCA,Angiotensinogen (Serpin A8),AGT,regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; vasoconstriction [GO:0042310],extracellular space [GO:0005615],serine-type endopeptidase inhibitor activity [GO:0004867]
712,A0A2I2UUQ5,A0A2I2UUQ5_FELCA,maleylacetoacetate isomerase (EC 5.2.1.2),GSTZ1,glutathione metabolic process [GO:0006749]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572],mitochondrion [GO:0005739],glutathione transferase activity [GO:0004364]; maleylacetoacetate isomerase activity [GO:0016034]
713,A0A2I2UUV9,A0A2I2UUV9_FELCA,"Solute carrier family 25 member 3 (Phosphate carrier protein, mitochondrial) (Phosphate transport protein)",SLC25A3,mitochondrial phosphate ion transmembrane transport [GO:1990547],mitochondrial inner membrane [GO:0005743],phosphate transmembrane transporter activity [GO:0005315]; symporter activity [GO:0015293]
714,A0A2I2UV24,A0A2I2UV24_FELCA,CCN family member 3 (Cellular communication network factor 3),CCN3,,extracellular region [GO:0005576]; gap junction [GO:0005921],growth factor activity [GO:0008083]
715,A0A2I2UV75,A0A2I2UV75_FELCA,Cystatin domain-containing protein,LOC101088567,,cytoplasm [GO:0005737]; extracellular space [GO:0005615]; vesicle [GO:0031982],cysteine-type endopeptidase inhibitor activity [GO:0004869]
716,A0A2I2UVJ9,A0A2I2UVJ9_FELCA,Heterogeneous nuclear ribonucleoproteins A2/B1,HNRNPA2B1,mRNA transport [GO:0051028],nucleus [GO:0005634],RNA binding [GO:0003723]
717,A0A2I2UVP6,A0A2I2UVP6_FELCA,EMAP like 5,EML5,,cytoskeleton [GO:0005856],microtubule binding [GO:0008017]
718,A0A2I2UVX8,A0A2I2UVX8_FELCA,Chloride intracellular channel protein,CLIC5,,chloride channel complex [GO:0034707]; cytoplasm [GO:0005737],chloride channel activity [GO:0005254]
719,A0A2I2UW30,A0A2I2UW30_FELCA,methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9),MTHFD2L,one-carbon metabolic process [GO:0006730],,methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]
720,A0A2I2UWU3,A0A2I2UWU3_FELCA,Protocadherin 17,PCDH17,homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],plasma membrane [GO:0005886],calcium ion binding [GO:0005509]
721,A0A2I2UX36,A0A2I2UX36_FELCA,"Signal peptide, CUB domain and EGF like domain containing 1",SCUBE1,positive regulation of smoothened signaling pathway [GO:0045880]; signal transduction [GO:0007165],cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615],calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]
722,A0A2I2UX74,A0A2I2UX74_FELCA,CD166 antigen (Activated leukocyte cell adhesion molecule),ALCAM,,axon [GO:0030424]; dendrite [GO:0030425]; plasma membrane [GO:0005886],
723,A0A2I2UXE2,A0A2I2UXE2_FELCA,Guanine nucleotide-binding protein subunit gamma,GNG12,G protein-coupled receptor signaling pathway [GO:0007186],heterotrimeric G-protein complex [GO:0005834],G-protein beta-subunit binding [GO:0031681]; PDZ domain binding [GO:0030165]
724,A0A2I2UXF5,A0A2I2UXF5_FELCA,Zinc finger with KRAB and SCAN domains 1,ZKSCAN1,regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"
725,A0A2I2UXF6,A0A2I2UXF6_FELCA,Tubulin beta chain,TUBB2B,microtubule-based process [GO:0007017],cytoplasm [GO:0005737]; microtubule [GO:0005874],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]
726,A0A2I2UXL4,A0A2I2UXL4_FELCA,Globin domain-containing protein,LOC101098159,,hemoglobin complex [GO:0005833],heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]
727,A0A2I2UXP2,A0A2I2UXP2_FELCA,Receptor tyrosine kinase like orphan receptor 2,ROR2,cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Wnt signaling pathway [GO:0016055],membrane [GO:0016020],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]
728,A0A2I2UXR9,A0A2I2UXR9_FELCA,Maltase-glucoamylase,MGAM,carbohydrate metabolic process [GO:0005975],apical plasma membrane [GO:0016324],alpha-glucosidase activity [GO:0090599]; carbohydrate binding [GO:0030246]
729,A0A2I2UXS9,A0A2I2UXS9_FELCA,Prostaglandin E2 receptor EP3 subtype (Prostanoid EP3 receptor),PTGER3,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; inflammatory response [GO:0006954]; intestine smooth muscle contraction [GO:0014827]; negative regulation of gastric acid secretion [GO:0060455]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204],plasma membrane [GO:0005886],prostaglandin E receptor activity [GO:0004957]
730,A0A2I2UXX3,A0A2I2UXX3_FELCA,Latent transforming growth factor beta binding protein 4,LTBP4,hormone secretion [GO:0046879]; transforming growth factor beta receptor signaling pathway [GO:0007179],collagen-containing extracellular matrix [GO:0062023]; microfibril [GO:0001527],calcium ion binding [GO:0005509]; transforming growth factor beta binding [GO:0050431]
731,A0A2I2UY37,A0A2I2UY37_FELCA,"Mannose-6-phosphate receptor, cation dependent",M6PR,protein targeting to lysosome [GO:0006622],endosome [GO:0005768]; Golgi apparatus [GO:0005794]; membrane [GO:0016020],protein domain specific binding [GO:0019904]
732,A0A2I2UYB0,A0A2I2UYB0_FELCA,Lipocalin/cytosolic fatty-acid binding domain-containing protein,LOC101091569,,extracellular space [GO:0005615],small molecule binding [GO:0036094]
733,A0A2I2UYF4,A0A2I2UYF4_FELCA,CD276 molecule,CD276,regulation of cytokine production [GO:0001817]; T cell receptor signaling pathway [GO:0050852],external side of plasma membrane [GO:0009897],signaling receptor binding [GO:0005102]
734,A0A2I2UYG1,A0A2I2UYG1_FELCA,MHC class I antigen,LOC105260551,antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; immune response [GO:0006955],lumenal side of endoplasmic reticulum membrane [GO:0098553]; MHC class I protein complex [GO:0042612]; phagocytic vesicle membrane [GO:0030670],
735,A0A2I2UYJ3,A0A2I2UYJ3_FELCA,Bactericidal permeability-increasing protein (BPI),BPIFC,defense response to Gram-negative bacterium [GO:0050829]; innate immune response [GO:0045087],extracellular space [GO:0005615],lipid binding [GO:0008289]
736,A0A2I2UYP6,A0A2I2UYP6_FELCA,CD177 molecule,CD177,cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction maintenance [GO:0045217]; leukocyte cell-cell adhesion [GO:0007159]; positive regulation of neutrophil degranulation [GO:0043315]; regulation of integrin-mediated signaling pathway [GO:2001044],plasma membrane raft [GO:0044853],
737,A0A2I2UZG1,A0A2I2UZG1_FELCA,L-lactate dehydrogenase (EC 1.1.1.27),LDHA,carboxylic acid metabolic process [GO:0019752],cytoplasm [GO:0005737],L-lactate dehydrogenase activity [GO:0004459]
738,A0A2I2UZT1,A0A2I2UZT1_FELCA,Protein shisa-5 (Scotin),SHISA5,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771],endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nuclear envelope [GO:0005635],
739,A0A2I2V0L4,A0A2I2V0L4_FELCA,BAR/IMD domain-containing adapter protein 2 (Brain-specific angiogenesis inhibitor 1-associated protein 2),BAIAP2,plasma membrane organization [GO:0007009]; regulation of actin cytoskeleton organization [GO:0032956],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; filopodium [GO:0030175]; membrane [GO:0016020]; ruffle [GO:0001726],cytoskeletal anchor activity [GO:0008093]
740,A0A2I2V0W1,A0A2I2V0W1_FELCA,"Thioredoxin reductase 1, cytoplasmic (EC 1.11.1.2) (EC 1.8.1.9) (Peroxidase TXNRD1) (Thioredoxin reductase TR1)",TXNRD1,cell redox homeostasis [GO:0045454],,flavin adenine dinucleotide binding [GO:0050660]; thioredoxin-disulfide reductase (NADPH) activity [GO:0004791]
741,A0A2I2V193,A0A2I2V193_FELCA,Mannose receptor C-type 1,MRC1,endocytosis [GO:0006897],membrane [GO:0016020],carbohydrate binding [GO:0030246]
742,A0A2I2V1K5,A0A2I2V1K5_FELCA,Voltage-dependent anion-selective channel protein 3,VDAC3,,mitochondrial outer membrane [GO:0005741]; pore complex [GO:0046930],porin activity [GO:0015288]; voltage-gated monoatomic anion channel activity [GO:0008308]
743,A0A2I2V287,A0A2I2V287_FELCA,Cathepsin L1-like,LOC111559124,immune response [GO:0006955]; positive regulation of apoptotic signaling pathway [GO:2001235]; proteolysis involved in protein catabolic process [GO:0051603],extracellular space [GO:0005615],cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; cysteine-type endopeptidase activity [GO:0004197]
744,A0A2I2V2A4,A0A2I2V2A4_FELCA,Talin 1,TLN1,cell adhesion [GO:0007155],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; ruffle [GO:0001726],actin filament binding [GO:0051015]; structural constituent of cytoskeleton [GO:0005200]
745,A0A2I2V2Q8,A0A2I2V2Q8_FELCA,protein disulfide-isomerase (EC 5.3.4.1),TXNDC5,protein folding [GO:0006457],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788],protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035]
746,A0A2I2V3I6,A0A2I2V3I6_FELCA,Rho-related GTP-binding protein RhoC,PPM1J,small GTPase-mediated signal transduction [GO:0007264],membrane [GO:0016020],GTP binding [GO:0005525]; GTPase activity [GO:0003924]
747,A0A2I2V3V6,A0A2I2V3V6_FELCA,Lactotransferrin,LTF,immune system process [GO:0002376]; ossification [GO:0001503]; proteolysis [GO:0006508],extracellular space [GO:0005615],serine-type peptidase activity [GO:0008236]
748,A0A2I2V460,A0A2I2V460_FELCA,Trans-golgi network protein 2,,,endosome [GO:0005768]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140],
749,A0A2I2V4D2,A0A2I2V4D2_FELCA,Leucine rich repeat neuronal 4,LRRN4,long-term memory [GO:0007616]; visual learning [GO:0008542],plasma membrane [GO:0005886],
750,A0A2I2V4L0,A0A2I2V4L0_FELCA,Regucalcin (EC 3.1.1.17) (Gluconolactonase) (Senescence marker protein 30),RGN,,cytoplasm [GO:0005737],calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]
751,A0A2I2V4V9,A0A2I2V4V9_FELCA,Endothelial cell adhesion molecule,ESAM,bicellular tight junction assembly [GO:0070830]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; protein localization [GO:0008104]; regulation of actin filament polymerization [GO:0030833],adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],cell-cell adhesion mediator activity [GO:0098632]
752,A0A2I2V5E5,A0A2I2V5E5_FELCA,Glutathione peroxidase,GPX3,hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979],extracellular space [GO:0005615],glutathione peroxidase activity [GO:0004602]; identical protein binding [GO:0042802]; selenium binding [GO:0008430]
753,A0A2I2V5H4,A0A2I2V5H4_FELCA,Enolase 4 (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase),ENO4,glycolytic process [GO:0006096],phosphopyruvate hydratase complex [GO:0000015],magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]
754,A0A337RU81,A0A337RU81_FELCA,Thioredoxin,TXN,,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; nucleus [GO:0005634],protein-disulfide reductase activity [GO:0015035]
755,A0A337RUC4,A0A337RUC4_FELCA,receptor protein serine/threonine kinase (EC 2.7.11.30),ACVR1B,,membrane [GO:0016020],ATP binding [GO:0005524]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]
756,A0A337RV46,A0A337RV46_FELCA,N-acyl-aliphatic-L-amino acid amidohydrolase (EC 3.5.1.14) (N-acyl-L-amino-acid amidohydrolase),ACY1,amino acid metabolic process [GO:0006520],cytoplasm [GO:0005737],aminoacylase activity [GO:0004046]; metal ion binding [GO:0046872]
757,A0A337RVW7,A0A337RVW7_FELCA,Semaphorin 5A,SEMA5A,cell differentiation [GO:0030154]; nervous system development [GO:0007399],membrane [GO:0016020],semaphorin receptor binding [GO:0030215]
758,A0A337RW59,A0A337RW59_FELCA,Collagen type VI alpha 3 chain,COL6A3,cell adhesion [GO:0007155],collagen trimer [GO:0005581]; extracellular region [GO:0005576],serine-type endopeptidase inhibitor activity [GO:0004867]
759,A0A337RWN1,A0A337RWN1_FELCA,aldehyde dehydrogenase (NAD(+)) (EC 1.2.1.3),ALDH7A1,,,aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]
760,A0A337RWP8,A0A337RWP8_FELCA,Ly-6/neurotoxin-like protein 1,LOC101087710,,dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886]; side of membrane [GO:0098552],
761,A0A337RWW9,A0A337RWW9_FELCA,MIA SH3 domain ER export factor 3,MIA3,,endoplasmic reticulum membrane [GO:0005789],
762,A0A337RXE3,A0A337RXE3_FELCA,Putative protein-lysine deacylase ABHD14B (Alpha/beta hydrolase domain-containing protein 14B),ABHD14B,positive regulation of transcription by RNA polymerase II [GO:0045944],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],acyltransferase activity [GO:0016746]; hydrolase activity [GO:0016787]
763,A0A337RXE8,A0A337RXE8_FELCA,Heat shock protein family A (Hsp70) member 1B,,chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein refolding [GO:0042026],centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; heat shock protein binding [GO:0031072]; protein folding chaperone [GO:0044183]
764,A0A337RXI4,A0A337RXI4_FELCA,SH2B adaptor protein 1,SH2B1,cell motility [GO:0048870]; intracellular signal transduction [GO:0035556]; lamellipodium assembly [GO:0030032]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of SMAD protein signal transduction [GO:0060391]; regulation of DNA biosynthetic process [GO:2000278],plasma membrane [GO:0005886],transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]
765,A0A337RY68,A0A337RY68_FELCA,Scavenger receptor class B member 2,SCARB2,,lysosome [GO:0005764]; membrane [GO:0016020],scavenger receptor activity [GO:0005044]
766,A0A337RY95,A0A337RY95_FELCA,protein-tyrosine-phosphatase (EC 3.1.3.48),PTPRK,,membrane [GO:0016020],protein tyrosine phosphatase activity [GO:0004725]
767,A0A337RYI0,A0A337RYI0_FELCA,Pyruvate kinase (EC 2.7.1.40),PKM,,,ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]
768,A0A337RYK1,A0A337RYK1_FELCA,Laminin subunit gamma 2,LAMC2,,basement membrane [GO:0005604]; extracellular region [GO:0005576],
769,A0A337RYL8,A0A337RYL8_FELCA,"SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3",SPOCK3,,,calcium ion binding [GO:0005509]
770,A0A337RZ36,A0A337RZ36_FELCA,Potassium channel tetramerization domain containing 12,KCTD12,protein homooligomerization [GO:0051260]; regulation of G protein-coupled receptor signaling pathway [GO:0008277],postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; receptor complex [GO:0043235],identical protein binding [GO:0042802]
771,A0A337RZ59,A0A337RZ59_FELCA,Eukaryotic translation initiation factor 5A-1 (Eukaryotic initiation factor 5A isoform 1) (eIF-4D),EIF5A,positive regulation of apoptotic process [GO:0043065]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; translational elongation [GO:0006414],endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; synapse [GO:0045202],ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]
772,A0A337RZ83,A0A337RZ83_FELCA,FAM20C golgi associated secretory pathway kinase,FAM20C,,,ATP binding [GO:0005524]; metal ion binding [GO:0046872]
773,A0A337S0D5,A0A337S0D5_FELCA,"Legumain (EC 3.4.22.34) (Protease, cysteine 1)",LGMN,proteolysis involved in protein catabolic process [GO:0051603],,cysteine-type endopeptidase activity [GO:0004197]
774,A0A337S0P1,A0A337S0P1_FELCA,phosphopyruvate hydratase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase),ENO1,glycolytic process [GO:0006096],phosphopyruvate hydratase complex [GO:0000015],magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]
775,A0A337S0Q6,A0A337S0Q6_FELCA,Decorin (Bone proteoglycan II),DCN,,extracellular region [GO:0005576],
776,A0A337S0Q7,A0A337S0Q7_FELCA,Transmembrane protein 123,TMEM123,,cytoplasmic vesicle [GO:0031410]; membrane [GO:0016020],
777,A0A337S130,A0A337S130_FELCA,Follistatin-related protein 1 (Follistatin-like protein 1),FSTL1,cell differentiation [GO:0030154]; endothelial cell differentiation [GO:0045446]; endothelial cell migration [GO:0043542]; hematopoietic stem cell homeostasis [GO:0061484]; negative regulation of apoptotic process [GO:0043066]; regulation of BMP signaling pathway [GO:0030510],extracellular region [GO:0005576],calcium ion binding [GO:0005509]; heparin binding [GO:0008201]
778,A0A337S137,A0A337S137_FELCA,Annexin,ANXA4,,zymogen granule membrane [GO:0042589],calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]
779,A0A337S164,A0A337S164_FELCA,Fibulin-5,FBLN5,,,calcium ion binding [GO:0005509]
780,A0A337S165,A0A337S165_FELCA,Lysosomal acid phosphatase (EC 3.1.3.2),ACP2,,lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765],
781,A0A337S1D0,A0A337S1D0_FELCA,Vesicle trafficking 1,VTA1,late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; protein transport [GO:0015031],endosome membrane [GO:0010008],
782,A0A337S1P2,A0A337S1P2_FELCA,Leucine rich alpha-2-glycoprotein 1,LRG1,"brown fat cell differentiation [GO:0050873]; keratinocyte migration [GO:0051546]; leukocyte adhesion to vascular endothelial cell [GO:0061756]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; response to bacterium [GO:0009617]; wound healing, spreading of epidermal cells [GO:0035313]",extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231],type I transforming growth factor beta receptor binding [GO:0034713]; type II transforming growth factor beta receptor binding [GO:0005114]
783,A0A337S1R3,A0A337S1R3_FELCA,Prothymosin alpha,PTMA,negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],DNA-binding transcription factor binding [GO:0140297]; histone binding [GO:0042393]
784,A0A337S1S7,A0A337S1S7_FELCA,Protein kinase C-binding protein NELL2 (NEL-like protein 2),NELL2,,,calcium ion binding [GO:0005509]
785,A0A337S1U9,A0A337S1U9_FELCA,Ribonuclease T2,RNASET2,RNA catabolic process [GO:0006401],endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202],ribonuclease T2 activity [GO:0033897]; RNA binding [GO:0003723]; RNA endonuclease activity [GO:0004521]
786,A0A337S1V9,A0A337S1V9_FELCA,Phosphoinositide-3-kinase-interacting protein 1 (Kringle domain-containing protein HGFL),PIK3IP1,,plasma membrane [GO:0005886],
787,A0A337S1Z7,A0A337S1Z7_FELCA,Protein tweety homolog,TTYH3,,chloride channel complex [GO:0034707],chloride channel activity [GO:0005254]
788,A0A337S209,A0A337S209_FELCA,receptor protein-tyrosine kinase (EC 2.7.10.1),TIE1,,membrane [GO:0016020],ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]
789,A0A337S2A4,A0A337S2A4_FELCA,Cartilage oligomeric matrix protein,COMP,cell adhesion [GO:0007155],extracellular region [GO:0005576],calcium ion binding [GO:0005509]
790,A0A337S2C9,A0A337S2C9_FELCA,Ig-like domain-containing protein,CEACAM1,regulation of immune system process [GO:0002682]; signal transduction [GO:0007165],cell surface [GO:0009986]; plasma membrane [GO:0005886],protein tyrosine kinase binding [GO:1990782]
791,A0A337S2P7,A0A337S2P7_FELCA,RAB11 family interacting protein 5,RAB11FIP5,protein transport [GO:0015031]; regulated exocytosis [GO:0045055],centriolar satellite [GO:0034451]; early endosome [GO:0005769]; membrane [GO:0016020]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; secretory granule [GO:0030141],small GTPase binding [GO:0031267]
792,A0A337S2X4,A0A337S2X4_FELCA,Histone H2A,H2AC14,heterochromatin formation [GO:0031507],nucleosome [GO:0000786]; nucleus [GO:0005634],nucleosomal DNA binding [GO:0031492]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]
793,A0A337S307,A0A337S307_FELCA,E2 ubiquitin-conjugating enzyme (EC 2.3.2.23),UBE2L3,,,ATP binding [GO:0005524]; transferase activity [GO:0016740]
794,A0A337S319,A0A337S319_FELCA,2-amino-3-carboxymuconate-6-semialdehyde decarboxylase (EC 4.1.1.45) (Picolinate carboxylase),ACMSD,negative regulation of quinolinate biosynthetic process [GO:1904985]; organic cyclic compound metabolic process [GO:1901360],cytosol [GO:0005829],aminocarboxymuconate-semialdehyde decarboxylase activity [GO:0001760]; hydrolase activity [GO:0016787]
795,A0A337S356,A0A337S356_FELCA,Ephrin-A1,EFNA1,ephrin receptor signaling pathway [GO:0048013],plasma membrane [GO:0005886]; side of membrane [GO:0098552],ephrin receptor binding [GO:0046875]
796,A0A337S396,A0A337S396_FELCA,Monoamine oxidase B,MAOB,,mitochondrial outer membrane [GO:0005741],oxidoreductase activity [GO:0016491]
797,A0A337S3N8,A0A337S3N8_FELCA,Selenoprotein F,SELENOF,,endoplasmic reticulum lumen [GO:0005788],oxidoreductase activity [GO:0016491]
798,A0A337S3Q0,A0A337S3Q0_FELCA,Myosin light chain kinase,MYLK,muscle structure development [GO:0061061],,ATP binding [GO:0005524]; protein kinase activity [GO:0004672]
799,A0A337S3Q9,A0A337S3Q9_FELCA,Midkine (MK),MDK,positive regulation of cell division [GO:0051781],extracellular region [GO:0005576],growth factor activity [GO:0008083]; heparin binding [GO:0008201]
800,A0A337S3R0,A0A337S3R0_FELCA,Sushi domain-containing protein,,complement activation [GO:0006956],extracellular space [GO:0005615],complement component C3b binding [GO:0001851]
801,A0A337S3S3,A0A337S3S3_FELCA,TNF superfamily member 13b,TNFSF13B,immune response [GO:0006955],extracellular region [GO:0005576]; membrane [GO:0016020],tumor necrosis factor receptor binding [GO:0005164]
802,A0A337S3Y7,A0A337S3Y7_FELCA,Uroplakin-1b (Uroplakin Ib),UPK1B,epithelial cell differentiation [GO:0030855]; response to bacterium [GO:0009617],apical plasma membrane urothelial plaque [GO:0120001],
803,A0A337S416,A0A337S416_FELCA,Fructose-bisphosphate aldolase (EC 4.1.2.13),ALDOA,glycolytic process [GO:0006096],I band [GO:0031674]; M band [GO:0031430],fructose-bisphosphate aldolase activity [GO:0004332]
804,A0A337S4F4,A0A337S4F4_FELCA,Semaphorin 5A,SEMA5A,axon extension [GO:0048675]; axon guidance [GO:0007411]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526],plasma membrane [GO:0005886],chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]
805,A0A337S4H2,A0A337S4H2_FELCA,Neural cell adhesion molecule 1,NCAM1,cell adhesion [GO:0007155],membrane [GO:0016020],
806,A0A337S4I1,A0A337S4I1_FELCA,Alpha-L-fucosidase 1,FUCA1,fucose metabolic process [GO:0006004],,alpha-L-fucosidase activity [GO:0004560]; hydroxymethylglutaryl-CoA lyase activity [GO:0004419]
807,A0A337S4N5,A0A337S4N5_FELCA,Tumor necrosis factor receptor superfamily member 5 (B-cell surface antigen CD40) (CD40L receptor),CD40,B cell activation [GO:0042113]; regulation of immune response [GO:0050776],external side of plasma membrane [GO:0009897],signaling receptor activity [GO:0038023]
808,A0A337S4V9,A0A337S4V9_FELCA,Collagen type VI alpha 3 chain,COL6A3,cell adhesion [GO:0007155],collagen trimer [GO:0005581]; extracellular region [GO:0005576],serine-type endopeptidase inhibitor activity [GO:0004867]
809,A0A337S566,A0A337S566_FELCA,CCN family member 2 (Cellular communication network factor 2) (Connective tissue growth factor),CCN2,DNA biosynthetic process [GO:0071897]; signal transduction [GO:0007165],extracellular region [GO:0005576],
810,A0A337S574,A0A337S574_FELCA,Histone H2A/H2B/H3 domain-containing protein,,,nucleosome [GO:0000786],DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]
811,A0A337S5C0,A0A337S5C0_FELCA,Annexin,ANXA5,negative regulation of coagulation [GO:0050819],,calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]
812,A0A337S5C8,A0A337S5C8_FELCA,Proteasome subunit alpha type,PSMA4,ubiquitin-dependent protein catabolic process [GO:0006511],"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex, alpha-subunit complex [GO:0019773]",
813,A0A337S5F4,A0A337S5F4_FELCA,protein-tyrosine-phosphatase (EC 3.1.3.48),PTPRG,,membrane [GO:0016020],protein tyrosine phosphatase activity [GO:0004725]
814,A0A337S5J7,A0A337S5J7_FELCA,Reticulon 4 receptor like 2,RTN4RL2,,external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615],signaling receptor activity [GO:0038023]
815,A0A337S5T6,A0A337S5T6_FELCA,Sarcalumenin,SRL,response to muscle activity involved in regulation of muscle adaptation [GO:0014873]; store-operated calcium entry [GO:0002115],membrane [GO:0016020],GTP binding [GO:0005525]
816,A0A337S649,A0A337S649_FELCA,Syndecan,SDC2,,membrane [GO:0016020],
817,A0A337S672,A0A337S672_FELCA,Butyrophilin-like protein 1,,extrathymic T cell selection [GO:0045062]; regulation of cytokine production [GO:0001817]; T cell receptor signaling pathway [GO:0050852],external side of plasma membrane [GO:0009897],signaling receptor binding [GO:0005102]
818,A0A337S693,A0A337S693_FELCA,Small integral membrane protein 22,SMIM22,lipid droplet formation [GO:0140042]; positive regulation of cell migration [GO:0030335]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127],membrane [GO:0016020],
819,A0A337S6M3,A0A337S6M3_FELCA,protein-tyrosine-phosphatase (EC 3.1.3.48),PTPRO,,membrane [GO:0016020],protein tyrosine phosphatase activity [GO:0004725]
820,A0A337S6P4,A0A337S6P4_FELCA,Exostosin like glycosyltransferase 2,EXTL2,N-acetylglucosamine metabolic process [GO:0006044]; UDP-N-acetylgalactosamine metabolic process [GO:0019276],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleoplasm [GO:0005654],"alpha-1,4-N-acetylgalactosaminyltransferase activity [GO:0035248]; glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0001888]; glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047237]; glycosaminoglycan binding [GO:0005539]; manganese ion binding [GO:0030145]"
821,A0A337S6Z7,A0A337S6Z7_FELCA,Dentin matrix acidic phosphoprotein 1,DMP1,extracellular matrix organization [GO:0030198]; ossification [GO:0001503]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of enamel mineralization [GO:0070173],cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; nucleus [GO:0005634],extracellular matrix binding [GO:0050840]
822,A0A337S703,A0A337S703_FELCA,Shisa family member 2,SHISA2,negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of Wnt signaling pathway [GO:0030178],endoplasmic reticulum [GO:0005783]; membrane [GO:0016020],
823,A0A337S713,A0A337S713_FELCA,RCAN family member 3,RCAN3,regulation of myelination [GO:0031641],paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; Schmidt-Lanterman incisure [GO:0043220],structural constituent of myelin sheath [GO:0019911]
824,A0A337S723,A0A337S723_FELCA,Histone H4,,nucleosome assembly [GO:0006334],nucleosome [GO:0000786]; nucleus [GO:0005634],DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]
825,A0A337S736,A0A337S736_FELCA,T-complex protein 1 subunit delta,CCT4,,chaperonin-containing T-complex [GO:0005832],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; unfolded protein binding [GO:0051082]
826,A0A337S764,A0A337S764_FELCA,Neuronal membrane glycoprotein M6-a,GPM6A,,dendritic spine [GO:0043197]; filopodium [GO:0030175]; membrane [GO:0016020],
827,A0A337S785,A0A337S785_FELCA,"Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase (EC 1.1.1.179) (EC 1.3.1.20) (D-xylose 1-dehydrogenase) (D-xylose-NADP dehydrogenase) (Dimeric dihydrodiol dehydrogenase)",DHDH,D-xylose catabolic process [GO:0042843],,D-xylose 1-dehydrogenase (NADP+) activity [GO:0047837]; nucleotide binding [GO:0000166]
828,A0A337S7D7,A0A337S7D7_FELCA,F-actin-capping protein subunit beta,CAPZB,actin cytoskeleton organization [GO:0030036]; barbed-end actin filament capping [GO:0051016],cytoplasm [GO:0005737]; F-actin capping protein complex [GO:0008290],actin binding [GO:0003779]
829,A0A337S7U4,A0A337S7U4_FELCA,Ig-like domain-containing protein,,,membrane [GO:0016020],
830,A0A337S803,A0A337S803_FELCA,Ovostatin homolog 2-like,LOC101081475,,extracellular space [GO:0005615],serine-type endopeptidase inhibitor activity [GO:0004867]
831,A0A337S837,A0A337S837_FELCA,Apolipoprotein A-I (Apolipoprotein A1),APOA1,cholesterol metabolic process [GO:0008203]; lipid transport [GO:0006869]; lipoprotein metabolic process [GO:0042157],high-density lipoprotein particle [GO:0034364],lipid binding [GO:0008289]
832,A0A337S8E4,A0A337S8E4_FELCA,Latent transforming growth factor beta binding protein 1,LTBP1,sequestering of TGFbeta in extracellular matrix [GO:0035583],collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; microfibril [GO:0001527]; protein-containing complex [GO:0032991],calcium ion binding [GO:0005509]; microfibril binding [GO:0050436]; transforming growth factor beta binding [GO:0050431]
833,A0A337S8H7,A0A337S8H7_FELCA,Matrix remodeling-associated protein 8,MXRA8,cell adhesion [GO:0007155],plasma membrane [GO:0005886],
834,A0A337S8L1,A0A337S8L1_FELCA,L-lactate dehydrogenase (EC 1.1.1.27),LDHA,lactate metabolic process [GO:0006089]; pyruvate metabolic process [GO:0006090],mitochondrion [GO:0005739],L-lactate dehydrogenase activity [GO:0004459]
835,A0A337S8X8,A0A337S8X8_FELCA,AHNAK nucleoprotein,,regulation of RNA splicing [GO:0043484],costamere [GO:0043034]; cytoplasm [GO:0005737]; nucleus [GO:0005634],
836,A0A337S915,A0A337S915_FELCA,Rab GDP dissociation inhibitor,GDI2,protein transport [GO:0015031]; small GTPase-mediated signal transduction [GO:0007264],cytoplasm [GO:0005737]; membrane [GO:0016020],GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]
837,A0A337S935,A0A337S935_FELCA,Bromodomain and WD repeat domain containing 1,BRWD1,cytoskeleton organization [GO:0007010]; regulation of cell shape [GO:0008360]; regulation of transcription by RNA polymerase II [GO:0006357],axoneme [GO:0005930]; cytosol [GO:0005829]; motile cilium [GO:0031514]; nucleolus [GO:0005730]; nucleus [GO:0005634],
838,A0A337S9F6,A0A337S9F6_FELCA,Neurexin 3,NRXN3,,presynaptic membrane [GO:0042734],
839,A0A337S9H7,A0A337S9H7_FELCA,Cadherin-6,CDH6,homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],plasma membrane [GO:0005886],calcium ion binding [GO:0005509]
840,A0A337S9J3,A0A337S9J3_FELCA,CD99 antigen-like protein 2,CD99L2,diapedesis [GO:0050904]; positive regulation of neutrophil extravasation [GO:2000391]; positive regulation of T cell extravasation [GO:2000409],adherens junction [GO:0005912]; cell surface [GO:0009986]; plasma membrane [GO:0005886],
841,A0A337S9Q3,A0A337S9Q3_FELCA,Cadherin 16,CDH16,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]
842,A0A337SA21,A0A337SA21_FELCA,Ig-like domain-containing protein,,immunoglobulin mediated immune response [GO:0016064]; nucleosome assembly [GO:0006334],immunoglobulin complex [GO:0019814]; nucleosome [GO:0000786],antigen binding [GO:0003823]; DNA binding [GO:0003677]; structural constituent of chromatin [GO:0030527]
843,A0A337SA37,A0A337SA37_FELCA,Phospholipid scramblase,,,membrane [GO:0016020],phospholipid scramblase activity [GO:0017128]
844,A0A337SA71,A0A337SA71_FELCA,Selenoprotein P N-terminal domain-containing protein,,selenium compound metabolic process [GO:0001887],extracellular region [GO:0005576]; membrane [GO:0016020],selenium binding [GO:0008430]
845,A0A337SAA4,A0A337SAA4_FELCA,Hyaluronidase (EC 3.2.1.35),HYAL2,carbohydrate metabolic process [GO:0005975],plasma membrane [GO:0005886],hyalurononglucosaminidase activity [GO:0004415]
846,A0A337SAA6,A0A337SAA6_FELCA,Lysosomal acid phosphatase (EC 3.1.3.2),ACP2,lysosome organization [GO:0007040],lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764],acid phosphatase activity [GO:0003993]
847,A0A337SAB7,A0A337SAB7_FELCA,Sodium/mannose cotransporter SLC5A10 (Sodium/glucose cotransporter 5) (Solute carrier family 5 member 10),SLC5A10,,apical plasma membrane [GO:0016324]; plasma membrane [GO:0005886],fructose:sodium symporter activity [GO:0140930]; glucose:sodium symporter activity [GO:0005412]; mannose:sodium symporter activity [GO:0140929]
848,A0A337SB41,A0A337SB41_FELCA,Folate hydrolase 1,FOLH1,proteolysis [GO:0006508],cell surface [GO:0009986]; plasma membrane [GO:0005886],Ac-Asp-Glu binding [GO:1904492]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; tetrahydrofolyl-poly(glutamate) polymer binding [GO:1904493]
849,A0A337SBE3,A0A337SBE3_FELCA,Protein amnionless,AMN,protein transport [GO:0015031],plasma membrane [GO:0005886],
850,A0A337SBJ0,A0A337SBJ0_FELCA,Annexin,ANXA5,negative regulation of coagulation [GO:0050819],,calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]
851,A0A337SBN3,A0A337SBN3_FELCA,Ephrin A4,EFNA4,axon guidance [GO:0007411]; ephrin receptor signaling pathway [GO:0048013],plasma membrane [GO:0005886]; side of membrane [GO:0098552],ephrin receptor binding [GO:0046875]
852,A0A337SBP5,A0A337SBP5_FELCA,Sarcoglycan alpha,SGCA,,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; sarcoglycan complex [GO:0016012],calcium ion binding [GO:0005509]
853,A0A337SBR8,A0A337SBR8_FELCA,Protein tyrosine kinase 7 (inactive),PTK7,,membrane [GO:0016020],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]
854,A0A337SBU9,A0A337SBU9_FELCA,Tetraspanin,CD82,,membrane [GO:0016020],
855,A0A337SC15,A0A337SC15_FELCA,N-acyl-aliphatic-L-amino acid amidohydrolase (EC 3.5.1.14) (N-acyl-L-amino-acid amidohydrolase),ACY1,amino acid metabolic process [GO:0006520],cytoplasm [GO:0005737]; extracellular exosome [GO:0070062],aminoacylase activity [GO:0004046]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]
856,A0A337SCH1,A0A337SCH1_FELCA,Amyloid beta protein binding family B member 1,APBB1 HPX,,,amyloid-beta binding [GO:0001540]
857,A0A337SCH3,A0A337SCH3_FELCA,WAP four-disulfide core domain protein 2,WFDC2,,extracellular region [GO:0005576],aspartic-type endopeptidase inhibitor activity [GO:0019828]; cysteine-type endopeptidase inhibitor activity [GO:0004869]
858,A0A337SCP9,A0A337SCP9_FELCA,IF rod domain-containing protein,KRT13,epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109]; regulation of translation in response to stress [GO:0043555],cytoskeleton [GO:0005856]; keratin filament [GO:0045095],structural molecule activity [GO:0005198]
859,A0A337SCS7,A0A337SCS7_FELCA,Nidogen 1,NID1,cell-matrix adhesion [GO:0007160],basement membrane [GO:0005604]; extracellular region [GO:0005576]; membrane [GO:0016020],
860,A0A337SCW1,A0A337SCW1_FELCA,"Actin, gamma-enteric smooth muscle (Gamma-2-actin) (Smooth muscle gamma-actin)",ACTG2,,cytoskeleton [GO:0005856],
861,A0A337SCW7,A0A337SCW7_FELCA,EGF containing fibulin extracellular matrix protein 2,EFEMP2,elastic fiber assembly [GO:0048251]; positive regulation of smooth muscle cell-matrix adhesion [GO:1905609],elastic fiber [GO:0071953],calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; protein homodimerization activity [GO:0042803]
862,A0A337SD26,A0A337SD26_FELCA,Proteasome subunit alpha type,PSMA3,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex, alpha-subunit complex [GO:0019773]; synapse [GO:0045202]",ubiquitin protein ligase binding [GO:0031625]
863,A0A337SD37,A0A337SD37_FELCA,Alpha-2-HS-glycoprotein (Fetuin-A),AHSG,,extracellular region [GO:0005576],cysteine-type endopeptidase inhibitor activity [GO:0004869]
864,A0A337SD81,A0A337SD81_FELCA,GDNF family receptor alpha 1,GFRA1,nervous system development [GO:0007399],external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235],glial cell-derived neurotrophic factor receptor activity [GO:0016167]; signaling receptor activity [GO:0038023]
865,A0A337SDR6,A0A337SDR6_FELCA,Protein S100-A11 (Calgizzarin) (S100 calcium-binding protein A11),,regulation of cell population proliferation [GO:0042127],cytoplasm [GO:0005737]; extracellular space [GO:0005615],calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; S100 protein binding [GO:0044548]
866,A0A337SDS2,A0A337SDS2_FELCA,ABI family member 3 binding protein,ABI3BP,extracellular matrix organization [GO:0030198]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of connective tissue replacement involved in inflammatory response wound healing [GO:1904597]; positive regulation of cardiocyte differentiation [GO:1905209]; positive regulation of cell-substrate adhesion [GO:0010811],collagen-containing extracellular matrix [GO:0062023]; interstitial matrix [GO:0005614],collagen binding [GO:0005518]; heparin binding [GO:0008201]
867,A0A337SDW1,A0A337SDW1_FELCA,LINE1 type transposase domain containing 1,L1TD1,retrotransposition [GO:0032197],intracellular membrane-bounded organelle [GO:0043231]; ribonucleoprotein complex [GO:1990904],single-stranded RNA binding [GO:0003727]
868,A0A337SE00,A0A337SE00_FELCA,C-X-C motif chemokine,LOC101094096,antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; defense response to protozoan [GO:0042832]; inflammatory response [GO:0006954]; neutrophil chemotaxis [GO:0030593],extracellular space [GO:0005615],chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]; heparin binding [GO:0008201]
869,A0A337SE59,A0A337SE59_FELCA,"Keratin, type I cytoskeletal 19 (Cytokeratin-19) (Keratin-19)",,epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109],cytoskeleton [GO:0005856]; intermediate filament [GO:0005882],structural molecule activity [GO:0005198]
870,A0A337SE70,A0A337SE70_FELCA,receptor protein-tyrosine kinase (EC 2.7.10.1),DDR1,collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063],membrane [GO:0016020],ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]
871,A0A337SEF0,A0A337SEF0_FELCA,Cofilin-2,CFL2,actin filament fragmentation [GO:0030043]; actin filament severing [GO:0051014],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737],actin filament binding [GO:0051015]
872,A0A337SEH4,A0A337SEH4_FELCA,"Keratin, type II cytoskeletal 8 (Cytokeratin-8) (Keratin-8)",,,cytoplasm [GO:0005737]; intermediate filament [GO:0005882]; nuclear matrix [GO:0016363],
873,A0A337SEH6,A0A337SEH6_FELCA,"Carboxypeptidase X, M14 family member 2",CPXM2,proteolysis [GO:0006508],extracellular region [GO:0005576],metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]
874,A0A337SEI8,A0A337SEI8_FELCA,"10 kDa heat shock protein, mitochondrial (10 kDa chaperonin) (Chaperonin 10)",HSPE1,chaperone cofactor-dependent protein refolding [GO:0051085],mitochondrial matrix [GO:0005759],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein folding chaperone [GO:0044183]; protein-folding chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]
875,A0A337SES4,A0A337SES4_FELCA,Ribonuclease 4,RNASE4,,extracellular region [GO:0005576],endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]
876,A0A337SEU6,A0A337SEU6_FELCA,Inter-alpha-trypsin inhibitor heavy chain H3,ITIH3,hyaluronan metabolic process [GO:0030212],extracellular region [GO:0005576],serine-type endopeptidase inhibitor activity [GO:0004867]
877,A0A337SEZ4,A0A337SEZ4_FELCA,Angiopoietin-2,ANGPT2,angiogenesis [GO:0001525]; cell differentiation [GO:0030154],extracellular region [GO:0005576],metal ion binding [GO:0046872]
878,A0A337SF46,A0A337SF46_FELCA,Lipocalin/cytosolic fatty-acid binding domain-containing protein,LOC111556219,,extracellular space [GO:0005615],small molecule binding [GO:0036094]
879,A0A337SF63,A0A337SF63_FELCA,Piezo type mechanosensitive ion channel component 2,PIEZO2,,plasma membrane [GO:0005886],mechanosensitive monoatomic ion channel activity [GO:0008381]
880,A0A337SF88,A0A337SF88_FELCA,Annexin,ANXA6,,zymogen granule membrane [GO:0042589],calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]
881,A0A337SFI6,A0A337SFI6_FELCA,Elongation factor like GTPase 1,EFL1,cytosolic ribosome assembly [GO:0042256]; GTP metabolic process [GO:0046039],cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]
882,A0A337SFJ9,A0A337SFJ9_FELCA,Chromogranin-A,CHGA,,extracellular region [GO:0005576]; secretory granule [GO:0030141]; transport vesicle [GO:0030133],
883,A0A337SFP3,A0A337SFP3_FELCA,Ras-related protein Rab-7a,RAB7A,,autophagosome membrane [GO:0000421]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome membrane [GO:0033162]; mitochondrial membrane [GO:0031966]; phagocytic vesicle membrane [GO:0030670],GTP binding [GO:0005525]; GTPase activity [GO:0003924]
884,A0A337SFV1,A0A337SFV1_FELCA,Sex hormone-binding globulin,SHBG,,extracellular region [GO:0005576],steroid binding [GO:0005496]
885,A0A337SFW4,A0A337SFW4_FELCA,Ig-like domain-containing protein,,regulation of immune system process [GO:0002682]; signal transduction [GO:0007165],cell surface [GO:0009986]; plasma membrane [GO:0005886],protein tyrosine kinase binding [GO:1990782]
886,A0A337SGE0,A0A337SGE0_FELCA,Chondrolectin,CHODL,positive regulation of axonogenesis [GO:0050772],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471],
887,A0A337SGM0,A0A337SGM0_FELCA,Metal transporter,CNNM4 CNNM3,magnesium ion homeostasis [GO:0010960],plasma membrane [GO:0005886],transmembrane transporter activity [GO:0022857]
888,A0A337SGU2,A0A337SGU2_FELCA,Cadherin-4,CDH4,homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],plasma membrane [GO:0005886],calcium ion binding [GO:0005509]
889,A0A337SH59,A0A337SH59_FELCA,Matrix remodeling-associated protein 8,MXRA8,cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; establishment of glial blood-brain barrier [GO:0060857],cell surface [GO:0009986]; plasma membrane [GO:0005886],
890,A0A337SHC5,A0A337SHC5_FELCA,Microfibril associated protein 4,MFAP4,cellular response to UV-B [GO:0071493]; elastic fiber assembly [GO:0048251]; regulation of collagen metabolic process [GO:0010712]; UV protection [GO:0009650],collagen-containing extracellular matrix [GO:0062023]; elastic fiber [GO:0071953]; extracellular space [GO:0005615]; microfibril [GO:0001527],
891,A0A337SHI7,A0A337SHI7_FELCA,MANSC domain containing 1,MANSC1,,Golgi apparatus [GO:0005794]; membrane [GO:0016020],
892,A0A337SHV5,A0A337SHV5_FELCA,V-type proton ATPase subunit H,ATP6V1H,,"vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]","proton-transporting ATPase activity, rotational mechanism [GO:0046961]"
893,A0A337SHX7,A0A337SHX7_FELCA,Apolipoprotein B,APOB,lipid metabolic process [GO:0006629],cytoplasm [GO:0005737]; lipid droplet [GO:0005811]; low-density lipoprotein particle [GO:0034362],lipid transporter activity [GO:0005319]
894,A0A337SIC4,A0A337SIC4_FELCA,Vacuolar protein sorting-associated protein 16 homolog,VPS16,intracellular protein transport [GO:0006886]; vacuole organization [GO:0007033],early endosome [GO:0005769]; protein-containing complex [GO:0032991],
895,A0A337SIG9,A0A337SIG9_FELCA,Peroxiredoxin-2 (EC 1.11.1.24) (Thioredoxin-dependent peroxiredoxin 2),PRDX2,,,antioxidant activity [GO:0016209]; oxidoreductase activity [GO:0016491]
896,A0A337SIN6,A0A337SIN6_FELCA,Delta like non-canonical Notch ligand 1,DLK1,,membrane [GO:0016020],calcium ion binding [GO:0005509]
897,A0A337SJ23,A0A337SJ23_FELCA,Glutathione synthetase (GSH-S) (EC 6.3.2.3),GSS,,,ATP binding [GO:0005524]; glutathione binding [GO:0043295]; glutathione synthase activity [GO:0004363]; magnesium ion binding [GO:0000287]
898,A0A337SJE3,A0A337SJE3_FELCA,Cystathionine gamma-lyase (EC 4.4.1.1) (Cysteine-protein sulfhydrase) (Gamma-cystathionase),CTH,cysteine biosynthetic process [GO:0019344]; transsulfuration [GO:0019346],,cystathionine gamma-lyase activity [GO:0004123]; L-cysteine desulfhydrase activity [GO:0080146]; L-cystine L-cysteine-lyase (deaminating) [GO:0044540]; pyridoxal phosphate binding [GO:0030170]
899,A0A337SJF6,A0A337SJF6_FELCA,VPS37D subunit of ESCRT-I,VPS37D,protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162],ESCRT I complex [GO:0000813]; late endosome membrane [GO:0031902],
900,A0A337SJG7,A0A337SJG7_FELCA,Complement C1q C chain,C1QC,"complement activation, classical pathway [GO:0006958]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of macrophage differentiation [GO:0045650]; synapse pruning [GO:0098883]",collagen trimer [GO:0005581]; complement component C1q complex [GO:0062167]; postsynapse [GO:0098794],
901,A0A337SJL0,A0A337SJL0_FELCA,Intercellular adhesion molecule 2,ICAM2,cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609],cleavage furrow [GO:0032154]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; uropod [GO:0001931],integrin binding [GO:0005178]
902,A0A337SK12,A0A337SK12_FELCA,T cell immunoreceptor with Ig and ITIM domains,TIGIT,negative regulation of interleukin-12 production [GO:0032695]; negative regulation of T cell activation [GO:0050868]; positive regulation of interleukin-10 production [GO:0032733],cell surface [GO:0009986]; membrane [GO:0016020],identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]
903,A0A337SK67,A0A337SK67_FELCA,V-type proton ATPase subunit E 1 (V-type proton ATPase subunit e 1) (Vacuolar proton pump subunit E 1),ATP6V1E1,,"clathrin-coated vesicle membrane [GO:0030665]; plasma membrane [GO:0005886]; proton-transporting two-sector ATPase complex, catalytic domain [GO:0033178]; synaptic vesicle membrane [GO:0030672]","proton-transporting ATPase activity, rotational mechanism [GO:0046961]"
904,A0A337SKM2,A0A337SKM2_FELCA,Protocadherin 7,PCDH7,cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],plasma membrane [GO:0005886],calcium ion binding [GO:0005509]
905,A0A337SKP2,A0A337SKP2_FELCA,Serum amyloid A protein,SAA1 LOC105260977,acute-phase response [GO:0006953],high-density lipoprotein particle [GO:0034364],
906,A0A337SKQ1,A0A337SKQ1_FELCA,V-type proton ATPase subunit C,ATP6V1C1,,"clathrin-coated vesicle membrane [GO:0030665]; proton-transporting V-type ATPase, V1 domain [GO:0033180]; synaptic vesicle membrane [GO:0030672]","proton-transporting ATPase activity, rotational mechanism [GO:0046961]"
907,A0A337SKT0,A0A337SKT0_FELCA,EF-hand domain-containing protein,,establishment of skin barrier [GO:0061436],cornified envelope [GO:0001533]; keratohyalin granule [GO:0036457],calcium ion binding [GO:0005509]; transition metal ion binding [GO:0046914]
908,A0A337SKV9,A0A337SKV9_FELCA,Semaphorin 4D,SEMA4D,cell differentiation [GO:0030154]; nervous system development [GO:0007399],membrane [GO:0016020],semaphorin receptor binding [GO:0030215]
909,A0A337SKX0,A0A337SKX0_FELCA,Proteasome subunit alpha type,PSMA4,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome core complex, alpha-subunit complex [GO:0019773]",
910,A0A337SL34,A0A337SL34_FELCA,Adhesion G protein-coupled receptor L4,ADGRL4,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166],plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]
911,A0A337SL83,A0A337SL83_FELCA,Multivesicular body subunit 12A (ESCRT-I complex subunit MVB12A) (Protein FAM125A),MVB12A,protein transport [GO:0015031],ESCRT I complex [GO:0000813]; late endosome membrane [GO:0031902],SH3 domain binding [GO:0017124]
912,A0A337SL92,A0A337SL92_FELCA,Charged multivesicular body protein 5 (Chromatin-modifying protein 5),CHMP5,late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; vesicle budding from membrane [GO:0006900],multivesicular body [GO:0005771],
913,A0A337SLR6,A0A337SLR6_FELCA,Folate receptor-like domain-containing protein,,cell adhesion [GO:0007155]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; sperm-egg recognition [GO:0035036],external side of plasma membrane [GO:0009897],signaling receptor activity [GO:0038023]
914,A0A337SM15,A0A337SM15_FELCA,Keratin 17,KRT17,epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109],cytoskeleton [GO:0005856]; keratin filament [GO:0045095],structural molecule activity [GO:0005198]
915,A0A337SM43,A0A337SM43_FELCA,Olfactory receptor,LOC101093693 LOC111560946,,plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]
916,A0A337SMK6,A0A337SMK6_FELCA,Colony stimulating factor 1,CSF1,,membrane [GO:0016020],cytokine activity [GO:0005125]; growth factor activity [GO:0008083]
917,A0A337SMM1,A0A337SMM1_FELCA,Prostate androgen-regulated mucin-like protein 1,CD1H11orf24,,Golgi apparatus [GO:0005794]; membrane [GO:0016020],
918,A0A337SMR1,A0A337SMR1_FELCA,Carboxypeptidase (EC 3.4.16.-),CTSA,proteolysis [GO:0006508],,serine-type carboxypeptidase activity [GO:0004185]
919,A0A337SMV2,A0A337SMV2_FELCA,"Discoidin, CUB and LCCL domain containing 2",DCBLD2,negative regulation of cell growth [GO:0030308]; wound healing [GO:0042060],cell surface [GO:0009986]; plasma membrane [GO:0005886],signaling receptor activity [GO:0038023]
920,A0A337SN04,A0A337SN04_FELCA,Collagen type IV alpha 5 chain,COL4A5,collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; extracellular matrix organization [GO:0030198]; neuromuscular junction development [GO:0007528],basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuromuscular junction [GO:0031594],extracellular matrix structural constituent conferring tensile strength [GO:0030020]
921,A0A337SN31,A0A337SN31_FELCA,Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D),CPD,proteolysis [GO:0006508],,metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]
922,A0A337SND7,A0A337SND7_FELCA,Endothelin-3 (Preproendothelin-3),EDN3,regulation of vasoconstriction [GO:0019229]; vasoconstriction [GO:0042310],extracellular region [GO:0005576],
923,A0A337SNE1,A0A337SNE1_FELCA,Phosphotriesterase-related protein (Parathion hydrolase-related protein),PTER,catabolic process [GO:0009056],,"hydrolase activity, acting on ester bonds [GO:0016788]; zinc ion binding [GO:0008270]"
924,A0A337SNJ1,A0A337SNJ1_FELCA,Proteasome subunit alpha type,PSMA6,ubiquitin-dependent protein catabolic process [GO:0006511],"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex, alpha-subunit complex [GO:0019773]",
925,A0A337SNS0,A0A337SNS0_FELCA,Olfactory receptor,,,plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]
926,A0A337SNX4,A0A337SNX4_FELCA,Moesin (Membrane-organizing extension spike protein),MSN,,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; microvillus [GO:0005902]; plasma membrane [GO:0005886],actin binding [GO:0003779]
927,A0A337SP25,A0A337SP25_FELCA,Desmoglein 1,DSG1,cell-cell adhesion [GO:0098609]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; protein stabilization [GO:0050821],cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; desmosome [GO:0030057]; nucleus [GO:0005634],calcium ion binding [GO:0005509]; gamma-catenin binding [GO:0045295]
928,A0A337SPR7,A0A337SPR7_FELCA,ANTXR cell adhesion molecule 2,ANTXR2,,membrane [GO:0016020],metal ion binding [GO:0046872]; signaling receptor activity [GO:0038023]
929,A0A337SQ55,A0A337SQ55_FELCA,Natural killer cells antigen CD94 (Killer cell lectin-like receptor subfamily D member 1),KLRD1,positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; stimulatory C-type lectin receptor signaling pathway [GO:0002223],external side of plasma membrane [GO:0009897],transmembrane signaling receptor activity [GO:0004888]
930,A0A337SQ63,A0A337SQ63_FELCA,Mucosal vascular addressin cell adhesion molecule 1,MADCAM1,integrin-mediated signaling pathway [GO:0007229]; positive regulation of lymphocyte migration [GO:2000403],membrane [GO:0016020],integrin binding involved in cell-matrix adhesion [GO:0098640]
931,A0A337SQ74,A0A337SQ74_FELCA,IGF like family member 3,LOC101101603,,extracellular space [GO:0005615],signaling receptor binding [GO:0005102]
932,A0A337SQJ3,A0A337SQJ3_FELCA,Complement factor D (EC 3.4.21.46) (Adipsin) (C3 convertase activator) (Properdin factor D),CFD,proteolysis [GO:0006508],,serine-type endopeptidase activity [GO:0004252]
933,A0A337SQR3,A0A337SQR3_FELCA,Carboxylic ester hydrolase (EC 3.1.1.-),CES4A,,,carboxylic ester hydrolase activity [GO:0052689]
934,A0A337SQW0,A0A337SQW0_FELCA,Inter-alpha-trypsin inhibitor heavy chain 2,ITIH2,hyaluronan metabolic process [GO:0030212],extracellular region [GO:0005576],hyaluronic acid binding [GO:0005540]; serine-type endopeptidase inhibitor activity [GO:0004867]
935,A0A337SQW4,A0A337SQW4_FELCA,Coagulation factor V,F5,,extracellular region [GO:0005576],copper ion binding [GO:0005507]
936,A0A337SRL8,A0A337SRL8_FELCA,Crumbs cell polarity complex component 2,CRB2,,membrane [GO:0016020],calcium ion binding [GO:0005509]
937,A0A337SRM7,A0A337SRM7_FELCA,Intercellular adhesion molecule 1,ICAM1,cell adhesion [GO:0007155],membrane [GO:0016020],integrin binding [GO:0005178]
938,A0A337SRV8,A0A337SRV8_FELCA,Interferon regulatory factor 2 binding protein like,IRF2BPL,negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],nucleoplasm [GO:0005654]; nucleus [GO:0005634],transcription corepressor activity [GO:0003714]; ubiquitin protein ligase activity [GO:0061630]
939,A0A337SS20,A0A337SS20_FELCA,Superoxide dismutase [Cu-Zn] (EC 1.15.1.1),SOD3,removal of superoxide radicals [GO:0019430]; response to hypoxia [GO:0001666],collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615],copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]
940,A0A337SSG2,A0A337SSG2_FELCA,Carboxypeptidase Z,CPZ,proteolysis [GO:0006508],,metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]
941,A0A337SSM4,A0A337SSM4_FELCA,small monomeric GTPase (EC 3.6.5.2),RAB5B,,early endosome membrane [GO:0031901]; plasma membrane [GO:0005886],GTP binding [GO:0005525]; GTPase activity [GO:0003924]
942,A0A337ST09,A0A337ST09_FELCA,Glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1,GPIHBP1,protein stabilization [GO:0050821]; response to heparin [GO:0071503]; triglyceride catabolic process [GO:0019433]; triglyceride homeostasis [GO:0070328],catalytic complex [GO:1902494]; external side of plasma membrane [GO:0009897]; plasma membrane [GO:0005886],acetylcholine receptor inhibitor activity [GO:0030550]; chylomicron binding [GO:0035478]; lipase binding [GO:0035473]; lipoprotein lipase activator activity [GO:0060230]
943,A0A337STH0,A0A337STH0_FELCA,Lysosomal associated membrane protein 2,LAMP2,autophagosome maturation [GO:0097352]; cellular response to starvation [GO:0009267]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740],autophagosome membrane [GO:0000421]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886],
944,A0A337STQ6,A0A337STQ6_FELCA,Ring finger protein 149,RNF149,cellular response to xenobiotic stimulus [GO:0071466]; negative regulation of MAPK cascade [GO:0043409]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; membrane [GO:0016020],ubiquitin protein ligase activity [GO:0061630]
945,A0A337STY8,A0A337STY8_FELCA,"Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2)",ALDH2,,mitochondrial matrix [GO:0005759],"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]"
946,A0A337SUC3,A0A337SUC3_FELCA,Pro-cathepsin H,CTSH,proteolysis [GO:0006508],lysosome [GO:0005764],cysteine-type peptidase activity [GO:0008234]
947,A0A337SUD5,A0A337SUD5_FELCA,Vasoactive intestinal peptide receptor 1,VIPR1,"adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]",plasma membrane [GO:0005886]; receptor complex [GO:0043235],G protein-coupled peptide receptor activity [GO:0008528]; peptide hormone binding [GO:0017046]; vasoactive intestinal polypeptide receptor activity [GO:0004999]
948,A0A337SUP1,A0A337SUP1_FELCA,Adhesion G protein-coupled receptor E2,ADGRE2,cell surface receptor signaling pathway [GO:0007166],plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]
949,A0A337SV16,A0A337SV16_FELCA,Crumbs cell polarity complex component 1,CRB1,,membrane [GO:0016020],calcium ion binding [GO:0005509]
950,A0A337SVW6,A0A337SVW6_FELCA,Annexin,LOC101087010,endosomal transport [GO:0016197]; endosome organization [GO:0007032],cytoplasm [GO:0005737]; sarcolemma [GO:0042383]; vesicle membrane [GO:0012506],calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylserine binding [GO:0001786]
951,A0A337SX28,A0A337SX28_FELCA,Leukocyte surface antigen CD47 (Integrin-associated protein),CD47,cell adhesion [GO:0007155]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of inflammatory response [GO:0050729]; positive regulation of phagocytosis [GO:0050766],plasma membrane [GO:0005886],thrombospondin receptor activity [GO:0070053]
952,A0A341ZMF3,A0A341ZMF3_FELCA,"alpha-1,6-mannosyl-glycoprotein 6-beta-N-acetylglucosaminyltransferase (EC 2.4.1.155)",MGAT5,protein N-linked glycosylation [GO:0006487],extracellular region [GO:0005576]; Golgi membrane [GO:0000139],"alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity [GO:0030144]"
953,A0A5F5XBM7,A0A5F5XBM7_FELCA,Putative hydroxypyruvate isomerase (EC 5.3.1.22),HYI,glyoxylate metabolic process [GO:0046487],,hydroxypyruvate isomerase activity [GO:0008903]
954,A0A5F5XBP3,A0A5F5XBP3_FELCA,protein-tyrosine-phosphatase (EC 3.1.3.48),PTPRJ,,plasma membrane [GO:0005886],protein tyrosine phosphatase activity [GO:0004725]
955,A0A5F5XBP7,A0A5F5XBP7_FELCA,cathepsin X (EC 3.4.18.1),CTSZ,proteolysis [GO:0006508],membrane [GO:0016020],cysteine-type peptidase activity [GO:0008234]
956,A0A5F5XC23,A0A5F5XC23_FELCA,Mannose receptor C-type 1,MRC1,cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898],cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886],cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]
957,A0A5F5XC25,A0A5F5XC25_FELCA,Omega-amidase NIT2 (EC 3.5.1.3) (Nitrilase homolog 2),NIT2,,,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]"
958,A0A5F5XC30,A0A5F5XC30_FELCA,Transporter,SLC6A18,,plasma membrane [GO:0005886],symporter activity [GO:0015293]
959,A0A5F5XC36,A0A5F5XC36_FELCA,Lactotransferrin,LTF,immune system process [GO:0002376]; ossification [GO:0001503]; proteolysis [GO:0006508],extracellular space [GO:0005615],serine-type peptidase activity [GO:0008236]
960,A0A5F5XC46,A0A5F5XC46_FELCA,"alpha-1,2-Mannosidase (EC 3.2.1.-)",MAN1A2,carbohydrate metabolic process [GO:0005975],membrane [GO:0016020],"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]"
961,A0A5F5XC52,A0A5F5XC52_FELCA,Joining chain of multimeric IgA and IgM,JCHAIN,adaptive immune response [GO:0002250]; antibacterial humoral response [GO:0019731]; glomerular filtration [GO:0003094]; humoral immune response [GO:0006959]; innate immune response [GO:0045087]; positive regulation of respiratory burst [GO:0060267]; protein-containing complex assembly [GO:0065003],monomeric IgA immunoglobulin complex [GO:0071748]; pentameric IgM immunoglobulin complex [GO:0071756]; secretory dimeric IgA immunoglobulin complex [GO:0071752],IgA binding [GO:0019862]; immunoglobulin receptor binding [GO:0034987]; peptidoglycan binding [GO:0042834]; phosphatidylcholine binding [GO:0031210]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]; single-stranded DNA binding [GO:0003697]
962,A0A5F5XC70,A0A5F5XC70_FELCA,Myosin light chain kinase 2,MYLK2,cardiac muscle tissue morphogenesis [GO:0055008]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of gene expression [GO:0010628]; regulation of muscle filament sliding [GO:0032971]; skeletal muscle satellite cell differentiation [GO:0014816]; striated muscle contraction [GO:0006941],cytoplasm [GO:0005737]; nucleus [GO:0005634]; synapse [GO:0045202],ATP binding [GO:0005524]; myosin light chain binding [GO:0032027]; myosin light chain kinase activity [GO:0004687]
963,A0A5F5XC75,A0A5F5XC75_FELCA,Collagen type XVIII alpha 1 chain,COL18A1,angiogenesis [GO:0001525]; collagen fibril organization [GO:0030199]; endothelial cell morphogenesis [GO:0001886]; notochord development [GO:0030903]; skeletal system development [GO:0001501],collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615],extracellular matrix structural constituent conferring tensile strength [GO:0030020]
964,A0A5F5XCB9,A0A5F5XCB9_FELCA,Basigin,BSG,,basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; lateral plasma membrane [GO:0016328],mannose binding [GO:0005537]
965,A0A5F5XCJ2,A0A5F5XCJ2_FELCA,Membrane cofactor protein,LOC102899273,single fertilization [GO:0007338],cell surface [GO:0009986]; inner acrosomal membrane [GO:0002079],
966,A0A5F5XCJ6,A0A5F5XCJ6_FELCA,Protein YIPF3 (YIP1 family member 3),YIPF3,cell differentiation [GO:0030154],Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133],
967,A0A5F5XCK9,A0A5F5XCK9_FELCA,Endoribonuclease LACTB2 (Beta-lactamase-like protein 2),LACTB2,,,endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]
968,A0A5F5XCL3,A0A5F5XCL3_FELCA,Eukaryotic translation initiation factor 5,EIF5,,,GTP binding [GO:0005525]; translation initiation factor activity [GO:0003743]
969,A0A5F5XCM7,A0A5F5XCM7_FELCA,ADAM metallopeptidase with thrombospondin type 1 motif 2,ADAMTS2,extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508],collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576],metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]
970,A0A5F5XCP1,A0A5F5XCP1_FELCA,1-alkyl-2-acetylglycerophosphocholine esterase (EC 3.1.1.47),PLA2G7,lipid oxidation [GO:0034440]; low-density lipoprotein particle remodeling [GO:0034374]; phosphatidylcholine catabolic process [GO:0034638]; plasma lipoprotein particle oxidation [GO:0034441]; platelet activating factor catabolic process [GO:0062234]; positive regulation of monocyte chemotaxis [GO:0090026],high-density lipoprotein particle [GO:0034364]; low-density lipoprotein particle [GO:0034362],1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; calcium-independent phospholipase A2 activity [GO:0047499]; phospholipid binding [GO:0005543]
971,A0A5F5XCZ2,A0A5F5XCZ2_FELCA,Chromogranin-A,CHGA,,extracellular region [GO:0005576]; secretory granule [GO:0030141]; transport vesicle [GO:0030133],
972,A0A5F5XDL4,A0A5F5XDL4_FELCA,Glycerophosphodiester phosphodiesterase domain containing 3,GDPD3,lipid metabolic process [GO:0006629],cytoplasm [GO:0005737]; membrane [GO:0016020],phosphoric diester hydrolase activity [GO:0008081]
973,A0A5F5XDM5,A0A5F5XDM5_FELCA,Serpin family G member 1,SERPING1,,extracellular space [GO:0005615],serine-type endopeptidase inhibitor activity [GO:0004867]
974,A0A5F5XDP8,A0A5F5XDP8_FELCA,Sex hormone-binding globulin,SHBG,,extracellular region [GO:0005576],steroid binding [GO:0005496]
975,A0A5F5XDQ7,A0A5F5XDQ7_FELCA,Aggrecan core protein (Cartilage-specific proteoglycan core protein),ACAN,cell adhesion [GO:0007155],extracellular region [GO:0005576],calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]
976,A0A5F5XDS7,A0A5F5XDS7_FELCA,Golgi associated kinase 1A,GASK1A,,endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; membrane [GO:0016020],
977,A0A5F5XE18,A0A5F5XE18_FELCA,"Protocadherin gamma subfamily A, 4",PCDHGA4,homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],plasma membrane [GO:0005886],calcium ion binding [GO:0005509]
978,A0A5F5XE96,A0A5F5XE96_FELCA,Kinesin family member 26A,KIF26A,cerebral cortex development [GO:0021987]; enteric nervous system development [GO:0048484]; microtubule-based movement [GO:0007018]; negative regulation of signal transduction [GO:0009968]; regulation of cell growth by extracellular stimulus [GO:0001560]; regulation of neuron migration [GO:2001222]; regulation of neuron projection development [GO:0010975],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856],ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]
979,A0A5F5XEB8,A0A5F5XEB8_FELCA,Dynein axonemal heavy chain 8,DNAH8,microtubule-based movement [GO:0007018],axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569]
980,A0A5F5XEP4,A0A5F5XEP4_FELCA,Sushi domain-containing protein,LOC102899713,,extracellular region [GO:0005576],
981,A0A5F5XER5,A0A5F5XER5_FELCA,Complement C3,,"complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; inflammatory response [GO:0006954]",extracellular region [GO:0005576],endopeptidase inhibitor activity [GO:0004866]
982,A0A5F5XEY9,A0A5F5XEY9_FELCA,Butyrophilin like 9,LOC101097782,regulation of cytokine production [GO:0001817]; T cell receptor signaling pathway [GO:0050852],external side of plasma membrane [GO:0009897],signaling receptor binding [GO:0005102]
983,A0A5F5XF14,A0A5F5XF14_FELCA,Adhesion G protein-coupled receptor E5,ADGRE5,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166],plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]
984,A0A5F5XF39,A0A5F5XF39_FELCA,Interleukin 6 cytokine family signal transducer,IL6ST,,membrane [GO:0016020],cytokine receptor activity [GO:0004896]
985,A0A5F5XF56,A0A5F5XF56_FELCA,"Keratin, type I cytoskeletal 17 (Cytokeratin-17) (Keratin-17)",KRT17,,cytoplasm [GO:0005737]; intermediate filament [GO:0005882],structural molecule activity [GO:0005198]
986,A0A5F5XFC6,A0A5F5XFC6_FELCA,Cell division cycle 5 like,CDC5L,"mRNA splicing, via spliceosome [GO:0000398]",Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681],DNA binding [GO:0003677]
987,A0A5F5XFR8,A0A5F5XFR8_FELCA,Dihydropyrimidinase,DPYS,CMP catabolic process [GO:0006248]; dCMP catabolic process [GO:0006249]; dUMP catabolic process [GO:0046079]; pyrimidine nucleobase catabolic process [GO:0006208]; UMP catabolic process [GO:0046050]; uracil catabolic process [GO:0006212],cytosol [GO:0005829],dihydropyrimidinase activity [GO:0004157]; phosphoprotein binding [GO:0051219]
988,A0A5F5XFT3,A0A5F5XFT3_FELCA,Proteasome subunit beta,PSMB1,proteolysis involved in protein catabolic process [GO:0051603],cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome core complex [GO:0005839],
989,A0A5F5XFU3,A0A5F5XFU3_FELCA,Ankyrin repeat and SOCS box containing 1,ASB1,intracellular signal transduction [GO:0035556]; male genitalia development [GO:0030539]; protein ubiquitination [GO:0016567],ubiquitin ligase complex [GO:0000151],ubiquitin protein ligase activity [GO:0061630]
990,A0A5F5XFU6,A0A5F5XFU6_FELCA,Uncharacterized protein,LOC101094346,"complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]",axon [GO:0030424]; dendrite [GO:0030425]; extracellular space [GO:0005615]; synapse [GO:0045202],endopeptidase inhibitor activity [GO:0004866]
991,A0A5F5XG49,A0A5F5XG49_FELCA,Pregnancy zone protein-like,LOC101080976,,extracellular space [GO:0005615],endopeptidase inhibitor activity [GO:0004866]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]
992,A0A5F5XGD0,A0A5F5XGD0_FELCA,Haptoglobin,HP,acute-phase response [GO:0006953]; defense response to bacterium [GO:0042742]; Notch signaling pathway [GO:0007219]; proteolysis [GO:0006508],extracellular space [GO:0005615],antioxidant activity [GO:0016209]; hemoglobin binding [GO:0030492]; serine-type endopeptidase activity [GO:0004252]
993,A0A5F5XGD3,A0A5F5XGD3_FELCA,LIF receptor subunit alpha,LIFR,,membrane [GO:0016020],cytokine receptor activity [GO:0004896]
994,A0A5F5XGI4,A0A5F5XGI4_FELCA,Collagen type V alpha 3 chain,COL5A3,cell-matrix adhesion [GO:0007160]; extracellular matrix organization [GO:0030198],collagen type V trimer [GO:0005588]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615],extracellular matrix structural constituent conferring tensile strength [GO:0030020]; heparin binding [GO:0008201]
995,A0A5F5XGS9,A0A5F5XGS9_FELCA,Collagen type IV alpha 2 chain,COL4A2,cellular response to transforming growth factor beta stimulus [GO:0071560]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; DNA-templated transcription [GO:0006351]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; negative regulation of angiogenesis [GO:0016525],basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; extracellular space [GO:0005615]; membrane [GO:0016020],extracellular matrix structural constituent conferring tensile strength [GO:0030020]
996,A0A5F5XGZ0,A0A5F5XGZ0_FELCA,Fibrinogen gamma chain,FGG,platelet activation [GO:0030168]; protein polymerization [GO:0051258],fibrinogen complex [GO:0005577],signaling receptor binding [GO:0005102]
997,A0A5F5XH25,A0A5F5XH25_FELCA,Tumor necrosis factor receptor superfamily member 1A,LOC105261012,positive regulation of apoptotic process [GO:0043065]; TRAIL-activated apoptotic signaling pathway [GO:0036462],cell surface [GO:0009986]; plasma membrane [GO:0005886],
998,A0A5F5XH49,A0A5F5XH49_FELCA,"Protocadherin alpha subfamily C, 2",PCDHAC2,homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],plasma membrane [GO:0005886],calcium ion binding [GO:0005509]
999,A0A5F5XH53,A0A5F5XH53_FELCA,Coagulation factor VIII,F8,wound healing [GO:0042060],extracellular region [GO:0005576]; plasma membrane [GO:0005886],copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491]; signaling receptor activity [GO:0038023]
1000,A0A5F5XH67,A0A5F5XH67_FELCA,Glypican 4,GPC4,regulation of signal transduction [GO:0009966],collagen-containing extracellular matrix [GO:0062023]; plasma membrane [GO:0005886]; side of membrane [GO:0098552],
1001,A0A5F5XHD8,A0A5F5XHD8_FELCA,Beta-2-glycoprotein 1 (Apolipoprotein H) (Beta-2-glycoprotein I),APOH,,,heparin binding [GO:0008201]
1002,A0A5F5XHF5,A0A5F5XHF5_FELCA,Complement C1s,C1S,"complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; proteolysis [GO:0006508]",extracellular space [GO:0005615],calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]
1003,A0A5F5XHI0,A0A5F5XHI0_FELCA,Macrophage migration inhibitory factor (EC 5.3.2.1) (EC 5.3.3.12) (L-dopachrome isomerase) (L-dopachrome tautomerase) (Phenylpyruvate tautomerase),MIF,,extracellular space [GO:0005615],cytokine activity [GO:0005125]; phenylpyruvate tautomerase activity [GO:0050178]
1004,A0A5F5XI16,A0A5F5XI16_FELCA,L1 transposable element RRM domain-containing protein,,retrotransposition [GO:0032197],ribonucleoprotein complex [GO:1990904],single-stranded RNA binding [GO:0003727]
1005,A0A5F5XI25,A0A5F5XI25_FELCA,L-gulonate 3-dehydrogenase (EC 1.1.1.45) (L-gulonate 3-dehydrogenase),CRYL1,fatty acid metabolic process [GO:0006631],,"NAD+ binding [GO:0070403]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]"
1006,A0A5F5XI37,A0A5F5XI37_FELCA,Lipocalin/cytosolic fatty-acid binding domain-containing protein,LOC109496317,,extracellular space [GO:0005615],odorant binding [GO:0005549]; small molecule binding [GO:0036094]
1007,A0A5F5XI42,A0A5F5XI42_FELCA,Erlin-1 (Endoplasmic reticulum lipid raft-associated protein 1),ERLIN1,,endoplasmic reticulum [GO:0005783]; membrane [GO:0016020],lipid binding [GO:0008289]; ubiquitin protein ligase binding [GO:0031625]
1008,A0A5F5XI47,A0A5F5XI47_FELCA,Prosaposin,PSAP,sphingolipid metabolic process [GO:0006665],extracellular region [GO:0005576]; lysosome [GO:0005764],
1009,A0A5F5XIJ2,A0A5F5XIJ2_FELCA,Complement C3,,"complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; inflammatory response [GO:0006954]",extracellular region [GO:0005576],endopeptidase inhibitor activity [GO:0004866]
1010,A0A5F5XIK0,A0A5F5XIK0_FELCA,Glycoprotein Ib platelet subunit alpha,GP1BA,"blood coagulation, intrinsic pathway [GO:0007597]; cell adhesion [GO:0007155]; fibrinolysis [GO:0042730]; positive regulation of platelet activation [GO:0010572]; release of sequestered calcium ion into cytosol [GO:0051209]",external side of plasma membrane [GO:0009897]; glycoprotein Ib-IX-V complex [GO:1990779]; plasma membrane [GO:0005886],
1011,A0A5F5XIM5,A0A5F5XIM5_FELCA,NSFL1 cofactor,NSFL1C,autophagosome assembly [GO:0000045]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; membrane fusion [GO:0061025]; negative regulation of protein localization to centrosome [GO:1904780]; nuclear membrane reassembly [GO:0031468]; positive regulation of mitotic centrosome separation [GO:0046604]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],cytosol [GO:0005829]; nucleus [GO:0005634]; VCP-NSFL1C complex [GO:1990730],ubiquitin binding [GO:0043130]
1012,A0A5F5XIT1,A0A5F5XIT1_FELCA,Fatty acid binding protein 5,FABP5,fatty acid transport [GO:0015908],cytosol [GO:0005829]; nucleus [GO:0005634],fatty acid binding [GO:0005504]
1013,A0A5F5XIU4,A0A5F5XIU4_FELCA,Vitamin K-dependent protein S,PROS1,fibrinolysis [GO:0042730],extracellular space [GO:0005615],calcium ion binding [GO:0005509]
1014,A0A5F5XIV3,A0A5F5XIV3_FELCA,Cadherin related family member 5,CDHR5,homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],plasma membrane [GO:0005886],calcium ion binding [GO:0005509]
1015,A0A5F5XJ51,A0A5F5XJ51_FELCA,Transcobalamin-2 (Transcobalamin II),TCN2,cobalamin transport [GO:0015889]; cobalt ion transport [GO:0006824],extracellular region [GO:0005576],cobalamin binding [GO:0031419]
1016,A0A5F5XJC4,A0A5F5XJC4_FELCA,Dynein axonemal heavy chain 11,DNAH11,microtubule-based movement [GO:0007018],cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514],ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569]
1017,A0A5F5XJG5,A0A5F5XJG5_FELCA,Immunoglobulin V-set domain-containing protein,LOC109494125,,plasma membrane [GO:0005886],
1018,A0A5F5XJU3,A0A5F5XJU3_FELCA,V-set and immunoglobulin domain containing 4,VSIG4,"negative regulation of complement activation, alternative pathway [GO:0045957]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of macrophage activation [GO:0043031]; negative regulation of T cell proliferation [GO:0042130]",membrane [GO:0016020]; protein-containing complex [GO:0032991],complement component C3b binding [GO:0001851]
1019,A0A5F5XJV1,A0A5F5XJV1_FELCA,Glycoprotein 2,GP2,neutrophil migration [GO:1990266],apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; endosome [GO:0005768]; extracellular space [GO:0005615],antigen binding [GO:0003823]
1020,A0A5F5XK05,A0A5F5XK05_FELCA,Procollagen C-endopeptidase enhancer,PCOLCE,proteolysis [GO:0006508],extracellular region [GO:0005576],collagen binding [GO:0005518]; heparin binding [GO:0008201]; peptidase activator activity [GO:0016504]
1021,A0A5F5XK30,A0A5F5XK30_FELCA,PDZK1-interacting protein 1,PDZK1IP1,,membrane [GO:0016020],
1022,A0A5F5XKI3,A0A5F5XKI3_FELCA,Sulfotransferase (EC 2.8.2.-),LOC101091370,sulfation [GO:0051923],cytoplasm [GO:0005737],sulfotransferase activity [GO:0008146]
1023,A0A5F5XKM9,A0A5F5XKM9_FELCA,"H1.4 linker histone, cluster member",H1-4,chromosome condensation [GO:0030261]; negative regulation of DNA recombination [GO:0045910]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome assembly [GO:0006334],euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nucleosome [GO:0000786]; nucleus [GO:0005634],double-stranded DNA binding [GO:0003690]; histone deacetylase binding [GO:0042826]; nucleosomal DNA binding [GO:0031492]; structural constituent of chromatin [GO:0030527]
1024,A0A5F5XKS1,A0A5F5XKS1_FELCA,Lipopolysaccharide-binding protein (LBP),LBP,defense response to Gram-negative bacterium [GO:0050829]; innate immune response [GO:0045087],extracellular space [GO:0005615],lipopolysaccharide binding [GO:0001530]
1025,A0A5F5XKV2,A0A5F5XKV2_FELCA,Frizzled class receptor 8,FZD8,canonical Wnt signaling pathway [GO:0060070]; non-canonical Wnt signaling pathway [GO:0035567],plasma membrane [GO:0005886],PDZ domain binding [GO:0030165]; ubiquitin protein ligase binding [GO:0031625]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]
1026,A0A5F5XKY6,A0A5F5XKY6_FELCA,SPARC (Osteonectin) (Secreted protein acidic and rich in cysteine),SPARC,,basement membrane [GO:0005604]; extracellular space [GO:0005615]; membrane [GO:0016020],calcium ion binding [GO:0005509]
1027,A0A5F5XL80,A0A5F5XL80_FELCA,Anaphylatoxin-like domain-containing protein,,"complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; inflammatory response [GO:0006954]",extracellular space [GO:0005615],endopeptidase inhibitor activity [GO:0004866]
1028,A0A5F5XL86,A0A5F5XL86_FELCA,Lactoylglutathione lyase (EC 4.4.1.5) (Glyoxalase I),GLO1,,,lactoylglutathione lyase activity [GO:0004462]; metal ion binding [GO:0046872]
1029,A0A5F5XLA0,A0A5F5XLA0_FELCA,"Keratin, type I cytoskeletal 17 (Cytokeratin-17) (Keratin-17)",KRT17,,cytoplasm [GO:0005737]; intermediate filament [GO:0005882],structural molecule activity [GO:0005198]
1030,A0A5F5XLH0,A0A5F5XLH0_FELCA,Nectin cell adhesion molecule 4,NECTIN4,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; symbiont entry into host cell [GO:0046718],adherens junction [GO:0005912]; plasma membrane [GO:0005886],identical protein binding [GO:0042802]
1031,A0A5F5XLU4,A0A5F5XLU4_FELCA,Pantetheinase (EC 3.5.1.92) (Pantetheine hydrolase) (Vascular non-inflammatory molecule 1),VNN1,,plasma membrane [GO:0005886]; side of membrane [GO:0098552],"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]"
1032,A0A5F5XM71,A0A5F5XM71_FELCA,"Beta-1,4-galactosyltransferase (Beta-1,4-GalTase) (EC 2.4.1.-)",B4GALT5,carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486],Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139],glycosyltransferase activity [GO:0016757]; metal ion binding [GO:0046872]
1033,A0A5F5XM97,A0A5F5XM97_FELCA,Anaphylatoxin-like domain-containing protein,,"complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; inflammatory response [GO:0006954]",extracellular space [GO:0005615],endopeptidase inhibitor activity [GO:0004866]
1034,A0A5F5XMZ9,A0A5F5XMZ9_FELCA,Inter-alpha-trypsin inhibitor heavy chain 5,ITIH5,hyaluronan metabolic process [GO:0030212],extracellular region [GO:0005576],serine-type endopeptidase inhibitor activity [GO:0004867]
1035,A0A5F5XN85,A0A5F5XN85_FELCA,WD repeat-containing protein 37,WDR37,,,
1036,A0A5F5XNC0,A0A5F5XNC0_FELCA,Thymocyte selection associated family member 2,THEMIS2,sphingomyelin catabolic process [GO:0006685],extracellular space [GO:0005615],metal ion binding [GO:0046872]; sphingomyelin phosphodiesterase activity [GO:0004767]
1037,A0A5F5XNG4,A0A5F5XNG4_FELCA,CD248 molecule,CD248,anatomical structure regression [GO:0060033]; cell migration [GO:0016477]; endothelial cell apoptotic process [GO:0072577]; fibroblast migration [GO:0010761]; fibroblast proliferation [GO:0048144]; lymph node development [GO:0048535]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of fibroblast proliferation [GO:0048146],cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897],calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; extracellular matrix protein binding [GO:1990430]
1038,A0A5F5XNL0,A0A5F5XNL0_FELCA,receptor protein-tyrosine kinase (EC 2.7.10.1),EPHA7,,plasma membrane [GO:0005886],ATP binding [GO:0005524]; ephrin receptor activity [GO:0005003]
1039,A0A5F5XNT6,A0A5F5XNT6_FELCA,Proteasome subunit beta,PSMB3,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex, beta-subunit complex [GO:0019774]",
1040,A0A5F5XP86,A0A5F5XP86_FELCA,Ig-like domain-containing protein,,adaptive immune response [GO:0002250]; nucleosome assembly [GO:0006334],immunoglobulin complex [GO:0019814]; nucleosome [GO:0000786],DNA binding [GO:0003677]; structural constituent of chromatin [GO:0030527]
1041,A0A5F5XPI7,A0A5F5XPI7_FELCA,Beta-2-glycoprotein 1 (Apolipoprotein H) (Beta-2-glycoprotein I),APOH,,,heparin binding [GO:0008201]
1042,A0A5F5XPJ5,A0A5F5XPJ5_FELCA,Complement C8 alpha chain,C8A,"complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; killing of cells of another organism [GO:0031640]",extracellular space [GO:0005615]; membrane attack complex [GO:0005579],
1043,A0A5F5XPQ2,A0A5F5XPQ2_FELCA,Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 2,PYROXD2,,mitochondrial matrix [GO:0005759],oxidoreductase activity [GO:0016491]
1044,A0A5F5XPS6,A0A5F5XPS6_FELCA,CD93 molecule,CD93,cell-cell adhesion [GO:0098609],cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; complement component C1q complex binding [GO:0001849]
1045,A0A5F5XPV2,A0A5F5XPV2_FELCA,Lipase,LIPA,lipid catabolic process [GO:0016042],,"hydrolase activity, acting on ester bonds [GO:0016788]"
1046,A0A5F5XQ21,A0A5F5XQ21_FELCA,Insulin like growth factor 2 receptor,IGF2R,lysosomal transport [GO:0007041],intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020],mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]
1047,A0A5F5XQ31,A0A5F5XQ31_FELCA,"Lectin, mannose binding 2",LMAN2,"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; positive regulation of phagocytosis [GO:0050766]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",cell surface [GO:0009986]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886],heat shock protein binding [GO:0031072]; mannose binding [GO:0005537]; protein dimerization activity [GO:0046983]
1048,A0A5F5XQC7,A0A5F5XQC7_FELCA,NADP-dependent oxidoreductase domain-containing protein,AKR1C3,daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; progesterone metabolic process [GO:0042448]; prostaglandin metabolic process [GO:0006693],cytosol [GO:0005829],aldose reductase (NADPH) activity [GO:0004032]; androsterone dehydrogenase activity [GO:0047023]; bile acid binding [GO:0032052]; ketosteroid monooxygenase activity [GO:0047086]
1049,A0A5F5XQI4,A0A5F5XQI4_FELCA,Choline transporter-like protein,EHMT2,,plasma membrane [GO:0005886],organic cation transmembrane transporter activity [GO:0015101]
1050,A0A5F5XQN8,A0A5F5XQN8_FELCA,Sodium/glucose cotransporter 1 (High affinity sodium-glucose cotransporter) (Solute carrier family 5 member 1),SLC5A1,organic substance transport [GO:0071702]; sodium ion transport [GO:0006814],apical plasma membrane [GO:0016324],transmembrane transporter activity [GO:0022857]
1051,A0A5F5XQN9,A0A5F5XQN9_FELCA,G protein-coupled receptor 108,GPR108,,membrane [GO:0016020],endopeptidase inhibitor activity [GO:0004866]
1052,A0A5F5XQT8,A0A5F5XQT8_FELCA,MAC-inhibitory protein (Membrane attack complex inhibition factor) (Protectin),CD59,negative regulation of activation of membrane attack complex [GO:0001971],plasma membrane [GO:0005886]; side of membrane [GO:0098552],complement binding [GO:0001848]
1053,A0A5F5XQW6,A0A5F5XQW6_FELCA,Phosphatidylinositol-glycan-specific phospholipase D (EC 3.1.4.50) (Glycosyl-phosphatidylinositol-specific phospholipase D),GPLD1,,extracellular region [GO:0005576],glycosylphosphatidylinositol phospholipase D activity [GO:0004621]
1054,A0A5F5XQX5,A0A5F5XQX5_FELCA,Transgelin,TAGLN2,actin filament organization [GO:0007015]; epithelial cell differentiation [GO:0030855],actin cytoskeleton [GO:0015629],actin filament binding [GO:0051015]
1055,A0A5F5XQY3,A0A5F5XQY3_FELCA,Amyloid beta like protein 1,APLP1,,endomembrane system [GO:0012505]; membrane [GO:0016020],heparin binding [GO:0008201]; transition metal ion binding [GO:0046914]
1056,A0A5F5XR95,A0A5F5XR95_FELCA,Guanylate cyclase activator 2B,GUCA2B,,extracellular region [GO:0005576],guanylate cyclase activator activity [GO:0030250]
1057,A0A5F5XRG8,A0A5F5XRG8_FELCA,BRO1 domain-containing protein BROX (BRO1 domain- and CAAX motif-containing protein),BROX,mitotic nuclear membrane reassembly [GO:0007084],nuclear envelope [GO:0005635],
1058,A0A5F5XRV1,A0A5F5XRV1_FELCA,Transmembrane protein 59,TMEM59,,Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886],
1059,A0A5F5XS51,A0A5F5XS51_FELCA,thioredoxin-dependent peroxiredoxin (EC 1.11.1.24),PRDX4,cell redox homeostasis [GO:0045454]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783],thioredoxin peroxidase activity [GO:0008379]
1060,A0A5F5XS55,A0A5F5XS55_FELCA,Aspartylglucosaminidase,AGA,,,hydrolase activity [GO:0016787]
1061,A0A5F5XSD6,A0A5F5XSD6_FELCA,TNF receptor superfamily member 14,TNFRSF14,,membrane [GO:0016020],
1062,A0A5F5XSY0,A0A5F5XSY0_FELCA,BAR/IMD domain containing adaptor protein 2 like 1,BAIAP2L1,actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; plasma membrane organization [GO:0007009]; positive regulation of actin filament polymerization [GO:0030838],actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],proline-rich region binding [GO:0070064]
1063,A0A5F5XSY1,A0A5F5XSY1_FELCA,C-X-C motif chemokine,PPBP,antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; inflammatory response [GO:0006954]; leukocyte migration involved in inflammatory response [GO:0002523]; neutrophil chemotaxis [GO:0030593],extracellular space [GO:0005615],chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]
1064,A0A5F5XTB2,A0A5F5XTB2_FELCA,Phosphatidylinositol-glycan-specific phospholipase D (EC 3.1.4.50) (Glycosyl-phosphatidylinositol-specific phospholipase D),GPLD1,,extracellular region [GO:0005576],glycosylphosphatidylinositol phospholipase D activity [GO:0004621]
1065,A0A5F5XTG9,A0A5F5XTG9_FELCA,Complement C7,C7,"complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; killing of cells of another organism [GO:0031640]",extracellular region [GO:0005576]; membrane attack complex [GO:0005579],
1066,A0A5F5XTV6,A0A5F5XTV6_FELCA,Secreted phosphoprotein 24 (Secreted phosphoprotein 2),SPP2,bone remodeling [GO:0046849],extracellular region [GO:0005576],
1067,A0A5F5XTW1,A0A5F5XTW1_FELCA,Lysosomal cobalamin transport escort protein LMBD1 (LMBR1 domain-containing protein 1),LMBRD1,gastrulation [GO:0007369],lysosomal membrane [GO:0005765],cobalamin binding [GO:0031419]
1068,A0A5F5XU81,A0A5F5XU81_FELCA,Secreted and transmembrane 1,,immune response [GO:0006955],membrane [GO:0016020],cytokine activity [GO:0005125]
1069,A0A5F5XUA3,A0A5F5XUA3_FELCA,"Mucin 2, oligomeric mucus/gel-forming",,,extracellular region [GO:0005576],
1070,A0A5F5XUE5,A0A5F5XUE5_FELCA,trypsin (EC 3.4.21.4),PRSS2,proteolysis [GO:0006508],,serine-type endopeptidase activity [GO:0004252]
1071,A0A5F5XUG7,A0A5F5XUG7_FELCA,Alpha-mannosidase (EC 3.2.1.-),MAN2A2,mannose metabolic process [GO:0006013]; N-glycan processing [GO:0006491],Golgi membrane [GO:0000139],"alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; metal ion binding [GO:0046872]"
1072,A0A5F5XUK2,A0A5F5XUK2_FELCA,Multimerin 2,MMRN2,cell migration involved in sprouting angiogenesis [GO:0002042]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of epithelial tube formation [GO:1905278],basement membrane [GO:0005604]; collagen trimer [GO:0005581]; extracellular space [GO:0005615],
1073,A0A5F5XUR3,A0A5F5XUR3_FELCA,Ketimine reductase mu-crystallin (EC 1.5.1.25) (NADP-regulated thyroid-hormone-binding protein),CRYM,,,thiomorpholine-carboxylate dehydrogenase activity [GO:0047127]
1074,A0A5F5XVF5,A0A5F5XVF5_FELCA,Kininogen 1,KNG1,blood coagulation [GO:0007596]; inflammatory response [GO:0006954]; negative regulation of blood coagulation [GO:0030195]; negative regulation of cell adhesion [GO:0007162]; negative regulation of proteolysis [GO:0045861]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; vasodilation [GO:0042311],extracellular region [GO:0005576]; extracellular space [GO:0005615],cysteine-type endopeptidase inhibitor activity [GO:0004869]; hormone activity [GO:0005179]
1075,A0A5F5XVJ0,A0A5F5XVJ0_FELCA,Uroplakin 3A,UPK3A,cell morphogenesis [GO:0000902]; epithelial cell differentiation [GO:0030855]; kidney development [GO:0001822]; potassium ion homeostasis [GO:0055075]; sodium ion homeostasis [GO:0055078]; urea transport [GO:0015840]; urinary bladder development [GO:0060157]; water transport [GO:0006833],apical plasma membrane urothelial plaque [GO:0120001]; plasma membrane [GO:0005886],
1076,A0A5F5XVS8,A0A5F5XVS8_FELCA,Dipeptidyl peptidase 7,DPP7,lysosomal protein catabolic process [GO:1905146]; proteolysis [GO:0006508],Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; vesicle [GO:0031982],dipeptidyl-peptidase activity [GO:0008239]; serine-type exopeptidase activity [GO:0070008]
1077,A0A5F5XVZ8,A0A5F5XVZ8_FELCA,Alpha-2-HS-glycoprotein (Fetuin-A),AHSG,acute-phase response [GO:0006953]; negative regulation of bone mineralization [GO:0030502]; ossification [GO:0001503]; positive regulation of phagocytosis [GO:0050766]; regulation of inflammatory response [GO:0050727],extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794],cysteine-type endopeptidase inhibitor activity [GO:0004869]; endopeptidase inhibitor activity [GO:0004866]
1078,A0A5F5XW04,A0A5F5XW04_FELCA,Serpin family A member 1,SERPINA1,,endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794],identical protein binding [GO:0042802]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]
1079,A0A5F5XWA2,A0A5F5XWA2_FELCA,Napsin A aspartic peptidase,NAPSA,membrane protein proteolysis [GO:0033619]; proteolysis [GO:0006508]; surfactant homeostasis [GO:0043129],alveolar lamellar body [GO:0097208]; extracellular space [GO:0005615]; lysosome [GO:0005764],aspartic-type endopeptidase activity [GO:0004190]
1080,A0A5F5XWJ8,A0A5F5XWJ8_FELCA,Vacuolar protein sorting-associated protein 28 homolog,VPS28,negative regulation of protein ubiquitination [GO:0031397]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328],cytosol [GO:0005829]; early endosome [GO:0005769]; ESCRT I complex [GO:0000813]; plasma membrane [GO:0005886],protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]
1081,A0A5F5XWJ9,A0A5F5XWJ9_FELCA,Ig-like domain-containing protein,,,membrane [GO:0016020],
1082,A0A5F5XWN0,A0A5F5XWN0_FELCA,"Actin alpha 1, skeletal muscle",ACTA1 CCSAP,axonogenesis [GO:0007409]; cell motility [GO:0048870],actin filament [GO:0005884]; axon [GO:0030424]; cytoplasm [GO:0005737]; membrane [GO:0016020]; NuA4 histone acetyltransferase complex [GO:0035267]; synapse [GO:0045202],protein kinase binding [GO:0019901]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]
1083,A0A5F5XWZ9,A0A5F5XWZ9_FELCA,folate gamma-glutamyl hydrolase (EC 3.4.19.9),GGH,glutamine metabolic process [GO:0006541]; tetrahydrofolylpolyglutamate metabolic process [GO:0046900],extracellular space [GO:0005615]; vacuole [GO:0005773],gamma-glutamyl-peptidase activity [GO:0034722]
1084,A0A5F5XXE9,A0A5F5XXE9_FELCA,Acyl-coenzyme A oxidase,ACOX3,fatty acid beta-oxidation [GO:0006635],peroxisome [GO:0005777],acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]
1085,A0A5F5XXF9,A0A5F5XXF9_FELCA,EPH receptor B6,EPHB6,,plasma membrane [GO:0005886],ATP binding [GO:0005524]; ephrin receptor activity [GO:0005003]
1086,A0A5F5XXX0,A0A5F5XXX0_FELCA,Transferrin,TF,iron ion transport [GO:0006826],extracellular space [GO:0005615],metal ion binding [GO:0046872]
1087,A0A5F5XYE2,A0A5F5XYE2_FELCA,Matrix metallopeptidase 11,MMP11,proteolysis [GO:0006508],extracellular matrix [GO:0031012],metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]
1088,A0A5F5XYF2,A0A5F5XYF2_FELCA,"Acetyl-CoA acetyltransferase, mitochondrial",ACAT1,,mitochondrion [GO:0005739],acetyl-CoA C-acyltransferase activity [GO:0003988]; metal ion binding [GO:0046872]
1089,A0A5F5XZ26,A0A5F5XZ26_FELCA,UPAR/Ly6 domain-containing protein,LOC102899673,acetylcholine receptor signaling pathway [GO:0095500],plasma membrane [GO:0005886]; synapse [GO:0045202],acetylcholine receptor binding [GO:0033130]; acetylcholine receptor inhibitor activity [GO:0030550]
1090,A0A5F5XZJ4,A0A5F5XZJ4_FELCA,14-3-3 protein theta,YWHAQ,negative regulation of DNA-templated transcription [GO:0045892]; protein localization [GO:0008104]; protein targeting [GO:0006605]; signal transduction [GO:0007165]; small GTPase-mediated signal transduction [GO:0007264],cytoplasm [GO:0005737]; protein-containing complex [GO:0032991],identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]
1091,A0A5F5XZT1,A0A5F5XZT1_FELCA,receptor protein-tyrosine kinase (EC 2.7.10.1),EPHA1,,plasma membrane [GO:0005886],ATP binding [GO:0005524]; ephrin receptor activity [GO:0005003]
1092,A0A5F5XZX3,A0A5F5XZX3_FELCA,acetyl-CoA C-acetyltransferase (EC 2.3.1.9),ACAT2,fatty acid beta-oxidation [GO:0006635],mitochondrion [GO:0005739],acetyl-CoA C-acetyltransferase activity [GO:0003985]
1093,A0A5F5Y013,A0A5F5Y013_FELCA,Alpha-amylase (EC 3.2.1.1),AMY2B,carbohydrate metabolic process [GO:0005975],,alpha-amylase activity [GO:0004556]; cation binding [GO:0043169]
1094,A0A5F5Y0A1,A0A5F5Y0A1_FELCA,Ig-like domain-containing protein,,cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; hydrogen peroxide catabolic process [GO:0042744],cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; peroxisome [GO:0005777],thioredoxin peroxidase activity [GO:0008379]
1095,A0A5F5Y0F7,A0A5F5Y0F7_FELCA,Fc epsilon receptor II,FCER2,B cell antigen processing and presentation [GO:0002450]; Fc receptor-mediated immune complex endocytosis [GO:0160006]; immune response [GO:0006955]; macrophage activation [GO:0042116]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of another organism [GO:0051712]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770],external side of plasma membrane [GO:0009897],carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; low-affinity IgE receptor activity [GO:0019769]
1096,A0A5F5Y0U4,A0A5F5Y0U4_FELCA,"Keratin, type II cytoskeletal 8 (Cytokeratin-8) (Keratin-8)",,,cytoplasm [GO:0005737]; intermediate filament [GO:0005882]; nuclear matrix [GO:0016363],
1097,A0A5F5Y1B8,A0A5F5Y1B8_FELCA,Collagen type III alpha 1 chain,COL3A1,,,extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]
1098,A0A5F5Y1D6,A0A5F5Y1D6_FELCA,MARVEL domain-containing protein,SYPL1,,synaptic vesicle membrane [GO:0030672],
1099,A0A5F5Y1L1,A0A5F5Y1L1_FELCA,Transketolase (EC 2.2.1.1),TKT,,cytoplasm [GO:0005737],metal ion binding [GO:0046872]; transferase activity [GO:0016740]
1100,A0A5F5Y1N6,A0A5F5Y1N6_FELCA,Cysteine rich secretory protein 3,CRISP3,,extracellular space [GO:0005615]; specific granule [GO:0042581],
1101,A0A5F5Y1U9,A0A5F5Y1U9_FELCA,Alpha-2-macroglobulin,A2M PZP,"negative regulation of complement activation, lectin pathway [GO:0001869]",extracellular space [GO:0005615],calcium-dependent protein binding [GO:0048306]; endopeptidase inhibitor activity [GO:0004866]; interleukin-1 binding [GO:0019966]; interleukin-8 binding [GO:0019959]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor binding [GO:0005102]; tumor necrosis factor binding [GO:0043120]
1102,A0A5F5Y223,A0A5F5Y223_FELCA,Sushi domain-containing protein,,complement activation [GO:0006956],extracellular space [GO:0005615],complement component C3b binding [GO:0001851]
1103,A0A5F5Y2C4,A0A5F5Y2C4_FELCA,Procollagen C-endopeptidase enhancer 2,PCOLCE2,cellular response to leukemia inhibitory factor [GO:1990830],extracellular region [GO:0005576],collagen binding [GO:0005518]; heparin binding [GO:0008201]; peptidase activator activity [GO:0016504]
1104,A0A5F5Y2G5,A0A5F5Y2G5_FELCA,Alpha-mannosidase (EC 3.2.1.-),MAN2A1,mannose metabolic process [GO:0006013],membrane [GO:0016020],alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]
1105,A0A5F5Y2L8,A0A5F5Y2L8_FELCA,Ephrin type-B receptor 3 (EC 2.7.10.1),EPHB3,,plasma membrane [GO:0005886],ATP binding [GO:0005524]; ephrin receptor activity [GO:0005003]
1106,A0A5F5Y2N0,A0A5F5Y2N0_FELCA,Polypeptide N-acetylgalactosaminyltransferase (EC 2.4.1.-) (Protein-UDP acetylgalactosaminyltransferase),GALNT18,protein glycosylation [GO:0006486],Golgi membrane [GO:0000139],carbohydrate binding [GO:0030246]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]
1107,A0A5F5Y369,A0A5F5Y369_FELCA,receptor protein-tyrosine kinase (EC 2.7.10.1),MERTK,,membrane [GO:0016020],ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]
1108,A0A5F5Y3A1,A0A5F5Y3A1_FELCA,Stanniocalcin-1 (STC-1),STC1,intracellular calcium ion homeostasis [GO:0006874],extracellular space [GO:0005615],hormone activity [GO:0005179]
1109,A0A5F5Y3T3,A0A5F5Y3T3_FELCA,4-hydroxyphenylpyruvate dioxygenase,HPD,aromatic amino acid metabolic process [GO:0009072],endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139],4-hydroxyphenylpyruvate dioxygenase activity [GO:0003868]; metal ion binding [GO:0046872]
1110,A0A5F5Y3X9,A0A5F5Y3X9_FELCA,carbonic anhydrase (EC 4.2.1.1),CA15,one-carbon metabolic process [GO:0006730],plasma membrane [GO:0005886],carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]
1111,A0A5F5Y3Z8,A0A5F5Y3Z8_FELCA,"Ribonuclease A family member 1, pancreatic",RNASE1,defense response to Gram-positive bacterium [GO:0050830],extracellular region [GO:0005576],endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA nuclease activity [GO:0004540]
1112,A0A5F5Y466,A0A5F5Y466_FELCA,Cadherin related family member 5,CDHR5,cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; intermicrovillar adhesion [GO:0090675]; regulation of microvillus length [GO:0032532],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886],beta-catenin binding [GO:0008013]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]
1113,A0A5F5Y4J4,A0A5F5Y4J4_FELCA,Collagen type IV alpha 1 chain,COL4A1,,basement membrane [GO:0005604]; collagen trimer [GO:0005581]; membrane [GO:0016020],extracellular matrix structural constituent [GO:0005201]
1114,A0A5F5Y5C4,A0A5F5Y5C4_FELCA,Shisa family member 7,SHISA7,gamma-aminobutyric acid receptor clustering [GO:0097112]; gamma-aminobutyric acid signaling pathway [GO:0007214]; memory [GO:0007613]; positive regulation of long-term synaptic potentiation [GO:1900273]; regulation of AMPA glutamate receptor clustering [GO:1904717]; regulation of short-term neuronal synaptic plasticity [GO:0048172],"AMPA glutamate receptor complex [GO:0032281]; asymmetric, glutamatergic, excitatory synapse [GO:0098985]; dendritic spine membrane [GO:0032591]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; postsynaptic specialization membrane [GO:0099634]",GABA receptor binding [GO:0050811]; ionotropic glutamate receptor binding [GO:0035255]
1115,A0A5F5Y5L0,A0A5F5Y5L0_FELCA,CD27 molecule,CD27,extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of apoptotic process [GO:0043066]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of T cell differentiation [GO:0045582],external side of plasma membrane [GO:0009897],cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; transmembrane signaling receptor activity [GO:0004888]
1116,A0A5F5Y6R8,A0A5F5Y6R8_FELCA,Heparan sulfate proteoglycan 2,HSPG2,cell differentiation [GO:0030154]; circulatory system development [GO:0072359],basement membrane [GO:0005604]; cytoplasm [GO:0005737],calcium ion binding [GO:0005509]
1117,A0A5F5Y6V1,A0A5F5Y6V1_FELCA,VWFA domain-containing protein,ITGAX,cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229],external side of plasma membrane [GO:0009897]; integrin complex [GO:0008305],integrin binding [GO:0005178]; metal ion binding [GO:0046872]
1118,A0A5F5Y6V8,A0A5F5Y6V8_FELCA,Sex hormone-binding globulin,SHBG,,extracellular region [GO:0005576],steroid binding [GO:0005496]
1119,A0A5F5Y7J8,A0A5F5Y7J8_FELCA,Annexin,ANXA5,,zymogen granule membrane [GO:0042589],calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]
1120,A0A5F5Y7M8,A0A5F5Y7M8_FELCA,Charged multivesicular body protein 3 (Chromatin-modifying protein 3) (Vacuolar protein sorting-associated protein 24),CHMP3,vacuolar transport [GO:0007034],late endosome membrane [GO:0031902],
1121,A0A5K1VP01,A0A5K1VP01_FELCA,Lamin A/C,LMNA,,intermediate filament [GO:0005882]; nuclear envelope [GO:0005635]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654],
1122,A0M8S9,CAZA2_FELCA,F-actin-capping protein subunit alpha-2 (CapZ alpha-2),CAPZA2,actin cytoskeleton organization [GO:0030036]; barbed-end actin filament capping [GO:0051016],cortical cytoskeleton [GO:0030863]; F-actin capping protein complex [GO:0008290],actin filament binding [GO:0051015]
1123,B4X8D7,B4X8D7_FELCA,Trefoil factor 1 (Trefoil factor family peptide 1),TFF1,cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of cell population proliferation [GO:0008285],extracellular space [GO:0005615],
1124,B4X8D8,B4X8D8_FELCA,Trefoil factor 2,TFF2,,extracellular region [GO:0005576],
1125,C6GGN9,C6GGN9_FELCA,Lysosomal associated membrane protein 1 (Lysosomal-associated membrane glycoprotein 1),LAMP1 LAMP-1,,endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886],
1126,F1C962,F1C962_FELCA,Cathelicidin,CAMP,amyloid fibril formation [GO:1990000]; antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; innate immune response in mucosa [GO:0002227]; killing by host of symbiont cells [GO:0051873]; neutrophil activation [GO:0042119],extracellular space [GO:0005615]; specific granule [GO:0042581],lipopolysaccharide binding [GO:0001530]
1127,M3VTY7,M3VTY7_FELCA,LY6/PLAUR domain containing 1,LYPD1,"acetylcholine receptor signaling pathway [GO:0095500]; behavioral fear response [GO:0001662]; negative regulation of protein localization to plasma membrane [GO:1903077]; protein localization to plasma membrane [GO:0072659]; response to nicotine [GO:0035094]; synaptic transmission, cholinergic [GO:0007271]",side of membrane [GO:0098552]; synapse [GO:0045202],acetylcholine receptor binding [GO:0033130]; acetylcholine receptor inhibitor activity [GO:0030550]
1128,M3VTY8,M3VTY8_FELCA,Reticulocalbin 3,RCN3,collagen biosynthetic process [GO:0032964]; ERAD pathway [GO:0036503]; lung epithelium development [GO:0060428]; phospholipid homeostasis [GO:0055091]; protein secretion [GO:0009306]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; surfactant homeostasis [GO:0043129],endoplasmic reticulum [GO:0005783],calcium ion binding [GO:0005509]
1129,M3VU73,M3VU73_FELCA,Kinesin-like protein,KIF12,microtubule-based movement [GO:0007018],cytoplasm [GO:0005737]; microtubule [GO:0005874],ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]
1130,M3VU75,M3VU75_FELCA,Lipocalin/cytosolic fatty-acid binding domain-containing protein,LOC100144393,acute-phase response [GO:0006953]; regulation of immune system process [GO:0002682],extracellular space [GO:0005615],
1131,M3VU91,M3VU91_FELCA,LDL receptor related protein 1,LRP1,endocytosis [GO:0006897],membrane [GO:0016020],calcium ion binding [GO:0005509]
1132,M3VUA4,M3VUA4_FELCA,"BOC cell adhesion associated, onco regulated",BOC,axon guidance [GO:0007411]; cell-cell adhesion [GO:0098609]; nervous system development [GO:0007399],axon [GO:0030424]; membrane [GO:0016020],
1133,M3VUF9,M3VUF9_FELCA,Keratin 74,KRT74,intermediate filament organization [GO:0045109]; keratinization [GO:0031424]; keratinocyte activation [GO:0032980]; keratinocyte development [GO:0003334]; keratinocyte migration [GO:0051546]; keratinocyte proliferation [GO:0043616]; positive regulation of epidermis development [GO:0045684],cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; keratin filament [GO:0045095],cytoskeletal protein binding [GO:0008092]; structural constituent of skin epidermis [GO:0030280]
1134,M3VUG7,M3VUG7_FELCA,Keratin 76,KRT76,intermediate filament organization [GO:0045109]; keratinization [GO:0031424]; pigmentation [GO:0043473]; sebaceous gland development [GO:0048733],keratin filament [GO:0045095],structural constituent of skin epidermis [GO:0030280]
1135,M3VUG8,M3VUG8_FELCA,Keratin 3,KRT3,intermediate filament organization [GO:0045109]; keratinization [GO:0031424],keratin filament [GO:0045095],structural constituent of skin epidermis [GO:0030280]
1136,M3VUH3,M3VUH3_FELCA,Keratin 18,KRT18,extrinsic apoptotic signaling pathway [GO:0097191]; Golgi to plasma membrane protein transport [GO:0043001]; hepatocyte apoptotic process [GO:0097284]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of apoptotic process [GO:0043066]; tumor necrosis factor-mediated signaling pathway [GO:0033209],cell periphery [GO:0071944]; centriolar satellite [GO:0034451]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; keratin filament [GO:0045095],scaffold protein binding [GO:0097110]; structural molecule activity [GO:0005198]
1137,M3VUH9,M3VUH9_FELCA,Insulin like growth factor binding protein 6,IGFBP6,cell migration [GO:0016477]; positive regulation of stress-activated MAPK cascade [GO:0032874]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567],extracellular space [GO:0005615]; insulin-like growth factor binary complex [GO:0042568],fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor II binding [GO:0031995]
1138,M3VUN7,M3VUN7_FELCA,Complement C8 gamma chain,C8G,complement activation [GO:0006956],extracellular region [GO:0005576]; membrane attack complex [GO:0005579],complement binding [GO:0001848]
1139,M3VUP6,M3VUP6_FELCA,Lymphatic vessel endothelial hyaluronan receptor 1,LYVE1,cell adhesion [GO:0007155]; hyaluronan catabolic process [GO:0030214]; positive regulation of cellular extravasation [GO:0002693]; receptor-mediated endocytosis [GO:0006898],plasma membrane [GO:0005886],cargo receptor activity [GO:0038024]; hyaluronic acid binding [GO:0005540]; transmembrane signaling receptor activity [GO:0004888]
1140,M3VUZ7,M3VUZ7_FELCA,Tetraspanin,TSPAN1,protein stabilization [GO:0050821],cell junction [GO:0030054]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982],
1141,M3VV12,M3VV12_FELCA,ER lipid raft associated 1,ERLIN1,peptide metabolic process [GO:0006518]; protein processing [GO:0016485],extracellular space [GO:0005615],metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]
1142,M3VV37,M3VV37_FELCA,Solute carrier family 3 member 1,SLC3A1,amino acid transport [GO:0006865]; aspartate transmembrane transport [GO:0015810]; carbohydrate metabolic process [GO:0005975]; gene expression [GO:0010467]; L-cystine transport [GO:0015811]; L-glutamate transmembrane transport [GO:0015813],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526],protein heterodimerization activity [GO:0046982]
1143,M3VV58,M3VV58_FELCA,Complement C5,C5,"complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; inflammatory response [GO:0006954]; negative regulation of macrophage chemotaxis [GO:0010760]; positive regulation of chemokine production [GO:0032722]; positive regulation of vascular endothelial growth factor production [GO:0010575]",extracellular space [GO:0005615]; membrane attack complex [GO:0005579],endopeptidase inhibitor activity [GO:0004866]
1144,M3VVC4,M3VVC4_FELCA,ADAMTS like 4,ADAMTSL4,epithelial cell development [GO:0002064]; extracellular matrix organization [GO:0030198]; pigment cell development [GO:0070285]; positive regulation of apoptotic process [GO:0043065],extracellular region [GO:0005576]; interstitial matrix [GO:0005614],protease binding [GO:0002020]
1145,M3VVE6,M3VVE6_FELCA,EGF containing fibulin extracellular matrix protein 1,EFEMP1,camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; negative regulation of chondrocyte differentiation [GO:0032331]; post-embryonic eye morphogenesis [GO:0048050]; regulation of DNA-templated transcription [GO:0006355],extracellular space [GO:0005615],calcium ion binding [GO:0005509]; epidermal growth factor receptor activity [GO:0005006]; epidermal growth factor receptor binding [GO:0005154]
1146,M3VVG9,M3VVG9_FELCA,Mimecan (Osteoglycin),OGN,articular cartilage development [GO:0061975]; bone development [GO:0060348],extracellular matrix [GO:0031012],growth factor activity [GO:0008083]
1147,M3VVP5,M3VVP5_FELCA,N-sulfoglucosamine sulfohydrolase,SGSH,determination of adult lifespan [GO:0008340]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200]; motor behavior [GO:0061744],lysosomal lumen [GO:0043202],N-sulfoglucosamine sulfohydrolase activity [GO:0016250]; sulfuric ester hydrolase activity [GO:0008484]
1148,M3VW19,M3VW19_FELCA,CXADR like membrane protein,CLMP,digestive tract development [GO:0048565],bicellular tight junction [GO:0005923]; cytoplasmic microtubule [GO:0005881]; membrane [GO:0016020],
1149,M3VWB5,M3VWB5_FELCA,UDP-glucose glycoprotein glucosyltransferase 1,UGGT1,ERAD pathway [GO:0036503]; protein N-linked glycosylation via asparagine [GO:0018279],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; protein-containing complex [GO:0032991],UDP-glucose:glycoprotein glucosyltransferase activity [GO:0003980]; unfolded protein binding [GO:0051082]
1150,M3VX59,M3VX59_FELCA,Solute carrier family 23 member 1,SLC23A1,brain development [GO:0007420]; lung development [GO:0030324]; response to toxic substance [GO:0009636],apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; intracellular organelle [GO:0043229],dehydroascorbic acid transmembrane transporter activity [GO:0033300]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; urate transmembrane transporter activity [GO:0015143]
1151,M3VXB4,M3VXB4_FELCA,"NPHS2 stomatin family member, podocin",NPHS2,actin cytoskeleton organization [GO:0030036]; gene expression [GO:0010467]; metanephric podocyte development [GO:0072249],cytoplasmic side of plasma membrane [GO:0009898]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; slit diaphragm [GO:0036057],
1152,M3VXK4,M3VXK4_FELCA,"Keratin, type I cytoskeletal 17 (Cytokeratin-17) (Keratin-17)",KRT17,,cytoplasm [GO:0005737]; intermediate filament [GO:0005882],structural molecule activity [GO:0005198]
1153,M3VXU3,M3VXU3_FELCA,Arginase (EC 3.5.3.1),ARG1,arginine metabolic process [GO:0006525]; urea cycle [GO:0000050],,arginase activity [GO:0004053]; metal ion binding [GO:0046872]
1154,M3VYS9,M3VYS9_FELCA,HtrA serine peptidase 4,HTRA4,positive regulation of apoptotic process [GO:0043065]; programmed cell death [GO:0012501]; proteolysis [GO:0006508],extracellular region [GO:0005576],identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]
1155,M3VZ88,M3VZ88_FELCA,acetyl-CoA C-acetyltransferase (EC 2.3.1.9),ACAT2,,,"acyltransferase activity, transferring groups other than amino-acyl groups [GO:0016747]"
1156,M3VZA9,M3VZA9_FELCA,RELT TNF receptor,RELT,amelogenesis [GO:0097186]; apoptotic process [GO:0006915],membrane [GO:0016020]; nucleoplasm [GO:0005654],
1157,M3VZE1,M3VZE1_FELCA,Sushi domain containing 5,SUSD5,cell adhesion [GO:0007155]; Notch signaling pathway [GO:0007219],membrane [GO:0016020],hyaluronic acid binding [GO:0005540]
1158,M3VZN4,M3VZN4_FELCA,Cadherin related family member 2,CDHR2,cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; epithelial cell differentiation [GO:0030855]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; intermicrovillar adhesion [GO:0090675]; negative regulation of cell growth involved in contact inhibition [GO:0060243]; regulation of microvillus length [GO:0032532],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; microvillus membrane [GO:0031528],calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]
1159,M3W006,M3W006_FELCA,Proteasome subunit alpha type,PSMA7,ubiquitin-dependent protein catabolic process [GO:0006511],"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex, alpha-subunit complex [GO:0019773]",
1160,M3W064,M3W064_FELCA,Nucleobindin-1,NUCB1,,endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; membrane [GO:0016020],calcium ion binding [GO:0005509]
1161,M3W0Q9,M3W0Q9_FELCA,HtrA serine peptidase 1,HTRA1,chorionic trophoblast cell differentiation [GO:0060718]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; placenta development [GO:0001890]; positive regulation of apoptotic process [GO:0043065]; programmed cell death [GO:0012501]; proteolysis [GO:0006508],collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]
1162,M3W105,M3W105_FELCA,Carboxylic ester hydrolase (EC 3.1.1.-),CES2,prostaglandin metabolic process [GO:0006693],intracellular membrane-bounded organelle [GO:0043231],carboxylesterase activity [GO:0106435]; carboxylic ester hydrolase activity [GO:0052689]
1163,M3W107,M3W107_FELCA,Inactive serine protease 35,PRSS35,proteolysis [GO:0006508],extracellular region [GO:0005576],serine-type endopeptidase activity [GO:0004252]
1164,M3W126,M3W126_FELCA,Melanotransferrin,MELTF,iron ion transport [GO:0006826]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of plasminogen activation [GO:0010756],cell surface [GO:0009986]; early endosome [GO:0005769]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037],iron ion binding [GO:0005506]
1165,M3W158,M3W158_FELCA,Complement C8 alpha chain,C8A,"complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; killing of cells of another organism [GO:0031640]",extracellular region [GO:0005576]; membrane attack complex [GO:0005579],
1166,M3W1C3,M3W1C3_FELCA,Protein FAM151A,FAM151A,,extracellular space [GO:0005615]; membrane [GO:0016020],
1167,M3W1G1,M3W1G1_FELCA,Transporter,SLC6A8,amino acid transport [GO:0006865]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725],apical plasma membrane [GO:0016324]; plasma membrane [GO:0005886],creatine:sodium symporter activity [GO:0005309]; gamma-aminobutyric acid:sodium:chloride symporter activity [GO:0005332]
1168,M3W2U8,M3W2U8_FELCA,Basal cell adhesion molecule (Lutheran blood group),BCAM,cell-matrix adhesion [GO:0007160],cell surface [GO:0009986]; plasma membrane [GO:0005886],laminin binding [GO:0043236]; laminin receptor activity [GO:0005055]
1169,M3W2V3,M3W2V3_FELCA,Apolipoprotein C-IV (Apolipoprotein C4),APOC4,positive regulation of sequestering of triglyceride [GO:0010890]; triglyceride homeostasis [GO:0070328],high-density lipoprotein particle [GO:0034364]; very-low-density lipoprotein particle [GO:0034361],
1170,M3W2Z1,M3W2Z1_FELCA,Vitamin D-binding protein (Gc-globulin) (Group-specific component),GC,vitamin D metabolic process [GO:0042359],cytoplasm [GO:0005737]; extracellular space [GO:0005615],actin binding [GO:0003779]; calcidiol binding [GO:1902118]; vitamin D binding [GO:0005499]; vitamin transmembrane transporter activity [GO:0090482]
1171,M3W340,M3W340_FELCA,Glucosidase 2 subunit beta,PRKCSH,in utero embryonic development [GO:0001701]; liver development [GO:0001889]; N-glycan processing [GO:0006491]; negative regulation of neuron projection development [GO:0010977],glucosidase II complex [GO:0017177],calcium ion binding [GO:0005509]; RNA binding [GO:0003723]
1172,M3W3H5,M3W3H5_FELCA,Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase),ASS1,arginine biosynthetic process [GO:0006526]; urea cycle [GO:0000050],,argininosuccinate synthase activity [GO:0004055]; ATP binding [GO:0005524]
1173,M3W3I3,M3W3I3_FELCA,Annexin A10,ANXA10,,cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506],calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylserine binding [GO:0001786]
1174,M3W3Q0,M3W3Q0_FELCA,Glutathione S-transferase (EC 2.5.1.18),LOC101096317,xenobiotic metabolic process [GO:0006805],cytosol [GO:0005829],glutathione transferase activity [GO:0004364]
1175,M3W4L2,M3W4L2_FELCA,Insulin-like growth factor-binding protein 1,IGFBP1,regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; response to insulin [GO:0032868],extracellular space [GO:0005615]; Golgi apparatus [GO:0005794],insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor II binding [GO:0031995]
1176,M3W551,M3W551_FELCA,Copper transport protein ATOX1 (Metal transport protein ATX1),ATOX1,copper ion transport [GO:0006825]; intracellular copper ion homeostasis [GO:0006878],cytosol [GO:0005829],copper chaperone activity [GO:0016531]; copper-dependent protein binding [GO:0032767]; cuprous ion binding [GO:1903136]
1177,M3W5G1,M3W5G1_FELCA,Guanylate cyclase activator 2B,GUCA2B,,extracellular region [GO:0005576],guanylate cyclase activator activity [GO:0030250]
1178,M3W5G2,M3W5G2_FELCA,Guanylin (Guanylate cyclase activator 2A),GUCA2A,,extracellular region [GO:0005576],guanylate cyclase activator activity [GO:0030250]
1179,M3W5N1,M3W5N1_FELCA,Serpin family F member 1,SERPINF1,epithelial cell proliferation involved in prostate gland development [GO:0060767]; negative regulation of angiogenesis [GO:0016525]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; positive regulation of neurogenesis [GO:0050769],extracellular space [GO:0005615],serine-type endopeptidase inhibitor activity [GO:0004867]
1180,M3W5Z6,M3W5Z6_FELCA,Polymeric immunoglobulin receptor,PIGR,detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; epidermal growth factor receptor signaling pathway [GO:0007173]; immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor [GO:0002415]; receptor clustering [GO:0043113],plasma membrane [GO:0005886]; receptor complex [GO:0043235]; secretory IgA immunoglobulin complex [GO:0071751],polymeric immunoglobulin binding [GO:0001790]; polymeric immunoglobulin receptor activity [GO:0001792]
1181,M3W6G1,M3W6G1_FELCA,Roundabout guidance receptor 4,ROBO4,angiogenesis [GO:0001525]; cell-cell adhesion [GO:0098609]; establishment of endothelial barrier [GO:0061028],,
1182,M3W7M8,M3W7M8_FELCA,Cathepsin F,CTSF,proteolysis involved in protein catabolic process [GO:0051603],endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosome [GO:0005764]; plasma membrane [GO:0005886],cysteine-type endopeptidase activity [GO:0004197]
1183,M3W7W5,M3W7W5_FELCA,Cobalamin binding intrinsic factor,CBLIF,cobalamin transport [GO:0015889]; cobalt ion transport [GO:0006824],apical plasma membrane [GO:0016324]; endosome [GO:0005768]; extracellular space [GO:0005615]; microvillus [GO:0005902],cargo receptor ligand activity [GO:0140355]; cobalamin binding [GO:0031419]
1184,M3W808,M3W808_FELCA,45 kDa calcium-binding protein (Stromal cell-derived factor 4),SDF4,calcium-ion regulated exocytosis [GO:0017156]; fat cell differentiation [GO:0045444],endoplasmic reticulum [GO:0005783]; Golgi lumen [GO:0005796]; late endosome [GO:0005770],calcium ion binding [GO:0005509]
1185,M3W8D8,M3W8D8_FELCA,CD200 molecule,CD200,heterotypic cell-cell adhesion [GO:0034113]; negative regulation of matrix metallopeptidase secretion [GO:1904465]; negative regulation of neuroinflammatory response [GO:0150079]; positive regulation of transforming growth factor beta production [GO:0071636],axon [GO:0030424]; cell surface [GO:0009986]; membrane [GO:0016020]; neuronal cell body [GO:0043025],cell-cell adhesion mediator activity [GO:0098632]
1186,M3W8T7,M3W8T7_FELCA,tRNA pseudouridine(55) synthase (EC 5.4.99.25),PUS10,primary miRNA processing [GO:0031053]; tRNA pseudouridine synthesis [GO:0031119],cytoplasm [GO:0005737]; nucleus [GO:0005634],primary miRNA binding [GO:0070878]; pseudouridine synthase activity [GO:0009982]; tRNA pseudouridine(55) synthase activity [GO:0160148]
1187,M3W8X2,M3W8X2_FELCA,Transmembrane serine protease 2,TMPRSS2,positive regulation of viral entry into host cell [GO:0046598]; protein autoprocessing [GO:0016540],nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],serine-type endopeptidase activity [GO:0004252]
1188,M3W922,M3W922_FELCA,Coagulation factor V,F5,blood circulation [GO:0008015]; blood coagulation [GO:0007596],extracellular space [GO:0005615]; platelet alpha granule [GO:0031091],copper ion binding [GO:0005507]
1189,M3W9H4,M3W9H4_FELCA,Serpin B10,SERPINB10,,cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654],serine-type endopeptidase inhibitor activity [GO:0004867]
1190,M3WAQ7,M3WAQ7_FELCA,Hexosyltransferase (EC 2.4.1.-),B3GNT2,axon guidance [GO:0007411]; cellular response to leukemia inhibitory factor [GO:1990830]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein O-linked glycosylation [GO:0006493]; sensory perception of smell [GO:0007608],Golgi membrane [GO:0000139],"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]"
1191,M3WAV4,M3WAV4_FELCA,aldehyde dehydrogenase (NAD(+)) (EC 1.2.1.3),ALDH1A1,cellular detoxification of aldehyde [GO:0110095]; fructosamine catabolic process [GO:0030392],cytosol [GO:0005829],3-deoxyglucosone dehydrogenase activity [GO:0106373]; benzaldehyde dehydrogenase (NAD+) activity [GO:0018479]
1192,M3WB64,M3WB64_FELCA,Metalloendopeptidase (EC 3.4.24.-),MEP1A,proteolysis [GO:0006508],membrane [GO:0016020],metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]
1193,M3WBC6,M3WBC6_FELCA,Protocadherin 1,PCDH1,cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],cell junction [GO:0030054]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]
1194,M3WBD8,M3WBD8_FELCA,Sushi domain containing 2,SUSD2,negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell division [GO:0051782],extracellular space [GO:0005615]; plasma membrane [GO:0005886],
1195,M3WBI8,M3WBI8_FELCA,C-type lectin domain family 18 member A,LOC101095392,,extracellular space [GO:0005615],polysaccharide binding [GO:0030247]
1196,M3WBM7,M3WBM7_FELCA,Transporter,SLC6A19,neutral amino acid transport [GO:0015804]; sodium ion transmembrane transport [GO:0035725],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; plasma membrane [GO:0005886],neutral L-amino acid transmembrane transporter activity [GO:0015175]; symporter activity [GO:0015293]
1197,M3WBQ5,M3WBQ5_FELCA,Transferrin,TF,iron ion transport [GO:0006826],extracellular space [GO:0005615],metal ion binding [GO:0046872]
1198,M3WBR7,M3WBR7_FELCA,Transmembrane protein 102,TMEM102,positive regulation of cell adhesion [GO:0045785]; positive regulation of T cell chemotaxis [GO:0010820]; regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901028]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; response to cytokine [GO:0034097]; signal transduction [GO:0007165],cell surface [GO:0009986]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991],
1199,M3WCA0,M3WCA0_FELCA,Golgi membrane protein 1,GOLM1,nucleus organization [GO:0006997]; regulation of lipid metabolic process [GO:0019216],Golgi apparatus [GO:0005794]; membrane [GO:0016020],
1200,M3WCF8,M3WCF8_FELCA,Monooxygenase DBH like 1,MOXD1,dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589],endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; secretory granule membrane [GO:0030667],copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]
1201,M3WCF9,M3WCF9_FELCA,Plexin domain containing 1,PLXDC1,,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],
1202,M3WCG8,M3WCG8_FELCA,Translation initiation factor eIF2B subunit gamma (eIF2B GDP-GTP exchange factor subunit gamma),EIF2B3,cytoplasmic translational initiation [GO:0002183]; oligodendrocyte development [GO:0014003]; T cell receptor signaling pathway [GO:0050852],cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]; guanyl-nucleotide exchange factor complex [GO:0032045],guanyl-nucleotide exchange factor activity [GO:0005085]; translation initiation factor activity [GO:0003743]
1203,M3WCI9,M3WCI9_FELCA,C-C motif chemokine,CCL16,antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; chemokine-mediated signaling pathway [GO:0070098]; eosinophil chemotaxis [GO:0048245]; inflammatory response [GO:0006954]; positive regulation of cell migration [GO:0030335],extracellular space [GO:0005615],CCR chemokine receptor binding [GO:0048020]; chemoattractant activity [GO:0042056]; chemokine activity [GO:0008009]
1204,M3WCX0,M3WCX0_FELCA,Corticosteroid-binding globulin (Serpin A6) (Transcortin),SERPINA6,glucocorticoid metabolic process [GO:0008211],extracellular space [GO:0005615],serine-type endopeptidase inhibitor activity [GO:0004867]; steroid binding [GO:0005496]
1205,M3WCX6,M3WCX6_FELCA,Serpin family A member 3,SERPINA3,,chromaffin granule [GO:0042583]; extracellular space [GO:0005615],serine-type endopeptidase inhibitor activity [GO:0004867]
1206,M3WDQ9,M3WDQ9_FELCA,Prominin 2,PROM2,negative regulation of caveolin-mediated endocytosis [GO:2001287]; negative regulation of pinocytosis [GO:0048550]; positive regulation of cell projection organization [GO:0031346]; positive regulation of protein phosphorylation [GO:0001934],apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cilium [GO:0005929]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; prominosome [GO:0071914],cholesterol binding [GO:0015485]
1207,M3WE80,M3WE80_FELCA,Mannose receptor C type 2,MRC2,collagen catabolic process [GO:0030574]; endocytosis [GO:0006897],membrane [GO:0016020],carbohydrate binding [GO:0030246]; collagen binding [GO:0005518]; signaling receptor activity [GO:0038023]
1208,M3WEL8,M3WEL8_FELCA,Profilin,PFN1,actin cytoskeleton organization [GO:0030036]; positive regulation of actin filament bundle assembly [GO:0032233]; regulation of actin filament polymerization [GO:0030833],cytoplasm [GO:0005737],actin binding [GO:0003779]
1209,M3WEM7,M3WEM7_FELCA,Inter-alpha-trypsin inhibitor heavy chain 5,ITIH5,hyaluronan metabolic process [GO:0030212],extracellular region [GO:0005576],serine-type endopeptidase inhibitor activity [GO:0004867]
1210,M3WEV9,M3WEV9_FELCA,Transthyretin,TTR,purine nucleobase metabolic process [GO:0006144],extracellular space [GO:0005615],hormone activity [GO:0005179]; identical protein binding [GO:0042802]; thyroid hormone binding [GO:0070324]
1211,M3WF05,M3WF05_FELCA,Proteasome subunit alpha type,PSMA1,negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],"centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome core complex, alpha-subunit complex [GO:0019773]",lipopolysaccharide binding [GO:0001530]
1212,M3WF16,M3WF16_FELCA,ATPase H+ transporting accessory protein 1,ATP6AP1,cellular response to increased oxygen levels [GO:0036295]; endosome to plasma membrane protein transport [GO:0099638]; intracellular iron ion homeostasis [GO:0006879]; osteoclast development [GO:0036035]; regulation of cellular pH [GO:0030641]; synaptic vesicle lumen acidification [GO:0097401],endosome membrane [GO:0010008]; presynapse [GO:0098793]; proton-transporting V-type ATPase complex [GO:0033176],ATPase activator activity [GO:0001671]; small GTPase binding [GO:0031267]; transporter activator activity [GO:0141109]
1213,M3WF53,M3WF53_FELCA,Cartilage intermediate layer protein,CILP,negative regulation of gene expression [GO:0010629]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512],collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615],carbohydrate binding [GO:0030246]
1214,M3WFA5,M3WFA5_FELCA,protein-lysine 6-oxidase (EC 1.4.3.13),LOXL1,collagen fibril organization [GO:0030199],collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615],copper ion binding [GO:0005507]; protein-lysine 6-oxidase activity [GO:0004720]
1215,M3WFG2,M3WFG2_FELCA,Cochlin,COCH,regulation of cell shape [GO:0008360]; sensory perception of sound [GO:0007605],collagen-containing extracellular matrix [GO:0062023],collagen binding [GO:0005518]
1216,M3WFY4,M3WFY4_FELCA,Platelet-derived growth factor receptor-like protein,PDGFRL,,extracellular region [GO:0005576],
1217,M3WGI2,M3WGI2_FELCA,Pro-cathepsin H,CTSH,proteolysis [GO:0006508],lysosome [GO:0005764],cysteine-type peptidase activity [GO:0008234]
1218,M3WGV2,M3WGV2_FELCA,Solute carrier family 22 member 13,SLC22A13,negative regulation of fatty acid metabolic process [GO:0045922]; positive regulation of T cell mediated cytotoxicity directed against tumor cell target [GO:0002854],apical plasma membrane [GO:0016324]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794],nicotinate transmembrane transporter activity [GO:0090416]; urate transmembrane transporter activity [GO:0015143]
1219,M3WH13,M3WH13_FELCA,glutaminyl-peptide cyclotransferase (EC 2.3.2.5),QPCTL,,Golgi apparatus [GO:0005794]; membrane [GO:0016020],glutaminyl-peptide cyclotransferase activity [GO:0016603]; zinc ion binding [GO:0008270]
1220,M3WH96,M3WH96_FELCA,"RTF1 homolog, Paf1/RNA polymerase II complex component",RTF1,blastocyst growth [GO:0001832]; chromatin organization [GO:0006325]; endodermal cell fate commitment [GO:0001711]; negative regulation of transcription by RNA polymerase II [GO:0000122]; stem cell population maintenance [GO:0019827]; transcription elongation by RNA polymerase II [GO:0006368],Cdc73/Paf1 complex [GO:0016593]; nucleolus [GO:0005730],RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; single-stranded DNA binding [GO:0003697]
1221,M3WHA5,M3WHA5_FELCA,Protein kinase C and casein kinase substrate in neurons 3,PACSIN3,cytoskeleton organization [GO:0007010]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of endocytosis [GO:0045806]; plasma membrane tubulation [GO:0097320]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of endocytosis [GO:0030100],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; plasma membrane [GO:0005886],calcium channel inhibitor activity [GO:0019855]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]
1222,M3WHB2,M3WHB2_FELCA,HGF activator,HGFAC,blood coagulation [GO:0007596]; zymogen activation [GO:0031638],extracellular space [GO:0005615]; rough endoplasmic reticulum [GO:0005791],serine-type endopeptidase activity [GO:0004252]
1223,M3WHB4,M3WHB4_FELCA,Rab GDP dissociation inhibitor,GDI2,negative regulation of cilium assembly [GO:1902018]; negative regulation of protein localization to cilium [GO:1903565]; protein transport [GO:0015031]; small GTPase-mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192],cytoplasm [GO:0005737]; membrane [GO:0016020],GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]
1224,M3WHG4,M3WHG4_FELCA,Collagen type VI alpha 3 chain,COL6A3,cell adhesion [GO:0007155]; neuron apoptotic process [GO:0051402]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; response to UV [GO:0009411],collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; sarcolemma [GO:0042383],serine-type endopeptidase inhibitor activity [GO:0004867]
1225,M3WHM8,M3WHM8_FELCA,SH3 domain-binding glutamic acid-rich-like protein 3,SH3BGRL3,cytoskeleton organization [GO:0007010],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; ruffle membrane [GO:0032587],
1226,M3WHT1,M3WHT1_FELCA,Ganglioside GM2 activator,GM2A,ganglioside catabolic process [GO:0006689]; learning or memory [GO:0007611]; lipid storage [GO:0019915]; lipid transport [GO:0006869]; maintenance of location in cell [GO:0051651]; neuromuscular process controlling balance [GO:0050885]; oligosaccharide catabolic process [GO:0009313],cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231],beta-N-acetylhexosaminidase activity [GO:0004563]; enzyme activator activity [GO:0008047]; lipid transporter activity [GO:0005319]
1227,M3WHT7,M3WHT7_FELCA,Ammonium transporter Rh type C (Rhesus blood group family type C glycoprotein),RHCG,,apical plasma membrane [GO:0016324],ammonium transmembrane transporter activity [GO:0008519]
1228,M3WI37,M3WI37_FELCA,Multimerin 1,MMRN1,cell adhesion mediated by integrin [GO:0033627]; negative regulation of wound healing [GO:0061045]; positive regulation of platelet aggregation [GO:1901731],collagen trimer [GO:0005581]; multimerin complex [GO:1990972]; platelet alpha granule [GO:0031091],extracellular matrix constituent conferring elasticity [GO:0030023]
1229,M3WI49,M3WI49_FELCA,"SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2",SPOCK2,cellular response to leukemia inhibitory factor [GO:1990830]; extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811],,calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; glycosaminoglycan binding [GO:0005539]
1230,M3WI50,M3WI50_FELCA,Tissue factor pathway inhibitor,TFPI,blood coagulation [GO:0007596]; cellular response to steroid hormone stimulus [GO:0071383]; negative regulation of blood coagulation [GO:0030195],caveola [GO:0005901]; cell surface [GO:0009986]; extracellular space [GO:0005615],serine-type endopeptidase inhibitor activity [GO:0004867]
1231,M3WIK5,M3WIK5_FELCA,Cystatin E/M,CST6,epidermis development [GO:0008544],cornified envelope [GO:0001533]; extracellular region [GO:0005576],cysteine-type endopeptidase inhibitor activity [GO:0004869]
1232,M3WJ85,M3WJ85_FELCA,Peptidoglycan recognition protein 2,PGLYRP2,biological process involved in interaction with host [GO:0051701]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterium [GO:0016045]; negative regulation of natural killer cell differentiation involved in immune response [GO:0032827]; negative regulation of type II interferon production [GO:0032689]; peptidoglycan catabolic process [GO:0009253]; regulation of inflammatory response [GO:0050727],membrane [GO:0016020],N-acetylmuramoyl-L-alanine amidase activity [GO:0008745]; peptidoglycan binding [GO:0042834]; peptidoglycan immune receptor activity [GO:0016019]; zinc ion binding [GO:0008270]
1233,M3WJA1,M3WJA1_FELCA,Pepsin A (EC 3.4.23.1),LOC101080826,digestion [GO:0007586]; proteolysis [GO:0006508],,aspartic-type endopeptidase activity [GO:0004190]
1234,M3WJJ1,M3WJJ1_FELCA,Solute carrier family 5 member 12,SLC5A12,sodium ion transport [GO:0006814],apical plasma membrane [GO:0016324]; nucleoplasm [GO:0005654],lactate transmembrane transporter activity [GO:0015129]; symporter activity [GO:0015293]
1235,M3WJK2,M3WJK2_FELCA,Complement component 4 binding protein beta,C4BPB,"negative regulation of complement activation, classical pathway [GO:0045959]; positive regulation of protein catabolic process [GO:0045732]; regulation of opsonization [GO:1903027]; response to symbiotic bacterium [GO:0009609]",extracellular space [GO:0005615],
1236,M3WK02,M3WK02_FELCA,S100 calcium binding protein A12,S100A12,antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response to fungus [GO:0050832]; endothelial cell migration [GO:0043542]; killing of cells of another organism [GO:0031640]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; nucleus [GO:0005634],calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; RAGE receptor binding [GO:0050786]
1237,M3WK50,M3WK50_FELCA,cAMP responsive element binding protein 3 like 3,CREB3L3,regulation of transcription by RNA polymerase II [GO:0006357]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986],endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"
1238,M3WKB5,M3WKB5_FELCA,Xaa-Arg dipeptidase,PM20D2,proteolysis [GO:0006508]; regulation of protein metabolic process [GO:0051246],nucleoplasm [GO:0005654],carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; identical protein binding [GO:0042802]
1239,M3WKB7,M3WKB7_FELCA,Carboxypeptidase A1 (EC 3.4.17.1),CPA1,proteolysis [GO:0006508],extracellular space [GO:0005615],metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]
1240,M3WKH4,M3WKH4_FELCA,Carboxylic ester hydrolase (EC 3.1.1.-),CES5A CES1,lipid catabolic process [GO:0016042],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; lipid droplet [GO:0005811],carboxylic ester hydrolase activity [GO:0052689]
1241,M3WKJ1,M3WKJ1_FELCA,Transforming growth factor-beta-induced protein ig-h3,TGFBI,angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; localization [GO:0051179],extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802],cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; identical protein binding [GO:0042802]
1242,M3WLL8,M3WLL8_FELCA,Antithrombin-III (Serpin C1),SERPINC1,blood coagulation [GO:0007596]; regulation of blood coagulation [GO:0030193],extracellular space [GO:0005615],heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]
1243,M3WM81,M3WM81_FELCA,Cadherin-5 (Vascular endothelial cadherin),CDH5,homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],plasma membrane [GO:0005886],calcium ion binding [GO:0005509]
1244,M3WMB7,M3WMB7_FELCA,HtrA serine peptidase 3,HTRA3,negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; proteolysis [GO:0006508],extracellular region [GO:0005576],identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]
1245,M3WMU1,M3WMU1_FELCA,"SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1",SPOCK1,establishment of protein localization to extracellular region [GO:0035592]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of neuron projection development [GO:0010977],extracellular space [GO:0005615],calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; metalloendopeptidase inhibitor activity [GO:0008191]
1246,M3WMZ2,M3WMZ2_FELCA,Endoplasmic reticulum protein 44,ERP44,glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986],cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793],protein disulfide isomerase activity [GO:0003756]
1247,M3WN23,M3WN23_FELCA,ATP binding cassette subfamily A member 6,ABCA6,lipid transport [GO:0006869],intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020],ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]
1248,M3WN53,M3WN53_FELCA,Stabilin 1,STAB1,cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; defense response to bacterium [GO:0042742]; negative regulation of angiogenesis [GO:0016525],plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; hyaluronic acid binding [GO:0005540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; scavenger receptor activity [GO:0005044]
1249,M3WN59,M3WN59_FELCA,Inter-alpha-trypsin inhibitor heavy chain H1,ITIH1,hyaluronan metabolic process [GO:0030212],extracellular region [GO:0005576],hyaluronic acid binding [GO:0005540]; serine-type endopeptidase inhibitor activity [GO:0004867]
1250,M3WN60,M3WN60_FELCA,Inter-alpha-trypsin inhibitor heavy chain H3,ITIH3,hyaluronan metabolic process [GO:0030212],extracellular region [GO:0005576],serine-type endopeptidase inhibitor activity [GO:0004867]
1251,M3WN82,M3WN82_FELCA,Collectin-12,COLEC12,,collagen trimer [GO:0005581]; membrane [GO:0016020],carbohydrate binding [GO:0030246]
1252,M3WNB8,M3WNB8_FELCA,Cysteine rich protein 1,CRIP1,cellular response to antibiotic [GO:0071236]; cellular response to UV-B [GO:0071493]; immune response [GO:0006955]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; prostate gland stromal morphogenesis [GO:0060741]; regulation of gene expression [GO:0010468]; response to organic substance [GO:0010033]; response to zinc ion [GO:0010043],cytoplasm [GO:0005737],peptide binding [GO:0042277]; zinc ion binding [GO:0008270]
1253,M3WNK3,M3WNK3_FELCA,Pulmonary surfactant-associated protein B (Pulmonary surfactant-associated proteolipid SPL(Phe)),SFTPB,respiratory gaseous exchange by respiratory system [GO:0007585]; sphingolipid metabolic process [GO:0006665],alveolar lamellar body [GO:0097208]; extracellular region [GO:0005576]; lysosome [GO:0005764]; multivesicular body [GO:0005771],
1254,M3WNU5,M3WNU5_FELCA,ADAMTS like 2,ADAMTSL2,extracellular matrix organization [GO:0030198]; lobar bronchus epithelium development [GO:0060481]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512],extracellular matrix [GO:0031012]; extracellular region [GO:0005576],microfibril binding [GO:0050436]
1255,M3WNX1,M3WNX1_FELCA,Apolipoprotein C-II (Apo-CII) (ApoC-II) (Apolipoprotein C2),APOC2,lipid catabolic process [GO:0016042]; lipid transport [GO:0006869]; positive regulation of phospholipid catabolic process [GO:0060697],chylomicron [GO:0042627]; high-density lipoprotein particle [GO:0034364]; low-density lipoprotein particle [GO:0034362]; very-low-density lipoprotein particle [GO:0034361],phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]
1256,M3WP30,M3WP30_FELCA,Transmembrane protein 132A,TMEM132A,negative regulation of protein catabolic process [GO:0042177]; positive regulation of Wnt protein secretion [GO:0061357]; positive regulation of Wnt signaling pathway [GO:0030177],endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886],protein homodimerization activity [GO:0042803]
1257,M3WPE0,M3WPE0_FELCA,Collagen type XXVIII alpha 1 chain,COL28A1,cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199],basement membrane [GO:0005604]; collagen type V trimer [GO:0005588]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615],extracellular matrix structural constituent conferring tensile strength [GO:0030020]; heparin binding [GO:0008201]; serine-type endopeptidase inhibitor activity [GO:0004867]
1258,M3WQ38,M3WQ38_FELCA,Gamma-glutamylaminecyclotransferase (EC 4.3.2.8),GGACT,cellular modified amino acid catabolic process [GO:0042219],cytosol [GO:0005829],gamma-glutamylaminecyclotransferase activity [GO:0061929]
1259,M3WQ85,M3WQ85_FELCA,Carboxypeptidase (EC 3.4.16.-),SCPEP1,blood vessel diameter maintenance [GO:0097746]; negative regulation of blood pressure [GO:0045776]; proteolysis [GO:0006508],,serine-type carboxypeptidase activity [GO:0004185]
1260,M3WQY4,M3WQY4_FELCA,"Fatty acid-binding protein, intestinal (Fatty acid-binding protein 2) (Intestinal-type fatty acid-binding protein)",FABP2,fatty acid transport [GO:0015908]; intestinal lipid absorption [GO:0098856],cytosol [GO:0005829]; nucleus [GO:0005634],long-chain fatty acid binding [GO:0036041]
1261,M3WRY2,M3WRY2_FELCA,Extracellular matrix protein 1,ECM1,negative regulation of bone mineralization [GO:0030502]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; regulation of bone mineralization [GO:0030500]; signal transduction [GO:0007165],collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615],protease binding [GO:0002020]
1262,M3WS40,M3WS40_FELCA,Carbonic anhydrase (EC 4.2.1.1),CA3,one-carbon metabolic process [GO:0006730]; response to bacterium [GO:0009617],cytoplasm [GO:0005737]; cytosol [GO:0005829],carbonate dehydratase activity [GO:0004089]; nickel cation binding [GO:0016151]; zinc ion binding [GO:0008270]
1263,M3WS63,M3WS63_FELCA,Complement C1q subcomponent subunit A,C1QA,"astrocyte activation [GO:0048143]; complement activation, classical pathway [GO:0006958]; complement-mediated synapse pruning [GO:0150062]; microglial cell activation [GO:0001774]; neuron remodeling [GO:0016322]; vertebrate eye-specific patterning [GO:0150064]",collagen trimer [GO:0005581]; complement component C1q complex [GO:0062167]; postsynapse [GO:0098794],
1264,M3WSF8,M3WSF8_FELCA,Immunoglobulin subtype domain-containing protein,GP6,collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; immune response-regulating signaling pathway [GO:0002764]; platelet aggregation [GO:0070527],cell surface [GO:0009986]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; tetraspanin-enriched microdomain [GO:0097197],collagen binding [GO:0005518]; collagen receptor activity [GO:0038064]; protein tyrosine kinase binding [GO:1990782]
1265,M3WSL5,M3WSL5_FELCA,Actin-related protein 2/3 complex subunit 4,ARPC4,actin filament polymerization [GO:0030041]; Arp2/3 complex-mediated actin nucleation [GO:0034314],Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737],actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; protein-macromolecule adaptor activity [GO:0030674]; structural constituent of cytoskeleton [GO:0005200]
1266,M3WSQ2,M3WSQ2_FELCA,von Willebrand factor A domain-containing protein 1,VWA1,behavioral response to pain [GO:0048266]; extracellular matrix organization [GO:0030198]; protein homooligomerization [GO:0051260],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; interstitial matrix [GO:0005614]; membrane [GO:0016020],microfibril binding [GO:0050436]; protein homodimerization activity [GO:0042803]
1267,M3WST2,M3WST2_FELCA,Glutaminyl-peptide cyclotransferase (EC 2.3.2.5) (Glutaminyl cyclase) (Glutaminyl-tRNA cyclotransferase),QPCT,,extracellular region [GO:0005576],glutaminyl-peptide cyclotransferase activity [GO:0016603]; zinc ion binding [GO:0008270]
1268,M3WTN0,M3WTN0_FELCA,Transmembrane serine protease 6,TMPRSS6,proteolysis [GO:0006508],membrane [GO:0016020],serine-type endopeptidase activity [GO:0004252]
1269,M3WTQ9,M3WTQ9_FELCA,Inorganic pyrophosphatase (EC 3.6.1.1) (Pyrophosphate phospho-hydrolase),PPA1,phosphate-containing compound metabolic process [GO:0006796],cytoplasm [GO:0005737],inorganic diphosphate phosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]
1270,M3WUC1,M3WUC1_FELCA,Cathepsin O,CTSO,proteolysis involved in protein catabolic process [GO:0051603],extracellular space [GO:0005615]; lysosome [GO:0005764],cysteine-type endopeptidase activity [GO:0004197]
1271,M3WVC7,M3WVC7_FELCA,14-3-3 protein zeta/delta,YWHAZ,protein localization [GO:0008104]; signal transduction [GO:0007165],cytoplasm [GO:0005737],
1272,M3WVN7,M3WVN7_FELCA,Platelet endothelial aggregation receptor 1,PEAR1,phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; platelet aggregation [GO:0070527]; positive regulation of platelet activation [GO:0010572]; recognition of apoptotic cell [GO:0043654],lamellipodium [GO:0030027]; membrane [GO:0016020]; phagocytic cup [GO:0001891],signaling receptor activity [GO:0038023]
1273,M3WVZ4,M3WVZ4_FELCA,Globin A1,LOC101098159 GLNA1,,hemoglobin complex [GO:0005833],heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]
1274,M3WWN6,M3WWN6_FELCA,Asporin,ASPN,bone mineralization [GO:0030282]; negative regulation of tooth mineralization [GO:0070171]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512],extracellular matrix [GO:0031012]; extracellular space [GO:0005615],calcium ion binding [GO:0005509]
1275,M3WXE7,M3WXE7_FELCA,EH domain containing 4,EHD4,cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659],cytoplasm [GO:0005737]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]
1276,M3WXF2,M3WXF2_FELCA,Peptidase inhibitor 16,PI16,negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052],extracellular space [GO:0005615]; membrane [GO:0016020],
1277,M3WZ15,M3WZ15_FELCA,Fibulin-1,FBLN1,extracellular matrix organization [GO:0030198],extracellular region [GO:0005576],calcium ion binding [GO:0005509]; peptidase activator activity [GO:0016504]
1278,M3WZD7,M3WZD7_FELCA,IF rod domain-containing protein,KRT89,intermediate filament organization [GO:0045109]; keratinization [GO:0031424],keratin filament [GO:0045095],structural constituent of skin epidermis [GO:0030280]
1279,M3X096,M3X096_FELCA,Carboxylic ester hydrolase (EC 3.1.1.-),CEL,ceramide catabolic process [GO:0046514]; intestinal cholesterol absorption [GO:0030299]; pancreatic juice secretion [GO:0030157],,retinyl-palmitate esterase activity [GO:0050253]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]
1280,M3X0F1,M3X0F1_FELCA,Aspartylglucosaminidase,AGA,,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosome [GO:0005764],N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity [GO:0003948]
1281,M3X143,M3X143_FELCA,Corneodesmosin,CDSN,cell-cell adhesion [GO:0098609]; skin morphogenesis [GO:0043589],extracellular region [GO:0005576],protein homodimerization activity [GO:0042803]
1282,M3X167,M3X167_FELCA,Leucine rich repeat containing 19,LRRC19,host-mediated regulation of intestinal microbiota composition [GO:0048874]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; regulation of cytokine production [GO:0001817]; regulation of inflammatory response [GO:0050727]; toll-like receptor signaling pathway [GO:0002224],plasma membrane [GO:0005886],signaling receptor activity [GO:0038023]
1283,M3X177,M3X177_FELCA,Fem-1 homolog A,FEM1A,negative regulation of inflammatory response [GO:0050728]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627],Cul2-RING ubiquitin ligase complex [GO:0031462]; mitochondrion [GO:0005739]; ubiquitin ligase complex [GO:0000151],EP4 subtype prostaglandin E2 receptor binding [GO:0031867]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]
1284,M3X1M2,M3X1M2_FELCA,Hemicentin 1,HMCN1,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; response to bacterium [GO:0009617],basement membrane [GO:0005604]; cell cortex [GO:0005938]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509]
1285,M3X277,M3X277_FELCA,RAS related,RRAS,face morphogenesis [GO:0060325]; leukocyte differentiation [GO:0002521]; negative regulation of Schwann cell migration [GO:1900148]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904906]; positive regulation of vasculogenesis [GO:2001214]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; Schwann cell migration [GO:0036135]; signal transduction [GO:0007165],plasma membrane [GO:0005886],GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein-containing complex binding [GO:0044877]
1286,M3X2X6,M3X2X6_FELCA,Centromere protein C,CENPC,attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; kinetochore assembly [GO:0051382]; spindle attachment to meiosis I kinetochore [GO:0051455],inner kinetochore [GO:0000939]; midbody [GO:0030496]; nuclear body [GO:0016604]; pericentric heterochromatin [GO:0005721],centromeric DNA binding [GO:0019237]; identical protein binding [GO:0042802]
1287,M3X4X2,M3X4X2_FELCA,EPS8 like 1,EPS8L1,positive regulation of ruffle assembly [GO:1900029]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266],cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587],actin binding [GO:0003779]; guanyl-nucleotide exchange factor activity [GO:0005085]; T cell receptor binding [GO:0042608]
1288,M3X557,M3X557_FELCA,Alpha-fetoprotein (Alpha-1-fetoprotein) (Alpha-fetoglobulin),AFP,ovulation from ovarian follicle [GO:0001542]; progesterone metabolic process [GO:0042448],cytoplasm [GO:0005737]; extracellular space [GO:0005615],metal ion binding [GO:0046872]; small molecule binding [GO:0036094]
1289,M3X588,M3X588_FELCA,Leucine rich repeat containing 15,LRRC15,negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of cell migration [GO:0030335]; receptor-mediated virion attachment to host cell [GO:0046813],apical plasma membrane [GO:0016324]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615],collagen binding [GO:0005518]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; protein sequestering activity [GO:0140311]
1290,M3X5H0,M3X5H0_FELCA,Alpha-amylase (EC 3.2.1.1),AMY2B,carbohydrate metabolic process [GO:0005975],extracellular space [GO:0005615],alpha-amylase activity [GO:0004556]; metal ion binding [GO:0046872]
1291,M3X5J0,M3X5J0_FELCA,ADAM metallopeptidase with thrombospondin type 1 motif 13,ADAMTS13,extracellular matrix organization [GO:0030198]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],extracellular matrix [GO:0031012]; extracellular region [GO:0005576],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]
1292,M3X5T9,M3X5T9_FELCA,G protein subunit beta 2,GNB2,G protein-coupled receptor signaling pathway [GO:0007186]; regulation of potassium ion transmembrane transport [GO:1901379],cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; perinuclear region of cytoplasm [GO:0048471],GTPase binding [GO:0051020]; protein-containing complex binding [GO:0044877]; signaling receptor complex adaptor activity [GO:0030159]
1293,M3X6F1,M3X6F1_FELCA,Charged multivesicular body protein 5 (Chromatin-modifying protein 5),CHMP5,vacuolar transport [GO:0007034],,
1294,M3X710,M3X710_FELCA,Delta like non-canonical Notch ligand 2,DLK2,negative regulation of Notch signaling pathway [GO:0045746]; regulation of fat cell differentiation [GO:0045598],membrane [GO:0016020],calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]
1295,M3X749,M3X749_FELCA,Angiopoietin 4,ANGPT4,cellular response to hypoxia [GO:0071456]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; Notch signaling pathway [GO:0007219]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; signal transduction [GO:0007165],collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615],receptor tyrosine kinase binding [GO:0030971]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]
1296,M3X7U8,M3X7U8_FELCA,Hemicentin 2,HMCN2,,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; extracellular region [GO:0005576],calcium ion binding [GO:0005509]
1297,M3X7Y2,M3X7Y2_FELCA,"Serine peptidase inhibitor, Kunitz type 2",SPINT2,basement membrane organization [GO:0071711]; epithelial cell morphogenesis involved in placental branching [GO:0060672]; establishment or maintenance of cell polarity [GO:0007163]; negative regulation of cell motility [GO:2000146]; negative regulation of cell-cell adhesion [GO:0022408]; neural tube closure [GO:0001843],cytoplasm [GO:0005737]; membrane [GO:0016020],serine-type endopeptidase inhibitor activity [GO:0004867]
1298,M3X9U2,M3X9U2_FELCA,Galactose-3-O-sulfotransferase 4,GAL3ST4,glycolipid biosynthetic process [GO:0009247]; glycoprotein biosynthetic process [GO:0009101],membrane [GO:0016020],galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]
1299,M3XAA2,M3XAA2_FELCA,Proteasome subunit alpha type,PSMA2,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to virus [GO:0009615],"nucleus [GO:0005634]; P-body [GO:0000932]; proteasome core complex, alpha-subunit complex [GO:0019773]",
1300,M3XAF3,M3XAF3_FELCA,S-formylglutathione hydrolase (EC 3.1.2.12),ESD,formaldehyde catabolic process [GO:0046294],cytosol [GO:0005829],carboxylic ester hydrolase activity [GO:0052689]; identical protein binding [GO:0042802]; S-formylglutathione hydrolase activity [GO:0018738]
1301,M3XAU5,M3XAU5_FELCA,NAD(P)(+)--arginine ADP-ribosyltransferase (EC 2.4.2.31) (Mono(ADP-ribosyl)transferase),ART1,,cell surface [GO:0009986]; membrane [GO:0016020],NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein-arginine ADP-ribosyltransferase activity [GO:0106274]; nucleotidyltransferase activity [GO:0016779]
1302,M3XB86,M3XB86_FELCA,RING-type E3 ubiquitin transferase (EC 2.3.2.27),MARCHF10,,,transferase activity [GO:0016740]; zinc ion binding [GO:0008270]
1303,M3XCB8,M3XCB8_FELCA,Stomatin,STOM,positive regulation by host of viral genome replication [GO:0044829]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of viral process [GO:0048524]; regulation of monoatomic ion transmembrane transport [GO:0034765],cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],ion channel inhibitor activity [GO:0008200]; protein homodimerization activity [GO:0042803]; RNA polymerase binding [GO:0070063]
1304,M3XCK7,M3XCK7_FELCA,Lipocalin like 1,LCNL1,,extracellular region [GO:0005576]; membrane [GO:0016020],small molecule binding [GO:0036094]
1305,M3XCS6,M3XCS6_FELCA,von Willebrand factor C and EGF domains,VWCE,cellular response to virus [GO:0098586],cytoplasm [GO:0005737]; extracellular region [GO:0005576],calcium ion binding [GO:0005509]
1306,M3XD95,M3XD95_FELCA,Semaphorin 4B,SEMA4B,axon guidance [GO:0007411]; negative chemotaxis [GO:0050919]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526],glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839],chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]
1307,M3XDK8,M3XDK8_FELCA,NAD(P)(+)--arginine ADP-ribosyltransferase (EC 2.4.2.31) (Mono(ADP-ribosyl)transferase),ART4,,,NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein-arginine ADP-ribosyltransferase activity [GO:0106274]; nucleotidyltransferase activity [GO:0016779]
1308,M3XEV5,M3XEV5_FELCA,Calpain 7,CAPN7,positive regulation of epithelial cell migration [GO:0010634]; proteolysis [GO:0006508]; self proteolysis [GO:0097264],centrosome [GO:0005813]; cytosol [GO:0005829],calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cysteine-type endopeptidase activity [GO:0004197]; MIT domain binding [GO:0090541]
1309,M3XEV8,M3XEV8_FELCA,Ferric chelate reductase 1,FRRS1,intracellular iron ion homeostasis [GO:0006879],membrane [GO:0016020],"metal ion binding [GO:0046872]; oxidoreductase activity, acting on metal ions [GO:0016722]"
1310,M3XF74,M3XF74_FELCA,Solute carrier organic anion transporter family member,SLCO4C1,monoatomic ion transport [GO:0006811]; sodium-independent organic anion transport [GO:0043252],basolateral plasma membrane [GO:0016323],sodium-independent organic anion transmembrane transporter activity [GO:0015347]
1311,M3XFJ6,M3XFJ6_FELCA,Transmembrane 7 superfamily member 3,TM7SF3,cellular response to unfolded protein [GO:0034620]; negative regulation of programmed cell death [GO:0043069]; positive regulation of insulin secretion [GO:0032024],plasma membrane [GO:0005886],
1312,M3XFR1,M3XFR1_FELCA,Meteorin-like protein,METRNL,energy homeostasis [GO:0097009]; positive regulation of brown fat cell differentiation [GO:0090336],extracellular space [GO:0005615],hormone activity [GO:0005179]
1313,M3XFW7,M3XFW7_FELCA,Ribosomal RNA-processing protein 42,EXOSC7,"exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; TRAMP-dependent tRNA surveillance pathway [GO:0071038]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]",cytoplasmic exosome (RNase complex) [GO:0000177]; nuclear exosome (RNase complex) [GO:0000176],carbohydrate binding [GO:0030246]; mRNA 3'-UTR AU-rich region binding [GO:0035925]
1314,M3XFZ3,M3XFZ3_FELCA,Annexin,ANXA11,,,calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]
1315,M3XG35,M3XG35_FELCA,Complement factor H related 5,CFHR5,complement activation [GO:0006956]; cytolysis by host of symbiont cells [GO:0051838],extracellular space [GO:0005615]; protein-containing complex [GO:0032991],complement component C3b binding [GO:0001851]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]
1316,M3XG70,M3XG70_FELCA,SMB domain-containing protein,,immune response [GO:0006955],collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615],polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]
1317,P14450,FIBA_FELCA,Fibrinogen alpha chain [Cleaved into: Fibrinopeptide A],FGA,adaptive immune response [GO:0002250]; blood coagulation [GO:0007596]; innate immune response [GO:0045087],extracellular region [GO:0005576],
1318,P14469,FIBB_FELCA,Fibrinogen beta chain [Cleaved into: Fibrinopeptide B],FGB,adaptive immune response [GO:0002250]; blood coagulation [GO:0007596]; innate immune response [GO:0045087],extracellular region [GO:0005576],
1319,Q8WNR9,CYTA_FELCA,Cystatin-A (allergen Fel d 3),CSTA,,cytosol [GO:0005829],cysteine-type endopeptidase inhibitor activity [GO:0004869]
1320,A0A2I2U035,A0A2I2U035_FELCA,LY6/PLAUR domain containing 6,LYPD6,positive regulation of canonical Wnt signaling pathway [GO:0090263],plasma membrane [GO:0005886],acetylcholine receptor inhibitor activity [GO:0030550]
1321,A0A2I2U095,A0A2I2U095_FELCA,"RAB35, member RAS onco family",RAB35,,,GTP binding [GO:0005525]; GTPase activity [GO:0003924]
1322,A0A2I2U0A2,A0A2I2U0A2_FELCA,Out at first protein homolog,OAF,,,
1323,A0A2I2U0E6,A0A2I2U0E6_FELCA,Nectin cell adhesion molecule 3,NECTIN3,cell adhesion [GO:0007155]; symbiont entry into host cell [GO:0046718],membrane [GO:0016020],
1324,A0A2I2U0I8,A0A2I2U0I8_FELCA,Early endosome antigen 1,EEA1,,,metal ion binding [GO:0046872]
1325,A0A2I2U0K1,A0A2I2U0K1_FELCA,Copine 4,CPNE4,,,calcium-dependent phospholipid binding [GO:0005544]
1326,A0A2I2U122,A0A2I2U122_FELCA,Galactose-3-O-sulfotransferase 1,GAL3ST1,glycolipid biosynthetic process [GO:0009247],membrane [GO:0016020],galactosylceramide sulfotransferase activity [GO:0001733]
1327,A0A2I2U1I0,A0A2I2U1I0_FELCA,Coiled-coil domain containing 154,CCDC154,bone mineralization involved in bone maturation [GO:0035630]; bone resorption [GO:0045453]; odontogenesis of dentin-containing tooth [GO:0042475]; tooth eruption [GO:0044691],,
1328,A0A2I2U1K0,A0A2I2U1K0_FELCA,Ig-like domain-containing protein,,immune response [GO:0006955],extracellular space [GO:0005615],
1329,A0A2I2U294,A0A2I2U294_FELCA,Kininogen 1,KNG1,vasodilation [GO:0042311],extracellular region [GO:0005576],cysteine-type endopeptidase inhibitor activity [GO:0004869]
1330,A0A2I2U2A7,A0A2I2U2A7_FELCA,BCL6 corepressor like 1,BCORL1,,,
1331,A0A2I2U2E0,A0A2I2U2E0_FELCA,Calcium voltage-gated channel auxiliary subunit alpha2delta 1,CACNA2D1,,monoatomic ion channel complex [GO:0034702],calcium channel activity [GO:0005262]
1332,A0A2I2U2G1,A0A2I2U2G1_FELCA,USH1 protein network component harmonin,USH1C,,cell projection [GO:0042995],
1333,A0A2I2U2M1,A0A2I2U2M1_FELCA,Peptidase D,PEPD,,,metal ion binding [GO:0046872]; peptidase activity [GO:0008233]
1334,A0A2I2U322,A0A2I2U322_FELCA,Eukaryotic translation initiation factor 4 gamma 3,EIF4G3,,,RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]
1335,A0A2I2U348,A0A2I2U348_FELCA,Transmembrane protein 9,TMEM9,,lysosomal membrane [GO:0005765],
1336,A0A2I2U3F2,A0A2I2U3F2_FELCA,KIAA0319 like,KIAA0319L,,plasma membrane [GO:0005886],
1337,A0A2I2U3P8,A0A2I2U3P8_FELCA,Poly(rC) binding protein 2,PCBP2,,,RNA binding [GO:0003723]
1338,A0A2I2U3S0,A0A2I2U3S0_FELCA,Dimethylarginine dimethylaminohydrolase 1,DDAH1,,,dimethylargininase activity [GO:0016403]
1339,A0A2I2U432,A0A2I2U432_FELCA,Collagen type XII alpha 1 chain,COL12A1,,collagen trimer [GO:0005581]; extracellular region [GO:0005576],
1340,A0A2I2U448,A0A2I2U448_FELCA,Calcium binding protein 39,CAB39,,,
1341,A0A2I2U4V9,A0A2I2U4V9_FELCA,Peptidase S1 domain-containing protein,LOC101089318,proteolysis [GO:0006508],,serine-type endopeptidase activity [GO:0004252]
1342,A0A2I2U5B2,A0A2I2U5B2_FELCA,Lipocalin/cytosolic fatty-acid binding domain-containing protein,LOC101098498,,extracellular region [GO:0005576],small molecule binding [GO:0036094]
1343,A0A2I2U5G8,A0A2I2U5G8_FELCA,Fibronectin type-III domain-containing protein,,,,
1344,A0A2I2U5M6,A0A2I2U5M6_FELCA,Ig-like domain-containing protein,,immunoglobulin mediated immune response [GO:0016064],immunoglobulin complex [GO:0019814],antigen binding [GO:0003823]
1345,A0A2I2U651,A0A2I2U651_FELCA,Guanine nucleotide-binding protein G(o) subunit alpha,GNAO1,adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188],,G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]
1346,A0A2I2U6F0,A0A2I2U6F0_FELCA,C-type lectin domain containing 11A,CLEC11A,ossification [GO:0001503]; positive regulation of cell population proliferation [GO:0008284],extracellular space [GO:0005615],carbohydrate binding [GO:0030246]; growth factor activity [GO:0008083]
1347,A0A2I2U6T7,A0A2I2U6T7_FELCA,L1 cell adhesion molecule,L1CAM,,,
1348,A0A2I2U6V1,A0A2I2U6V1_FELCA,Follistatin like 3,FSTL3,,,
1349,A0A2I2U709,A0A2I2U709_FELCA,Galectin,LGALS9,,,carbohydrate binding [GO:0030246]
1350,A0A2I2U769,A0A2I2U769_FELCA,Bone marrow stromal cell antigen 2,BST2,defense response to virus [GO:0051607]; innate immune response [GO:0045087],cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; membrane [GO:0016020],metalloendopeptidase inhibitor activity [GO:0008191]
1351,A0A2I2U794,A0A2I2U794_FELCA,Coiled-coil domain containing 150,CCDC150,,,
1352,A0A2I2U7C2,A0A2I2U7C2_FELCA,Adaptor related protein complex 1 subunit beta 1,AP1B1,intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192],clathrin adaptor complex [GO:0030131],
1353,A0A2I2U7D8,A0A2I2U7D8_FELCA,Chromosome D1 C11orf54 homolog,CD1H11orf54,,nucleus [GO:0005634],
1354,A0A2I2U7G3,A0A2I2U7G3_FELCA,Collagen type VIII alpha 1 chain,COL8A1,,collagen trimer [GO:0005581]; extracellular region [GO:0005576]; membrane [GO:0016020],
1355,A0A2I2U7R4,A0A2I2U7R4_FELCA,Inter-alpha-trypsin inhibitor heavy chain 4,ITIH4,hyaluronan metabolic process [GO:0030212],extracellular region [GO:0005576],serine-type endopeptidase inhibitor activity [GO:0004867]
1356,A0A2I2U7U8,A0A2I2U7U8_FELCA,Immunoglobulin superfamily member 8,IGSF8,,membrane [GO:0016020],
1357,A0A2I2U7X7,A0A2I2U7X7_FELCA,Ig-like domain-containing protein,LOC105259814,,membrane [GO:0016020],
1358,A0A2I2U844,A0A2I2U844_FELCA,Dihydropyrimidinase,DPYS,,cytoplasm [GO:0005737],"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]"
1359,A0A2I2U855,A0A2I2U855_FELCA,GLI pathogenesis related 2,GLIPR2,positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374],extracellular space [GO:0005615]; Golgi membrane [GO:0000139],protein homodimerization activity [GO:0042803]
1360,A0A2I2U968,A0A2I2U968_FELCA,Contactin-1,CNTN1,cell adhesion [GO:0007155],,
1361,A0A2I2U998,A0A2I2U998_FELCA,EF-hand domain-containing protein,,,,calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]
1362,A0A2I2UA72,A0A2I2UA72_FELCA,Interleukin 1 receptor accessory protein,IL1RAP,inflammatory response [GO:0006954],membrane [GO:0016020],hydrolase activity [GO:0016787]; interleukin-1 receptor activity [GO:0004908]
1363,A0A2I2UAS8,A0A2I2UAS8_FELCA,IgLON family member 5,IGLON5,,,
1364,A0A2I2UBH5,A0A2I2UBH5_FELCA,"RAP2C, member of RAS onco family",RAP2C,signal transduction [GO:0007165],membrane [GO:0016020],GTP binding [GO:0005525]; GTPase activity [GO:0003924]
1365,A0A2I2UBJ4,A0A2I2UBJ4_FELCA,Glycoprotein M6B,GPM6B,,membrane [GO:0016020],
1366,A0A2I2UBK6,A0A2I2UBK6_FELCA,Immunoglobulin superfamily member 5,IGSF5,,membrane [GO:0016020],
1367,A0A2I2UBZ5,A0A2I2UBZ5_FELCA,PDZ domain containing 1,PDZK1,,,
1368,A0A2I2UC78,A0A2I2UC78_FELCA,Uncharacterized protein,,,,
1369,A0A2I2UC81,A0A2I2UC81_FELCA,Cysteine rich secretory protein 3,CRISP3,,extracellular region [GO:0005576],
1370,A0A2I2UCJ0,A0A2I2UCJ0_FELCA,Glucosylceramidase beta 3,GBA3,carbohydrate metabolic process [GO:0005975]; glycosylceramide catabolic process [GO:0046477],cytosol [GO:0005829],beta-galactosidase activity [GO:0004565]; glycosylceramidase activity [GO:0017042]
1371,A0A2I2UCP1,A0A2I2UCP1_FELCA,WAP domain-containing protein,,antibacterial humoral response [GO:0019731]; innate immune response [GO:0045087],extracellular space [GO:0005615],serine-type endopeptidase inhibitor activity [GO:0004867]
1372,A0A2I2UDI7,A0A2I2UDI7_FELCA,Cartilage acidic protein 1,CRTAC1,axonal fasciculation [GO:0007413],,calcium ion binding [GO:0005509]
1373,A0A2I2UDW9,A0A2I2UDW9_FELCA,Tetraspanin,TSPAN3,,plasma membrane [GO:0005886],
1374,A0A2I2UDZ7,A0A2I2UDZ7_FELCA,VWFD domain-containing protein,FCGBP,,,
1375,A0A2I2UE55,A0A2I2UE55_FELCA,C-type lectin domain containing 7A,CLEC7A,cellular response to molecule of fungal origin [GO:0071226],membrane [GO:0016020],(1->3)-beta-D-glucan binding [GO:0001872]
1376,A0A2I2UEP1,A0A2I2UEP1_FELCA,WD repeat domain 1,WDR1,,,
1377,A0A2I2UF05,A0A2I2UF05_FELCA,GIPC PDZ domain containing family member 2,GIPC2,,,identical protein binding [GO:0042802]
1378,A0A2I2UF36,A0A2I2UF36_FELCA,Interleukin 18 binding protein,IL18BP,T-helper 1 type immune response [GO:0042088],extracellular space [GO:0005615],interleukin-18 binding [GO:0042007]
1379,A0A2I2UGD4,A0A2I2UGD4_FELCA,Desmocollin 2,DSC2,homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],plasma membrane [GO:0005886],calcium ion binding [GO:0005509]
1380,A0A2I2UHE7,A0A2I2UHE7_FELCA,Myelin protein zero like 1,MPZL1,,plasma membrane [GO:0005886],
1381,A0A2I2UHR0,A0A2I2UHR0_FELCA,Myosin light chain 6,MYL6,,,calcium ion binding [GO:0005509]
1382,A0A2I2UHS4,A0A2I2UHS4_FELCA,Pseudouridine 5'-phosphatase,PUDP,,,phosphatase activity [GO:0016791]
1383,A0A2I2UI16,A0A2I2UI16_FELCA,Ig-like domain-containing protein,,immune response [GO:0006955],extracellular space [GO:0005615],
1384,A0A2I2UI30,A0A2I2UI30_FELCA,G protein-coupled receptor class C group 5 member C,GPRC5C,,plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930]
1385,A0A2I2UJ66,A0A2I2UJ66_FELCA,Kazal-like domain-containing protein,,spermatid development [GO:0007286],,serine-type endopeptidase inhibitor activity [GO:0004867]
1386,A0A2I2UJG2,A0A2I2UJG2_FELCA,CutA divalent cation tolerance homolog,CUTA,response to metal ion [GO:0010038],,
1387,A0A2I2UJP1,A0A2I2UJP1_FELCA,Peptidase inhibitor 15,PI15,,extracellular space [GO:0005615],peptidase inhibitor activity [GO:0030414]
1388,A0A2I2UJV2,A0A2I2UJV2_FELCA,Neural cell adhesion molecule 1,NCAM1,cell adhesion [GO:0007155],membrane [GO:0016020],
1389,A0A2I2ULF8,A0A2I2ULF8_FELCA,Cell adhesion molecule 4,CADM4,,membrane [GO:0016020],
1390,A0A2I2UM62,A0A2I2UM62_FELCA,Prostate stem cell antigen,PSCA,negative regulation of ERK1 and ERK2 cascade [GO:0070373],plasma membrane [GO:0005886],acetylcholine receptor binding [GO:0033130]
1391,A0A2I2UM84,A0A2I2UM84_FELCA,Spondin 2,SPON2,cell adhesion [GO:0007155],extracellular matrix [GO:0031012]; extracellular region [GO:0005576],metal ion binding [GO:0046872]
1392,A0A2I2UMJ9,A0A2I2UMJ9_FELCA,Opioid binding protein/cell adhesion molecule like,OPCML,,,
1393,A0A2I2UMM1,A0A2I2UMM1_FELCA,Uncharacterized protein,LOC101082733,,membrane [GO:0016020],
1394,A0A2I2UN09,A0A2I2UN09_FELCA,Ig-like domain-containing protein,,,,
1395,A0A2I2UNI7,A0A2I2UNI7_FELCA,UBC core domain-containing protein,,postreplication repair [GO:0006301]; protein K63-linked ubiquitination [GO:0070534],nucleus [GO:0005634],ubiquitin conjugating enzyme activity [GO:0061631]
1396,A0A2I2UNJ5,A0A2I2UNJ5_FELCA,Deoxyribonuclease 1 like 2,DNASE1L2,apoptotic process [GO:0006915]; DNA catabolic process [GO:0006308],,deoxyribonuclease I activity [GO:0004530]
1397,A0A2I2UP64,A0A2I2UP64_FELCA,LY6/PLAUR domain containing 6B,LYPD6B,,plasma membrane [GO:0005886],acetylcholine receptor regulator activity [GO:0030548]
1398,A0A2I2UQ88,A0A2I2UQ88_FELCA,Serpin family B member 11,SERPINB11,,extracellular space [GO:0005615],serine-type endopeptidase inhibitor activity [GO:0004867]
1399,A0A2I2UQM8,A0A2I2UQM8_FELCA,RING-type E3 ubiquitin transferase (EC 2.3.2.27),TRIM36,,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856],zinc ion binding [GO:0008270]
1400,A0A2I2UR43,A0A2I2UR43_FELCA,Cell adhesion molecule 1,CADM1,,membrane [GO:0016020],
1401,A0A2I2UR81,A0A2I2UR81_FELCA,Ig-like domain-containing protein,,immune response [GO:0006955],extracellular space [GO:0005615],
1402,A0A2I2US09,A0A2I2US09_FELCA,Filamin B,FLNB,actin cytoskeleton organization [GO:0030036],intracellular non-membrane-bounded organelle [GO:0043232],actin filament binding [GO:0051015]
1403,A0A2I2USA1,A0A2I2USA1_FELCA,Cadherin 8,CDH8,homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],plasma membrane [GO:0005886],calcium ion binding [GO:0005509]
1404,A0A2I2UT16,A0A2I2UT16_FELCA,Albumin domain-containing protein,LOC101095098,,extracellular space [GO:0005615],
1405,A0A2I2UTC5,A0A2I2UTC5_FELCA,Zinc finger C4H2-type containing,ZC4H2,,,
1406,A0A2I2UTJ7,A0A2I2UTJ7_FELCA,Ig-like domain-containing protein,,adaptive immune response [GO:0002250],immunoglobulin complex [GO:0019814],
1407,A0A2I2UTM6,A0A2I2UTM6_FELCA,CD69 molecule,CD69,,external side of plasma membrane [GO:0009897]; protein-containing complex [GO:0032991],carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]
1408,A0A2I2UUB3,A0A2I2UUB3_FELCA,Neurotrimin,NTM,,,
1409,A0A2I2UUH5,A0A2I2UUH5_FELCA,Cell adhesion molecule 2,CADM2,,membrane [GO:0016020],
1410,A0A2I2UUX6,A0A2I2UUX6_FELCA,Vanin 1,VNN1,,,
1411,A0A2I2UV69,A0A2I2UV69_FELCA,Secreted LY6/PLAUR domain containing 1,SLURP1,,,acetylcholine receptor activator activity [GO:0030549]
1412,A0A2I2UW10,A0A2I2UW10_FELCA,Protease associated domain containing 1,PRADC1,,extracellular region [GO:0005576],
1413,A0A2I2UX82,A0A2I2UX82_FELCA,Neuronal growth regulator 1,NEGR1,,plasma membrane [GO:0005886]; side of membrane [GO:0098552],
1414,A0A2I2UY85,A0A2I2UY85_FELCA,Tropomyosin 3,TPM3,,cytoskeleton [GO:0005856],actin binding [GO:0003779]
1415,A0A2I2UYJ1,A0A2I2UYJ1_FELCA,Lactate/malate dehydrogenase C-terminal domain-containing protein,,,,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]"
1416,A0A2I2UZ18,A0A2I2UZ18_FELCA,Kazal-like domain-containing protein,SPINK2,spermatid development [GO:0007286],,serine-type endopeptidase inhibitor activity [GO:0004867]
1417,A0A2I2UZ31,A0A2I2UZ31_FELCA,Gamma-glutamyltransferase 6,GGT6,,,
1418,A0A2I2UZA9,A0A2I2UZA9_FELCA,Desmocollin 1,DSC1,homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],plasma membrane [GO:0005886],calcium ion binding [GO:0005509]
1419,A0A2I2UZP1,A0A2I2UZP1_FELCA,G protein subunit alpha 13,GNA13,G protein-coupled receptor signaling pathway [GO:0007186]; Rho protein signal transduction [GO:0007266],,G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]
1420,A0A2I2UZV7,A0A2I2UZV7_FELCA,Protein FAM3C,FAM3C,,extracellular region [GO:0005576],carbohydrate binding [GO:0030246]
1421,A0A2I2UZY7,A0A2I2UZY7_FELCA,Neuroplastin,NPTN,,membrane [GO:0016020],
1422,A0A2I2V0Y5,A0A2I2V0Y5_FELCA,Neural cell adhesion molecule 2,NCAM2,cell adhesion [GO:0007155],membrane [GO:0016020],
1423,A0A2I2V139,A0A2I2V139_FELCA,Chromosome 19 open reading frame 33,C19orf33,,cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],
1424,A0A2I2V147,A0A2I2V147_FELCA,Phytanoyl-CoA dioxygenase domain-containing protein 1,PHYHD1,,,
1425,A0A2I2V2G8,A0A2I2V2G8_FELCA,"Cell adhesion associated, onco regulated",CDON,,membrane [GO:0016020],
1426,A0A2I2V2W1,A0A2I2V2W1_FELCA,Proteasome 20S subunit alpha 2,PSMA2,proteolysis involved in protein catabolic process [GO:0051603],"nucleus [GO:0005634]; proteasome core complex, alpha-subunit complex [GO:0019773]",
1427,A0A2I2V2Y7,A0A2I2V2Y7_FELCA,Sushi domain-containing protein,,,,
1428,A0A2I2V326,A0A2I2V326_FELCA,Copine 1,CPNE1,,,calcium-dependent phospholipid binding [GO:0005544]
1429,A0A2I2V332,A0A2I2V332_FELCA,Protein phosphatase 4 regulatory subunit 4,PPP4R4,,,
1430,A0A2I2V340,A0A2I2V340_FELCA,Platelet and endothelial cell adhesion molecule 1,PECAM1,,plasma membrane [GO:0005886],
1431,A0A2I2V346,A0A2I2V346_FELCA,Granulin,GRN,,extracellular region [GO:0005576],
1432,A0A2I2V4A6,A0A2I2V4A6_FELCA,Protein phosphatase 2 scaffold subunit Aalpha,PPP2R1A,,,
1433,A0A337RTP4,A0A337RTP4_FELCA,Serine protease 22,PRSS22,proteolysis [GO:0006508],extracellular space [GO:0005615],peptidase activator activity [GO:0016504]; serine-type endopeptidase activity [GO:0004252]
1434,A0A337RUS6,A0A337RUS6_FELCA,Triggering receptor expressed on myeloid cells like 1,TREML1,,membrane [GO:0016020],
1435,A0A337RV27,A0A337RV27_FELCA,Solute carrier family 22 member 12,SLC22A12,,membrane [GO:0016020],transmembrane transporter activity [GO:0022857]
1436,A0A337RV83,A0A337RV83_FELCA,Collagen type XV alpha 1 chain,COL15A1,,collagen trimer [GO:0005581],
1437,A0A337RVE0,A0A337RVE0_FELCA,"CEA cell adhesion molecule 16, tectorial membrane component",CEACAM16,sensory perception of sound [GO:0007605],extracellular space [GO:0005615]; stereocilium tip [GO:0032426],identical protein binding [GO:0042802]
1438,A0A337RVF9,A0A337RVF9_FELCA,ADF-H domain-containing protein,COTL1,,,actin binding [GO:0003779]
1439,A0A337RWR2,A0A337RWR2_FELCA,Olfactomedin like 3,OLFML3,,,
1440,A0A337RXZ6,A0A337RXZ6_FELCA,Vascular cell adhesion molecule 1,VCAM1,cell-cell adhesion [GO:0098609],plasma membrane [GO:0005886],integrin binding [GO:0005178]
1441,A0A337RY82,A0A337RY82_FELCA,Family with sequence similarity 174 member B,FAM174B,,membrane [GO:0016020],
1442,A0A337RYP8,A0A337RYP8_FELCA,Phosphatidylethanolamine binding protein 4,PEBP4,,,
1443,A0A337RYU6,A0A337RYU6_FELCA,PKHD1 ciliary IPT domain containing fibrocystin/polyductin,PKHD1,,membrane [GO:0016020],
1444,A0A337RZ12,A0A337RZ12_FELCA,Cathepsin S,CTSS,proteolysis [GO:0006508],,cysteine-type peptidase activity [GO:0008234]
1445,A0A337RZD5,A0A337RZD5_FELCA,Collagen type XIV alpha 1 chain,COL14A1,,collagen trimer [GO:0005581]; extracellular region [GO:0005576],
1446,A0A337RZH0,A0A337RZH0_FELCA,Fetuin B,FETUB,,extracellular space [GO:0005615],cysteine-type endopeptidase inhibitor activity [GO:0004869]
1447,A0A337RZN4,A0A337RZN4_FELCA,Kirre like nephrin family adhesion molecule 1,KIRREL1,,plasma membrane [GO:0005886],
1448,A0A337S014,A0A337S014_FELCA,Ig-like domain-containing protein,LOC105259814,,membrane [GO:0016020],
1449,A0A337S046,A0A337S046_FELCA,Dipeptidyl peptidase like 10,DPP10,proteolysis [GO:0006508],plasma membrane [GO:0005886],serine-type peptidase activity [GO:0008236]
1450,A0A337S0D4,A0A337S0D4_FELCA,Vanin 1,VNN1,,,
1451,A0A337S0T3,A0A337S0T3_FELCA,Syndecan binding protein,SDCBP,,,
1452,A0A337S0Y0,A0A337S0Y0_FELCA,Sulfurtransferase,MPST,,mitochondrion [GO:0005739],3-mercaptopyruvate sulfurtransferase activity [GO:0016784]; thiosulfate sulfurtransferase activity [GO:0004792]
1453,A0A337S103,A0A337S103_FELCA,Metallothionein,LOC111558024,,,metal ion binding [GO:0046872]
1454,A0A337S133,A0A337S133_FELCA,Costars family protein ABRACL (ABRA C-terminal-like protein),ABRACL,regulation of actin filament-based process [GO:0032970],,
1455,A0A337S172,A0A337S172_FELCA,Cysteine rich transmembrane BMP regulator 1,CRIM1,,extracellular region [GO:0005576]; membrane [GO:0016020],serine-type endopeptidase inhibitor activity [GO:0004867]
1456,A0A337S1A5,A0A337S1A5_FELCA,DnaJ heat shock protein family (Hsp40) member C11,DNAJC11,,,
1457,A0A337S1N7,A0A337S1N7_FELCA,Interleukin 6 cytokine family signal transducer,IL6ST,,membrane [GO:0016020],
1458,A0A337S1R1,A0A337S1R1_FELCA,Fc mu receptor,FCMR,,membrane [GO:0016020],
1459,A0A337S1X7,A0A337S1X7_FELCA,Ig-like domain-containing protein,,,,
1460,A0A337S217,A0A337S217_FELCA,CUB domain-containing protein,C1R,,,calcium ion binding [GO:0005509]; serine-type peptidase activity [GO:0008236]
1461,A0A337S2I4,A0A337S2I4_FELCA,CD84 molecule,CD84,,membrane [GO:0016020],
1462,A0A337S2J9,A0A337S2J9_FELCA,Aldehyde dehydrogenase 8 family member A1,ALDH8A1,,,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]"
1463,A0A337S388,A0A337S388_FELCA,Urokinase plasminogen activator surface receptor,PLAUR,,membrane [GO:0016020],
1464,A0A337S3K5,A0A337S3K5_FELCA,Alpha-2-macroglobulin like 1,A2ML1,,extracellular space [GO:0005615],serine-type endopeptidase inhibitor activity [GO:0004867]
1465,A0A337S3R5,A0A337S3R5_FELCA,Multiple inositol-polyphosphate phosphatase 1,MINPP1,,,hydrolase activity [GO:0016787]
1466,A0A337S3Z8,A0A337S3Z8_FELCA,Natriuretic peptide receptor 3,NPR3,,membrane [GO:0016020],
1467,A0A337S431,A0A337S431_FELCA,Latent transforming growth factor beta binding protein 1,LTBP1,,extracellular region [GO:0005576],calcium ion binding [GO:0005509]
1468,A0A337S496,A0A337S496_FELCA,Collagen type XI alpha 1 chain,COL11A1,,,extracellular matrix structural constituent [GO:0005201]
1469,A0A337S4A1,A0A337S4A1_FELCA,Proteasome subunit alpha type-7,PSMA7,ubiquitin-dependent protein catabolic process [GO:0006511],"nucleus [GO:0005634]; proteasome core complex, alpha-subunit complex [GO:0019773]",
1470,A0A337S4A6,A0A337S4A6_FELCA,Megakaryocyte and platelet inhibitory receptor G6b,MPIG6B,,membrane [GO:0016020],
1471,A0A337S4Q8,A0A337S4Q8_FELCA,Chromosome B4 C12orf56 homolog,CB4H12orf56,,,
1472,A0A337S4U7,A0A337S4U7_FELCA,Cerebellin 2,CBLN2,,,
1473,A0A337S4X8,A0A337S4X8_FELCA,CUB domain-containing protein,,,,
1474,A0A337S4Z9,A0A337S4Z9_FELCA,Olfactomedin 1,OLFM1,,extracellular region [GO:0005576]; synapse [GO:0045202],
1475,A0A337S505,A0A337S505_FELCA,Interleukin 6 cytokine family signal transducer,IL6ST,,membrane [GO:0016020],
1476,A0A337S538,A0A337S538_FELCA,Keratin 74,KRT74,,keratin filament [GO:0045095],
1477,A0A337S5K9,A0A337S5K9_FELCA,Tubulointerstitial nephritis antigen like 1,TINAGL1,proteolysis [GO:0006508],extracellular space [GO:0005615],cysteine-type peptidase activity [GO:0008234]
1478,A0A337S5Y7,A0A337S5Y7_FELCA,Kirre like nephrin family adhesion molecule 1,KIRREL1,,plasma membrane [GO:0005886],
1479,A0A337S6A5,A0A337S6A5_FELCA,ATP binding cassette subfamily B member 9,ABCB9,,lysosomal membrane [GO:0005765],ABC-type peptide transporter activity [GO:0015440]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]
1480,A0A337S6A6,A0A337S6A6_FELCA,Exostosin like glycosyltransferase 2,EXTL2,,endoplasmic reticulum membrane [GO:0005789],glycosyltransferase activity [GO:0016757]
1481,A0A337S6F7,A0A337S6F7_FELCA,Shisa family member 6,SHISA6,,membrane [GO:0016020],
1482,A0A337S6R6,A0A337S6R6_FELCA,CD300 molecule like family member g,CD300LG,,membrane [GO:0016020],
1483,A0A337S6Y2,A0A337S6Y2_FELCA,DAB adaptor protein 2,DAB2,cell differentiation [GO:0030154],,
1484,A0A337S746,A0A337S746_FELCA,Resistin,RETN,,extracellular space [GO:0005615],hormone activity [GO:0005179]
1485,A0A337S7Y7,A0A337S7Y7_FELCA,Fibulin 7,FBLN7,,extracellular region [GO:0005576],calcium ion binding [GO:0005509]
1486,A0A337S804,A0A337S804_FELCA,Ig-like domain-containing protein,,,,
1487,A0A337S8C4,A0A337S8C4_FELCA,Charged multivesicular body protein 2B,CHMP2B,vacuolar transport [GO:0007034],late endosome membrane [GO:0031902],
1488,A0A337S8F8,A0A337S8F8_FELCA,MBL associated serine protease 2,MASP2,,extracellular region [GO:0005576],calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]
1489,A0A337S8S6,A0A337S8S6_FELCA,Peptidase S1 domain-containing protein,LOC101085453,proteolysis [GO:0006508],,serine-type endopeptidase activity [GO:0004252]
1490,A0A337S8U6,A0A337S8U6_FELCA,CD81 molecule,CD81,,plasma membrane [GO:0005886],
1491,A0A337S914,A0A337S914_FELCA,Nucleosome assembly protein 1 like 4,NAP1L4,nucleosome assembly [GO:0006334],nucleus [GO:0005634],
1492,A0A337S9H1,A0A337S9H1_FELCA,ADAM metallopeptidase domain 9,ADAM9,,,
1493,A0A337S9P2,A0A337S9P2_FELCA,NIPA like domain containing 1,NIPAL1,magnesium ion transport [GO:0015693],Golgi apparatus [GO:0005794]; membrane [GO:0016020],magnesium ion transmembrane transporter activity [GO:0015095]
1494,A0A337S9Y1,A0A337S9Y1_FELCA,FAM3 metabolism regulating signaling molecule B,FAM3B,insulin secretion [GO:0030073],extracellular space [GO:0005615],carbohydrate binding [GO:0030246]
1495,A0A337SA15,A0A337SA15_FELCA,Tubulointerstitial nephritis antigen,TINAG,,,
1496,A0A337SA19,A0A337SA19_FELCA,Ig-like domain-containing protein,,immunoglobulin mediated immune response [GO:0016064],IgG immunoglobulin complex [GO:0071735],antigen binding [GO:0003823]
1497,A0A337SAH5,A0A337SAH5_FELCA,PITH domain containing 1,PITHD1,,,
1498,A0A337SAI4,A0A337SAI4_FELCA,Titin,TTN,,,ATP binding [GO:0005524]; protein kinase activity [GO:0004672]
1499,A0A337SAN3,A0A337SAN3_FELCA,Asialoglycoprotein receptor 1,ASGR1,,membrane [GO:0016020],carbohydrate binding [GO:0030246]
1500,A0A337SAQ9,A0A337SAQ9_FELCA,B and T lymphocyte associated,BTLA,immune response-regulating cell surface receptor signaling pathway [GO:0002768],plasma membrane [GO:0005886],signaling receptor activity [GO:0038023]
1501,A0A337SAT8,A0A337SAT8_FELCA,Junction adhesion molecule like,JAML,,membrane [GO:0016020],
1502,A0A337SB54,A0A337SB54_FELCA,CD109 molecule,CD109,,extracellular space [GO:0005615],serine-type endopeptidase inhibitor activity [GO:0004867]
1503,A0A337SBU4,A0A337SBU4_FELCA,Shisa family member 3,SHISA3,negative regulation of canonical Wnt signaling pathway [GO:0090090],membrane [GO:0016020],
1504,A0A337SCF8,A0A337SCF8_FELCA,Resistin,RETN,,extracellular region [GO:0005576],hormone activity [GO:0005179]
1505,A0A337SCZ0,A0A337SCZ0_FELCA,Tenascin N,TNN,,,
1506,A0A337SCZ5,A0A337SCZ5_FELCA,Solute carrier family 22 member 11,SLC22A11,,membrane [GO:0016020],transmembrane transporter activity [GO:0022857]
1507,A0A337SDJ8,A0A337SDJ8_FELCA,Insulin like growth factor binding protein acid labile subunit,IGFALS,,endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; insulin-like growth factor ternary complex [GO:0042567]; plasma membrane [GO:0005886],
1508,A0A337SE08,A0A337SE08_FELCA,Cystatin domain-containing protein,CSTB,,cytoplasm [GO:0005737],cysteine-type endopeptidase inhibitor activity [GO:0004869]
1509,A0A337SE86,A0A337SE86_FELCA,TNF receptor superfamily member 1B,TNFRSF1B,,,
1510,A0A337SEF1,A0A337SEF1_FELCA,Junctional adhesion molecule 3,JAM3,cell adhesion [GO:0007155],membrane [GO:0016020],protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]
1511,A0A337SF20,A0A337SF20_FELCA,Aldehyde dehydrogenase 8 family member A1,ALDH8A1,,,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]"
1512,A0A337SFT2,A0A337SFT2_FELCA,Attractin,ATRN,,membrane [GO:0016020],carbohydrate binding [GO:0030246]
1513,A0A337SFW3,A0A337SFW3_FELCA,Coiled-coil domain containing 126,CCDC126,,extracellular region [GO:0005576],
1514,A0A337SGN2,A0A337SGN2_FELCA,Repulsive guidance molecule BMP co-receptor a,RGMA,,plasma membrane [GO:0005886]; side of membrane [GO:0098552],
1515,A0A337SGQ6,A0A337SGQ6_FELCA,Cellular communication network factor 4,CCN4,signal transduction [GO:0007165],extracellular region [GO:0005576],
1516,A0A337SH50,A0A337SH50_FELCA,Glycerophosphodiester phosphodiesterase domain containing 2,GDPD2,lipid metabolic process [GO:0006629],membrane [GO:0016020],phosphoric diester hydrolase activity [GO:0008081]
1517,A0A337SHY2,A0A337SHY2_FELCA,Collagen triple helix repeat containing 1,CTHRC1,,,
1518,A0A337SIG2,A0A337SIG2_FELCA,Annexin,ANXA13,,,calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]
1519,A0A337SIV7,A0A337SIV7_FELCA,ANTXR cell adhesion molecule 1,ANTXR1,,membrane [GO:0016020],signaling receptor activity [GO:0038023]
1520,A0A337SJ42,A0A337SJ42_FELCA,Lymphocyte antigen 6 family member D,LY6D,lymphocyte differentiation [GO:0030098]; response to stilbenoid [GO:0035634],cell surface [GO:0009986],
1521,A0A337SJ76,A0A337SJ76_FELCA,Cadherin domain-containing protein,CDH5,homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],plasma membrane [GO:0005886],calcium ion binding [GO:0005509]
1522,A0A337SJA7,A0A337SJA7_FELCA,Calmodulin 2 (Calmodulin 3),CALM3 CALM2,,,calcium ion binding [GO:0005509]
1523,A0A337SJA8,A0A337SJA8_FELCA,Layilin,LAYN,,membrane [GO:0016020],hyaluronic acid binding [GO:0005540]
1524,A0A337SJR3,A0A337SJR3_FELCA,Complement C3d receptor 2,CR2,,membrane [GO:0016020],
1525,A0A337SJW2,A0A337SJW2_FELCA,Copine 3,CPNE3,,,calcium-dependent phospholipid binding [GO:0005544]
1526,A0A337SJX9,A0A337SJX9_FELCA,Iduronate 2-sulfatase,IDS,,,hydrolase activity [GO:0016787]
1527,A0A337SL30,A0A337SL30_FELCA,Inter-alpha-trypsin inhibitor heavy chain 3,ITIH3,,,
1528,A0A337SLM1,A0A337SLM1_FELCA,Zinc finger with KRAB and SCAN domains 1,ZKSCAN1,,,
1529,A0A337SLQ6,A0A337SLQ6_FELCA,IGF like family receptor 1,IGFLR1,,nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],
1530,A0A337SMV4,A0A337SMV4_FELCA,N-ribosyldihydronicotinamide:quinone reductase 2,NQO2,,,
1531,A0A337SN48,A0A337SN48_FELCA,TNF superfamily member 12,TNFSF12,immune response [GO:0006955],extracellular region [GO:0005576]; membrane [GO:0016020],tumor necrosis factor receptor binding [GO:0005164]
1532,A0A337SNI2,A0A337SNI2_FELCA,Rac family small GTPase 3,RAC3,small GTPase-mediated signal transduction [GO:0007264],,GTP binding [GO:0005525]; GTPase activity [GO:0003924]
1533,A0A337SNT6,A0A337SNT6_FELCA,CUB domain-containing protein,,,,
1534,A0A337SNU3,A0A337SNU3_FELCA,TBC1 domain family member 32,TBC1D32,,,
1535,A0A337SNW6,A0A337SNW6_FELCA,Proprotein convertase subtilisin/kexin type 5,PCSK5,proteolysis [GO:0006508],,serine-type endopeptidase activity [GO:0004252]
1536,A0A337SNZ0,A0A337SNZ0_FELCA,Protein amnionless,AMN,protein transport [GO:0015031],plasma membrane [GO:0005886],
1537,A0A337SP16,A0A337SP16_FELCA,Plexin domain containing 2,PLXDC2,,membrane [GO:0016020],
1538,A0A337SP31,A0A337SP31_FELCA,Galectin,,,,carbohydrate binding [GO:0030246]
1539,A0A337SPY8,A0A337SPY8_FELCA,NTR domain-containing protein,,,,
1540,A0A337SQ46,A0A337SQ46_FELCA,Biliverdin reductase B,BLVRB,,,
1541,A0A337SQ52,A0A337SQ52_FELCA,Pentraxin 4,PTX4,,,
1542,A0A337SQM4,A0A337SQM4_FELCA,Inducible T cell costimulator ligand,ICOSLG,,membrane [GO:0016020],
1543,A0A337SQU4,A0A337SQU4_FELCA,ADP dependent glucokinase,ADPGK,glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096],endoplasmic reticulum [GO:0005783],ADP-specific glucokinase activity [GO:0043843]
1544,A0A337SSG0,A0A337SSG0_FELCA,Asialoglycoprotein receptor 1,ASGR1,,membrane [GO:0016020],
1545,A0A337ST48,A0A337ST48_FELCA,Cadherin 13,CDH13,,membrane [GO:0016020],calcium ion binding [GO:0005509]
1546,A0A337STF2,A0A337STF2_FELCA,Parkinsonism associated deglycase,PARK7,autophagy [GO:0006914]; inflammatory response [GO:0006954],membrane [GO:0016020],
1547,A0A337STZ5,A0A337STZ5_FELCA,Brain abundant membrane attached signal protein 1,BASP1,,,
1548,A0A337SU18,A0A337SU18_FELCA,Palmitoyl-protein thioesterase 1,PPT1,,,hydrolase activity [GO:0016787]
1549,A0A337SUF8,A0A337SUF8_FELCA,Stomatin,STOM,,plasma membrane [GO:0005886],
1550,A0A337SUI1,A0A337SUI1_FELCA,Cadherin 13,CDH13,homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],plasma membrane [GO:0005886],calcium ion binding [GO:0005509]
1551,A0A337SUS1,A0A337SUS1_FELCA,Carnosine dipeptidase 2,CNDP2,,,carboxypeptidase activity [GO:0004180]
1552,A0A337SVD2,A0A337SVD2_FELCA,EF-hand domain-containing protein,CALM1,,cytoplasm [GO:0005737]; spindle pole [GO:0000922],calcium ion binding [GO:0005509]
1553,A0A337SVW8,A0A337SVW8_FELCA,Proteasome 20S subunit alpha 6,PSMA6,proteolysis involved in protein catabolic process [GO:0051603],"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex, alpha-subunit complex [GO:0019773]",
1554,A0A337SVX9,A0A337SVX9_FELCA,Crystallin zeta,CRYZ,,,oxidoreductase activity [GO:0016491]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]
1555,A0A337SW69,A0A337SW69_FELCA,C-type lectin domain containing 7A,CLEC7A,cellular response to molecule of fungal origin [GO:0071226],membrane [GO:0016020],(1->3)-beta-D-glucan binding [GO:0001872]
1556,A0A337SWS1,A0A337SWS1_FELCA,"Signal peptide, CUB domain and EGF like domain containing 2",SCUBE2,,extracellular region [GO:0005576],calcium ion binding [GO:0005509]
1557,A0A337SX21,A0A337SX21_FELCA,Asialoglycoprotein receptor 1,ASGR1,,membrane [GO:0016020],carbohydrate binding [GO:0030246]
1558,A0A337SXC1,A0A337SXC1_FELCA,Fibulin 7,FBLN7,,,calcium ion binding [GO:0005509]
1559,A0A5F5XBP5,A0A5F5XBP5_FELCA,Zymogen granule protein 16B,ZG16B,,extracellular space [GO:0005615],
1560,A0A5F5XBX1,A0A5F5XBX1_FELCA,CASK interacting protein 1,CASKIN1,,,
1561,A0A5F5XBZ0,A0A5F5XBZ0_FELCA,Lipocalin/cytosolic fatty-acid binding domain-containing protein,LOC101098498,,extracellular region [GO:0005576],small molecule binding [GO:0036094]
1562,A0A5F5XC24,A0A5F5XC24_FELCA,Kallikrein B1,KLKB1,blood coagulation [GO:0007596]; plasminogen activation [GO:0031639]; positive regulation of fibrinolysis [GO:0051919],extracellular space [GO:0005615],serine-type endopeptidase activity [GO:0004252]
1563,A0A5F5XCK5,A0A5F5XCK5_FELCA,Proline rich transmembrane protein 4,PRRT4 RBM28,,nucleolus [GO:0005730],RNA binding [GO:0003723]
1564,A0A5F5XCM1,A0A5F5XCM1_FELCA,Sushi domain-containing protein,,,,
1565,A0A5F5XCM6,A0A5F5XCM6_FELCA,Ig-like domain-containing protein,,immunoglobulin mediated immune response [GO:0016064],immunoglobulin complex [GO:0019814],antigen binding [GO:0003823]
1566,A0A5F5XCT0,A0A5F5XCT0_FELCA,Alpha-1-B glycoprotein,A1BG,immune response-regulating signaling pathway [GO:0002764],extracellular region [GO:0005576]; plasma membrane [GO:0005886],
1567,A0A5F5XCW1,A0A5F5XCW1_FELCA,Amyloid beta protein binding family B member 1,APBB1 HPX,,extracellular region [GO:0005576],
1568,A0A5F5XCX3,A0A5F5XCX3_FELCA,Proteasome 20S subunit alpha 1,PSMA1,proteolysis involved in protein catabolic process [GO:0051603],"nucleus [GO:0005634]; proteasome core complex, alpha-subunit complex [GO:0019773]",
1569,A0A5F5XCZ4,A0A5F5XCZ4_FELCA,Anaphylatoxin-like domain-containing protein,,"complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; inflammatory response [GO:0006954]",extracellular region [GO:0005576],endopeptidase inhibitor activity [GO:0004866]
1570,A0A5F5XD04,A0A5F5XD04_FELCA,Ig-like domain-containing protein,LOC105259618,,membrane [GO:0016020],
1571,A0A5F5XD47,A0A5F5XD47_FELCA,TBC1 domain family member 8B,TBC1D8B,,membrane [GO:0016020],
1572,A0A5F5XD66,A0A5F5XD66_FELCA,C1q and TNF related 5,C1QTNF5,,collagen trimer [GO:0005581]; extracellular region [GO:0005576],
1573,A0A5F5XD74,A0A5F5XD74_FELCA,Solute carrier family 12 member 3,SLC12A3,sodium ion transmembrane transport [GO:0035725],apical plasma membrane [GO:0016324],chloride:monoatomic cation symporter activity [GO:0015377]; metal ion transmembrane transporter activity [GO:0046873]
1574,A0A5F5XDA0,A0A5F5XDA0_FELCA,CD58 molecule,CD58,,membrane [GO:0016020],
1575,A0A5F5XDF0,A0A5F5XDF0_FELCA,Transmembrane protein 132A,TMEM132A,,membrane [GO:0016020],
1576,A0A5F5XDG7,A0A5F5XDG7_FELCA,Pregnancy zone protein,LOC101080976,,extracellular space [GO:0005615],serine-type endopeptidase inhibitor activity [GO:0004867]
1577,A0A5F5XDK9,A0A5F5XDK9_FELCA,Tissue factor pathway inhibitor 2,TFPI2,blood coagulation [GO:0007596],extracellular region [GO:0005576],serine-type endopeptidase inhibitor activity [GO:0004867]
1578,A0A5F5XDM4,A0A5F5XDM4_FELCA,"Actin, cytoplasmic 1 (Beta-actin)",ACTB,,,
1579,A0A5F5XDM8,A0A5F5XDM8_FELCA,Chymotrypsin C,CTRC,intracellular calcium ion homeostasis [GO:0006874]; proteolysis [GO:0006508],,serine-type endopeptidase activity [GO:0004252]
1580,A0A5F5XDQ5,A0A5F5XDQ5_FELCA,Solute carrier family 5 member 2,SLC5A2,sodium ion transport [GO:0006814],membrane [GO:0016020],transmembrane transporter activity [GO:0022857]
1581,A0A5F5XDU4,A0A5F5XDU4_FELCA,Phenazine biosynthesis like protein domain containing,PBLD,biosynthetic process [GO:0009058],,isomerase activity [GO:0016853]
1582,A0A5F5XDY3,A0A5F5XDY3_FELCA,Tubulin beta 4B class IVb,TUBB4B,microtubule-based process [GO:0007017],cytoplasm [GO:0005737]; microtubule [GO:0005874],GTP binding [GO:0005525]
1583,A0A5F5XE10,A0A5F5XE10_FELCA,Milk fat globule EGF and factor V/VIII domain containing,MFGE8,,,
1584,A0A5F5XE39,A0A5F5XE39_FELCA,Dermokine,DMKN,cornified envelope assembly [GO:1903575],,
1585,A0A5F5XE98,A0A5F5XE98_FELCA,"Protein kinase domain containing, cytoplasmic",PKDCC,,,ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]
1586,A0A5F5XEF9,A0A5F5XEF9_FELCA,Isthmin 1,ISM1,,,
1587,A0A5F5XEN1,A0A5F5XEN1_FELCA,Serine protease 53,PRSS53,proteolysis [GO:0006508],,serine-type endopeptidase activity [GO:0004252]
1588,A0A5F5XEN6,A0A5F5XEN6_FELCA,Solute carrier family 5 member 9,SLC5A9,,plasma membrane [GO:0005886],glucose:sodium symporter activity [GO:0005412]
1589,A0A5F5XF46,A0A5F5XF46_FELCA,Sushi domain containing 5,SUSD5,,membrane [GO:0016020],
1590,A0A5F5XF61,A0A5F5XF61_FELCA,DnaJ heat shock protein family (Hsp40) member C28,DNAJC28,,,
1591,A0A5F5XF87,A0A5F5XF87_FELCA,Coagulation factor XIII B chain,F13B,,,
1592,A0A5F5XFA5,A0A5F5XFA5_FELCA,Ig-like domain-containing protein,,,,
1593,A0A5F5XFC0,A0A5F5XFC0_FELCA,Fibronectin type III domain containing 1,FNDC1,,,
1594,A0A5F5XFE9,A0A5F5XFE9_FELCA,Microtubule interacting and trafficking domain containing 1,MITD1,,,
1595,A0A5F5XFM9,A0A5F5XFM9_FELCA,Sphingomyelin phosphodiesterase acid like 3A,SMPDL3A,nucleoside triphosphate catabolic process [GO:0009143],extracellular space [GO:0005615],phosphoric diester hydrolase activity [GO:0008081]; zinc ion binding [GO:0008270]
1596,A0A5F5XG15,A0A5F5XG15_FELCA,Fatty acid binding protein 2,FABP2,,cytoplasm [GO:0005737],lipid binding [GO:0008289]
1597,A0A5F5XGA1,A0A5F5XGA1_FELCA,Growth arrest specific 6,GAS6,,extracellular region [GO:0005576],calcium ion binding [GO:0005509]
1598,A0A5F5XGI8,A0A5F5XGI8_FELCA,Filaggrin,,,,structural molecule activity [GO:0005198]
1599,A0A5F5XGS1,A0A5F5XGS1_FELCA,Family with sequence similarity 234 member A,FAM234A,,membrane [GO:0016020],
1600,A0A5F5XGS4,A0A5F5XGS4_FELCA,Docking protein 7,DOK7,neuromuscular junction development [GO:0007528],mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],protein kinase binding [GO:0019901]
1601,A0A5F5XGU3,A0A5F5XGU3_FELCA,VPS18 core subunit of CORVET and HOPS complexes,VPS18,,membrane [GO:0016020],serine-type endopeptidase inhibitor activity [GO:0004867]
1602,A0A5F5XGZ4,A0A5F5XGZ4_FELCA,Cingulin like 1,CGNL1,,myosin complex [GO:0016459],
1603,A0A5F5XHB5,A0A5F5XHB5_FELCA,Melanoma cell adhesion molecule,MCAM,,membrane [GO:0016020],
1604,A0A5F5XHE0,A0A5F5XHE0_FELCA,Secernin-2,SCRN2,proteolysis [GO:0006508],,cysteine-type exopeptidase activity [GO:0070004]; dipeptidase activity [GO:0016805]
1605,A0A5F5XHK0,A0A5F5XHK0_FELCA,"Serine peptidase inhibitor, Kunitz type 2",SPINT2,,membrane [GO:0016020],serine-type endopeptidase inhibitor activity [GO:0004867]
1606,A0A5F5XI45,A0A5F5XI45_FELCA,Tropomyosin 3,TPM3,,cytoskeleton [GO:0005856],actin binding [GO:0003779]
1607,A0A5F5XIG1,A0A5F5XIG1_FELCA,Peptidase S1 domain-containing protein,,proteolysis [GO:0006508],,serine-type endopeptidase activity [GO:0004252]
1608,A0A5F5XIK4,A0A5F5XIK4_FELCA,Ig-like domain-containing protein,,positive regulation of phagocytosis [GO:0050766]; positive regulation of T cell activation [GO:0050870],plasma membrane [GO:0005886],
1609,A0A5F5XIW6,A0A5F5XIW6_FELCA,SREBP regulating gene protein,SPRING1,positive regulation of SREBP signaling pathway [GO:2000640],Golgi membrane [GO:0000139],
1610,A0A5F5XJH2,A0A5F5XJH2_FELCA,BRO1 domain-containing protein BROX (BRO1 domain- and CAAX motif-containing protein),BROX,,,
1611,A0A5F5XJM9,A0A5F5XJM9_FELCA,Peptidase inhibitor 16,PI16,,extracellular region [GO:0005576],
1612,A0A5F5XJY1,A0A5F5XJY1_FELCA,Cellular repressor of E1A stimulateds 1,CREG1,,extracellular space [GO:0005615],
1613,A0A5F5XK14,A0A5F5XK14_FELCA,Sortilin 1,SORT1,,membrane [GO:0016020],
1614,A0A5F5XK17,A0A5F5XK17_FELCA,Heat shock protein family B (small) member 1,HSPB1,,cytoplasm [GO:0005737]; nucleus [GO:0005634],
1615,A0A5F5XK20,A0A5F5XK20_FELCA,Protein-glucosylgalactosylhydroxylysine glucosidase,PGGHG,carbohydrate metabolic process [GO:0005975],cytosol [GO:0005829],protein-glucosylgalactosylhydroxylysine glucosidase activity [GO:0047402]
1616,A0A5F5XK46,A0A5F5XK46_FELCA,Reversion inducing cysteine rich protein with kazal motifs,RECK,,,metalloendopeptidase inhibitor activity [GO:0008191]
1617,A0A5F5XKA4,A0A5F5XKA4_FELCA,Anaphylatoxin-like domain-containing protein,,"complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; inflammatory response [GO:0006954]",extracellular region [GO:0005576],endopeptidase inhibitor activity [GO:0004866]
1618,A0A5F5XKD6,A0A5F5XKD6_FELCA,Suprabasin,SBSN,,,
1619,A0A5F5XKE9,A0A5F5XKE9_FELCA,Cytidine/uridine monophosphate kinase 2,CMPK2,,,
1620,A0A5F5XKF7,A0A5F5XKF7_FELCA,Serine protease 8,PRSS8,proteolysis [GO:0006508],membrane [GO:0016020],serine-type endopeptidase activity [GO:0004252]
1621,A0A5F5XKG5,A0A5F5XKG5_FELCA,Keratin 77,KRT77,,keratin filament [GO:0045095],
1622,A0A5F5XKR0,A0A5F5XKR0_FELCA,Arylsulfatase G,ARSG,,,hydrolase activity [GO:0016787]
1623,A0A5F5XLC7,A0A5F5XLC7_FELCA,Serpin family I member 1,SERPINI1,,extracellular space [GO:0005615],serine-type endopeptidase inhibitor activity [GO:0004867]
1624,A0A5F5XLL3,A0A5F5XLL3_FELCA,Dermokine,DMKN,cornified envelope assembly [GO:1903575],,
1625,A0A5F5XMF4,A0A5F5XMF4_FELCA,Leucine rich single-pass membrane protein 2,LSMEM2,,membrane [GO:0016020],
1626,A0A5F5XMF6,A0A5F5XMF6_FELCA,RING-type E3 ubiquitin transferase (EC 2.3.2.27),RNF13,,,metal ion binding [GO:0046872]
1627,A0A5F5XMS8,A0A5F5XMS8_FELCA,Protein C receptor,PROCR,negative regulation of coagulation [GO:0050819],extracellular space [GO:0005615],signaling receptor activity [GO:0038023]
1628,A0A5F5XMU9,A0A5F5XMU9_FELCA,Coiled-coil domain-containing protein 170-like,LOC101086571,,,
1629,A0A5F5XMZ4,A0A5F5XMZ4_FELCA,SEA domain-containing protein,,,,
1630,A0A5F5XNI1,A0A5F5XNI1_FELCA,Transferrin,TF,iron ion transport [GO:0006826],extracellular space [GO:0005615],metal ion binding [GO:0046872]
1631,A0A5F5XNW4,A0A5F5XNW4_FELCA,Syndecan 1,SDC1,,membrane [GO:0016020],
1632,A0A5F5XNX6,A0A5F5XNX6_FELCA,Angiopoietin like 1,ANGPTL1,,,
1633,A0A5F5XNZ1,A0A5F5XNZ1_FELCA,Migration and invasion enhancer 1,MIEN1,,,
1634,A0A5F5XP31,A0A5F5XP31_FELCA,Kazal-like domain-containing protein,LOC123379994,,,
1635,A0A5F5XP94,A0A5F5XP94_FELCA,Golgi membrane protein 1,GOLM1,,membrane [GO:0016020],
1636,A0A5F5XQF5,A0A5F5XQF5_FELCA,Immunoglobulin V-set domain-containing protein,LOC111557803,,plasma membrane [GO:0005886],
1637,A0A5F5XQL5,A0A5F5XQL5_FELCA,"Papilin, proteoglycan like sulfated glycoprotein",PAPLN,extracellular matrix organization [GO:0030198],extracellular region [GO:0005576],serine-type endopeptidase inhibitor activity [GO:0004867]
1638,A0A5F5XQP4,A0A5F5XQP4_FELCA,Leukocyte associated immunoglobulin like receptor 1,LAIR1,,membrane [GO:0016020],
1639,A0A5F5XQW5,A0A5F5XQW5_FELCA,Proteasome 20S subunit beta 1,PSMB1,proteolysis involved in protein catabolic process [GO:0051603],nucleus [GO:0005634]; proteasome core complex [GO:0005839],
1640,A0A5F5XR50,A0A5F5XR50_FELCA,SPARC like 1,SPARCL1,,extracellular space [GO:0005615],calcium ion binding [GO:0005509]
1641,A0A5F5XRP7,A0A5F5XRP7_FELCA,Ig-like domain-containing protein,,immune response [GO:0006955],extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814],
1642,A0A5F5XS16,A0A5F5XS16_FELCA,Sushi domain-containing protein,,,,
1643,A0A5F5XSK3,A0A5F5XSK3_FELCA,Carbonic anhydrase 14,CA14,one-carbon metabolic process [GO:0006730],plasma membrane [GO:0005886],carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]
1644,A0A5F5XSQ0,A0A5F5XSQ0_FELCA,"Elastase, neutrophil expressed",ELANE,acute inflammatory response to antigenic stimulus [GO:0002438]; phagocytosis [GO:0006909]; proteolysis [GO:0006508],extracellular space [GO:0005615],serine-type endopeptidase activity [GO:0004252]
1645,A0A5F5XT84,A0A5F5XT84_FELCA,Ig-like domain-containing protein,,immune response [GO:0006955],extracellular space [GO:0005615],
1646,A0A5F5XT89,A0A5F5XT89_FELCA,Peptidase S1 domain-containing protein,LOC101094275,proteolysis [GO:0006508],extracellular space [GO:0005615],serine-type endopeptidase activity [GO:0004252]
1647,A0A5F5XTD3,A0A5F5XTD3_FELCA,Galactosamine (N-acetyl)-6-sulfatase,GALNS,,lysosome [GO:0005764],arylsulfatase activity [GO:0004065]; N-acetylgalactosamine-6-sulfatase activity [GO:0043890]
1648,A0A5F5XTD9,A0A5F5XTD9_FELCA,Sulfotransferase (EC 2.8.2.-),LOC101091370,,,sulfotransferase activity [GO:0008146]
1649,A0A5F5XTH2,A0A5F5XTH2_FELCA,Vanin 1,VNN1,,,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]"
1650,A0A5F5XTV7,A0A5F5XTV7_FELCA,Immunoglobulin V-set domain-containing protein,,immune response [GO:0006955],extracellular space [GO:0005615],
1651,A0A5F5XTX9,A0A5F5XTX9_FELCA,CD80 molecule,CD80,,membrane [GO:0016020],
1652,A0A5F5XUA4,A0A5F5XUA4_FELCA,Leukocyte cell derived chemotaxin 2,LECT2,,,metal ion binding [GO:0046872]
1653,A0A5F5XUR6,A0A5F5XUR6_FELCA,Growth arrest specific 1,GAS1,cellular response to vascular endothelial growth factor stimulus [GO:0035924]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of protein processing [GO:0010955]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628],plasma membrane [GO:0005886],
1654,A0A5F5XV52,A0A5F5XV52_FELCA,Peptidase S1 domain-containing protein,LOC101089318,proteolysis [GO:0006508],,serine-type endopeptidase activity [GO:0004252]
1655,A0A5F5XVE3,A0A5F5XVE3_FELCA,"FYVE, RhoGEF and PH domain containing 3",FGD3,,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856],guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]
1656,A0A5F5XVE8,A0A5F5XVE8_FELCA,Cysteine rich secretory protein 3,CRISP3,,extracellular region [GO:0005576],
1657,A0A5F5XVL7,A0A5F5XVL7_FELCA,Sulfotransferase (EC 2.8.2.-),LOC101091370,,,sulfotransferase activity [GO:0008146]
1658,A0A5F5XVX5,A0A5F5XVX5_FELCA,Ig-like domain-containing protein,,immune response [GO:0006955],extracellular space [GO:0005615],
1659,A0A5F5XW18,A0A5F5XW18_FELCA,Palmitoyl-protein thioesterase 2,PPT2,,lysosome [GO:0005764],palmitoyl hydrolase activity [GO:0098599]; thiolester hydrolase activity [GO:0016790]
1660,A0A5F5XX38,A0A5F5XX38_FELCA,POTRA domain-containing protein,PNPLA3,,mitochondrial outer membrane [GO:0005741],
1661,A0A5F5XX70,A0A5F5XX70_FELCA,Junctional adhesion molecule 3,JAM3,cell adhesion [GO:0007155],membrane [GO:0016020],protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]
1662,A0A5F5XXG1,A0A5F5XXG1_FELCA,Fer-1 like family member 6,FER1L6,,membrane [GO:0016020],metal ion binding [GO:0046872]
1663,A0A5F5XXT2,A0A5F5XXT2_FELCA,Nectin cell adhesion molecule 2,NECTIN2,,membrane [GO:0016020],
1664,A0A5F5XYD4,A0A5F5XYD4_FELCA,IF rod domain-containing protein,,,intermediate filament [GO:0005882],structural molecule activity [GO:0005198]
1665,A0A5F5XYM1,A0A5F5XYM1_FELCA,Collagen type I alpha 2 chain,COL1A2,,,extracellular matrix structural constituent [GO:0005201]
1666,A0A5F5XYV1,A0A5F5XYV1_FELCA,Syndecan binding protein,SDCBP,,,
1667,A0A5F5XZ87,A0A5F5XZ87_FELCA,Sushi domain-containing protein,,complement activation [GO:0006956],extracellular space [GO:0005615],complement component C3b binding [GO:0001851]
1668,A0A5F5XZA0,A0A5F5XZA0_FELCA,N-acetylglucosamine-1-phosphate transferase subunit gamma,GNPTG,,Golgi apparatus [GO:0005794],
1669,A0A5F5XZG6,A0A5F5XZG6_FELCA,Ig-like domain-containing protein,,,,
1670,A0A5F5XZL1,A0A5F5XZL1_FELCA,Solute carrier family 28 member 1,SLC28A1,,plasma membrane [GO:0005886],nucleoside transmembrane transporter activity [GO:0005337]
1671,A0A5F5XZL7,A0A5F5XZL7_FELCA,Pepsinogen B1,PGB1,proteolysis [GO:0006508],,aspartic-type endopeptidase activity [GO:0004190]
1672,A0A5F5XZM2,A0A5F5XZM2_FELCA,Carboxypeptidase A1,CPA1,proteolysis [GO:0006508],,metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]
1673,A0A5F5XZP8,A0A5F5XZP8_FELCA,Transmembrane protein 277,TMEM277 KLK1,proteolysis [GO:0006508],,serine-type endopeptidase activity [GO:0004252]
1674,A0A5F5XZS8,A0A5F5XZS8_FELCA,Peptidase S1 domain-containing protein,LOC101094275,proteolysis [GO:0006508],,serine-type endopeptidase activity [GO:0004252]
1675,A0A5F5Y006,A0A5F5Y006_FELCA,CUB domain-containing protein,,,,serine-type peptidase activity [GO:0008236]
1676,A0A5F5Y062,A0A5F5Y062_FELCA,Hyaluronan binding protein 2,HABP2,proteolysis [GO:0006508],extracellular space [GO:0005615],serine-type endopeptidase activity [GO:0004252]
1677,A0A5F5Y090,A0A5F5Y090_FELCA,Serpin family G member 1,SERPING1,"negative regulation of complement activation, lectin pathway [GO:0001869]",extracellular space [GO:0005615],serine-type endopeptidase inhibitor activity [GO:0004867]
1678,A0A5F5Y0R2,A0A5F5Y0R2_FELCA,Family with sequence similarity 234 member A,FAM234A,,cell surface [GO:0009986]; membrane [GO:0016020],
1679,A0A5F5Y0X6,A0A5F5Y0X6_FELCA,Complement component 4 binding protein alpha,C4BPA,,,
1680,A0A5F5Y101,A0A5F5Y101_FELCA,Corneodesmosin,CDSN,,,
1681,A0A5F5Y107,A0A5F5Y107_FELCA,Enoyl reductase (ER) domain-containing protein,LOC101100387,small molecule metabolic process [GO:0044281],,oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270]
1682,A0A5F5Y1K1,A0A5F5Y1K1_FELCA,Angiopoietin like 6,ANGPTL6,,collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; secretory granule [GO:0030141],signaling receptor binding [GO:0005102]
1683,A0A5F5Y1P9,A0A5F5Y1P9_FELCA,Programmed cell death 6 interacting protein,PDCD6IP,mitotic cytokinesis [GO:0000281]; multivesicular body sorting pathway [GO:0071985],endosome [GO:0005768],
1684,A0A5F5Y1Y2,A0A5F5Y1Y2_FELCA,Plexin domain containing 2,PLXDC2,,membrane [GO:0016020],
1685,A0A5F5Y205,A0A5F5Y205_FELCA,Ig-like domain-containing protein,,,membrane [GO:0016020],
1686,A0A5F5Y208,A0A5F5Y208_FELCA,TNF receptor superfamily member 4,TNFRSF4,inflammatory response [GO:0006954],external side of plasma membrane [GO:0009897],tumor necrosis factor receptor activity [GO:0005031]
1687,A0A5F5Y249,A0A5F5Y249_FELCA,Envelope polyprotein,,,,
1688,A0A5F5Y2F0,A0A5F5Y2F0_FELCA,VAMP associated protein B and C,VAPB,response to unfolded protein [GO:0006986],endoplasmic reticulum membrane [GO:0005789],
1689,A0A5F5Y2H9,A0A5F5Y2H9_FELCA,CD34 molecule,CD34,cell adhesion [GO:0007155],membrane [GO:0016020],
1690,A0A5F5Y2W6,A0A5F5Y2W6_FELCA,Cadherin 17,CDH17,homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],plasma membrane [GO:0005886],calcium ion binding [GO:0005509]
1691,A0A5F5Y328,A0A5F5Y328_FELCA,Alpha-2-macroglobulin,A2M PZP,,extracellular space [GO:0005615],serine-type endopeptidase inhibitor activity [GO:0004867]
1692,A0A5F5Y442,A0A5F5Y442_FELCA,Complement component 4 binding protein alpha,C4BPA,"negative regulation of complement activation, classical pathway [GO:0045959]; T cell mediated immunity [GO:0002456]",extracellular space [GO:0005615]; plasma membrane [GO:0005886],
1693,A0A5F5Y493,A0A5F5Y493_FELCA,Integrin alpha FG-GAP repeat containing 1,ITFG1,,,
1694,A0A5F5Y4C0,A0A5F5Y4C0_FELCA,N-myc downstream regulated 1,NDRG1,,,
1695,A0A5F5Y4N4,A0A5F5Y4N4_FELCA,Galactosamine (N-acetyl)-6-sulfatase,GALNS,,lysosome [GO:0005764],hydrolase activity [GO:0016787]
1696,A0A5F5Y4Q7,A0A5F5Y4Q7_FELCA,SPARC related modular calcium binding 1,SMOC1,,,metal ion binding [GO:0046872]
1697,A0A5F5Y4V7,A0A5F5Y4V7_FELCA,Ig-like domain-containing protein,,,,
1698,A0A5F5Y561,A0A5F5Y561_FELCA,Otoraplin,OTOR,cartilage condensation [GO:0001502],,
1699,A0A5F5Y5F1,A0A5F5Y5F1_FELCA,Complement component 4 binding protein alpha,C4BPA,,,
1700,A0A5F5Y5G3,A0A5F5Y5G3_FELCA,Serpin family A member 5,SERPINA5,,extracellular space [GO:0005615],serine-type endopeptidase inhibitor activity [GO:0004867]
1701,A0A5F5Y6H2,A0A5F5Y6H2_FELCA,AHNAK nucleoprotein,,regulation of RNA splicing [GO:0043484],costamere [GO:0043034]; cytoplasm [GO:0005737]; nucleus [GO:0005634],
1702,A0A5F5Y6R9,A0A5F5Y6R9_FELCA,Fc gamma receptor Ia,FCGR1A,,,
1703,A0A5F5Y768,A0A5F5Y768_FELCA,Keratin 17,KRT17,,intermediate filament [GO:0005882],structural molecule activity [GO:0005198]
1704,A0A5K1VG18,A0A5K1VG18_FELCA,14-3-3 protein zeta/delta,YWHAZ,,,
1705,E5D2Z5,E5D2Z5_FELCA,Fel d 7 allergen,LOC100533977,,extracellular region [GO:0005576],metal ion binding [GO:0046872]
1706,M3VU52,M3VU52_FELCA,LY6/PLAUR domain containing 2,LYPD2,,plasma membrane [GO:0005886]; side of membrane [GO:0098552],
1707,M3VU82,M3VU82_FELCA,Peptidase S1 domain-containing protein,,zymogen activation [GO:0031638],extracellular space [GO:0005615],serine-type endopeptidase activity [GO:0004252]
1708,M3VU84,M3VU84_FELCA,Peptidase S1 domain-containing protein,,proteolysis [GO:0006508],,serine-type endopeptidase activity [GO:0004252]
1709,M3VUF8,M3VUF8_FELCA,CEA cell adhesion molecule 19,CEACAM19,,membrane [GO:0016020],
1710,M3VUS4,M3VUS4_FELCA,Shisa family member 4,SHISA4,,membrane [GO:0016020],
1711,M3VVT0,M3VVT0_FELCA,SREBP regulating gene protein,SPRING1,positive regulation of SREBP signaling pathway [GO:2000640],Golgi membrane [GO:0000139],
1712,M3VVW0,M3VVW0_FELCA,Biliverdin reductase B,BLVRB,,,
1713,M3VWB9,M3VWB9_FELCA,Cysteine-rich and transmembrane domain-containing protein 1,CYSTM1,,,
1714,M3VXN4,M3VXN4_FELCA,Prostaglandin F2 receptor inhibitor,PTGFRN,lipid droplet organization [GO:0034389]; myoblast fusion involved in skeletal muscle regeneration [GO:0014905],membrane [GO:0016020],
1715,M3VYU4,M3VYU4_FELCA,Sialic acid acetylesterase,SIAE,carbohydrate metabolic process [GO:0005975]; regulation of immune system process [GO:0002682],lysosome [GO:0005764],sialate O-acetylesterase activity [GO:0001681]
1716,M3VZG5,M3VZG5_FELCA,CD163 molecule,CD163,,external side of plasma membrane [GO:0009897],scaffold protein binding [GO:0097110]
1717,M3VZN9,M3VZN9_FELCA,Interleukin 9 receptor,IL9R,cytokine-mediated signaling pathway [GO:0019221]; immunoglobulin mediated immune response [GO:0016064],external side of plasma membrane [GO:0009897],interleukin-9 binding [GO:0019983]; interleukin-9 receptor activity [GO:0004919]
1718,M3W019,M3W019_FELCA,Chymotrypsin C,CTRC,proteolysis [GO:0006508],,serine-type endopeptidase activity [GO:0004252]
1719,M3W0R2,M3W0R2_FELCA,SRCR domain-containing protein,,,membrane [GO:0016020],
1720,M3W0W4,M3W0W4_FELCA,Alpha-1-B glycoprotein,A1BG,,,
1721,M3W2D2,M3W2D2_FELCA,EF-hand calcium binding domain 14,EFCAB14,,membrane [GO:0016020],calcium ion binding [GO:0005509]
1722,M3W2J4,M3W2J4_FELCA,Amyloid beta protein binding family B member 1,APBB1 HPX,,extracellular region [GO:0005576],
1723,M3W2W3,M3W2W3_FELCA,LRP2-binding protein,LRP2BP,,cytoplasm [GO:0005737],
1724,M3W3E7,M3W3E7_FELCA,Alpha-2-macroglobulin,A2M PZP,,extracellular space [GO:0005615],serine-type endopeptidase inhibitor activity [GO:0004867]
1725,M3W543,M3W543_FELCA,Serpin family D member 1,SERPIND1,blood coagulation [GO:0007596],extracellular space [GO:0005615],serine-type endopeptidase inhibitor activity [GO:0004867]
1726,M3W6K9,M3W6K9_FELCA,Procollagen C-endopeptidase enhancer,PCOLCE,,extracellular region [GO:0005576],
1727,M3W6U8,M3W6U8_FELCA,Sialic acid acetylesterase,SIAE,,membrane [GO:0016020],
1728,M3W7M9,M3W7M9_FELCA,WDFY family member 4,WDFY4,"antigen processing and presentation [GO:0019882]; CD8-positive, alpha-beta T cell activation [GO:0036037]; cellular response to virus [GO:0098586]",,
1729,M3W803,M3W803_FELCA,Gastrokine 1,GKN1,positive regulation of cell population proliferation [GO:0008284]; regulation of cell population proliferation [GO:0042127],extracellular space [GO:0005615]; secretory granule [GO:0030141],growth factor activity [GO:0008083]
1730,M3W832,M3W832_FELCA,Integrator complex subunit 1,INTS1,embryo implantation [GO:0007566]; inner cell mass cell proliferation [GO:0001833]; negative regulation of apoptotic process [GO:0043066]; U2 snRNA 3'-end processing [GO:0034474],integrator complex [GO:0032039],
1731,M3W858,M3W858_FELCA,Enoyl-CoA delta isomerase 1,ECI1,fatty acid beta-oxidation [GO:0006635],mitochondrion [GO:0005739],delta(3)-delta(2)-enoyl-CoA isomerase activity [GO:0004165]
1732,M3W8U6,M3W8U6_FELCA,Vitelline membrane outer layer 1 homolog,VMO1,,extracellular space [GO:0005615],
1733,M3W8X1,M3W8X1_FELCA,X-prolyl aminopeptidase 2,XPNPEP2,,extracellular exosome [GO:0070062],metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]
1734,M3W950,M3W950_FELCA,Complement factor properdin,CFP,"complement activation, alternative pathway [GO:0006957]",cytoplasmic side of Golgi membrane [GO:0098548]; extracellular space [GO:0005615]; secretory granule [GO:0030141],
1735,M3WA23,M3WA23_FELCA,Angiopoietin like 2,ANGPTL2,,collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615],signaling receptor binding [GO:0005102]
1736,M3WA76,M3WA76_FELCA,Aldo-keto reductase family 7 like (gene/pseudogene),AKR7L,,cytoplasm [GO:0005737],aldo-keto reductase (NADPH) activity [GO:0004033]
1737,M3WBA3,M3WBA3_FELCA,Secernin-2,SCRN2,proteolysis [GO:0006508],,cysteine-type exopeptidase activity [GO:0070004]; dipeptidase activity [GO:0016805]
1738,M3WBP8,M3WBP8_FELCA,RAS related 2,RRAS2,Ras protein signal transduction [GO:0007265],plasma membrane [GO:0005886],GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]
1739,M3WCX1,M3WCX1_FELCA,Serpin family A member 1,SERPINA1,,extracellular space [GO:0005615],serine-type endopeptidase inhibitor activity [GO:0004867]
1740,M3WCX2,M3WCX2_FELCA,Serpin family A member 11,SERPINA11,,extracellular space [GO:0005615],serine-type endopeptidase inhibitor activity [GO:0004867]
1741,M3WCX4,M3WCX4_FELCA,Serpin family A member 4,SERPINA4,,extracellular space [GO:0005615],serine-type endopeptidase inhibitor activity [GO:0004867]
1742,M3WDK2,M3WDK2_FELCA,Arylsulfatase A,ARSA,binding of sperm to zona pellucida [GO:0007339],plasma membrane [GO:0005886],arylsulfatase activity [GO:0004065]
1743,M3WEH0,M3WEH0_FELCA,V-set and transmembrane domain containing 2B,VSTM2B,,membrane [GO:0016020],
1744,M3WEU6,M3WEU6_FELCA,Glycosylated integral membrane protein 1,GINM1,,membrane [GO:0016020],
1745,M3WFQ7,M3WFQ7_FELCA,Myelin protein zero like 2,MPZL2,cell-cell adhesion [GO:0098609],plasma membrane [GO:0005886],
1746,M3WFU5,M3WFU5_FELCA,Hyaluronan binding protein 2,HABP2,proteolysis [GO:0006508],,serine-type endopeptidase activity [GO:0004252]
1747,M3WGB1,M3WGB1_FELCA,Coiled-coil domain containing 68,CCDC68,intracellular signal transduction [GO:0035556]; microtubule anchoring at centrosome [GO:0034454]; protein localization [GO:0008104],centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814],
1748,M3WHR1,M3WHR1_FELCA,Chymotrypsin like,CTRL,proteolysis [GO:0006508],extracellular space [GO:0005615],serine-type endopeptidase activity [GO:0004252]
1749,M3WIA9,M3WIA9_FELCA,Vesicle amine transport 1,VAT1,negative regulation of mitochondrial fusion [GO:0010637],mitochondrial outer membrane [GO:0005741],oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270]
1750,M3WJK3,M3WJK3_FELCA,Complement component 4 binding protein alpha,C4BPA,,,
1751,M3WJN8,M3WJN8_FELCA,Protein-glucosylgalactosylhydroxylysine glucosidase,PGGHG,carbohydrate metabolic process [GO:0005975],,catalytic activity [GO:0003824]
1752,M3WK60,M3WK60_FELCA,Calpain small subunit 1,CAPNS1,,calpain complex [GO:0110158]; cytosol [GO:0005829]; membrane [GO:0016020],calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]
1753,M3WKE5,M3WKE5_FELCA,Calcium binding protein 39 like,CAB39L,,,
1754,M3WKI3,M3WKI3_FELCA,Cartilage intermediate layer protein 2,CILP2,,extracellular space [GO:0005615],
1755,M3WKX0,M3WKX0_FELCA,Leukocyte cell derived chemotaxin 2,LECT2,,,identical protein binding [GO:0042802]; metal ion binding [GO:0046872]
1756,M3WLC0,M3WLC0_FELCA,Solute carrier family 3 member 2,SLC3A2,amino acid transport [GO:0006865],,
1757,M3WLS9,M3WLS9_FELCA,Aspartate dehydrogenase domain-containing protein,ASPDH,NAD biosynthetic process [GO:0009435],,aspartate dehydrogenase activity [GO:0033735]; NADP binding [GO:0050661]
1758,M3WMA2,M3WMA2_FELCA,Cell adhesion molecule 3,CADM3,,membrane [GO:0016020],
1759,M3WMF1,M3WMF1_FELCA,Carboxypeptidase N subunit 2,CPN2,,extracellular matrix [GO:0031012]; extracellular space [GO:0005615],
1760,M3WP64,M3WP64_FELCA,Peptidase S1 domain-containing protein,LOC101085453,proteolysis [GO:0006508],extracellular space [GO:0005615],serine-type endopeptidase activity [GO:0004252]
1761,M3WPJ4,M3WPJ4_FELCA,2-oxoglutarate and iron dependent oxygenase domain containing 3,OGFOD3,,,"dioxygenase activity [GO:0051213]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
1762,M3WPL3,M3WPL3_FELCA,Transmembrane and coiled-coil domains 5B,TMCO5B,,membrane [GO:0016020],
1763,M3WPT0,M3WPT0_FELCA,Zinc finger with KRAB and SCAN domains 1,ZKSCAN1,,,
1764,M3WPV6,M3WPV6_FELCA,Migration and invasion enhancer 1,MIEN1,negative regulation of apoptotic process [GO:0043066]; positive regulation of cell migration [GO:0030335]; positive regulation of filopodium assembly [GO:0051491],cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829],
1765,M3WPX9,M3WPX9_FELCA,Tetratricopeptide repeat protein 38,TTC38,,,
1766,M3WSW8,M3WSW8_FELCA,Transmembrane protein 256,TMEM256,,membrane [GO:0016020],
1767,M3WSX6,M3WSX6_FELCA,Chromosome E3 C16orf89 homolog,CE3H16orf89,,cytosol [GO:0005829]; membrane [GO:0016020],protein homodimerization activity [GO:0042803]
1768,M3WTZ2,M3WTZ2_FELCA,Chromosome A1 C5orf15 homolog,CA1H5orf15,,membrane [GO:0016020],
1769,M3WUB8,M3WUB8_FELCA,G protein-coupled receptor 180,GPR180,G protein-coupled receptor signaling pathway [GO:0007186]; response to pheromone [GO:0019236],membrane [GO:0016020],
1770,M3WUK1,M3WUK1_FELCA,Uroplakin 2,UPK2,epithelial cell differentiation [GO:0030855],apical plasma membrane [GO:0016324],
1771,M3WXB6,M3WXB6_FELCA,Layilin,LAYN,,membrane [GO:0016020],
1772,M3WY30,M3WY30_FELCA,LY6/PLAUR domain containing 3,LYPD3,negative regulation of smooth muscle cell apoptotic process [GO:0034392],plasma membrane [GO:0005886],
1773,M3WYD3,M3WYD3_FELCA,Theg spermatid protein like,SPMAP2L THEGL,,,
1774,M3X050,M3X050_FELCA,Ig-like domain-containing protein,,immune response [GO:0006955],extracellular space [GO:0005615],
1775,M3X1B4,M3X1B4_FELCA,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,ENPP5,,membrane [GO:0016020],NAD+ diphosphatase activity [GO:0000210]; zinc ion binding [GO:0008270]
1776,M3X260,M3X260_FELCA,Transferrin,TF,,extracellular space [GO:0005615],
1777,M3X2R3,M3X2R3_FELCA,Mesothelin,LOC101091333,cell-matrix adhesion [GO:0007160],cell surface [GO:0009986]; membrane [GO:0016020],
1778,M3X315,M3X315_FELCA,Immunoglobulin superfamily containing leucine rich repeat,ISLR,,,
1779,M3X3M9,M3X3M9_FELCA,Glutaredoxin-1,GLRX,,,glutathione disulfide oxidoreductase activity [GO:0015038]
1780,M3X3Z1,M3X3Z1_FELCA,PKHD1 like 1,PKHD1L1,sensory perception of sound [GO:0007605],membrane [GO:0016020]; stereocilium coat [GO:0120234]; stereocilium tip [GO:0032426],
1781,M3X4Z4,M3X4Z4_FELCA,Phospholipase A2 inhibitor and LY6/PLAUR domain containing,PINLYP,,extracellular region [GO:0005576],phospholipase inhibitor activity [GO:0004859]
1782,M3X5X6,M3X5X6_FELCA,Sushi domain-containing protein,,,,
1783,M3X7A8,M3X7A8_FELCA,Ubiquitin like 7,UBL7,ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829],molecular adaptor activity [GO:0060090]; polyubiquitin modification-dependent protein binding [GO:0031593]
1784,M3X7R1,M3X7R1_FELCA,Ig-like domain-containing protein,,immune response [GO:0006955],extracellular space [GO:0005615],
1785,M3X9S4,M3X9S4_FELCA,Pepsinogen B2,PGB2 OVGP1,proteolysis [GO:0006508],,aspartic-type endopeptidase activity [GO:0004190]
1786,M3XB79,M3XB79_FELCA,Metallothionein,LOC111558024,,,metal ion binding [GO:0046872]
1787,M3XC02,M3XC02_FELCA,Dimethylarginine dimethylaminohydrolase 2,DDAH2,,mitochondrion [GO:0005739],dimethylargininase activity [GO:0016403]
1788,M3XCE8,M3XCE8_FELCA,V-set and transmembrane domain containing 5,VSTM5,filopodium assembly [GO:0046847]; positive regulation of excitatory synapse assembly [GO:1904891],axon [GO:0030424]; dendrite [GO:0030425]; plasma membrane [GO:0005886],
1789,M3XDA8,M3XDA8_FELCA,Integrator complex subunit 4,INTS4,snRNA processing [GO:0016180],integrator complex [GO:0032039]; nucleolus [GO:0005730],
1790,M3XDQ5,M3XDQ5_FELCA,"Elastase, neutrophil expressed",ELANE,proteolysis [GO:0006508],,serine-type endopeptidase activity [GO:0004252]
1791,M3XDV4,M3XDV4_FELCA,Ig-like domain-containing protein,,immune response [GO:0006955],extracellular space [GO:0005615],
1792,M3XE23,M3XE23_FELCA,Immunoglobulin V-set domain-containing protein,,immune response [GO:0006955],extracellular space [GO:0005615],
1793,M3XE34,M3XE34_FELCA,Dermatopontin,DPT,collagen fibril organization [GO:0030199]; negative regulation of cell population proliferation [GO:0008285],extracellular region [GO:0005576],
1794,M3XEH2,M3XEH2_FELCA,Arrestin domain containing 1,ARRDC1,,,
1795,M3XG22,M3XG22_FELCA,Ig-like domain-containing protein,,immune response [GO:0006955],extracellular space [GO:0005615],
1796,M3XG34,M3XG34_FELCA,Programmed cell death 6 interacting protein,PDCD6IP,multivesicular body sorting pathway [GO:0071985],,
1797,M3XGC9,M3XGC9_FELCA,Endonuclease domain containing 1,ENDOD1,,membrane [GO:0016020],hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]
1798,M3XGE7,M3XGE7_FELCA,Microfibril associated protein 4,MFAP4,,,
1799,T2HUL6,T2HUL6_FELCA,Restriction factor for feline retrovirus X,,,,
1800,T2HUV9,T2HUV9_FELCA,Restriction factor for feline retrovirus X,,,,
